data_2n1w_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n1w _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 . . . . . 0 N--CA 1.441 -0.925 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.3 pt -129.6 156.44 41.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.148 0.499 . . . . 0.0 110.658 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.454 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -96.53 113.61 25.2 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.887 -178.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.481 ' HG ' ' SD ' ' A' ' 78' ' ' MET . 1.5 mm? -109.57 128.58 55.31 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.094 0.473 . . . . 0.0 109.752 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 37.3 ttpt -106.66 141.89 37.19 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.127 0.489 . . . . 0.0 111.168 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.1 t -112.48 124.18 68.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.38 112.05 13.43 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.509 0.671 . . . . 0.0 110.81 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.26 148.68 19.07 Favored Glycine 0 C--N 1.299 -1.499 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.143 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -60.58 -11.65 7.76 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.342 0.591 . . . . 0.0 112.355 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -71.25 -18.49 62.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.601 0.715 . . . . 0.0 110.132 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.24 -10.21 50.63 Favored Glycine 0 C--N 1.316 -0.557 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.6 m -78.51 116.87 19.2 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.973 0.416 . . . . 0.0 109.982 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 p -142.34 135.49 27.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.318 0.58 . . . . 0.0 111.282 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.413 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 25.0 t -145.27 151.89 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.301 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.62 136.23 49.31 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.413 ' CZ ' ' HB ' ' A' ' 30' ' ' VAL . 17.0 m-85 -131.9 133.06 44.17 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.075 0.464 . . . . 0.0 111.095 -175.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 60.7 mtpt -107.51 107.67 18.63 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.911 -0.493 . . . . 0.0 110.988 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.4 pt -121.59 173.18 7.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.227 0.536 . . . . 0.0 110.459 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -81.27 150.57 28.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.12 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -58.32 -20.9 46.84 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.893 0.477 . . . . 0.0 111.926 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -108.73 2.64 21.95 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.861 -0.525 . . . . 0.0 111.014 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.7 m -85.89 133.12 42.03 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.793 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.21 146.47 81.45 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.728 2.285 . . . . 0.0 112.383 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.429 HD11 ' OD2' ' A' ' 71' ' ' ASP . 31.0 mt -65.86 -16.95 64.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.941 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.4 p -50.15 -37.62 35.38 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.797 0.439 . . . . 0.0 111.365 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -57.41 -52.49 65.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.91 -31.64 61.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.336 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.558 ' N ' HD12 ' A' ' 43' ' ' LEU . 56.3 mtt -59.44 -54.7 43.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.55 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.568 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 38.0 mmtm -66.06 -41.18 91.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 109.911 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.79 -47.31 86.22 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.373 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -54.49 -49.74 69.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.597 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 75.4 m -66.28 -34.99 79.25 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 84.3 mt-10 -61.03 -44.6 97.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.188 0.518 . . . . 0.0 111.141 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.9 ptp85 -85.42 -28.22 25.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -90.8 -18.7 24.46 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.817 -0.552 . . . . 0.0 112.184 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.36 41.59 9.98 Favored Glycine 0 C--N 1.309 -0.971 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.748 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.55 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.3 mm? -114.06 153.41 29.49 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.294 -0.533 . . . . 0.0 110.806 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 75.2 m -95.7 124.11 39.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.747 0.308 . . . . 0.0 110.447 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.496 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 92.0 mmm -60.11 -25.51 65.51 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -28.55 26.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.299 0.571 . . . . 0.0 111.178 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.672 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -83.17 -40.91 19.1 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.163 0.506 . . . . 0.0 110.772 -178.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.546 HD13 ' SG ' ' A' ' 48' ' ' CYS . 13.0 pt -90.86 178.06 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.115 0.484 . . . . 0.0 110.929 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -155.43 142.66 19.34 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.874 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.7 m-85 -92.33 137.08 32.66 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.085 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -140.6 134.71 30.9 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.051 0.453 . . . . 0.0 110.028 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.402 ' CZ ' ' HG3' ' A' ' 78' ' ' MET . 72.3 t80 -143.81 135.53 26.23 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.04 26.43 5.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.512 0.672 . . . . 0.0 111.11 176.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.03 -6.35 71.57 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.1 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -118.4 142.61 31.65 Favored Pre-proline 0 C--N 1.319 -0.76 0 O-C-N 122.284 -0.539 . . . . 0.0 110.53 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.37 141.22 46.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.112 1.875 . . . . 0.0 111.104 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 pt -115.8 160.39 15.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.236 0.541 . . . . 0.0 110.905 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.64 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -118.97 153.31 34.84 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.566 -178.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.7 pt-20 -60.5 -12.0 8.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.019 0.438 . . . . 0.0 112.039 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -94.15 4.83 53.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.626 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.64 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -91.84 156.7 17.32 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 121.672 -0.643 . . . . 0.0 110.395 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.7 p -119.06 148.64 45.27 Favored Pre-proline 0 N--CA 1.439 -0.981 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.838 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.29 -17.48 46.96 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.705 2.27 . . . . 0.0 112.417 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.37 -16.52 32.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.095 0.474 . . . . 0.0 111.268 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -82.61 -55.68 4.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.335 0.588 . . . . 0.0 110.567 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -85.11 3.37 39.25 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.996 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 62.74 62.31 1.09 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.449 0.642 . . . . 0.0 112.455 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.516 ' SD ' HD13 ' A' ' 84' ' ' ILE . 29.7 ttm -90.41 139.27 30.83 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -109.33 171.14 7.61 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.416 0.627 . . . . 0.0 111.705 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -65.91 141.27 58.29 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.085 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 65.47 13.95 9.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.687 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.96 170.66 15.33 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.2 m -128.55 144.21 51.11 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.516 HD13 ' SD ' ' A' ' 78' ' ' MET . 4.1 mp -104.8 133.08 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.764 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -94.15 125.57 38.86 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.31 0.576 . . . . 0.0 110.873 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 41.6 t -108.82 136.28 45.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.245 0.545 . . . . 0.0 111.147 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -128.78 153.01 47.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.034 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.419 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.6 mp0 . . . . . 0 C--N 1.321 -0.672 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.6 pt -130.92 159.15 43.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.285 0.564 . . . . 0.0 110.744 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.499 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.2 OUTLIER -93.75 127.15 39.33 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.7 mt -126.49 125.59 42.33 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 83' ' ' THR . 31.9 ttpt -106.41 141.37 37.84 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.401 0.62 . . . . 0.0 111.224 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.9 t -114.15 126.88 71.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.503 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.29 121.95 27.06 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.454 0.645 . . . . 0.0 110.803 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.2 148.89 18.57 Favored Glycine 0 C--N 1.298 -1.567 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.54 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -16.49 27.34 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.262 0.553 . . . . 0.0 112.142 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -70.36 -15.7 62.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.548 0.689 . . . . 0.0 110.709 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.68 -10.9 53.29 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.566 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.537 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . 70.2 m -78.54 115.34 18.18 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.107 0.48 . . . . 0.0 110.242 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.73 135.21 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.329 0.585 . . . . 0.0 111.781 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.4 t -140.68 150.12 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.93 -177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.499 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -108.51 140.55 41.68 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.9 0.381 . . . . 0.0 110.667 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -134.81 163.45 29.79 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 110.367 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HZ2' ' HB2' ' A' ' 33' ' ' LYS . 6.2 mtmp? -134.85 110.31 9.09 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.3 pt -126.03 166.95 21.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.916 0.389 . . . . 0.0 110.434 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -74.71 147.43 41.42 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.431 ' HG2' ' HB1' ' A' ' 74' ' ' ALA . 42.7 ttm180 -65.16 -15.41 62.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.187 0.518 . . . . 0.0 111.909 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -103.11 -3.52 25.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.746 0.784 . . . . 0.0 109.079 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 m -88.99 133.55 35.2 Favored Pre-proline 0 N--CA 1.439 -1.01 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.132 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.0 150.67 87.77 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.643 2.228 . . . . 0.0 112.708 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.1 mt -65.44 -15.67 62.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.578 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 34.3 p -49.97 -37.4 32.17 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 122.768 0.427 . . . . 0.0 111.731 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 7.4 mmpt? -57.61 -52.39 65.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.242 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.44 -31.94 62.46 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.366 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.581 ' N ' HD12 ' A' ' 43' ' ' LEU . 57.7 mtt -60.98 -54.53 43.83 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 34.8 mmtp -68.54 -37.03 79.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.554 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.558 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.84 -47.94 81.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.986 0.422 . . . . 0.0 110.543 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.418 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 57.1 t80 -56.06 -51.93 66.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.343 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 p -61.09 -35.12 76.15 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.068 -0.395 . . . . 0.0 111.425 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 37.6 mt-10 -67.38 -43.27 81.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.439 . . . . 0.0 111.798 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 13.3 ptp180 -80.66 -25.89 37.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.809 0.337 . . . . 0.0 111.646 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.537 ' OE1' ' HB3' ' A' ' 28' ' ' SER . 20.5 mm-40 -93.85 -2.63 53.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.793 0.33 . . . . 0.0 111.822 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.91 91.84 Favored Glycine 0 CA--C 1.508 -0.344 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.74 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' A' ' 58' ' ' ILE . 84.9 mt -119.25 157.04 28.83 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.19 0.519 . . . . 0.0 110.714 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.7 m -107.12 129.51 54.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.568 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.439 ' CE ' ' HB3' ' A' ' 44' ' ' MET . 98.4 mmm -63.17 -22.47 66.89 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.164 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.06 -23.91 30.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.436 0.636 . . . . 0.0 110.422 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.85 -44.47 8.92 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.076 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.477 HG23 ' HB3' ' A' ' 53' ' ' LEU . 15.3 pt -88.52 166.83 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 O-C-N 121.661 -0.649 . . . . 0.0 110.348 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -144.43 137.85 27.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.951 0.405 . . . . 0.0 110.155 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -93.5 139.99 30.1 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.853 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -144.88 143.42 30.58 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.035 0.445 . . . . 0.0 110.291 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -152.28 135.85 16.1 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t70 67.34 25.77 8.64 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.471 0.653 . . . . 0.0 111.107 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.02 0.58 76.58 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.622 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -118.74 145.04 36.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 121.912 -0.758 . . . . 0.0 110.088 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.36 141.98 23.43 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.872 1.715 . . . . 0.0 111.166 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.8 pt -115.01 160.45 14.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.275 0.559 . . . . 0.0 111.289 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.597 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -121.66 155.42 35.2 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.805 -178.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 9.8 pt-20 -61.97 -9.76 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.172 0.511 . . . . 0.0 111.738 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -97.09 9.45 42.07 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 122.054 -0.404 . . . . 0.0 111.313 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.597 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -96.57 154.58 17.19 Favored 'General case' 0 C--O 1.243 0.718 0 O-C-N 121.74 -0.6 . . . . 0.0 109.734 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.3 p -117.16 146.98 39.37 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.551 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.87 -22.48 68.61 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.649 2.233 . . . . 0.0 112.091 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' HB1' ' HG2' ' A' ' 36' ' ' ARG . . . -80.35 -17.25 52.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.159 0.504 . . . . 0.0 110.904 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -79.23 -54.86 5.56 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.341 0.591 . . . . 0.0 110.023 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -87.54 12.25 12.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.223 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 57.08 58.73 3.79 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.491 0.662 . . . . 0.0 111.55 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.61 131.77 34.57 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.726 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -97.35 167.13 11.2 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.164 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.441 ' HB2' HD21 ' A' ' 19' ' ' ASN . 4.3 p-10 -76.69 150.58 36.31 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.111 0.481 . . . . 0.0 110.82 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 67.28 13.87 9.52 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.015 0.926 . . . . 0.0 112.209 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.17 171.38 13.74 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 17.6 m -125.97 147.7 49.45 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.393 0.616 . . . . 0.0 112.354 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.3 133.66 54.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.38 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.03 121.39 31.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.235 0.541 . . . . 0.0 111.275 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.81 138.93 35.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.244 0.545 . . . . 0.0 111.384 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -128.45 150.21 50.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.489 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.284 0.564 . . . . 0.0 111.643 -179.874 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 pt -130.63 165.1 31.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.047 0.451 . . . . 0.0 110.591 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.12 120.51 40.57 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -111.83 124.57 52.63 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -104.81 142.16 35.23 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.046 0.45 . . . . 0.0 110.634 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.84 127.71 71.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 120.958 0.409 . . . . 0.0 110.112 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.18 123.38 26.95 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.491 0.662 . . . . 0.0 110.146 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.9 148.41 16.47 Favored Glycine 0 C--N 1.3 -1.437 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.986 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -7.26 4.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -82.94 -10.63 58.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.482 0.658 . . . . 0.0 109.897 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.67 -13.36 46.54 Favored Glycine 0 CA--C 1.511 -0.193 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.338 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.1 m -77.31 119.24 20.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.962 0.41 . . . . 0.0 110.678 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.81 135.31 33.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.583 0.706 . . . . 0.0 111.366 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -143.33 149.46 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.0 139.77 42.15 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.106 -0.371 . . . . 0.0 110.4 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -128.43 163.7 24.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.32 0.581 . . . . 0.0 110.758 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -137.7 111.73 8.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.951 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 pt -136.44 173.33 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.323 0.582 . . . . 0.0 111.085 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 11.5 tmtt? -77.08 147.98 36.36 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.591 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.487 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 40.1 ttm180 -60.29 -18.12 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -112.59 5.11 17.68 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.372 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -83.03 133.98 47.25 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.29 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.1 140.34 83.45 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.684 2.256 . . . . 0.0 113.045 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.439 HD12 ' OD2' ' A' ' 71' ' ' ASP . 42.3 mt -65.1 -15.7 62.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.824 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.584 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 23.0 t -49.27 -39.63 31.3 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 122.615 0.366 . . . . 0.0 111.27 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.514 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -58.3 -52.46 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.6 -32.01 62.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.922 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.611 ' N ' HD12 ' A' ' 43' ' ' LEU . 38.9 ttm -61.78 -52.01 65.97 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.61 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 50.5 mmtt -68.61 -42.57 77.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.001 0.429 . . . . 0.0 110.03 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.76 -45.24 90.18 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.955 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.407 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 49.2 t80 -57.95 -52.34 65.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.455 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.521 ' SG ' ' HG2' ' A' ' 55' ' ' MET . 14.4 p -62.4 -37.62 86.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.119 0.485 . . . . 0.0 110.982 -177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 48.1 mt-10 -67.63 -37.59 82.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.987 0.422 . . . . 0.0 111.898 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.6 ptp180 -85.7 -23.41 27.41 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.104 -0.372 . . . . 0.0 111.552 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.407 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 19.6 mm-40 -97.01 -4.53 39.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.938 0.399 . . . . 0.0 111.75 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.45 54.62 Favored Glycine 0 C--N 1.322 -0.201 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.249 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.6 mp -116.65 154.43 30.56 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.156 0.503 . . . . 0.0 110.614 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.0 m -102.45 122.37 44.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.493 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.521 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 97.8 mmm -56.09 -25.48 45.67 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -83.75 -30.92 26.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.614 0.721 . . . . 0.0 109.985 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.71 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -88.52 -24.34 22.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.256 -177.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 54' ' ' SER . 21.9 pt -107.25 174.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 121.895 -0.503 . . . . 0.0 110.158 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -159.05 134.35 8.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.203 0.525 . . . . 0.0 110.509 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 4.1 m-85 -85.64 143.18 28.57 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.625 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.429 ' HG3' ' C ' ' A' ' 65' ' ' GLN . 26.0 ttm180 -142.1 141.78 32.74 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.066 0.46 . . . . 0.0 110.541 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -150.32 136.91 19.0 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.25 27.68 8.28 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.342 0.592 . . . . 0.0 111.207 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.4 2.08 83.28 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.239 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.429 ' C ' ' HG3' ' A' ' 61' ' ' ARG . 7.5 pt20 -125.5 144.52 48.18 Favored Pre-proline 0 C--N 1.317 -0.836 0 O-C-N 122.178 -0.601 . . . . 0.0 110.26 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.85 143.0 53.79 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.039 1.826 . . . . 0.0 111.442 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.7 pt -113.63 171.45 3.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.058 0.456 . . . . 0.0 110.552 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.649 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.59 155.48 47.46 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.7 -177.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 41' ' ' SER . 12.6 pt-20 -63.02 -8.83 8.12 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.134 0.492 . . . . 0.0 111.897 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 t -99.11 9.39 43.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 121.982 -0.449 . . . . 0.0 111.293 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.649 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.4 157.74 16.21 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.789 179.1 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.6 p -123.61 151.7 64.08 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.487 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 12.2 Cg_endo -57.54 -19.85 38.71 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.76 2.307 . . . . 0.0 112.641 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.2 35.23 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.94 -0.475 . . . . 0.0 110.97 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -72.44 -56.26 5.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.186 0.517 . . . . 0.0 110.86 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -81.88 6.06 16.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.634 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 56.64 64.14 1.76 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.722 0.772 . . . . 0.0 111.145 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.79 -170.69 1.12 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.258 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -147.57 149.73 33.13 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.74 143.87 47.84 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 68.3 14.93 9.28 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.228 0.611 . . . . 0.0 111.878 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -87.61 173.95 8.74 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.044 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.3 m -126.41 142.42 51.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.699 0.761 . . . . 0.0 112.757 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.76 133.09 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.786 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -90.55 119.95 31.23 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.041 0.448 . . . . 0.0 110.623 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.27 136.7 41.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.491 0.662 . . . . 0.0 111.609 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -134.78 165.71 24.64 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 C--N 1.314 -0.957 0 CA-C-O 121.079 0.466 . . . . 0.0 110.196 177.744 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.667 0 CA-C-O 122.384 1.087 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 pt -116.05 158.07 16.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.19 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.409 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -96.79 114.49 26.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.7 mt -110.98 124.8 52.86 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 83' ' ' THR . 32.3 ttpt -102.38 136.8 41.56 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.284 0.564 . . . . 0.0 111.185 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 29' ' ' VAL . 48.2 t -112.46 125.71 69.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.226 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.15 125.84 41.86 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.44 0.638 . . . . 0.0 110.61 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.95 152.07 20.16 Favored Glycine 0 C--N 1.302 -1.354 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.018 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -19.38 38.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.227 0.513 . . . . 0.0 112.32 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.13 -22.97 63.92 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.942 0.877 . . . . 0.0 109.742 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.47 -9.3 38.28 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.483 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . 67.1 m -68.97 125.36 26.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 22' ' ' VAL . 7.1 p -146.36 145.35 19.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.24 0.543 . . . . 0.0 111.569 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.1 t -146.79 151.51 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.409 ' NE2' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -111.08 132.26 54.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.236 0.541 . . . . 0.0 109.879 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 32.7 m-85 -122.02 168.16 12.26 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.782 -175.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -137.58 119.67 15.51 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 pt -138.47 163.6 28.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 32.0 tttt -76.32 165.13 25.29 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.293 0.568 . . . . 0.0 111.795 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -71.65 -19.31 62.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.408 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -105.55 -6.8 19.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.9 0.857 . . . . 0.0 108.872 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.4 m -78.19 131.75 68.48 Favored Pre-proline 0 N--CA 1.435 -1.183 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.576 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.86 148.58 86.44 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.415 2.077 . . . . 0.0 111.707 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.15 -16.48 63.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.737 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 13.2 p -50.64 -37.45 40.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.824 0.449 . . . . 0.0 112.091 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 9.4 mmpt? -55.47 -53.88 50.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.912 0.387 . . . . 0.0 110.925 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 44' ' ' MET . 4.0 pp -75.66 -32.58 60.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.325 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.643 ' N ' HD13 ' A' ' 43' ' ' LEU . 46.2 ttm -59.33 -50.32 74.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.082 0.468 . . . . 0.0 110.458 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.637 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 1.9 mmmp? -69.9 -44.24 70.1 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.001 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.62 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.54 -42.97 93.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.739 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 34.1 t80 -54.27 -51.11 65.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.882 0.372 . . . . 0.0 110.623 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.676 ' SG ' HD13 ' A' ' 58' ' ' ILE . 23.3 m -63.66 -34.54 78.06 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.023 0.44 . . . . 0.0 111.12 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 48.9 mm-40 -63.64 -39.47 94.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.067 0.461 . . . . 0.0 111.734 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.62 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -90.68 -20.82 22.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.791 0.329 . . . . 0.0 111.862 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 28' ' ' SER . 19.5 mm-40 -95.11 -4.57 45.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.95 9.78 85.19 Favored Glycine 0 C--O 1.236 0.279 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.76 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.41 162.46 17.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.552 0.691 . . . . 0.0 112.007 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.419 ' O ' HG12 ' A' ' 58' ' ' ILE . 7.3 m -114.07 136.94 52.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.87 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.494 ' HE2' ' HG2' ' A' ' 44' ' ' MET . 68.8 mmm -60.17 -28.35 67.86 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.776 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.414 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -83.39 -33.24 25.82 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.417 0.627 . . . . 0.0 110.911 -178.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.5 -20.91 46.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.395 0.616 . . . . 0.0 111.187 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.676 HD13 ' SG ' ' A' ' 48' ' ' CYS . 9.4 pt -118.15 179.72 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.134 0.492 . . . . 0.0 111.915 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -158.51 142.25 15.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.842 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -96.52 142.16 28.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.076 0.465 . . . . 0.0 111.008 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -144.18 143.15 30.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.075 0.464 . . . . 0.0 110.789 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -152.68 139.35 18.81 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.1 t70 65.47 23.97 11.89 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.828 0.823 . . . . 0.0 110.079 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.27 -23.47 8.24 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.885 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -94.68 140.14 22.5 Favored Pre-proline 0 C--N 1.322 -0.587 0 O-C-N 122.427 -0.455 . . . . 0.0 110.984 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.15 136.14 31.24 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.868 1.712 . . . . 0.0 110.623 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.604 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 10.8 pt -102.95 177.63 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.738 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.426 ' C ' ' HE1' ' A' ' 44' ' ' MET . 0.8 OUTLIER -138.34 170.03 16.73 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.827 0.822 . . . . 0.0 111.066 -174.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 12.0 pt-20 -73.44 -9.87 59.14 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.523 0.677 . . . . 0.0 109.708 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.2 t -107.9 10.94 28.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.211 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.604 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -99.84 155.4 17.68 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.908 178.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.8 p -118.53 147.87 42.91 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.329 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.12 -18.81 63.98 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.008 2.472 . . . . 0.0 112.177 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.65 -29.63 41.0 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.237 0.541 . . . . 0.0 110.511 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -67.85 -55.26 13.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.202 0.525 . . . . 0.0 110.825 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -88.53 12.44 14.48 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.738 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 52.28 62.81 2.51 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.724 0.773 . . . . 0.0 112.085 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.78 126.84 32.32 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.891 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.04 157.0 19.01 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -74.39 153.21 39.34 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 121.742 -0.599 . . . . 0.0 110.44 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 69.57 14.79 8.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.112 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -81.77 166.43 20.04 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.809 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 18.9 m -124.85 137.6 54.29 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.583 0.706 . . . . 0.0 112.88 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.99 140.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.659 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -95.31 117.86 31.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.089 0.471 . . . . 0.0 110.897 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -106.41 137.94 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.173 0.511 . . . . 0.0 111.414 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -129.55 155.71 45.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.899 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.987 0.422 . . . . 0.0 110.293 177.629 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.17 166.98 27.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.075 0.464 . . . . 0.0 110.168 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.432 ' OD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -108.45 121.26 44.58 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.36 131.22 56.63 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 83' ' ' THR . 31.1 ttpt -107.81 140.66 40.56 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.072 0.463 . . . . 0.0 110.521 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 39.1 t -114.08 127.5 71.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.099 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.99 127.26 35.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.143 0.497 . . . . 0.0 110.333 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.57 153.72 16.8 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.221 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.6 pp0? -61.39 -17.74 55.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.402 0.62 . . . . 0.0 111.126 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.1 -15.1 62.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.982 0.896 . . . . 0.0 109.757 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.65 -16.1 55.11 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.796 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -70.11 118.6 13.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.049 0.452 . . . . 0.0 110.688 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.6 p -142.98 136.27 25.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.148 0.499 . . . . 0.0 111.527 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 t -146.86 151.99 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.246 0.618 . . . . 0.0 109.516 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' A' ' 31' ' ' GLN . 1.0 OUTLIER -110.77 141.85 43.53 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.231 -0.293 . . . . 0.0 110.497 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -135.59 156.43 48.87 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.055 0.455 . . . . 0.0 110.826 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.432 ' HE3' ' OD1' ' A' ' 19' ' ' ASN . 48.3 mttp -125.46 110.32 13.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 110.433 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.2 pt -125.27 173.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 110.673 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -83.54 148.36 27.24 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -64.59 -14.51 58.18 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -107.6 -1.52 21.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.542 0.686 . . . . 0.0 109.835 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.8 m -86.73 133.54 39.46 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.679 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 151.0 85.05 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.606 2.204 . . . . 0.0 112.473 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.8 mt -65.18 -16.63 63.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.631 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 24.5 p -49.9 -37.76 32.89 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.933 0.493 . . . . 0.0 111.822 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 8.7 mmpt? -56.27 -53.56 55.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.872 0.368 . . . . 0.0 110.654 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -75.39 -31.85 60.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.47 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.567 ' N ' HD13 ' A' ' 43' ' ' LEU . 53.4 mtt -57.32 -55.99 27.64 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.793 0.33 . . . . 0.0 111.721 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -70.13 -39.19 75.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.54 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.25 -44.99 88.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.145 0.497 . . . . 0.0 110.609 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -60.17 -51.92 67.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.675 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.79 ' SG ' HD13 ' A' ' 58' ' ' ILE . 40.0 m -63.63 -34.55 78.08 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.009 0.433 . . . . 0.0 111.801 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 17.9 mm-40 -67.83 -39.38 83.88 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.051 0.453 . . . . 0.0 111.474 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.0 ptp180 -84.55 -22.54 30.06 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.917 0.389 . . . . 0.0 111.417 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -96.77 -3.05 43.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.253 0.549 . . . . 0.0 111.697 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.81 43.33 91.89 Favored Glycine 0 C--N 1.32 -0.351 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.349 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.487 ' HB3' HG21 ' A' ' 58' ' ' ILE . 28.6 mt -117.94 154.96 31.04 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.12 0.486 . . . . 0.0 110.594 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 75.2 m -102.03 126.51 48.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.696 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.532 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 92.7 mmm -55.5 -27.97 51.78 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.464 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -84.21 -30.76 25.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.419 0.628 . . . . 0.0 111.185 -177.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 0.8 OUTLIER -87.01 -28.88 22.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.686 -178.099 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.79 HD13 ' SG ' ' A' ' 48' ' ' CYS . 5.8 pt -105.07 177.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -157.31 141.18 16.02 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.113 0.482 . . . . 0.0 110.59 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 5.2 m-85 -91.97 141.9 28.12 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.135 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -139.81 138.79 36.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.154 0.502 . . . . 0.0 110.706 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -148.48 140.88 24.25 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 t70 67.72 23.46 8.63 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.766 0.793 . . . . 0.0 109.822 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.41 -0.24 75.98 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.26 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -119.4 138.01 26.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 O-C-N 122.206 -0.585 . . . . 0.0 110.411 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.85 141.46 71.57 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.015 1.81 . . . . 0.0 111.25 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.9 pt -114.78 167.55 7.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.86 0.362 . . . . 0.0 111.05 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.659 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -128.17 155.97 43.63 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.553 -177.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.498 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.3 pt-20 -60.12 -10.75 4.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 112.001 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.2 t -99.29 9.1 44.01 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 122.039 -0.413 . . . . 0.0 111.786 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.659 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -98.03 159.75 14.74 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 121.658 -0.651 . . . . 0.0 110.65 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.1 p -117.76 148.99 44.35 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.617 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.97 -19.8 69.97 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.514 2.142 . . . . 0.0 111.904 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.12 -20.95 40.31 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.005 0.431 . . . . 0.0 111.074 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -74.76 -53.86 8.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.545 0.688 . . . . 0.0 110.565 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.31 4.4 31.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.333 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 61.39 62.84 1.28 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.61 0.719 . . . . 0.0 111.832 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 mtt -79.19 126.56 30.91 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.176 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.69 157.75 18.43 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.517 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.6 147.26 49.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.859 0.361 . . . . 0.0 110.264 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 67.18 15.18 9.99 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.426 0.69 . . . . 0.0 112.167 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -82.73 168.28 17.36 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 19.1 m -125.6 140.41 52.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.842 0.83 . . . . 0.0 112.849 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.84 134.27 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.85 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.79 125.23 40.21 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.191 0.52 . . . . 0.0 111.254 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 44.0 t -108.48 137.94 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.414 0.626 . . . . 0.0 112.12 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -136.12 166.54 23.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' A' ' 58' ' ' ILE . 2.5 mp0 . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 121.028 0.442 . . . . 0.0 111.406 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 38.1 p-80 . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 120.847 0.356 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 pt -129.77 167.9 24.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.027 0.441 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.609 ' OD1' ' HE3' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -103.69 128.37 51.04 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.61 124.94 44.63 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 83' ' ' THR . 36.0 ttpt -104.1 140.04 38.33 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.171 0.51 . . . . 0.0 111.037 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.0 t -112.86 124.71 69.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.884 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.38 126.17 40.12 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.623 0.725 . . . . 0.0 110.096 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.41 146.66 17.38 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.656 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -4.59 1.56 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.566 0.698 . . . . 0.0 112.023 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.603 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 27.6 t70 -77.65 -16.87 58.25 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.647 0.779 . . . . 0.0 110.188 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.54 -13.18 50.92 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -82.06 119.93 24.64 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.116 0.484 . . . . 0.0 110.624 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.51 137.83 28.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 111.156 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.447 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 11.3 t -144.75 151.82 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.36 137.78 46.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.447 ' CZ ' ' HB ' ' A' ' 30' ' ' VAL . 30.8 m-85 -130.55 139.48 50.46 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.406 0.622 . . . . 0.0 111.406 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.609 ' HE3' ' OD1' ' A' ' 19' ' ' ASN . 22.9 tttt -112.17 107.96 17.04 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.674 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 pt -128.89 172.18 15.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.148 0.499 . . . . 0.0 111.186 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.8 tmtt? -80.23 149.77 30.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.877 0.37 . . . . 0.0 110.294 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 20.0 tpp85 -61.31 -19.48 61.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.144 0.577 . . . . 0.0 111.574 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -107.52 -1.95 20.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.476 0.655 . . . . 0.0 109.825 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.7 m -82.24 131.52 55.9 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.917 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.94 147.4 89.17 Favored 'Trans proline' 0 C--O 1.241 0.638 0 C-N-CA 122.377 2.051 . . . . 0.0 112.151 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.84 -15.73 62.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.559 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 37.4 p -49.89 -39.78 40.78 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.198 0.599 . . . . 0.0 111.366 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.61 -53.19 60.52 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.374 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.94 -32.38 61.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.022 0.439 . . . . 0.0 111.045 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.602 ' N ' HD12 ' A' ' 43' ' ' LEU . 45.7 ttm -60.6 -50.04 75.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 110.369 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.557 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 30.0 mmtp -71.39 -42.58 68.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.429 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.636 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.48 -46.11 91.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.594 0.357 . . . . 0.0 111.898 -177.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -53.89 -49.39 68.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.992 0.425 . . . . 0.0 110.323 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.63 ' SG ' HD12 ' A' ' 58' ' ' ILE . 37.1 m -66.34 -34.32 77.7 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.27 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 45.6 mm-40 -58.14 -49.22 77.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.431 0.634 . . . . 0.0 110.992 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.636 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 5.7 ptp180 -83.99 -24.92 30.37 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -95.8 -11.61 26.62 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.93 44.86 35.4 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.973 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.4 153.22 30.25 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.379 -0.483 . . . . 0.0 110.689 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.1 m -95.75 126.14 40.81 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 120.776 0.322 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.492 ' HE3' ' HG2' ' A' ' 44' ' ' MET . 52.9 mmm -61.6 -26.71 68.15 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.417 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -82.54 -29.78 30.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 111.257 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.99 -45.64 10.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.366 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.63 HD12 ' SG ' ' A' ' 48' ' ' CYS . 8.7 pt -84.6 172.98 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 121.692 -0.63 . . . . 0.0 111.317 -177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 23.6 tpt180 -151.7 137.38 17.9 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.259 0.552 . . . . 0.0 110.351 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.405 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 8.1 m-85 -92.07 134.08 35.16 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.987 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -139.55 139.74 36.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.104 0.478 . . . . 0.0 110.509 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -145.76 137.83 25.38 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t70 67.08 24.7 9.35 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.849 0.833 . . . . 0.0 110.314 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.95 81.21 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.334 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -119.17 131.92 24.17 Favored Pre-proline 0 N--CA 1.451 -0.405 0 O-C-N 122.283 -0.54 . . . . 0.0 110.622 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -64.02 138.58 63.05 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.288 1.992 . . . . 0.0 111.295 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.7 pt -111.79 167.97 5.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.138 0.494 . . . . 0.0 111.259 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.604 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.32 158.94 39.34 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.29 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' A' ' 41' ' ' SER . 5.4 pt-20 -63.21 -9.66 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.226 0.536 . . . . 0.0 111.604 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 t -99.59 10.66 40.97 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.939 -0.475 . . . . 0.0 111.604 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.604 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -100.07 157.34 16.62 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 121.714 -0.616 . . . . 0.0 110.686 178.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.7 p -120.72 147.77 46.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.693 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 34.6 Cg_endo -63.89 -19.02 66.17 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.917 2.411 . . . . 0.0 112.35 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.59 -25.95 41.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.008 0.432 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -73.49 -55.71 5.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.398 0.618 . . . . 0.0 111.286 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.412 HD21 ' HG3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -81.61 -2.69 51.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.613 -178.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 67.31 63.31 0.44 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.014 0.912 . . . . 0.0 110.799 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.412 ' HG3' HD21 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -82.31 128.71 34.47 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.684 -178.228 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.05 164.02 16.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.952 0.406 . . . . 0.0 110.095 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.19 147.0 31.47 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.039 0.447 . . . . 0.0 110.88 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 69.17 14.83 8.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.308 1.043 . . . . 0.0 111.896 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -81.21 169.64 17.09 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 21.6 m -124.97 141.46 52.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.509 0.671 . . . . 0.0 112.564 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.36 138.17 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.243 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.04 120.45 33.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.076 0.465 . . . . 0.0 110.544 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.46 137.48 42.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.343 0.592 . . . . 0.0 111.594 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -130.97 153.84 48.78 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.729 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.603 ' OE1' ' HB2' ' A' ' 26' ' ' ASP . 2.0 mp0 . . . . . 0 C--N 1.332 -0.168 0 CA-C-O 121.08 0.467 . . . . 0.0 111.582 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 12.8 p-80 . . . . . 0 N--CA 1.444 -0.734 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.0 pt -131.34 161.46 41.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.501 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -102.05 125.15 48.66 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.72 125.3 49.36 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -103.14 140.32 37.5 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.955 0.407 . . . . 0.0 110.535 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -111.19 124.14 67.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 29' ' ' VAL . . . -121.14 123.72 42.99 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.582 0.706 . . . . 0.0 110.778 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.46 139.55 14.46 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 120.111 -1.042 . . . . 0.0 111.075 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -64.06 -9.07 14.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.195 0.497 . . . . 0.0 112.33 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -83.6 -8.16 59.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.681 0.753 . . . . 0.0 109.554 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.47 -9.52 45.27 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.602 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.2 m -78.27 110.72 13.53 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 122.366 -0.491 . . . . 0.0 109.95 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 23' ' ' ALA . 61.8 t -137.27 134.72 47.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 122.087 -0.383 . . . . 0.0 110.362 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.405 HG22 ' HD3' ' A' ' 50' ' ' ARG . 21.1 t -148.64 152.7 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.471 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -108.94 142.33 39.74 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.166 -0.334 . . . . 0.0 110.603 -178.05 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -136.95 155.88 49.16 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.048 0.452 . . . . 0.0 111.229 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.501 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 44.5 mtmt -127.62 120.12 27.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.415 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 pt -136.93 170.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 110.393 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 6.2 tmtt? -73.34 147.35 44.49 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 33.7 ttm180 -64.37 -14.64 57.56 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.203 0.525 . . . . 0.0 111.665 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -110.09 1.34 18.81 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.496 0.665 . . . . 0.0 109.738 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 m -84.79 135.02 40.69 Favored Pre-proline 0 N--CA 1.444 -0.739 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.007 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.44 143.78 97.71 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.524 2.15 . . . . 0.0 112.301 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.412 HD13 ' OD2' ' A' ' 71' ' ' ASP . 43.3 mt -65.14 -16.18 63.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.609 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.451 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 55.6 p -49.46 -38.19 28.84 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.034 0.534 . . . . 0.0 111.633 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -56.25 -53.72 53.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.754 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.609 HD11 ' N ' ' A' ' 44' ' ' MET . 4.0 pp -75.59 -32.19 60.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.876 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.609 ' N ' HD11 ' A' ' 43' ' ' LEU . 58.7 mtt -59.23 -55.43 34.99 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.315 0.579 . . . . 0.0 111.208 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.524 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 41.9 mtpt -70.91 -34.41 71.51 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.197 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.65 -44.11 97.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.144 0.497 . . . . 0.0 110.136 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -58.95 -51.12 71.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.469 ' SG ' ' HG2' ' A' ' 55' ' ' MET . 17.8 p -63.15 -36.61 84.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.056 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 36.8 mt-10 -68.31 -39.06 82.13 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 11.5 ptm180 -83.53 -23.82 31.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.006 0.432 . . . . 0.0 111.376 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -95.03 -6.44 42.21 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.72 42.74 53.37 Favored Glycine 0 C--N 1.322 -0.222 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.689 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.95 156.38 28.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.228 0.537 . . . . 0.0 110.608 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 58' ' ' ILE . 45.0 m -104.8 125.91 51.34 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.341 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.469 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 97.2 mmm -59.09 -22.6 61.06 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.102 0.477 . . . . 0.0 111.89 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.457 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -83.64 -33.85 25.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.517 0.675 . . . . 0.0 110.467 -179.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.457 ' NE2' ' HB2' ' A' ' 56' ' ' ARG . 0.8 OUTLIER -90.61 -10.59 42.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.942 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 54' ' ' SER . 21.0 pt -117.74 171.89 5.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 O-C-N 121.896 -0.503 . . . . 0.0 110.788 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -151.96 138.03 18.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.973 0.416 . . . . 0.0 110.089 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.8 m-85 -93.22 139.37 30.69 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.214 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -141.16 141.18 34.14 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.239 0.542 . . . . 0.0 110.721 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -146.75 132.17 18.62 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 68.44 25.45 6.87 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.749 0.785 . . . . 0.0 110.303 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.02 -24.7 5.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.957 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -91.58 133.68 30.68 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 122.369 -0.489 . . . . 0.0 111.222 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.88 143.09 59.56 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.239 1.959 . . . . 0.0 111.385 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.8 pt -117.28 162.6 15.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.164 0.507 . . . . 0.0 111.006 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.654 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -123.47 156.88 34.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.313 -177.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.455 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 3.9 pt-20 -57.81 -14.55 6.15 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.114 0.483 . . . . 0.0 111.866 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -98.32 8.81 44.33 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 122.021 -0.424 . . . . 0.0 111.971 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.654 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -95.84 159.52 14.93 Favored 'General case' 0 C--O 1.24 0.598 0 O-C-N 121.894 -0.504 . . . . 0.0 110.372 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.3 p -121.27 144.03 38.81 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.531 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 14.4 Cg_endo -57.47 -24.82 63.24 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.032 2.488 . . . . 0.0 112.65 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.75 -26.79 57.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.21 0.529 . . . . 0.0 111.075 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -71.31 -55.71 7.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.26 0.552 . . . . 0.0 110.546 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -85.07 2.65 42.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.041 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 61.57 64.2 1.08 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.854 0.835 . . . . 0.0 112.034 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.1 ttt -82.66 128.86 34.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.131 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -84.55 154.39 22.68 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 120.86 0.362 . . . . 0.0 110.187 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -72.82 147.33 45.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.992 0.425 . . . . 0.0 110.068 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 68.91 14.11 8.86 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.694 0.798 . . . . 0.0 111.256 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -82.61 172.37 13.03 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.1 m -126.29 141.79 51.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.568 0.699 . . . . 0.0 112.704 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -103.15 139.58 23.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.107 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -97.53 121.69 39.73 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.211 0.529 . . . . 0.0 110.701 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 39.0 t -108.47 137.5 39.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.237 0.541 . . . . 0.0 111.82 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -131.36 158.19 41.39 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 121.167 0.508 . . . . 0.0 110.801 178.614 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 13.7 p-80 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.9 pt -128.86 159.77 40.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.294 0.569 . . . . 0.0 111.244 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.419 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -101.57 119.62 39.06 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.004 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.7 140.99 47.79 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.987 0.422 . . . . 0.0 109.862 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -115.32 139.66 49.79 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.319 0.581 . . . . 0.0 111.085 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 29' ' ' VAL . 46.4 t -112.04 124.81 69.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.676 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.39 122.95 35.02 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.479 0.656 . . . . 0.0 110.437 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.33 147.69 16.33 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.934 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -7.89 2.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -78.12 -14.61 59.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.747 0.784 . . . . 0.0 110.243 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.92 -11.78 56.04 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.2 m -78.61 118.76 21.02 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 120.945 0.402 . . . . 0.0 110.09 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.7 p -141.94 137.9 30.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.215 0.531 . . . . 0.0 111.116 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -142.93 150.96 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.419 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.1 tm0? -110.29 141.23 43.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.888 0.375 . . . . 0.0 110.374 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -135.87 147.26 48.13 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.034 0.445 . . . . 0.0 110.996 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -115.2 109.59 18.21 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.061 0.458 . . . . 0.0 110.649 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.7 pt -124.38 178.42 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 22.4 tttt -89.91 159.2 17.06 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.465 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -62.25 -24.16 67.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.47 0.708 . . . . 0.0 111.884 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -105.74 -1.92 23.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.574 0.702 . . . . 0.0 109.857 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 m -83.96 132.18 49.15 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.64 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.88 149.86 86.18 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.593 2.195 . . . . 0.0 112.424 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.65 -15.6 62.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.036 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 22.3 p -49.37 -39.83 33.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.078 0.551 . . . . 0.0 111.995 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -55.5 -53.25 58.69 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.792 0.33 . . . . 0.0 111.19 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.573 HD11 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.29 -31.87 62.67 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.713 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.573 ' N ' HD11 ' A' ' 43' ' ' LEU . 57.1 mtt -59.96 -56.43 21.77 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.003 0.43 . . . . 0.0 111.596 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -67.16 -39.86 86.56 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.815 0.341 . . . . 0.0 110.499 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.45 -46.47 86.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.121 0.486 . . . . 0.0 110.582 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -57.81 -52.05 67.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.177 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.8 p -61.57 -36.79 81.65 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.059 0.457 . . . . 0.0 111.072 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -64.77 -47.98 76.19 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.959 0.409 . . . . 0.0 111.853 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 18.5 ptp180 -78.17 -24.97 47.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.83 0.348 . . . . 0.0 111.567 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -96.88 -7.63 32.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.43 45.76 22.63 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.986 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.05 159.96 23.75 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.413 -0.463 . . . . 0.0 110.547 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -106.09 126.26 51.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.645 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.443 ' CE ' ' HB3' ' A' ' 44' ' ' MET . 93.0 mmm -57.39 -28.17 62.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.414 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.71 -28.67 26.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.294 0.568 . . . . 0.0 110.839 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.696 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -83.19 -34.12 26.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.383 0.611 . . . . 0.0 110.549 -177.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.495 HG22 ' HG3' ' A' ' 88' ' ' GLN . 20.5 pt -92.94 165.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.354 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -143.36 128.69 18.87 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.909 0.385 . . . . 0.0 110.167 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -87.05 139.67 30.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.026 0.441 . . . . 0.0 110.054 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -142.14 143.12 32.85 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.115 0.483 . . . . 0.0 111.057 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -149.38 132.41 16.23 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.18 25.33 7.33 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.884 0.85 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.51 -25.57 5.01 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.156 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -91.36 138.43 25.57 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.429 -0.454 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.16 143.69 49.66 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.047 1.832 . . . . 0.0 110.981 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.547 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 12.7 pt -114.11 170.69 4.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.794 0.331 . . . . 0.0 111.116 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.427 ' C ' ' HE3' ' A' ' 44' ' ' MET . 0.5 OUTLIER -130.71 164.68 24.53 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.555 0.693 . . . . 0.0 110.921 -175.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 12.0 pt-20 -69.45 -7.67 39.94 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.39 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -102.03 6.19 40.98 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.599 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.547 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -99.21 155.04 17.69 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.918 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.5 p -120.63 152.01 55.03 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.49 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.34 -15.66 46.4 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.629 2.22 . . . . 0.0 112.165 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.56 -16.17 37.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.176 0.513 . . . . 0.0 110.829 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -80.2 -55.03 5.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.368 0.604 . . . . 0.0 111.215 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.401 HD22 ' HE2' ' A' ' 78' ' ' MET . 1.5 pt? -93.16 12.58 23.86 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.848 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 53.33 63.43 2.22 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.516 ' SD ' HD11 ' A' ' 84' ' ' ILE . 25.4 ttm -87.63 133.06 33.88 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 5.8 mm-40 -104.67 174.18 5.99 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.855 0.359 . . . . 0.0 110.636 -176.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -66.21 141.56 58.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.972 0.415 . . . . 0.0 110.693 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 69.88 15.94 7.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.625 0.77 . . . . 0.0 111.747 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -80.11 160.7 25.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -126.24 143.78 51.02 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.487 0.66 . . . . 0.0 112.645 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.516 HD11 ' SD ' ' A' ' 78' ' ' MET . 4.1 mp -108.16 138.9 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -95.05 123.97 38.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.122 0.487 . . . . 0.0 110.486 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.13 139.85 31.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.307 0.575 . . . . 0.0 111.448 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -130.78 154.5 47.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.694 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.495 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.8 mp0 . . . . . 0 C--N 1.326 -0.443 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 . . . . . 0 N--CA 1.444 -0.732 0 CA-C-O 120.842 0.353 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.2 pt -125.11 165.61 22.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 121.318 0.58 . . . . 0.0 110.881 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.431 ' ND2' ' HB2' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -100.09 135.5 41.42 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.82 126.38 30.41 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -107.19 140.08 40.61 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.245 0.545 . . . . 0.0 111.49 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.0 t -113.82 124.36 70.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.006 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.9 124.17 34.51 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.605 0.717 . . . . 0.0 110.846 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.35 151.87 19.45 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.259 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.5 pp0? -60.53 -20.22 59.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.187 0.517 . . . . 0.0 111.681 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.7 -7.44 55.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.634 0.731 . . . . 0.0 110.454 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.35 -16.07 55.57 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.686 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 m -68.76 116.73 9.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.851 0.357 . . . . 0.0 110.241 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -143.83 139.6 25.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.032 0.444 . . . . 0.0 111.423 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.2 t -145.83 151.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.22 139.91 40.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.935 0.397 . . . . 0.0 110.1 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -133.42 166.97 21.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.385 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -140.29 114.12 8.87 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.903 0.382 . . . . 0.0 110.516 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 pt -127.91 174.8 10.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.116 0.484 . . . . 0.0 110.757 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 9.7 tmtt? -87.46 149.76 24.21 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.183 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.416 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 22.7 tpp180 -54.02 -28.64 39.47 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.49 0.716 . . . . 0.0 112.376 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -105.08 -0.26 26.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.48 0.657 . . . . 0.0 110.613 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 m -85.83 133.6 41.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.181 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.99 151.87 84.33 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.502 2.135 . . . . 0.0 112.316 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.92 -15.23 61.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.943 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.519 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 25.8 p -49.28 -38.24 26.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 122.967 0.507 . . . . 0.0 111.976 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -56.35 -54.09 49.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.502 0.191 . . . . 0.0 110.845 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.635 HD11 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.96 -33.6 57.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.887 0.375 . . . . 0.0 111.629 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.635 ' N ' HD11 ' A' ' 43' ' ' LEU . 45.3 ttm -62.07 -53.27 57.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.02 0.438 . . . . 0.0 111.002 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.626 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 8.7 mmmm -70.3 -36.7 74.49 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.207 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.66 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -61.3 -45.66 93.55 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.001 -0.437 . . . . 0.0 111.05 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -56.33 -51.45 68.18 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.431 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.1 p -63.53 -35.31 80.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.107 0.48 . . . . 0.0 110.843 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.626 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 6.2 mm-40 -65.75 -43.78 87.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.009 0.433 . . . . 0.0 111.586 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.66 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 13.1 ptp180 -83.22 -20.98 33.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -96.95 -9.66 27.88 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.831 -0.543 . . . . 0.0 111.818 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.67 40.71 26.1 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.031 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.41 157.9 25.4 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.038 0.446 . . . . 0.0 110.016 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.416 ' O ' HG12 ' A' ' 58' ' ' ILE . 8.2 m -109.65 134.76 51.59 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.702 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.507 ' CE ' ' HG2' ' A' ' 44' ' ' MET . 97.1 mmm -58.76 -25.99 63.56 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.15 -24.94 27.75 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.325 0.583 . . . . 0.0 111.109 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.64 -19.34 26.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.296 0.57 . . . . 0.0 110.7 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 54' ' ' SER . 14.4 pt -120.94 174.32 5.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.095 0.474 . . . . 0.0 111.173 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -154.29 138.98 16.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.113 0.482 . . . . 0.0 109.927 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -91.87 137.3 32.48 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.227 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HG3' ' C ' ' A' ' 65' ' ' GLN . 16.3 ttm180 -136.62 134.59 37.51 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.321 0.581 . . . . 0.0 110.881 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -145.29 144.26 30.66 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 68.33 24.35 7.38 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.855 0.836 . . . . 0.0 109.447 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.34 -5.62 59.53 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.366 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.473 ' C ' ' HG3' ' A' ' 61' ' ' ARG . 5.0 pt20 -118.69 143.96 34.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 O-C-N 122.196 -0.591 . . . . 0.0 111.26 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.64 133.96 36.23 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.067 1.845 . . . . 0.0 111.145 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.594 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 12.0 pt -106.87 -177.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.92 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.86 164.53 27.36 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 121.394 0.616 . . . . 0.0 109.793 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 41' ' ' SER . 15.9 pt-20 -74.39 -9.47 58.62 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.714 0.769 . . . . 0.0 109.403 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 t -103.4 10.31 37.4 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.853 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.594 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -98.39 159.0 15.24 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.4 p -117.08 148.51 42.46 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.568 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.84 -12.17 34.06 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.798 2.332 . . . . 0.0 112.081 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.5 -28.35 23.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.125 0.488 . . . . 0.0 110.654 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -69.63 -55.32 10.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 111.685 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -88.38 9.9 21.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.002 0.429 . . . . 0.0 111.636 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 53.74 63.88 2.04 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.935 0.874 . . . . 0.0 112.735 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -78.48 129.01 34.38 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.222 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -91.19 158.11 16.8 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.431 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 4.7 p-10 -70.05 147.8 49.6 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.986 -0.446 . . . . 0.0 110.478 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 66.72 15.25 10.08 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.342 0.657 . . . . 0.0 111.733 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -79.57 167.04 21.27 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -121.83 137.48 54.76 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.659 0.742 . . . . 0.0 112.923 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.13 134.35 41.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.986 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.87 122.14 36.05 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.123 0.487 . . . . 0.0 110.471 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 40.3 t -107.68 138.38 34.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.234 0.54 . . . . 0.0 111.64 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -131.55 155.67 47.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.734 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.08 0.467 . . . . 0.0 111.192 178.652 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 6.1 p-80 . . . . . 0 CA--C 1.504 -0.826 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 80' ' ' ASP . 45.2 pt -131.08 160.44 42.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.269 0.556 . . . . 0.0 110.233 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.546 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.4 OUTLIER -98.65 120.95 39.95 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.055 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.06 125.16 54.08 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -104.17 140.55 37.65 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.222 0.534 . . . . 0.0 110.596 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.75 124.21 68.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.484 ' HA ' HG21 ' A' ' 29' ' ' VAL . . . -122.31 122.44 39.08 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.549 0.69 . . . . 0.0 110.993 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.72 139.51 14.46 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.228 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -60.06 -17.07 36.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.382 0.611 . . . . 0.0 111.398 178.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.29 -6.61 58.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.751 0.786 . . . . 0.0 110.127 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.95 -11.16 48.89 Favored Glycine 0 CA--C 1.507 -0.462 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.048 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.8 m -78.6 108.08 11.73 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.153 0.502 . . . . 0.0 109.836 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.484 HG21 ' HA ' ' A' ' 23' ' ' ALA . 59.6 t -135.33 131.29 51.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 120.959 0.409 . . . . 0.0 110.112 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -141.92 150.7 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.546 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -109.5 139.38 44.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.0 110.121 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 30.4 m-85 -130.11 159.46 36.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.321 0.582 . . . . 0.0 111.263 -176.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 42.3 mtmt -131.43 113.25 13.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.302 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.6 pt -135.04 176.3 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.69 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.4 tmtt? -82.6 149.03 27.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 22.1 ttm-85 -61.87 -19.42 62.62 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -105.61 1.31 27.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.695 0.76 . . . . 0.0 109.526 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.5 m -84.99 131.9 47.38 Favored Pre-proline 0 N--CA 1.442 -0.863 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.231 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.2 145.33 88.76 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 122.633 2.222 . . . . 0.0 112.177 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.475 HD13 ' OD1' ' A' ' 71' ' ' ASP . 34.3 mt -64.93 -16.29 63.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.933 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 12.3 t -50.06 -37.19 32.29 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 122.457 0.303 . . . . 0.0 111.102 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -56.04 -53.46 56.73 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-O 120.848 0.356 . . . . 0.0 111.026 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.58 HD11 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.81 -31.87 61.83 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.529 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.58 ' N ' HD11 ' A' ' 43' ' ' LEU . 56.9 mtt -60.4 -54.56 44.1 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.927 0.394 . . . . 0.0 111.537 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 31.2 mmtp -66.71 -39.96 88.23 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.84 -47.98 83.88 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 28.0 t80 -55.22 -51.72 65.67 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.857 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.657 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.3 m -63.94 -38.53 91.44 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.568 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 40.2 mt-10 -64.09 -42.32 96.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.743 0.306 . . . . 0.0 111.356 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.2 ptp180 -80.39 -24.29 39.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.908 0.385 . . . . 0.0 111.573 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -96.0 -8.74 32.84 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.63 2.98 90.69 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.897 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.482 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 7.3 mp -80.53 158.17 25.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.615 0.722 . . . . 0.0 112.005 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.0 m -107.81 132.27 53.59 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.034 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.549 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 95.7 mmm -57.36 -31.06 65.37 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.462 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -84.35 -31.21 24.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.341 0.591 . . . . 0.0 111.126 -178.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 0.7 OUTLIER -84.42 -16.69 41.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.39 0.614 . . . . 0.0 110.816 -177.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.657 HD11 ' SG ' ' A' ' 48' ' ' CYS . 10.3 pt -117.81 179.17 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.369 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -156.07 132.77 10.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 120.983 0.42 . . . . 0.0 110.088 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.4 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.4 m-85 -83.54 139.32 32.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.669 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -144.11 144.24 31.5 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.218 0.532 . . . . 0.0 110.987 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -149.18 134.88 18.72 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 t70 68.44 25.04 6.98 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.535 0.683 . . . . 0.0 110.359 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.33 -24.05 6.68 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.137 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -93.69 137.55 23.19 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 122.301 -0.529 . . . . 0.0 110.803 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.3 145.54 60.15 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.038 1.825 . . . . 0.0 111.249 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 pt -113.55 160.65 12.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.982 0.42 . . . . 0.0 110.22 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.624 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -121.18 153.88 36.97 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.757 -177.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 41' ' ' SER . 10.0 pt-20 -59.72 -12.6 7.41 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.143 0.497 . . . . 0.0 111.944 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.2 t -95.82 8.12 44.44 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 120.717 0.294 . . . . 0.0 111.135 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.624 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -95.0 156.33 16.36 Favored 'General case' 0 C--O 1.244 0.78 0 O-C-N 121.89 -0.506 . . . . 0.0 110.017 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.4 p -118.12 146.64 39.72 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.613 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 18.4 Cg_endo -60.36 -22.92 73.02 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.762 2.308 . . . . 0.0 112.338 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HB3' ' HG2' ' A' ' 36' ' ' ARG . . . -78.1 -22.79 48.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.166 0.508 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -71.59 -55.27 8.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.397 0.618 . . . . 0.0 110.442 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -85.91 9.02 18.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.542 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 55.79 60.08 3.47 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.776 0.798 . . . . 0.0 112.246 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.4 mtt -84.38 141.24 31.01 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.645 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -108.76 177.35 4.8 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.121 0.486 . . . . 0.0 111.15 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.447 ' HA ' ' HB ' ' A' ' 18' ' ' ILE . 5.2 m-20 -64.54 138.27 58.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.745 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 68.82 19.42 8.37 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.678 0.791 . . . . 0.0 112.497 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -73.47 159.0 33.86 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.6 m -124.41 144.56 49.98 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.72 142.22 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.215 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.494 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 11.3 m-20 -94.83 122.5 37.53 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 110.505 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.555 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 28.7 t -109.83 136.69 45.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 O-C-N 121.886 -0.509 . . . . 0.0 111.594 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CE1' ' HB3' ' A' ' 85' ' ' ASP . 60.1 m-85 -132.73 157.61 44.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.469 0.652 . . . . 0.0 111.133 179.348 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 20.0 p-80 . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.2 pt -132.95 166.79 28.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.108 0.48 . . . . 0.0 110.731 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.652 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -103.78 125.94 50.58 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.17 124.07 47.06 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 83' ' ' THR . 31.8 ttpt -103.95 140.65 37.41 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.102 0.477 . . . . 0.0 110.593 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.67 125.43 70.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.897 0.379 . . . . 0.0 110.084 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.6 121.75 27.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.533 0.682 . . . . 0.0 110.49 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.56 148.85 16.81 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 120.249 -0.976 . . . . 0.0 112.207 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -6.09 2.85 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.365 0.602 . . . . 0.0 112.294 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.92 -14.14 59.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.728 0.775 . . . . 0.0 109.845 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.6 -15.05 53.51 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.635 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.7 m -77.08 122.76 25.41 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.926 0.393 . . . . 0.0 110.63 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.28 137.83 29.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.138 0.494 . . . . 0.0 111.253 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 t -143.09 151.08 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.652 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -106.34 142.0 36.73 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.343 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -135.29 146.61 48.68 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.237 0.542 . . . . 0.0 110.461 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -121.65 114.17 20.78 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.03 0.443 . . . . 0.0 110.455 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.8 pt -134.46 177.76 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.24 0.543 . . . . 0.0 111.264 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 11.3 tmtt? -86.45 152.16 22.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.474 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 13.6 tpp180 -60.53 -19.16 56.33 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.943 0.497 . . . . 0.0 111.734 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -107.73 -3.3 19.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.55 0.691 . . . . 0.0 109.653 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -83.67 132.44 49.14 Favored Pre-proline 0 N--CA 1.441 -0.906 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.217 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.15 149.81 88.46 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.557 2.171 . . . . 0.0 112.853 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.449 HD11 ' OD2' ' A' ' 71' ' ' ASP . 28.0 mt -65.59 -13.95 60.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.065 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 p -55.13 -34.48 63.77 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.327 0.584 . . . . 0.0 110.663 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -55.93 -55.98 26.14 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.603 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -77.38 -32.73 55.11 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.626 ' N ' HD13 ' A' ' 43' ' ' LEU . 38.7 ttm -62.41 -54.01 46.53 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.067 0.46 . . . . 0.0 110.959 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 33.6 mtpt -72.37 -32.99 66.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.491 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -64.18 -43.74 94.16 Favored 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 121.92 -0.488 . . . . 0.0 110.434 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -57.39 -50.53 72.69 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.105 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 14.8 p -61.48 -36.96 81.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 0.0 110.909 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.1 mt-10 -69.02 -40.05 78.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.4 ptp180 -83.85 -24.75 30.77 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.936 -0.477 . . . . 0.0 112.167 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -95.41 -11.83 26.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.182 0.515 . . . . 0.0 111.461 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.43 41.49 13.29 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.491 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 48' ' ' CYS . 3.4 mm? -117.23 158.24 24.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.041 0.448 . . . . 0.0 110.301 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.477 ' O ' HG12 ' A' ' 58' ' ' ILE . 15.2 m -106.38 131.99 52.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.283 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.485 ' HE1' ' HG2' ' A' ' 44' ' ' MET . 85.4 mmm -55.07 -29.14 56.91 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.928 0.491 . . . . 0.0 111.817 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.554 ' N ' ' HD3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -83.86 -28.79 27.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.4 0.619 . . . . 0.0 111.179 -177.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.7 -7.53 46.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.117 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 54' ' ' SER . 17.5 pt -125.1 170.18 15.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 120.943 0.402 . . . . 0.0 110.965 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -149.99 135.86 18.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.12 0.486 . . . . 0.0 110.164 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -89.82 137.26 32.49 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.028 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -137.28 143.02 41.94 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.258 0.551 . . . . 0.0 110.622 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -150.83 138.59 19.81 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 t70 69.79 25.35 5.08 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.605 0.716 . . . . 0.0 110.282 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.01 -1.56 79.12 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.538 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -122.73 142.92 38.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 O-C-N 122.122 -0.634 . . . . 0.0 111.409 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.04 141.89 59.59 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.503 2.135 . . . . 0.0 111.866 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 pt -117.08 172.83 4.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.102 0.477 . . . . 0.0 111.01 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.677 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.96 156.33 46.38 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.818 -178.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.58 -13.14 12.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.778 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.0 t -96.61 10.21 39.2 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 122.157 -0.339 . . . . 0.0 111.374 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.677 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.81 157.4 16.53 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.96 177.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.3 p -120.76 151.01 53.9 Favored Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.199 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.42 -18.23 52.22 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.968 2.445 . . . . 0.0 112.699 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.02 -27.15 30.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.331 0.586 . . . . 0.0 110.896 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -71.61 -55.9 6.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.478 0.656 . . . . 0.0 110.623 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -88.49 20.77 3.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.571 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 43.08 62.52 1.79 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.087 0.946 . . . . 0.0 112.662 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -78.87 122.5 26.18 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.697 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.58 156.7 30.7 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.051 0.453 . . . . 0.0 110.848 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -68.89 142.86 54.66 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.886 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 66.71 18.21 10.68 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.269 0.627 . . . . 0.0 111.437 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -81.51 171.25 14.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.976 0.417 . . . . 0.0 110.64 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 21.9 m -126.05 145.0 50.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.577 0.703 . . . . 0.0 112.352 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.03 138.74 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.283 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -94.91 121.79 36.88 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.964 0.411 . . . . 0.0 110.225 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.3 t -108.9 137.41 41.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.267 0.555 . . . . 0.0 111.757 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -130.49 151.52 50.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--N 1.321 -0.632 0 CA-C-O 121.074 0.464 . . . . 0.0 111.931 -179.055 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.788 0.327 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 pt -135.37 168.05 24.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 120.896 0.379 . . . . 0.0 110.373 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.525 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -106.0 116.52 32.08 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.923 0.392 . . . . 0.0 110.311 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.66 131.68 54.14 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 83' ' ' THR . 32.5 ttpt -111.42 141.32 45.12 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.293 0.568 . . . . 0.0 111.198 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 29' ' ' VAL . 41.0 t -112.77 125.71 70.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.174 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.28 118.1 20.8 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.546 0.688 . . . . 0.0 110.658 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.33 150.47 18.55 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.009 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -11.21 8.0 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.36 0.6 . . . . 0.0 112.202 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.1 -16.82 62.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.658 0.742 . . . . 0.0 110.32 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.07 -12.99 55.87 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -78.05 122.87 26.14 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.932 0.396 . . . . 0.0 110.436 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 22' ' ' VAL . 3.1 p -144.59 137.41 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.424 0.631 . . . . 0.0 111.195 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.7 t -144.47 151.09 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.582 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.525 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -110.15 141.89 42.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.821 0.343 . . . . 0.0 110.526 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -137.06 138.77 40.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.162 0.505 . . . . 0.0 111.534 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -106.48 114.92 29.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.052 0.453 . . . . 0.0 110.51 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.1 pt -132.68 170.46 19.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.139 0.495 . . . . 0.0 110.563 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.571 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.2 tmtp? -80.41 149.24 30.23 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.571 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 9.2 tpp180 -56.83 -25.2 55.66 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -107.28 3.3 25.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.722 0.773 . . . . 0.0 109.749 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 m -81.5 131.03 59.47 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 33.7 Cg_endo -63.13 147.75 93.89 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.208 1.939 . . . . 0.0 112.152 -177.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.6 mt -64.6 -15.24 60.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 57.1 p -50.97 -38.48 51.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.096 0.558 . . . . 0.0 111.466 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 39' ' ' PRO . 12.3 mmmm -55.85 -54.45 44.45 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 44' ' ' MET . 4.3 pp -75.86 -32.27 59.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.999 0.428 . . . . 0.0 111.322 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.593 ' N ' HD13 ' A' ' 43' ' ' LEU . 37.0 ttm -61.47 -50.25 73.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.615 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 69.4 mmtt -70.38 -41.64 72.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.84 0.352 . . . . 0.0 110.094 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.16 -45.46 92.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.265 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -56.49 -50.2 72.45 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.063 0.459 . . . . 0.0 110.466 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.622 ' SG ' HD13 ' A' ' 58' ' ' ILE . 58.2 m -63.1 -38.28 90.57 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.97 0.414 . . . . 0.0 111.498 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 48.6 mt-10 -64.34 -40.22 95.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.117 0.484 . . . . 0.0 111.571 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.3 ptp180 -86.2 -23.14 26.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -98.66 -10.73 22.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.979 0.418 . . . . 0.0 112.081 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.49 43.9 14.35 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.957 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.4 mm? -119.69 157.9 27.56 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 122.307 -0.525 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.2 m -107.53 128.31 54.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.166 0.507 . . . . 0.0 111.235 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.461 ' HE1' ' HG2' ' A' ' 44' ' ' MET . 58.0 mmm -56.62 -30.57 63.41 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.548 0.739 . . . . 0.0 112.766 -177.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.597 ' N ' ' HD3' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -83.35 -28.98 28.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.47 0.652 . . . . 0.0 111.081 -176.354 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -40.18 16.49 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.88 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.622 HD13 ' SG ' ' A' ' 48' ' ' CYS . 12.8 pt -91.63 174.45 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 O-C-N 121.906 -0.496 . . . . 0.0 110.443 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -150.36 130.85 13.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.266 0.555 . . . . 0.0 110.257 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -83.02 137.04 34.28 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.848 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -136.53 143.04 43.5 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.155 0.503 . . . . 0.0 110.576 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -148.84 130.3 14.8 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 69.24 25.71 5.59 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.83 0.824 . . . . 0.0 110.199 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.91 -24.55 5.91 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.192 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -92.68 136.23 25.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 122.479 -0.424 . . . . 0.0 110.93 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -67.81 142.65 58.4 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.11 1.873 . . . . 0.0 111.387 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 pt -112.71 174.8 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.068 0.461 . . . . 0.0 110.985 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.617 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -138.27 159.16 42.78 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.135 0.493 . . . . 0.0 111.995 -176.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 11.6 pt-20 -62.56 -10.21 11.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.775 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -97.99 7.42 46.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.886 0.374 . . . . 0.0 111.396 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.617 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.29 155.94 17.24 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 121.719 -0.613 . . . . 0.0 110.594 179.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 p -120.76 146.83 44.48 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.966 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.556 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 20.2 Cg_endo -60.64 -25.31 80.61 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.778 2.319 . . . . 0.0 112.494 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 -31.66 62.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.377 0.608 . . . . 0.0 110.519 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -68.15 -55.71 11.39 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.252 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -85.12 6.92 23.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.883 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 58.73 63.15 1.74 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.958 0.885 . . . . 0.0 112.275 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.5 mtt -84.1 134.52 34.6 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.488 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -96.89 175.12 6.46 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.009 0.433 . . . . 0.0 110.146 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -77.92 147.14 35.15 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 68.51 13.63 8.98 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.13 0.572 . . . . 0.0 112.248 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.97 162.9 23.66 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 15.8 m -124.73 142.14 51.62 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.68 0.753 . . . . 0.0 113.001 -173.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.65 135.28 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.082 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -93.74 121.31 35.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.048 0.452 . . . . 0.0 110.366 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.63 138.93 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.225 0.536 . . . . 0.0 112.006 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -130.92 152.74 49.92 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.86 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 121.271 0.558 . . . . 0.0 111.91 -179.237 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.4 pt -124.17 167.63 17.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.0 0.429 . . . . 0.0 110.061 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.466 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -106.52 124.1 49.09 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.811 0.338 . . . . 0.0 110.143 -178.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.3 125.09 49.37 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 35.5 ttpt -105.26 140.68 38.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.05 0.452 . . . . 0.0 111.004 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.4 ' O ' HG22 ' A' ' 29' ' ' VAL . 42.0 t -110.66 123.89 66.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.77 128.1 43.33 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.502 0.668 . . . . 0.0 110.514 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.39 148.86 16.52 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.692 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -5.4 2.3 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -82.54 -12.18 57.93 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.721 0.772 . . . . 0.0 110.122 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.28 -9.96 57.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.738 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.8 m -78.36 119.7 22.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 22' ' ' VAL . 4.2 p -145.48 141.22 22.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.365 0.603 . . . . 0.0 111.782 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 40.9 t -146.84 151.23 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.4 0.68 . . . . 0.0 109.174 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.466 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -110.41 141.44 43.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.931 0.396 . . . . 0.0 110.336 -179.071 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -136.54 153.58 50.96 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.067 0.46 . . . . 0.0 110.728 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 90.0 mttt -124.58 113.75 18.48 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.827 0.346 . . . . 0.0 110.246 178.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.4 pt -127.26 172.53 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.935 0.398 . . . . 0.0 110.658 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.6 tmtp? -80.91 152.04 28.28 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.477 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 9.6 tpp180 -54.67 -23.9 19.4 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -112.63 2.56 16.22 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.415 -0.803 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 m -79.49 131.65 64.42 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.562 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.33 144.82 92.12 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.636 2.224 . . . . 0.0 112.458 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.428 HD13 ' OD2' ' A' ' 71' ' ' ASP . 40.2 mt -65.01 -15.61 62.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.073 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.594 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 32.1 t -48.96 -37.82 21.19 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.643 0.377 . . . . 0.0 111.417 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -55.37 -53.29 58.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.714 0.293 . . . . 0.0 110.985 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 44' ' ' MET . 4.4 pp -75.48 -32.1 60.45 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.367 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.528 ' N ' HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -54.44 -56.74 15.63 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.3 0.571 . . . . 0.0 111.337 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 41' ' ' SER . 6.5 mmmt -71.47 -41.24 69.61 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.254 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.18 -49.01 78.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.939 0.399 . . . . 0.0 111.551 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -55.17 -51.66 65.79 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 121.029 0.443 . . . . 0.0 110.744 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.716 ' SG ' HD11 ' A' ' 58' ' ' ILE . 33.5 m -63.99 -36.68 84.78 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.869 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 41.6 mt-10 -65.86 -39.55 90.85 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.909 0.385 . . . . 0.0 111.525 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.5 ptp180 -85.96 -21.93 27.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.879 0.371 . . . . 0.0 111.707 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -96.11 -6.25 38.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.885 0.374 . . . . 0.0 111.467 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.87 41.89 71.45 Favored Glycine 0 C--N 1.321 -0.289 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.468 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 mp -115.8 153.54 31.26 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.358 0.599 . . . . 0.0 110.94 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.1 m -102.27 127.39 49.27 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.094 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.503 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 93.1 mmm -55.44 -31.98 62.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.039 0.536 . . . . 0.0 112.279 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -84.98 -28.3 25.89 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.158 0.504 . . . . 0.0 112.022 -178.081 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.714 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -91.19 -5.05 55.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.372 0.606 . . . . 0.0 110.488 -178.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.716 HD11 ' SG ' ' A' ' 48' ' ' CYS . 13.7 pt -122.71 170.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.967 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -143.94 138.51 28.54 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 120.875 0.369 . . . . 0.0 110.111 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -96.88 129.21 44.36 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.778 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -136.59 143.02 43.38 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.043 0.449 . . . . 0.0 110.276 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -148.38 133.45 18.24 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t70 68.21 24.56 7.5 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.675 0.75 . . . . 0.0 110.274 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.28 -21.39 6.06 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.144 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -93.11 141.73 24.44 Favored Pre-proline 0 C--N 1.317 -0.83 0 O-C-N 122.35 -0.5 . . . . 0.0 110.494 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.9 137.22 24.07 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.187 1.925 . . . . 0.0 111.649 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.8 pt -114.43 170.94 4.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.241 0.544 . . . . 0.0 110.663 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.682 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.31 155.64 46.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.025 -179.139 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 41' ' ' SER . 13.4 pt-20 -59.86 -10.17 3.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.08 0.467 . . . . 0.0 111.93 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -100.62 6.43 44.1 Favored 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 121.766 -0.583 . . . . 0.0 111.595 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.682 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -92.93 165.23 12.98 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 121.615 -0.678 . . . . 0.0 110.384 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.1 p -122.4 148.82 53.61 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.524 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.97 -20.14 58.83 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.141 2.561 . . . . 0.0 112.585 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.53 -31.54 37.02 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.052 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -67.53 -56.29 10.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.273 0.559 . . . . 0.0 110.991 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -81.84 8.73 9.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.018 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 57.69 63.08 1.91 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.587 0.708 . . . . 0.0 111.463 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.7 mtt -79.67 -165.58 0.83 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.989 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.44 169.81 15.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.55 139.51 42.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.205 0.526 . . . . 0.0 111.271 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 70.75 18.88 6.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.525 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -84.68 165.55 17.81 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 19.4 m -127.03 141.64 51.74 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.666 0.746 . . . . 0.0 112.852 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.06 140.28 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.223 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.32 121.76 38.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.11 0.481 . . . . 0.0 110.895 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.9 t -109.44 137.66 40.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.343 0.592 . . . . 0.0 111.555 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -128.71 149.55 50.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.963 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.366 0.603 . . . . 0.0 110.991 179.549 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 . . . . . 0 N--CA 1.447 -0.61 0 CA-C-O 120.719 0.295 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.6 pt -140.96 165.71 19.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.99 0.424 . . . . 0.0 110.29 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.564 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -106.22 122.37 46.07 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.37 124.43 47.69 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 36.5 ttpt -100.75 145.71 28.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.02 0.438 . . . . 0.0 110.266 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' HG22 ' A' ' 29' ' ' VAL . 46.6 t -115.87 125.87 73.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.74 124.02 34.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.57 0.7 . . . . 0.0 110.893 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.99 149.0 17.46 Favored Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.472 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -63.01 -11.4 18.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.525 0.679 . . . . 0.0 111.47 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.81 -14.05 60.64 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.76 0.79 . . . . 0.0 110.062 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.84 -9.78 58.53 Favored Glycine 0 C--N 1.307 -1.067 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.902 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -79.33 117.45 20.33 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.089 0.471 . . . . 0.0 110.055 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.7 p -143.38 139.19 26.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.215 0.531 . . . . 0.0 111.455 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.462 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 48.3 t -145.91 151.16 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.564 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -104.73 142.17 35.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 36.6 m-85 -132.41 157.36 44.75 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.556 0.693 . . . . 0.0 111.301 -177.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -134.38 110.61 9.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.407 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 pt -131.45 173.8 14.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.248 0.547 . . . . 0.0 111.256 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.402 ' O ' ' HB ' ' A' ' 38' ' ' THR . 2.1 tmtp? -80.48 146.39 31.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 33.6 ttm180 -64.4 -16.75 62.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.393 0.616 . . . . 0.0 112.157 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.6 2.03 30.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.405 0.621 . . . . 0.0 110.241 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 5.6 m -88.45 133.45 36.4 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.046 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.43 146.3 93.08 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.655 2.237 . . . . 0.0 112.54 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.444 HD13 ' OD1' ' A' ' 71' ' ' ASP . 30.5 mt -65.49 -15.26 62.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.923 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 13.8 p -54.61 -33.11 59.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.271 0.558 . . . . 0.0 110.568 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -57.65 -53.95 52.43 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.676 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.585 HD11 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.08 -31.9 58.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.432 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.585 ' N ' HD11 ' A' ' 43' ' ' LEU . 58.2 mtt -57.18 -56.73 18.07 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.994 0.426 . . . . 0.0 111.549 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -71.66 -34.64 69.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.914 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -61.5 -47.03 87.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.996 0.427 . . . . 0.0 110.726 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 20.5 t80 -55.05 -50.22 69.64 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 110.49 177.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.706 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.4 m -63.27 -40.68 98.09 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.568 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 41.5 mt-10 -64.03 -34.97 79.22 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.8 ptp180 -89.66 -26.06 20.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -94.14 -16.39 23.78 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.191 0.52 . . . . 0.0 112.157 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.19 35.94 10.44 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.251 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.617 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.5 mm? -113.81 154.31 27.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.293 0.568 . . . . 0.0 110.821 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -105.17 136.97 43.68 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.548 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.497 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 92.1 mmm -63.4 -22.48 66.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.144 0.497 . . . . 0.0 111.012 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.48 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -83.67 -28.58 28.25 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.421 0.629 . . . . 0.0 110.342 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.48 ' NE2' ' HB2' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -93.67 -10.95 32.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.881 -177.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.706 HD11 ' SG ' ' A' ' 48' ' ' CYS . 7.3 pt -128.3 170.86 17.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.093 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 tpp180 -148.7 135.9 20.17 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.102 0.477 . . . . 0.0 110.291 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.2 m-85 -91.01 138.96 31.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -141.61 140.92 33.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.028 0.442 . . . . 0.0 110.72 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -146.31 134.34 21.48 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 69.53 27.49 4.85 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.907 0.86 . . . . 0.0 110.533 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.26 -6.84 49.16 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.572 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -111.43 140.56 23.17 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 122.165 -0.609 . . . . 0.0 110.826 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.11 139.19 35.08 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.269 1.98 . . . . 0.0 111.273 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.1 pt -113.15 153.62 14.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.333 0.587 . . . . 0.0 111.708 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.7 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -108.56 152.98 24.02 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.343 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.577 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 13.8 pt-20 -60.95 -14.92 25.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.178 0.513 . . . . 0.0 111.924 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -93.42 7.71 43.42 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.7 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -91.58 158.07 16.64 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 121.587 -0.695 . . . . 0.0 110.714 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.5 p -118.55 145.61 37.85 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.881 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.443 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 18.2 Cg_endo -59.14 -21.53 59.89 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.798 2.332 . . . . 0.0 112.664 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 36' ' ' ARG . . . -81.26 -19.41 43.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.029 0.443 . . . . 0.0 111.266 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -80.69 -54.67 5.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.311 0.576 . . . . 0.0 110.783 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -82.68 10.53 7.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.135 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 57.85 62.44 2.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.35 0.595 . . . . 0.0 111.123 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -83.09 121.1 26.61 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.146 0.498 . . . . 0.0 110.36 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 82' ' ' ASP . 11.4 pt-20 -80.95 159.64 24.87 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.312 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -74.78 149.19 39.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.881 0.372 . . . . 0.0 111.465 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 63.15 19.31 11.58 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.818 0.847 . . . . 0.0 112.079 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.457 ' HB2' ' HG3' ' A' ' 79' ' ' GLU . 1.7 t70 -89.28 -178.02 5.53 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.543 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 16.4 m -130.11 151.43 50.65 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.376 0.608 . . . . 0.0 112.037 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.81 137.71 42.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 123.387 0.675 . . . . 0.0 109.215 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -91.76 124.67 36.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 110.807 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 47.4 t -111.52 136.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.296 0.57 . . . . 0.0 111.795 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -126.2 144.47 50.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.12 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.455 ' HG3' HG23 ' A' ' 58' ' ' ILE . 1.5 mp0 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 120.628 0.251 . . . . 0.0 110.75 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.922 0.391 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.6 pt -125.43 167.45 19.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.113 0.482 . . . . 0.0 110.068 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.511 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -107.37 126.82 52.96 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.833 -178.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.82 125.45 48.59 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -104.48 139.72 38.98 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.872 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 40.2 t -111.82 123.21 67.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.967 0.413 . . . . 0.0 110.03 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.72 112.43 14.8 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.763 0.792 . . . . 0.0 110.751 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.95 147.7 18.7 Favored Glycine 0 C--N 1.297 -1.608 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.271 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -10.27 7.91 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.243 0.544 . . . . 0.0 112.143 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -73.36 -13.66 61.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.631 0.729 . . . . 0.0 110.315 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.8 -15.25 55.75 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.8 m -74.7 117.03 16.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.247 0.546 . . . . 0.0 110.49 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 3.3 p -142.52 136.48 27.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.397 0.618 . . . . 0.0 111.1 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -145.39 151.66 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.463 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -108.32 140.45 41.58 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -134.2 155.3 50.39 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.133 0.492 . . . . 0.0 110.945 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 90.1 mttt -128.08 111.1 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.107 0.479 . . . . 0.0 110.642 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.3 pt -127.62 173.58 12.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.029 0.442 . . . . 0.0 110.283 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.6 tmtp? -78.6 146.37 34.2 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.456 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 40.0 ttm180 -64.32 -12.75 45.14 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.334 0.588 . . . . 0.0 111.865 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -107.04 -3.38 20.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.669 0.747 . . . . 0.0 109.617 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.8 m -83.5 135.05 44.07 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.609 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.88 145.05 89.91 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.708 2.272 . . . . 0.0 112.624 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 48.5 mt -65.67 -16.84 64.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.02 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 32.6 p -54.25 -34.8 61.56 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.01 0.433 . . . . 0.0 111.061 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -57.46 -52.1 66.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.566 HD13 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.73 -32.16 62.04 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.884 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.566 ' N ' HD13 ' A' ' 43' ' ' LEU . 58.5 mtt -58.12 -53.89 53.12 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.183 0.516 . . . . 0.0 110.903 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 34.2 mmtp -66.69 -41.74 87.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.019 0.438 . . . . 0.0 110.079 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.582 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.9 -48.02 83.4 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.115 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -55.73 -49.05 74.1 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.68 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.597 ' SG ' HD12 ' A' ' 58' ' ' ILE . 62.7 m -67.2 -36.27 81.38 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 47.7 mt-10 -62.61 -39.69 94.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.093 0.473 . . . . 0.0 111.215 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 14.8 ptp180 -86.73 -25.71 24.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -93.52 -8.65 40.8 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.98 -0.45 . . . . 0.0 111.817 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.15 43.78 46.68 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.727 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.9 mp -115.91 152.89 32.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.39 0.614 . . . . 0.0 111.043 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.2 m -99.15 124.33 44.11 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.973 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.506 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 95.4 mmm -60.85 -22.33 64.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.949 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.471 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.3 OUTLIER -84.68 -32.62 23.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.482 0.658 . . . . 0.0 110.804 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.734 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -84.73 -20.66 30.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.909 -176.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.597 HD12 ' SG ' ' A' ' 48' ' ' CYS . 16.0 pt -113.02 176.17 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.231 0.539 . . . . 0.0 111.949 -177.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -149.22 140.23 22.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.407 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.435 ' CD2' ' HG2' ' A' ' 44' ' ' MET . 6.4 m-85 -94.61 129.44 41.45 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.594 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -130.55 143.58 50.85 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.538 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -150.12 136.82 19.17 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 t70 67.32 26.98 8.38 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.834 0.826 . . . . 0.0 110.815 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.38 -5.61 59.67 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.991 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -116.63 142.09 29.09 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 122.076 -0.661 . . . . 0.0 110.883 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.11 134.66 34.75 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.067 1.845 . . . . 0.0 110.799 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.706 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 12.1 pt -104.49 -177.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.137 0.494 . . . . 0.0 111.631 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' A' ' 71' ' ' ASP . 0.5 OUTLIER -129.39 161.63 29.88 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 121.689 0.757 . . . . 0.0 110.649 -175.132 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.1 pt-20 -67.98 -15.28 63.54 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.764 0.792 . . . . 0.0 109.583 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 t -110.01 16.49 21.85 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.706 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 1.8 p-10 -98.23 101.5 12.98 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 118.517 -1.273 . . . . 0.0 110.722 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 p -60.31 141.22 91.21 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.73 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 11.1 Cg_endo -56.39 -24.25 51.09 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.991 2.46 . . . . 0.0 112.288 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.26 -34.2 68.07 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.128 0.49 . . . . 0.0 110.647 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -64.95 -55.78 17.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.986 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.405 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 2.1 pt? -85.09 6.57 24.96 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.712 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 60.37 52.6 4.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.716 0.769 . . . . 0.0 111.499 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.76 131.64 40.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.273 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -94.94 165.75 12.29 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.028 0.442 . . . . 0.0 110.613 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -76.37 148.28 37.5 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.359 0.6 . . . . 0.0 110.553 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 65.64 14.72 9.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.768 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.62 167.21 20.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.8 m -123.04 140.77 52.68 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.03 135.93 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.191 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -94.98 118.97 32.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.064 0.459 . . . . 0.0 110.296 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.37 138.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.148 0.499 . . . . 0.0 111.793 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -128.6 150.87 50.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.952 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.425 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.1 mp0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 111.672 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 121.78 0.8 . . . . 0.0 111.16 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.7 pt -128.96 160.04 40.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.01 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.525 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.2 OUTLIER -95.72 123.87 39.49 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.478 HD23 ' SD ' ' A' ' 78' ' ' MET . 86.4 mt -122.89 125.9 46.25 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.229 0.538 . . . . 0.0 110.206 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 83' ' ' THR . 36.7 ttpt -106.82 142.82 35.85 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.283 0.563 . . . . 0.0 110.98 -178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 41.1 t -115.77 126.92 73.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.65 126.51 38.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.401 0.619 . . . . 0.0 110.526 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.51 147.35 16.61 Favored Glycine 0 C--N 1.301 -1.404 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.749 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.4 pp0? -60.64 -15.45 28.53 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 112.221 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -76.37 -11.81 59.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.926 0.87 . . . . 0.0 109.636 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.85 -11.54 45.47 Favored Glycine 0 C--N 1.318 -0.463 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.434 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -73.34 114.63 11.76 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.472 -0.428 . . . . 0.0 110.755 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 4.9 p -141.14 135.9 32.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.312 0.577 . . . . 0.0 111.367 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -145.67 151.04 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.397 -177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.525 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -109.45 138.89 45.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.016 0.436 . . . . 0.0 110.091 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 18.1 m-85 -133.39 164.17 27.72 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 121.12 0.486 . . . . 0.0 110.638 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -135.27 112.38 10.37 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 122.199 -0.313 . . . . 0.0 110.22 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 pt -126.84 168.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.946 0.403 . . . . 0.0 110.779 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 1.1 tmtp? -77.7 152.69 33.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.865 0.364 . . . . 0.0 110.391 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.419 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 10.2 tpp180 -60.96 -21.74 63.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.001 0.52 . . . . 0.0 112.071 -177.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -105.76 -2.02 23.7 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.823 -0.548 . . . . 0.0 110.099 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.7 m -82.35 132.21 53.49 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.658 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.99 147.8 85.01 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.707 2.271 . . . . 0.0 112.31 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.19 -16.12 63.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.99 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 22.7 t -49.76 -38.64 34.84 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.495 0.318 . . . . 0.0 111.079 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 6.7 mmpt? -56.55 -53.48 57.09 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -75.79 -32.33 59.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.612 ' N ' HD12 ' A' ' 43' ' ' LEU . 41.2 ttm -61.24 -50.4 73.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.891 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.532 ' HD2' ' SD ' ' A' ' 55' ' ' MET . 13.5 mmmm -70.67 -40.85 72.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.8 0.333 . . . . 0.0 110.184 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.69 -46.37 89.28 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.084 0.469 . . . . 0.0 111.444 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 24.1 t80 -55.73 -50.96 68.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.063 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.696 ' SG ' HD12 ' A' ' 58' ' ' ILE . 35.0 m -63.91 -37.32 86.97 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.032 0.444 . . . . 0.0 111.167 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -62.44 -40.39 96.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.993 0.425 . . . . 0.0 111.695 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.7 ptp180 -87.94 -21.96 24.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.843 0.354 . . . . 0.0 111.8 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -96.36 -11.35 25.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.35 7.07 85.39 Favored Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.694 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 7.2 mp -82.79 155.12 24.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.614 0.721 . . . . 0.0 112.176 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.6 m -106.15 132.82 51.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.832 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.532 ' SD ' ' HD2' ' A' ' 45' ' ' LYS . 63.7 mmm -56.18 -33.45 65.28 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -177.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -25.84 28.15 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.909 -0.495 . . . . 0.0 111.657 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.99 -19.93 31.31 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.304 0.573 . . . . 0.0 110.85 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.696 HD12 ' SG ' ' A' ' 48' ' ' CYS . 8.4 pt -116.76 174.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.046 0.45 . . . . 0.0 110.971 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -153.81 138.8 17.25 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -92.83 137.35 32.44 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.306 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -136.94 139.37 41.49 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.301 0.572 . . . . 0.0 111.299 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -150.25 143.33 24.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 t70 67.3 24.1 9.13 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.873 0.845 . . . . 0.0 110.115 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.19 -2.44 81.42 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.391 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -121.96 142.36 36.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 122.059 -0.671 . . . . 0.0 110.887 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.97 138.69 53.57 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.012 1.808 . . . . 0.0 110.835 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.432 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 13.6 pt -112.46 172.95 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.096 0.474 . . . . 0.0 110.856 -177.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.622 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -133.76 157.98 44.49 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.079 0.466 . . . . 0.0 111.574 -177.491 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 41' ' ' SER . 17.2 pt-20 -60.4 -11.84 7.8 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.714 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -100.97 11.36 39.77 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.817 0.341 . . . . 0.0 111.582 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.622 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -99.5 157.15 16.64 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 121.721 -0.612 . . . . 0.0 109.593 177.5 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.2 p -118.51 148.06 43.29 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.704 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.86 -18.69 62.34 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.691 2.261 . . . . 0.0 112.284 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.419 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -85.9 -15.69 40.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.196 0.522 . . . . 0.0 111.193 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -82.26 -56.36 3.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.299 0.571 . . . . 0.0 110.436 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -86.8 1.98 50.45 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.221 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 62.28 61.59 1.28 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.609 0.719 . . . . 0.0 112.908 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.595 ' SD ' HD13 ' A' ' 84' ' ' ILE . 29.4 ttm -89.08 137.45 32.31 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -106.83 176.79 5.06 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.897 0.38 . . . . 0.0 110.79 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -75.3 143.52 42.91 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.169 0.509 . . . . 0.0 110.793 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 71.9 13.58 6.01 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.024 0.93 . . . . 0.0 110.855 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -80.38 161.88 24.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 22.9 m -127.34 145.84 50.66 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.342 0.591 . . . . 0.0 112.316 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.595 HD13 ' SD ' ' A' ' 78' ' ' MET . 4.0 mp -110.32 136.89 44.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.426 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -93.76 130.94 39.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.1 0.476 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 46.5 t -112.74 138.63 41.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.508 0.67 . . . . 0.0 111.854 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -134.08 163.64 29.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.361 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--N 1.323 -0.569 0 CA-C-O 120.814 0.34 . . . . 0.0 111.228 179.116 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 . . . . . 0 N--CA 1.446 -0.666 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.432 HD13 ' HB2' ' A' ' 73' ' ' PRO . 19.1 pt -132.28 167.85 25.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.285 0.564 . . . . 0.0 110.815 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.642 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -99.75 129.57 45.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.754 -179.268 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.97 126.93 45.13 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 83' ' ' THR . 35.0 ttpt -109.49 141.81 41.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.329 0.585 . . . . 0.0 111.221 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.27 127.04 70.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.167 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.18 121.95 25.75 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.661 0.743 . . . . 0.0 110.502 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.2 149.39 16.61 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.242 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -11.55 11.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.474 0.654 . . . . 0.0 112.043 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.85 -18.46 62.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.544 0.687 . . . . 0.0 110.435 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.12 -5.37 45.75 Favored Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.9 m -86.82 121.65 29.61 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.884 0.373 . . . . 0.0 110.381 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 p -144.35 138.33 23.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.366 0.603 . . . . 0.0 111.415 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -146.3 151.01 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.642 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -109.93 140.65 43.67 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -132.24 157.82 43.37 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 121.19 0.519 . . . . 0.0 111.255 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -127.82 108.55 10.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.8 pt -124.19 176.36 5.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.203 0.525 . . . . 0.0 110.73 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.3 tmtp? -85.44 149.61 25.29 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.097 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.487 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 17.6 tpp180 -53.06 -26.67 16.73 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.601 0.761 . . . . 0.0 112.576 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -111.87 6.49 19.6 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.588 -0.695 . . . . 0.0 111.748 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 m -81.64 133.93 51.7 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.0 145.07 84.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.645 2.23 . . . . 0.0 112.361 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 48.1 mt -65.2 -17.06 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.927 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.47 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 35.5 p -50.47 -37.89 40.95 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.561 0.344 . . . . 0.0 111.686 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.7 mmpt? -56.36 -52.57 64.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.755 0.312 . . . . 0.0 110.72 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.88 -31.86 61.7 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.363 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.574 ' N ' HD12 ' A' ' 43' ' ' LEU . 53.2 mtt -58.2 -54.91 41.67 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.25 0.547 . . . . 0.0 110.979 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.573 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 57.6 mmtt -65.49 -44.43 87.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.936 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.723 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -57.56 -49.04 77.67 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.071 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -54.92 -51.7 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.593 ' SG ' HD13 ' A' ' 58' ' ' ILE . 34.1 m -67.19 -35.05 78.82 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.935 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.573 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 51.4 mt-10 -66.97 -36.18 81.61 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.209 -0.307 . . . . 0.0 111.682 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.723 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -88.13 -25.81 22.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 178.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -92.25 -6.06 51.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 111.555 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.2 46.38 57.95 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.158 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.8 mp -117.36 151.51 36.86 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.224 0.535 . . . . 0.0 110.827 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 71.4 m -96.76 123.0 40.32 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.905 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.489 ' HE1' ' HB3' ' A' ' 44' ' ' MET . 92.3 mmm -56.64 -28.13 59.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.993 0.517 . . . . 0.0 111.903 -178.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -84.39 -34.87 23.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.261 0.553 . . . . 0.0 111.116 -178.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.71 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -81.66 -18.91 42.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.066 0.46 . . . . 0.0 111.338 -177.373 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.593 HD13 ' SG ' ' A' ' 48' ' ' CYS . 14.3 pt -110.57 -179.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 120.968 0.413 . . . . 0.0 110.671 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -157.31 133.3 9.49 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.173 0.511 . . . . 0.0 110.433 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.9 m-85 -85.54 135.87 33.64 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.063 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -144.79 148.21 33.8 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.997 0.427 . . . . 0.0 110.362 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -154.69 138.96 16.62 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.1 t70 65.84 25.19 11.28 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.59 0.709 . . . . 0.0 110.306 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 -26.56 5.75 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.763 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -90.94 144.62 30.38 Favored Pre-proline 0 C--N 1.327 -0.386 0 O-C-N 122.408 -0.466 . . . . 0.0 110.811 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.85 141.88 27.67 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.9 1.733 . . . . 0.0 110.338 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.653 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 6.9 pt -106.08 -179.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.832 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.473 HD21 ' HB3' ' A' ' 71' ' ' ASP . 0.4 OUTLIER -129.93 165.42 22.12 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.599 0.714 . . . . 0.0 110.714 -174.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.486 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 11.1 pt-20 -67.82 -12.94 61.65 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.943 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -118.87 16.93 13.47 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.653 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 3.6 p-10 -91.27 98.76 11.92 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.415 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 p -58.49 145.56 75.75 Favored Pre-proline 0 C--N 1.301 -1.508 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.044 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HB2' HD13 ' A' ' 18' ' ' ILE . 17.9 Cg_endo -59.57 -15.82 32.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.899 2.4 . . . . 0.0 111.58 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 36' ' ' ARG . . . -80.01 -31.1 39.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.462 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -67.54 -54.67 18.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.264 0.554 . . . . 0.0 111.657 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -84.2 7.84 17.69 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.809 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 57.66 40.49 26.56 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.508 0.671 . . . . 0.0 111.224 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.86 130.29 43.55 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.463 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.86 169.75 17.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.14 0.495 . . . . 0.0 110.417 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -79.05 145.4 33.86 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 66.28 20.24 11.04 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.447 0.699 . . . . 0.0 110.975 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.03 161.42 28.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.071 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 30.3 m -121.51 135.35 55.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.645 0.736 . . . . 0.0 112.379 -175.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.84 137.94 24.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.164 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -93.62 117.38 30.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.29 0.567 . . . . 0.0 110.85 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.82 134.89 46.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.427 0.632 . . . . 0.0 111.737 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -131.84 159.87 37.3 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.442 ' HG3' HG21 ' A' ' 58' ' ' ILE . 2.1 mp0 . . . . . 0 C--N 1.318 -0.778 0 CA-C-O 121.139 0.495 . . . . 0.0 110.496 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 . . . . . 0 N--CA 1.44 -0.938 0 CA-C-O 120.769 0.318 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.8 pt -131.61 163.52 37.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.026 0.441 . . . . 0.0 110.19 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.522 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -97.23 141.22 30.62 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.5 mt -137.51 125.19 22.32 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 83' ' ' THR . 33.4 ttpt -108.36 140.67 41.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.243 0.544 . . . . 0.0 111.422 -176.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.5 t -114.54 127.55 71.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.847 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.61 120.37 23.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.437 0.637 . . . . 0.0 110.582 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.52 150.83 17.7 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.405 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.58 -8.94 7.27 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 112.502 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.54 -13.77 60.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.706 0.765 . . . . 0.0 109.945 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.85 -10.61 58.87 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.0 m -81.42 123.72 28.81 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.001 0.429 . . . . 0.0 110.264 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 22' ' ' VAL . 3.6 p -143.71 138.28 25.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 121.278 0.561 . . . . 0.0 110.955 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.3 t -143.04 150.8 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.595 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.522 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -107.63 137.67 45.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.087 0.47 . . . . 0.0 109.971 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 29.9 m-85 -128.15 166.44 18.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 121.382 0.61 . . . . 0.0 110.503 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -141.63 111.46 6.66 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.469 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.2 pt -131.04 176.29 9.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.395 0.616 . . . . 0.0 111.549 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.426 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 1.9 tmtp? -88.45 150.52 23.1 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.267 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.426 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 21.8 tpp180 -54.98 -27.46 44.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.944 0.898 . . . . 0.0 112.712 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -108.47 3.55 23.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.272 0.558 . . . . 0.0 111.026 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.7 m -85.16 131.81 47.32 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.195 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.52 148.7 90.62 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.508 2.139 . . . . 0.0 112.484 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.4 mt -65.61 -15.6 62.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.763 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 54.1 p -50.96 -37.91 47.43 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 122.91 0.484 . . . . 0.0 111.343 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -56.91 -53.68 55.16 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.073 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.38 -32.4 58.55 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.0 0.429 . . . . 0.0 111.317 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.62 ' N ' HD12 ' A' ' 43' ' ' LEU . 41.8 ttm -60.44 -52.12 66.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.682 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 33.1 mmtp -70.49 -37.74 74.25 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.884 0.373 . . . . 0.0 110.283 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.94 -45.4 94.84 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.92 0.391 . . . . 0.0 111.004 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 21.1 t80 -56.78 -51.92 67.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.364 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.3 p -61.63 -36.59 81.19 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.216 0.532 . . . . 0.0 110.608 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 61.6 mm-40 -67.06 -45.41 77.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.878 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.9 ptp180 -78.99 -25.59 43.37 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -93.47 -12.27 30.12 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.979 -0.45 . . . . 0.0 112.2 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.95 43.81 9.59 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.323 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.442 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.0 mm? -120.6 160.06 24.0 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.016 0.436 . . . . 0.0 110.162 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.404 ' O ' HG12 ' A' ' 58' ' ' ILE . 4.7 m -109.65 135.65 50.27 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.737 0.303 . . . . 0.0 111.013 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.427 ' HE1' ' HG2' ' A' ' 44' ' ' MET . 86.3 mmm -58.01 -27.8 63.84 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.25 -24.14 27.91 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.783 -0.573 . . . . 0.0 111.443 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.68 -14.07 32.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.25 0.548 . . . . 0.0 110.136 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.442 HG21 ' HB3' ' A' ' 53' ' ' LEU . 16.1 pt -120.5 169.94 11.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 120.944 0.402 . . . . 0.0 110.674 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -149.9 136.6 19.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -95.13 136.04 35.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.146 0.498 . . . . 0.0 110.342 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.35 142.13 37.61 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.109 0.48 . . . . 0.0 110.885 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -153.44 143.27 22.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 64.63 23.76 12.87 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.411 0.624 . . . . 0.0 110.696 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.89 -2.93 82.09 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.491 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -118.35 149.29 45.65 Favored Pre-proline 0 C--N 1.332 -0.153 0 O-C-N 122.163 -0.61 . . . . 0.0 110.376 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.47 139.81 20.98 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.846 1.697 . . . . 0.0 110.575 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.9 pt -113.46 160.73 12.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.43 0.633 . . . . 0.0 111.487 -176.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.641 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -120.2 157.14 29.71 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.424 -178.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 41' ' ' SER . 7.3 pt-20 -62.77 -9.78 10.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.994 0.426 . . . . 0.0 111.92 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.0 t -99.02 7.68 45.73 Favored 'General case' 0 N--CA 1.441 -0.916 0 O-C-N 122.036 -0.415 . . . . 0.0 111.898 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.641 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.4 OUTLIER -92.71 156.65 16.91 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 121.682 -0.636 . . . . 0.0 109.898 178.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.2 p -115.99 146.77 37.79 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.8 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.81 -12.89 33.92 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.793 2.329 . . . . 0.0 112.279 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.83 -24.49 23.7 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.326 0.584 . . . . 0.0 110.604 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -72.54 -55.33 7.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.39 0.614 . . . . 0.0 110.851 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -88.7 12.39 14.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.969 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 53.38 62.95 2.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.518 0.675 . . . . 0.0 111.576 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.84 130.15 35.09 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.683 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.48 166.88 11.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.923 0.392 . . . . 0.0 110.602 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.429 ' HB2' HD21 ' A' ' 19' ' ' ASN . 6.2 p-10 -73.06 143.74 47.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.22 0.533 . . . . 0.0 110.941 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 66.8 15.0 10.03 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.863 0.865 . . . . 0.0 112.129 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -76.98 166.63 23.07 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 18.8 m -121.68 138.21 54.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.22 135.91 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.152 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -93.6 121.58 35.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.086 0.47 . . . . 0.0 110.973 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.3 t -109.79 136.83 44.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.201 0.524 . . . . 0.0 111.613 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -129.45 151.06 50.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.089 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--N 1.326 -0.437 0 CA-C-O 121.054 0.454 . . . . 0.0 110.868 178.112 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 16.2 p-80 . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.95 0.405 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.451 HD13 HD11 ' A' ' 20' ' ' LEU . 15.9 pt -133.87 166.65 28.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.096 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.604 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -102.85 115.45 30.62 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 120.835 0.35 . . . . 0.0 110.226 -179.029 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.451 HD11 HD13 ' A' ' 18' ' ' ILE . 6.6 mp -112.55 125.66 54.49 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.431 0.634 . . . . 0.0 109.947 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 83' ' ' THR . 34.1 ttpt -105.56 146.51 29.52 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.349 0.595 . . . . 0.0 111.356 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 39.4 t -116.64 128.95 73.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.97 121.42 22.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.433 0.635 . . . . 0.0 110.489 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.0 150.31 17.1 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.839 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.46 -10.58 7.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.583 0.706 . . . . 0.0 111.86 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.534 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 21.0 t70 -71.22 -19.45 62.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.253 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.89 -13.89 49.44 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -74.94 112.34 11.08 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.796 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.3 p -139.12 131.97 37.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.281 0.563 . . . . 0.0 110.913 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.53 150.83 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.604 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -106.36 142.22 36.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.847 0.356 . . . . 0.0 110.568 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -137.29 139.0 40.64 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.133 0.492 . . . . 0.0 111.076 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.437 ' HZ1' ' HB2' ' A' ' 33' ' ' LYS . 7.7 mtmp? -106.6 113.93 27.74 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.97 -0.456 . . . . 0.0 110.028 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.3 pt -126.9 170.09 17.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.972 0.415 . . . . 0.0 110.743 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.0 tmtp? -81.4 148.04 29.51 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 11.7 tpp180 -56.26 -26.14 50.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.85 0.46 . . . . 0.0 112.032 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -102.46 -2.4 28.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.531 0.681 . . . . 0.0 110.127 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.0 m -81.33 132.07 56.93 Favored Pre-proline 0 N--CA 1.434 -1.231 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.307 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.2 148.2 88.67 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.523 2.149 . . . . 0.0 111.841 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.4 mt -64.81 -15.18 61.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.743 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 11.8 p -49.22 -37.52 23.28 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -56.57 -53.42 57.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.85 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.512 HD11 ' N ' ' A' ' 44' ' ' MET . 4.3 pp -74.44 -31.63 62.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.377 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.512 ' N ' HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -53.13 -58.06 8.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.023 0.439 . . . . 0.0 111.244 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.507 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -72.38 -38.14 68.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.399 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.35 -48.17 82.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.179 0.514 . . . . 0.0 110.958 -177.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -56.51 -51.35 68.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.886 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.797 ' SG ' HD11 ' A' ' 58' ' ' ILE . 31.4 m -63.75 -36.57 84.29 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.968 0.413 . . . . 0.0 111.914 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 40.4 mt-10 -64.35 -42.27 96.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.053 0.454 . . . . 0.0 111.189 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.1 ptp180 -84.35 -19.87 32.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 0.0 111.683 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -100.75 -2.4 32.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.96 48.04 69.19 Favored Glycine 0 C--O 1.235 0.202 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.348 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.435 ' HB3' HG22 ' A' ' 58' ' ' ILE . 49.5 mt -122.69 154.53 37.95 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.067 0.46 . . . . 0.0 110.673 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.2 m -103.67 126.66 50.95 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.354 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.486 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 81.0 mmm -57.92 -26.89 62.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.035 0.534 . . . . 0.0 111.808 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -28.12 27.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.243 0.544 . . . . 0.0 111.05 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.678 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -93.01 -27.48 16.98 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.937 -177.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.797 HD11 ' SG ' ' A' ' 48' ' ' CYS . 10.0 pt -103.11 163.63 3.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 O-C-N 121.375 -0.828 . . . . 0.0 110.766 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -136.97 132.15 33.94 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.073 0.463 . . . . 0.0 110.657 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -90.32 126.98 36.04 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -138.29 144.84 40.65 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.281 0.562 . . . . 0.0 111.493 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -149.83 141.83 23.89 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 t70 64.69 25.42 13.04 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.906 0.86 . . . . 0.0 110.0 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.97 -15.38 10.52 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.521 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -100.4 135.35 20.25 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 122.184 -0.597 . . . . 0.0 110.879 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.09 131.95 24.96 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.032 1.821 . . . . 0.0 111.081 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.577 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 5.7 pt -98.75 -177.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.426 HD21 ' HB3' ' A' ' 71' ' ' ASP . 0.7 OUTLIER -133.82 166.75 21.92 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-O 121.54 0.686 . . . . 0.0 110.437 -174.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 10.3 pt-20 -78.9 -8.17 58.61 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.753 0.787 . . . . 0.0 108.964 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -107.38 16.24 24.12 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.058 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.577 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -103.81 151.55 22.94 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.9 p -115.79 150.17 44.42 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.035 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.416 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 19.3 Cg_endo -61.55 -17.0 51.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.509 2.14 . . . . 0.0 111.444 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.44 -20.48 40.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.935 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.64 -53.77 8.7 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.29 0.567 . . . . 0.0 110.468 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.91 12.25 20.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.325 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 57.33 52.78 8.31 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.244 0.545 . . . . 0.0 111.439 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.37 137.08 34.85 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -104.13 -175.61 2.85 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.949 0.404 . . . . 0.0 110.4 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.451 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 11.6 p-10 -80.0 153.86 28.59 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.352 0.596 . . . . 0.0 110.319 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 63.24 18.83 11.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.916 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.75 157.57 25.78 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 25.4 m -130.21 147.68 51.96 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.595 -0.691 . . . . 0.0 112.69 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.25 140.28 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.066 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -93.86 124.25 37.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.937 0.398 . . . . 0.0 111.033 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.5 t -109.79 139.8 31.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.261 0.553 . . . . 0.0 111.522 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -132.14 156.9 45.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.743 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.534 ' OE1' ' HB2' ' A' ' 26' ' ' ASP . 2.0 mp0 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 121.131 0.491 . . . . 0.0 111.85 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.401 HG13 HD23 ' A' ' 20' ' ' LEU . 34.0 pt -127.41 158.14 38.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.073 0.463 . . . . 0.0 110.389 177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.0 119.27 34.19 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.405 HD21 HG12 ' A' ' 34' ' ' ILE . 2.7 mm? -110.8 125.05 53.16 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 34.1 ttpt -104.55 139.71 39.03 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.063 0.459 . . . . 0.0 110.628 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.26 125.74 69.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.82 120.99 24.52 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.728 0.775 . . . . 0.0 110.959 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.41 146.59 18.33 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -62.61 -6.88 3.89 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.19 -4.46 59.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.735 0.779 . . . . 0.0 110.061 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.14 -10.06 56.62 Favored Glycine 0 C--N 1.316 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.57 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -74.1 113.58 11.45 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 122.753 -0.263 . . . . 0.0 110.307 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.55 137.22 28.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.461 0.648 . . . . 0.0 112.229 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.2 t -145.36 150.86 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -112.36 135.15 53.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.167 0.508 . . . . 0.0 110.569 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -126.36 166.87 16.36 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.217 0.532 . . . . 0.0 111.009 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -133.93 119.41 19.06 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.089 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.405 HG12 HD21 ' A' ' 20' ' ' LEU . 44.8 pt -134.61 170.79 18.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.073 0.463 . . . . 0.0 110.43 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.525 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.4 tmtp? -82.95 153.14 25.18 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.525 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 13.6 tpp180 -54.21 -24.45 18.46 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.109 0.564 . . . . 0.0 112.27 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -106.67 -5.06 18.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.565 0.697 . . . . 0.0 110.103 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.4 m -78.65 131.16 68.63 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.659 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.33 146.25 85.41 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.748 2.299 . . . . 0.0 112.325 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.44 -17.19 64.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.724 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.0 p -50.23 -38.96 43.13 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.76 0.424 . . . . 0.0 111.525 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.6 mmpt? -55.96 -53.33 58.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.573 HD11 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.86 -31.95 61.76 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.459 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.573 ' N ' HD11 ' A' ' 43' ' ' LEU . 53.8 mtt -60.12 -54.9 40.43 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.018 0.437 . . . . 0.0 111.41 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.542 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 11.2 mmmm -67.27 -39.01 86.01 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.227 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.78 79.77 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 111.298 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 26.4 t80 -55.33 -50.77 68.78 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.042 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 58' ' ' ILE . 35.3 m -63.96 -34.27 77.6 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.842 0.353 . . . . 0.0 111.873 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.9 mt-10 -66.57 -39.54 88.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.911 0.386 . . . . 0.0 111.376 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -86.25 -21.94 27.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.976 0.417 . . . . 0.0 111.622 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.412 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 21.5 mm-40 -96.99 0.33 48.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.021 0.439 . . . . 0.0 111.561 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.01 45.19 96.63 Favored Glycine 0 CA--C 1.512 -0.145 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.964 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.462 ' HB3' HG22 ' A' ' 58' ' ' ILE . 86.2 mt -119.41 157.58 27.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.166 0.508 . . . . 0.0 110.587 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.3 m -106.33 131.81 53.1 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.394 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.536 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 88.1 mmm -58.99 -23.37 61.8 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.253 0.549 . . . . 0.0 111.255 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.515 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.5 OUTLIER -84.66 -34.12 23.1 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.211 0.529 . . . . 0.0 111.236 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.515 ' NE2' ' HB2' ' A' ' 56' ' ' ARG . 0.8 OUTLIER -88.38 -17.1 31.26 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.992 0.425 . . . . 0.0 111.612 -176.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.773 HD12 ' SG ' ' A' ' 48' ' ' CYS . 6.3 pt -117.33 172.56 4.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.79 144.78 23.73 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.141 0.496 . . . . 0.0 110.628 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.433 ' CE2' ' HG2' ' A' ' 44' ' ' MET . 6.1 m-85 -99.37 136.61 39.07 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.744 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -137.21 141.0 42.1 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.022 0.439 . . . . 0.0 110.379 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -151.18 140.69 21.57 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t0 68.65 24.68 6.73 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.832 0.825 . . . . 0.0 110.068 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.9 -0.72 65.24 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.964 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -118.45 136.07 23.88 Favored Pre-proline 0 N--CA 1.445 -0.721 0 O-C-N 122.157 -0.614 . . . . 0.0 110.466 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.58 136.38 49.87 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.906 1.738 . . . . 0.0 110.685 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.459 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 15.0 pt -112.21 169.94 4.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.383 0.611 . . . . 0.0 111.251 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.677 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -129.9 153.52 48.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.004 -177.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.463 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.6 pt-20 -59.17 -11.13 3.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.045 0.45 . . . . 0.0 112.207 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -96.63 5.3 50.99 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 122.043 -0.41 . . . . 0.0 111.65 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.677 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -96.54 161.76 13.76 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 121.574 -0.704 . . . . 0.0 110.425 -179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.5 p -121.63 150.94 56.26 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.708 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.4 -23.15 62.13 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.955 2.437 . . . . 0.0 112.244 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -77.03 -31.67 56.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.219 0.533 . . . . 0.0 110.788 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -72.11 -55.85 6.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.565 -176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -81.96 10.07 7.15 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 56.48 62.25 2.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 111.84 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 mtt -77.75 -169.91 1.67 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.347 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -156.59 158.61 37.41 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.63 141.98 40.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.16 0.505 . . . . 0.0 110.489 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 67.87 17.49 9.67 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.945 0.898 . . . . 0.0 112.017 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.57 171.66 11.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 m -125.11 138.57 54.17 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.581 0.705 . . . . 0.0 112.665 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.51 134.78 35.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -93.9 122.06 36.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.115 0.483 . . . . 0.0 110.602 -178.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 49.7 t -109.43 138.17 38.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.325 0.583 . . . . 0.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.86 155.24 46.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.523 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.484 ' HG3' HG21 ' A' ' 58' ' ' ILE . 2.7 mp0 . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 120.704 0.287 . . . . 0.0 110.879 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 120.794 0.331 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.18 -53.82 1.04 Allowed 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -112.71 -10.58 13.61 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.367 0.604 . . . . 0.0 112.028 -176.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.69 -34.19 6.55 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.227 0.536 . . . . 0.0 109.662 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -150.76 71.42 8.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.325 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -75.14 153.67 41.27 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.343 2.029 . . . . 0.0 111.62 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -69.65 -15.86 63.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.032 0.444 . . . . 0.0 111.454 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -72.86 -72.39 0.25 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.878 0.847 . . . . 0.0 110.082 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.29 -54.4 3.9 Favored Glycine 0 C--N 1.291 -1.937 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.115 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.33 152.15 4.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 120.939 0.4 . . . . 0.0 110.348 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.548 ' N ' ' HE3' ' A' ' 11' ' ' LYS . 0.8 OUTLIER -66.12 173.61 3.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.016 0.436 . . . . 0.0 110.854 178.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 m -71.74 93.15 1.25 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.801 0.81 . . . . 0.0 110.501 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -93.34 151.38 19.81 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.386 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -82.02 166.56 19.68 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -79.77 73.96 6.49 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.883 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 36' ' ' ARG . 2.6 p-10 -107.2 91.28 3.59 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 122.344 1.069 . . . . 0.0 108.725 171.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -118.73 150.53 39.62 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.506 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.3 pt -129.6 156.44 41.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.148 0.499 . . . . 0.0 110.658 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.454 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -96.53 113.61 25.2 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.887 -178.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.481 ' HG ' ' SD ' ' A' ' 78' ' ' MET . 1.5 mm? -109.57 128.58 55.31 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.094 0.473 . . . . 0.0 109.752 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 37.3 ttpt -106.66 141.89 37.19 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.127 0.489 . . . . 0.0 111.168 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.1 t -112.48 124.18 68.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.38 112.05 13.43 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.509 0.671 . . . . 0.0 110.81 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.26 148.68 19.07 Favored Glycine 0 C--N 1.299 -1.499 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.143 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -60.58 -11.65 7.76 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.342 0.591 . . . . 0.0 112.355 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -71.25 -18.49 62.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.601 0.715 . . . . 0.0 110.132 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.24 -10.21 50.63 Favored Glycine 0 C--N 1.316 -0.557 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.6 m -78.51 116.87 19.2 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.973 0.416 . . . . 0.0 109.982 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 p -142.34 135.49 27.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.318 0.58 . . . . 0.0 111.282 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.413 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 25.0 t -145.27 151.89 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.301 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.62 136.23 49.31 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.413 ' CZ ' ' HB ' ' A' ' 30' ' ' VAL . 17.0 m-85 -131.9 133.06 44.17 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.075 0.464 . . . . 0.0 111.095 -175.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 60.7 mtpt -107.51 107.67 18.63 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.911 -0.493 . . . . 0.0 110.988 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.4 pt -121.59 173.18 7.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.227 0.536 . . . . 0.0 110.459 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -81.27 150.57 28.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.12 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.411 ' HB3' ' OD2' ' A' ' 16' ' ' ASP . 7.3 tpp180 -58.32 -20.9 46.84 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.893 0.477 . . . . 0.0 111.926 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -108.73 2.64 21.95 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.861 -0.525 . . . . 0.0 111.014 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.7 m -85.89 133.12 42.03 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.793 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.21 146.47 81.45 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.728 2.285 . . . . 0.0 112.383 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.429 HD11 ' OD2' ' A' ' 71' ' ' ASP . 31.0 mt -65.86 -16.95 64.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.941 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.4 p -50.15 -37.62 35.38 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.797 0.439 . . . . 0.0 111.365 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -57.41 -52.49 65.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.91 -31.64 61.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.336 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.558 ' N ' HD12 ' A' ' 43' ' ' LEU . 56.3 mtt -59.44 -54.7 43.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.55 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.568 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 38.0 mmtm -66.06 -41.18 91.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 109.911 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.79 -47.31 86.22 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.373 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -54.49 -49.74 69.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.597 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 75.4 m -66.28 -34.99 79.25 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 84.3 mt-10 -61.03 -44.6 97.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.188 0.518 . . . . 0.0 111.141 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.9 ptp85 -85.42 -28.22 25.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -90.8 -18.7 24.46 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.817 -0.552 . . . . 0.0 112.184 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.36 41.59 9.98 Favored Glycine 0 C--N 1.309 -0.971 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.748 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.55 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.3 mm? -114.06 153.41 29.49 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.294 -0.533 . . . . 0.0 110.806 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 75.2 m -95.7 124.11 39.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.747 0.308 . . . . 0.0 110.447 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.496 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 92.0 mmm -60.11 -25.51 65.51 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -28.55 26.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.299 0.571 . . . . 0.0 111.178 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.672 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -83.17 -40.91 19.1 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.163 0.506 . . . . 0.0 110.772 -178.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.546 HD13 ' SG ' ' A' ' 48' ' ' CYS . 13.0 pt -90.86 178.06 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.115 0.484 . . . . 0.0 110.929 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -155.43 142.66 19.34 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.874 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.7 m-85 -92.33 137.08 32.66 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.085 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -140.6 134.71 30.9 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.051 0.453 . . . . 0.0 110.028 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.402 ' CZ ' ' HG3' ' A' ' 78' ' ' MET . 72.3 t80 -143.81 135.53 26.23 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.04 26.43 5.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.512 0.672 . . . . 0.0 111.11 176.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.03 -6.35 71.57 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.1 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -118.4 142.61 31.65 Favored Pre-proline 0 C--N 1.319 -0.76 0 O-C-N 122.284 -0.539 . . . . 0.0 110.53 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.37 141.22 46.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.112 1.875 . . . . 0.0 111.104 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 pt -115.8 160.39 15.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.236 0.541 . . . . 0.0 110.905 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.64 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -118.97 153.31 34.84 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.566 -178.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.7 pt-20 -60.5 -12.0 8.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.019 0.438 . . . . 0.0 112.039 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -94.15 4.83 53.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.626 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.64 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -91.84 156.7 17.32 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 121.672 -0.643 . . . . 0.0 110.395 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.7 p -119.06 148.64 45.27 Favored Pre-proline 0 N--CA 1.439 -0.981 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.838 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.29 -17.48 46.96 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.705 2.27 . . . . 0.0 112.417 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.37 -16.52 32.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.095 0.474 . . . . 0.0 111.268 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -82.61 -55.68 4.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.335 0.588 . . . . 0.0 110.567 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -85.11 3.37 39.25 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.996 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 62.74 62.31 1.09 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.449 0.642 . . . . 0.0 112.455 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.516 ' SD ' HD13 ' A' ' 84' ' ' ILE . 29.7 ttm -90.41 139.27 30.83 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -109.33 171.14 7.61 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.416 0.627 . . . . 0.0 111.705 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -65.91 141.27 58.29 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.085 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 65.47 13.95 9.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.687 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.96 170.66 15.33 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.2 m -128.55 144.21 51.11 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.516 HD13 ' SD ' ' A' ' 78' ' ' MET . 4.1 mp -104.8 133.08 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.764 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -94.15 125.57 38.86 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.31 0.576 . . . . 0.0 110.873 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 41.6 t -108.82 136.28 45.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.245 0.545 . . . . 0.0 111.147 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -128.78 153.01 47.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.034 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.419 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.6 mp0 -102.75 111.07 23.22 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.413 ' H ' ' NE2' ' A' ' 89' ' ' GLN . 2.1 mp0 -59.01 -57.47 12.92 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.582 0.706 . . . . 0.0 110.762 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -83.73 -170.21 2.95 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.082 175.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -81.77 -173.15 4.28 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.874 0.368 . . . . 0.0 111.424 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.87 -17.99 0.1 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.392 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.766 0 CA-C-O 118.938 -0.923 . . . . 0.0 111.584 179.506 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 121.469 0.652 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.5 20.78 2.2 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.15 23.13 6.82 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.776 -175.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -76.97 -59.62 2.7 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.922 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -159.37 82.27 2.47 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 121.927 0.87 . . . . 0.0 110.82 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.97 148.5 35.5 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.265 1.977 . . . . 0.0 110.625 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -143.77 40.61 1.41 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.54 174.92 6.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.68 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.44 -11.66 16.38 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.671 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.55 120.5 10.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.299 -0.45 . . . . 0.0 110.067 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -127.29 22.35 6.57 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.614 0.721 . . . . 0.0 111.025 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -85.17 80.83 9.08 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.763 0.792 . . . . 0.0 110.436 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -93.6 96.28 9.75 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.86 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -131.43 42.06 3.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.842 0.83 . . . . 0.0 109.825 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -157.76 167.08 31.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.176 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.38 82.1 7.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.876 0.37 . . . . 0.0 110.237 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -124.68 151.78 44.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.6 pt -130.92 159.15 43.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.285 0.564 . . . . 0.0 110.744 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.499 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.2 OUTLIER -93.75 127.15 39.33 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.7 mt -126.49 125.59 42.33 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 83' ' ' THR . 31.9 ttpt -106.41 141.37 37.84 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.401 0.62 . . . . 0.0 111.224 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.9 t -114.15 126.88 71.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.503 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.29 121.95 27.06 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.454 0.645 . . . . 0.0 110.803 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.2 148.89 18.57 Favored Glycine 0 C--N 1.298 -1.567 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.54 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -16.49 27.34 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.262 0.553 . . . . 0.0 112.142 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -70.36 -15.7 62.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.548 0.689 . . . . 0.0 110.709 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.68 -10.9 53.29 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.566 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.537 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . 70.2 m -78.54 115.34 18.18 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.107 0.48 . . . . 0.0 110.242 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.73 135.21 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.329 0.585 . . . . 0.0 111.781 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.4 t -140.68 150.12 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.93 -177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.499 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -108.51 140.55 41.68 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.9 0.381 . . . . 0.0 110.667 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -134.81 163.45 29.79 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 110.367 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HB2' ' HZ2' ' A' ' 33' ' ' LYS . 6.2 mtmp? -134.85 110.31 9.09 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.3 pt -126.03 166.95 21.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.916 0.389 . . . . 0.0 110.434 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -74.71 147.43 41.42 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.431 ' HG2' ' HB1' ' A' ' 74' ' ' ALA . 42.7 ttm180 -65.16 -15.41 62.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.187 0.518 . . . . 0.0 111.909 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -103.11 -3.52 25.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.746 0.784 . . . . 0.0 109.079 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 m -88.99 133.55 35.2 Favored Pre-proline 0 N--CA 1.439 -1.01 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.132 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.0 150.67 87.77 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.643 2.228 . . . . 0.0 112.708 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.1 mt -65.44 -15.67 62.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.578 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 34.3 p -49.97 -37.4 32.17 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 122.768 0.427 . . . . 0.0 111.731 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 7.4 mmpt? -57.61 -52.39 65.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.242 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.44 -31.94 62.46 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.366 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.581 ' N ' HD12 ' A' ' 43' ' ' LEU . 57.7 mtt -60.98 -54.53 43.83 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.527 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 34.8 mmtp -68.54 -37.03 79.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.554 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.558 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.84 -47.94 81.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.986 0.422 . . . . 0.0 110.543 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.418 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 57.1 t80 -56.06 -51.93 66.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.343 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 p -61.09 -35.12 76.15 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.068 -0.395 . . . . 0.0 111.425 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 37.6 mt-10 -67.38 -43.27 81.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.439 . . . . 0.0 111.798 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 13.3 ptp180 -80.66 -25.89 37.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.809 0.337 . . . . 0.0 111.646 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.537 ' OE1' ' HB3' ' A' ' 28' ' ' SER . 20.5 mm-40 -93.85 -2.63 53.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.793 0.33 . . . . 0.0 111.822 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.91 91.84 Favored Glycine 0 CA--C 1.508 -0.344 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.74 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' A' ' 58' ' ' ILE . 84.9 mt -119.25 157.04 28.83 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.19 0.519 . . . . 0.0 110.714 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.7 m -107.12 129.51 54.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.568 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.439 ' CE ' ' HB3' ' A' ' 44' ' ' MET . 98.4 mmm -63.17 -22.47 66.89 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.164 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.06 -23.91 30.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.436 0.636 . . . . 0.0 110.422 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.85 -44.47 8.92 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.076 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.477 HG23 ' HB3' ' A' ' 53' ' ' LEU . 15.3 pt -88.52 166.83 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 O-C-N 121.661 -0.649 . . . . 0.0 110.348 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -144.43 137.85 27.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.951 0.405 . . . . 0.0 110.155 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -93.5 139.99 30.1 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.853 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -144.88 143.42 30.58 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.035 0.445 . . . . 0.0 110.291 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -152.28 135.85 16.1 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t70 67.34 25.77 8.64 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.471 0.653 . . . . 0.0 111.107 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.02 0.58 76.58 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.622 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -118.74 145.04 36.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 121.912 -0.758 . . . . 0.0 110.088 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.36 141.98 23.43 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.872 1.715 . . . . 0.0 111.166 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.8 pt -115.01 160.45 14.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.275 0.559 . . . . 0.0 111.289 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.597 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -121.66 155.42 35.2 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.805 -178.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 9.8 pt-20 -61.97 -9.76 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.172 0.511 . . . . 0.0 111.738 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -97.09 9.45 42.07 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 122.054 -0.404 . . . . 0.0 111.313 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.597 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -96.57 154.58 17.19 Favored 'General case' 0 C--O 1.243 0.718 0 O-C-N 121.74 -0.6 . . . . 0.0 109.734 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.3 p -117.16 146.98 39.37 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.551 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.87 -22.48 68.61 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.649 2.233 . . . . 0.0 112.091 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' HB1' ' HG2' ' A' ' 36' ' ' ARG . . . -80.35 -17.25 52.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.159 0.504 . . . . 0.0 110.904 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -79.23 -54.86 5.56 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.341 0.591 . . . . 0.0 110.023 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -87.54 12.25 12.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.223 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 57.08 58.73 3.79 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.491 0.662 . . . . 0.0 111.55 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.61 131.77 34.57 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.726 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -97.35 167.13 11.2 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.164 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.441 ' HB2' HD21 ' A' ' 19' ' ' ASN . 4.3 p-10 -76.69 150.58 36.31 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.111 0.481 . . . . 0.0 110.82 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 67.28 13.87 9.52 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.015 0.926 . . . . 0.0 112.209 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.17 171.38 13.74 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 17.6 m -125.97 147.7 49.45 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.393 0.616 . . . . 0.0 112.354 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.3 133.66 54.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.38 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.03 121.39 31.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.235 0.541 . . . . 0.0 111.275 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.81 138.93 35.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.244 0.545 . . . . 0.0 111.384 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -128.45 150.21 50.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.489 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -101.86 112.69 25.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.284 0.564 . . . . 0.0 111.643 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -99.93 -176.12 3.16 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.57 ' HA ' HE21 ' A' ' 90' ' ' GLN . 0.0 OUTLIER 60.43 21.33 10.97 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.331 0.653 . . . . 0.0 109.99 -178.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 m 58.86 65.46 1.22 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.736 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.01 -20.87 77.2 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.498 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.462 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.385 178.863 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.713 0.292 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.58 27.62 11.48 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.474 0.71 . . . . 0.0 111.293 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -136.45 18.76 3.13 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.853 0.835 . . . . 0.0 109.621 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -83.77 27.52 0.63 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.614 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 68.48 56.51 0.65 Allowed Pre-proline 0 N--CA 1.466 0.375 0 C-N-CA 123.394 0.677 . . . . 0.0 110.564 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.68 161.84 44.66 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.541 2.16 . . . . 0.0 111.713 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -86.09 -13.19 47.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.197 0.522 . . . . 0.0 111.09 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -121.77 132.93 54.88 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' LYS . . . 64.96 56.08 18.32 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.874 -178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.21 38.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 122.005 0.907 . . . . 0.0 110.571 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER 49.21 34.47 6.13 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.016 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 p -113.09 -84.73 0.59 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.825 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.72 160.74 42.41 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.368 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.1 m120 62.95 43.58 6.65 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.857 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -67.62 174.62 3.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.442 0.639 . . . . 0.0 111.651 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.13 85.74 5.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.272 1.034 . . . . 0.0 110.743 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -121.03 143.87 48.83 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.126 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 pt -130.63 165.1 31.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.047 0.451 . . . . 0.0 110.591 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.12 120.51 40.57 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -111.83 124.57 52.63 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -104.81 142.16 35.23 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.046 0.45 . . . . 0.0 110.634 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.84 127.71 71.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 120.958 0.409 . . . . 0.0 110.112 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.18 123.38 26.95 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.491 0.662 . . . . 0.0 110.146 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.9 148.41 16.47 Favored Glycine 0 C--N 1.3 -1.437 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.986 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -7.26 4.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -82.94 -10.63 58.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.482 0.658 . . . . 0.0 109.897 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.67 -13.36 46.54 Favored Glycine 0 CA--C 1.511 -0.193 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.338 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.1 m -77.31 119.24 20.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.962 0.41 . . . . 0.0 110.678 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.81 135.31 33.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.583 0.706 . . . . 0.0 111.366 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -143.33 149.46 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.0 139.77 42.15 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.106 -0.371 . . . . 0.0 110.4 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -128.43 163.7 24.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.32 0.581 . . . . 0.0 110.758 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -137.7 111.73 8.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.951 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 pt -136.44 173.33 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.323 0.582 . . . . 0.0 111.085 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 11.5 tmtt? -77.08 147.98 36.36 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.591 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.487 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 40.1 ttm180 -60.29 -18.12 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -112.59 5.11 17.68 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.372 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -83.03 133.98 47.25 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.29 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.1 140.34 83.45 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.684 2.256 . . . . 0.0 113.045 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.439 HD12 ' OD2' ' A' ' 71' ' ' ASP . 42.3 mt -65.1 -15.7 62.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.824 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.584 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 23.0 t -49.27 -39.63 31.3 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 122.615 0.366 . . . . 0.0 111.27 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.514 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -58.3 -52.46 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.6 -32.01 62.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.922 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.611 ' N ' HD12 ' A' ' 43' ' ' LEU . 38.9 ttm -61.78 -52.01 65.97 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.61 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 50.5 mmtt -68.61 -42.57 77.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.001 0.429 . . . . 0.0 110.03 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.76 -45.24 90.18 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.955 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.407 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 49.2 t80 -57.95 -52.34 65.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.455 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.521 ' SG ' ' HG2' ' A' ' 55' ' ' MET . 14.4 p -62.4 -37.62 86.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.119 0.485 . . . . 0.0 110.982 -177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 48.1 mt-10 -67.63 -37.59 82.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.987 0.422 . . . . 0.0 111.898 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.6 ptp180 -85.7 -23.41 27.41 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.104 -0.372 . . . . 0.0 111.552 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.407 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 19.6 mm-40 -97.01 -4.53 39.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.938 0.399 . . . . 0.0 111.75 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.45 54.62 Favored Glycine 0 C--N 1.322 -0.201 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.249 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.6 mp -116.65 154.43 30.56 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.156 0.503 . . . . 0.0 110.614 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.0 m -102.45 122.37 44.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.493 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.521 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 97.8 mmm -56.09 -25.48 45.67 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -83.75 -30.92 26.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.614 0.721 . . . . 0.0 109.985 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.71 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -88.52 -24.34 22.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.256 -177.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 54' ' ' SER . 21.9 pt -107.25 174.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 121.895 -0.503 . . . . 0.0 110.158 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 1.9 tpp180 -159.05 134.35 8.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.203 0.525 . . . . 0.0 110.509 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 4.1 m-85 -85.64 143.18 28.57 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.625 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.429 ' HG3' ' C ' ' A' ' 65' ' ' GLN . 26.0 ttm180 -142.1 141.78 32.74 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.066 0.46 . . . . 0.0 110.541 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -150.32 136.91 19.0 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.25 27.68 8.28 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.342 0.592 . . . . 0.0 111.207 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.4 2.08 83.28 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.239 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.429 ' C ' ' HG3' ' A' ' 61' ' ' ARG . 7.5 pt20 -125.5 144.52 48.18 Favored Pre-proline 0 C--N 1.317 -0.836 0 O-C-N 122.178 -0.601 . . . . 0.0 110.26 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.85 143.0 53.79 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.039 1.826 . . . . 0.0 111.442 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.7 pt -113.63 171.45 3.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.058 0.456 . . . . 0.0 110.552 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.649 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.59 155.48 47.46 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.7 -177.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 41' ' ' SER . 12.6 pt-20 -63.02 -8.83 8.12 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.134 0.492 . . . . 0.0 111.897 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 t -99.11 9.39 43.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 121.982 -0.449 . . . . 0.0 111.293 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.649 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.4 157.74 16.21 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.789 179.1 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.6 p -123.61 151.7 64.08 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.487 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 12.2 Cg_endo -57.54 -19.85 38.71 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.76 2.307 . . . . 0.0 112.641 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.2 35.23 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.94 -0.475 . . . . 0.0 110.97 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -72.44 -56.26 5.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.186 0.517 . . . . 0.0 110.86 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -81.88 6.06 16.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.634 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 56.64 64.14 1.76 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.722 0.772 . . . . 0.0 111.145 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.79 -170.69 1.12 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.258 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -147.57 149.73 33.13 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.74 143.87 47.84 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 68.3 14.93 9.28 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.228 0.611 . . . . 0.0 111.878 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -87.61 173.95 8.74 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.044 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.3 m -126.41 142.42 51.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.699 0.761 . . . . 0.0 112.757 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.76 133.09 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.786 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -90.55 119.95 31.23 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.041 0.448 . . . . 0.0 110.623 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.27 136.7 41.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.491 0.662 . . . . 0.0 111.609 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -134.78 165.71 24.64 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -107.54 110.86 22.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.079 0.466 . . . . 0.0 110.196 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.47 ' NE2' ' HB3' ' A' ' 59' ' ' ARG . 2.0 mp0 -110.25 70.28 0.72 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.39 0.614 . . . . 0.0 110.877 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -86.87 -27.82 23.22 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.7 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.4 p -81.46 -70.82 0.51 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.223 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.06 26.88 0.02 OUTLIER Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.857 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.82 0 CA-C-O 119.16 -0.8 . . . . 0.0 111.479 179.7 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.963 0.411 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.05 -5.13 42.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.56 0.695 . . . . 0.0 110.599 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -80.53 -21.41 41.85 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.972 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -78.94 -36.68 41.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.463 0.649 . . . . 0.0 109.408 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.51 ' O ' ' HG2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -151.59 87.97 4.37 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-O 121.605 0.717 . . . . 0.0 111.962 178.15 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.0 -177.02 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.497 2.132 . . . . 0.0 111.392 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -82.04 -34.38 29.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -78.33 130.06 35.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.971 0.415 . . . . 0.0 110.564 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.16 -30.46 34.34 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.725 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -63.26 119.26 6.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.522 0.677 . . . . 0.0 110.413 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -101.74 89.89 3.83 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.564 0.697 . . . . 0.0 111.117 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -103.42 42.03 1.21 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 122.195 0.998 . . . . 0.0 109.446 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -165.46 -173.67 2.88 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.48 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -138.7 131.6 29.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.136 0.493 . . . . 0.0 110.986 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.592 ' OD1' ' HE3' ' A' ' 35' ' ' LYS . 50.0 t30 -124.37 132.92 53.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.369 0.604 . . . . 0.0 110.29 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -105.35 -85.75 0.48 Allowed 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.791 0.805 . . . . 0.0 109.098 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 72.92 104.41 0.07 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.418 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 pt -116.05 158.07 16.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.19 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.409 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -96.79 114.49 26.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.7 mt -110.98 124.8 52.86 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 83' ' ' THR . 32.3 ttpt -102.38 136.8 41.56 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.284 0.564 . . . . 0.0 111.185 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 29' ' ' VAL . 48.2 t -112.46 125.71 69.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.226 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.15 125.84 41.86 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.44 0.638 . . . . 0.0 110.61 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.95 152.07 20.16 Favored Glycine 0 C--N 1.302 -1.354 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.018 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -19.38 38.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.227 0.513 . . . . 0.0 112.32 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.13 -22.97 63.92 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.942 0.877 . . . . 0.0 109.742 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.47 -9.3 38.28 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.483 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . 67.1 m -68.97 125.36 26.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 22' ' ' VAL . 7.1 p -146.36 145.35 19.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.24 0.543 . . . . 0.0 111.569 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.1 t -146.79 151.51 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.409 ' NE2' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -111.08 132.26 54.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.236 0.541 . . . . 0.0 109.879 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 32.7 m-85 -122.02 168.16 12.26 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.782 -175.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -137.58 119.67 15.51 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 pt -138.47 163.6 28.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 32.0 tttt -76.32 165.13 25.29 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.293 0.568 . . . . 0.0 111.795 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -71.65 -19.31 62.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.408 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -105.55 -6.8 19.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.9 0.857 . . . . 0.0 108.872 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.4 m -78.19 131.75 68.48 Favored Pre-proline 0 N--CA 1.435 -1.183 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.576 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.86 148.58 86.44 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.415 2.077 . . . . 0.0 111.707 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.15 -16.48 63.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.737 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 13.2 p -50.64 -37.45 40.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.824 0.449 . . . . 0.0 112.091 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 9.4 mmpt? -55.47 -53.88 50.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.912 0.387 . . . . 0.0 110.925 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 44' ' ' MET . 4.0 pp -75.66 -32.58 60.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.325 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.643 ' N ' HD13 ' A' ' 43' ' ' LEU . 46.2 ttm -59.33 -50.32 74.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.082 0.468 . . . . 0.0 110.458 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.637 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 1.9 mmmp? -69.9 -44.24 70.1 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.001 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.62 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.54 -42.97 93.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.739 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 34.1 t80 -54.27 -51.11 65.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.882 0.372 . . . . 0.0 110.623 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.676 ' SG ' HD13 ' A' ' 58' ' ' ILE . 23.3 m -63.66 -34.54 78.06 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.023 0.44 . . . . 0.0 111.12 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 48.9 mm-40 -63.64 -39.47 94.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.067 0.461 . . . . 0.0 111.734 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.62 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -90.68 -20.82 22.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.791 0.329 . . . . 0.0 111.862 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 28' ' ' SER . 19.5 mm-40 -95.11 -4.57 45.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.95 9.78 85.19 Favored Glycine 0 C--O 1.236 0.279 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.76 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.41 162.46 17.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.552 0.691 . . . . 0.0 112.007 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.419 ' O ' HG12 ' A' ' 58' ' ' ILE . 7.3 m -114.07 136.94 52.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.87 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.494 ' HE2' ' HG2' ' A' ' 44' ' ' MET . 68.8 mmm -60.17 -28.35 67.86 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.776 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.414 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -83.39 -33.24 25.82 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.417 0.627 . . . . 0.0 110.911 -178.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.5 -20.91 46.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.395 0.616 . . . . 0.0 111.187 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.676 HD13 ' SG ' ' A' ' 48' ' ' CYS . 9.4 pt -118.15 179.72 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.134 0.492 . . . . 0.0 111.915 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -158.51 142.25 15.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.842 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -96.52 142.16 28.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.076 0.465 . . . . 0.0 111.008 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -144.18 143.15 30.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.075 0.464 . . . . 0.0 110.789 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -152.68 139.35 18.81 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.1 t70 65.47 23.97 11.89 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.828 0.823 . . . . 0.0 110.079 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.27 -23.47 8.24 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.885 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -94.68 140.14 22.5 Favored Pre-proline 0 C--N 1.322 -0.587 0 O-C-N 122.427 -0.455 . . . . 0.0 110.984 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.15 136.14 31.24 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.868 1.712 . . . . 0.0 110.623 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.604 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 10.8 pt -102.95 177.63 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.738 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.426 ' C ' ' HE1' ' A' ' 44' ' ' MET . 0.8 OUTLIER -138.34 170.03 16.73 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.827 0.822 . . . . 0.0 111.066 -174.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 12.0 pt-20 -73.44 -9.87 59.14 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.523 0.677 . . . . 0.0 109.708 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.2 t -107.9 10.94 28.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.211 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.604 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -99.84 155.4 17.68 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.908 178.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.8 p -118.53 147.87 42.91 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.329 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.12 -18.81 63.98 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.008 2.472 . . . . 0.0 112.177 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.65 -29.63 41.0 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.237 0.541 . . . . 0.0 110.511 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -67.85 -55.26 13.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.202 0.525 . . . . 0.0 110.825 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -88.53 12.44 14.48 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.738 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 52.28 62.81 2.51 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.724 0.773 . . . . 0.0 112.085 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.78 126.84 32.32 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.891 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.04 157.0 19.01 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -74.39 153.21 39.34 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 121.742 -0.599 . . . . 0.0 110.44 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 69.57 14.79 8.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.112 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -81.77 166.43 20.04 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.809 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 18.9 m -124.85 137.6 54.29 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.583 0.706 . . . . 0.0 112.88 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.99 140.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.659 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -95.31 117.86 31.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.089 0.471 . . . . 0.0 110.897 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -106.41 137.94 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.173 0.511 . . . . 0.0 111.414 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -129.55 155.71 45.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.899 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -102.14 111.74 24.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.987 0.422 . . . . 0.0 110.293 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.579 HE21 ' N ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -111.12 63.51 0.61 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.521 0.677 . . . . 0.0 111.126 179.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -131.49 83.82 2.13 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.1 m -73.67 110.94 8.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.227 0.537 . . . . 0.0 112.215 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.49 -122.64 5.13 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.925 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.449 179.133 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.105 0.479 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.98 1.19 55.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.795 0.807 . . . . 0.0 110.328 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -88.8 17.89 5.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.576 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.87 -48.98 27.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.524 0.678 . . . . 0.0 109.363 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -135.06 81.4 45.3 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-O 121.504 0.669 . . . . 0.0 111.692 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.1 144.23 29.67 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 123.254 2.636 . . . . 0.0 112.381 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -89.76 57.81 4.02 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.768 0.794 . . . . 0.0 109.404 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -75.38 142.5 43.1 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.635 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.93 39.83 32.15 Favored Glycine 0 CA--C 1.505 -0.587 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.342 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.45 146.93 6.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 120.922 0.391 . . . . 0.0 110.743 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -145.58 161.89 38.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.176 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.1 p -132.69 139.21 47.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.189 0.519 . . . . 0.0 112.147 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -140.68 117.0 10.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 57.44 85.76 0.08 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.745 0.783 . . . . 0.0 111.424 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -151.73 143.02 23.37 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.631 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.645 ' OD2' ' HD2' ' A' ' 36' ' ' ARG . 1.9 t70 -88.68 85.74 6.85 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.591 0.71 . . . . 0.0 109.334 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -119.28 146.48 45.22 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.507 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.17 166.98 27.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.075 0.464 . . . . 0.0 110.168 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.432 ' OD1' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -108.45 121.26 44.58 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.36 131.22 56.63 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 83' ' ' THR . 31.1 ttpt -107.81 140.66 40.56 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.072 0.463 . . . . 0.0 110.521 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 39.1 t -114.08 127.5 71.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.099 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.99 127.26 35.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.143 0.497 . . . . 0.0 110.333 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.57 153.72 16.8 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.221 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.6 pp0? -61.39 -17.74 55.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.402 0.62 . . . . 0.0 111.126 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.1 -15.1 62.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.982 0.896 . . . . 0.0 109.757 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.65 -16.1 55.11 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.796 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -70.11 118.6 13.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.049 0.452 . . . . 0.0 110.688 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.6 p -142.98 136.27 25.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.148 0.499 . . . . 0.0 111.527 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 t -146.86 151.99 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.246 0.618 . . . . 0.0 109.516 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' A' ' 31' ' ' GLN . 1.0 OUTLIER -110.77 141.85 43.53 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.231 -0.293 . . . . 0.0 110.497 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -135.59 156.43 48.87 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.055 0.455 . . . . 0.0 110.826 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.432 ' HE3' ' OD1' ' A' ' 19' ' ' ASN . 48.3 mttp -125.46 110.32 13.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 110.433 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.2 pt -125.27 173.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 110.673 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -83.54 148.36 27.24 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.645 ' HD2' ' OD2' ' A' ' 16' ' ' ASP . 28.7 ttm180 -64.59 -14.51 58.18 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -107.6 -1.52 21.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.542 0.686 . . . . 0.0 109.835 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.8 m -86.73 133.54 39.46 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.679 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 151.0 85.05 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.606 2.204 . . . . 0.0 112.473 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.8 mt -65.18 -16.63 63.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.631 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 24.5 p -49.9 -37.76 32.89 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.933 0.493 . . . . 0.0 111.822 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 8.7 mmpt? -56.27 -53.56 55.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.872 0.368 . . . . 0.0 110.654 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -75.39 -31.85 60.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.47 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.567 ' N ' HD13 ' A' ' 43' ' ' LEU . 53.4 mtt -57.32 -55.99 27.64 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.793 0.33 . . . . 0.0 111.721 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -70.13 -39.19 75.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.54 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.25 -44.99 88.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.145 0.497 . . . . 0.0 110.609 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -60.17 -51.92 67.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.675 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.79 ' SG ' HD13 ' A' ' 58' ' ' ILE . 40.0 m -63.63 -34.55 78.08 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.009 0.433 . . . . 0.0 111.801 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 17.9 mm-40 -67.83 -39.38 83.88 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.051 0.453 . . . . 0.0 111.474 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.0 ptp180 -84.55 -22.54 30.06 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.917 0.389 . . . . 0.0 111.417 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -96.77 -3.05 43.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.253 0.549 . . . . 0.0 111.697 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.81 43.33 91.89 Favored Glycine 0 C--N 1.32 -0.351 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.349 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.487 ' HB3' HG21 ' A' ' 58' ' ' ILE . 28.6 mt -117.94 154.96 31.04 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.12 0.486 . . . . 0.0 110.594 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 75.2 m -102.03 126.51 48.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.696 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.532 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 92.7 mmm -55.5 -27.97 51.78 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.464 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -84.21 -30.76 25.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.419 0.628 . . . . 0.0 111.185 -177.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 0.8 OUTLIER -87.01 -28.88 22.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.686 -178.099 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.79 HD13 ' SG ' ' A' ' 48' ' ' CYS . 5.8 pt -105.07 177.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -157.31 141.18 16.02 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.113 0.482 . . . . 0.0 110.59 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 5.2 m-85 -91.97 141.9 28.12 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.135 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -139.81 138.79 36.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.154 0.502 . . . . 0.0 110.706 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -148.48 140.88 24.25 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 t70 67.72 23.46 8.63 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.766 0.793 . . . . 0.0 109.822 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.41 -0.24 75.98 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.26 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -119.4 138.01 26.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 O-C-N 122.206 -0.585 . . . . 0.0 110.411 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.85 141.46 71.57 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.015 1.81 . . . . 0.0 111.25 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.9 pt -114.78 167.55 7.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.86 0.362 . . . . 0.0 111.05 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.659 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -128.17 155.97 43.63 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.553 -177.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.3 pt-20 -60.12 -10.75 4.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 112.001 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.2 t -99.29 9.1 44.01 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 122.039 -0.413 . . . . 0.0 111.786 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.659 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -98.03 159.75 14.74 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 121.658 -0.651 . . . . 0.0 110.65 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.1 p -117.76 148.99 44.35 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.617 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.97 -19.8 69.97 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.514 2.142 . . . . 0.0 111.904 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.12 -20.95 40.31 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.005 0.431 . . . . 0.0 111.074 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -74.76 -53.86 8.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.545 0.688 . . . . 0.0 110.565 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.31 4.4 31.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.333 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 61.39 62.84 1.28 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.61 0.719 . . . . 0.0 111.832 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 mtt -79.19 126.56 30.91 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.176 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.69 157.75 18.43 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.517 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.6 147.26 49.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.859 0.361 . . . . 0.0 110.264 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 67.18 15.18 9.99 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.426 0.69 . . . . 0.0 112.167 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -82.73 168.28 17.36 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 19.1 m -125.6 140.41 52.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.842 0.83 . . . . 0.0 112.849 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.84 134.27 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.85 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.79 125.23 40.21 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.191 0.52 . . . . 0.0 111.254 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 44.0 t -108.48 137.94 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.414 0.626 . . . . 0.0 112.12 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -136.12 166.54 23.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' A' ' 58' ' ' ILE . 2.5 mp0 -112.3 112.78 24.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.028 0.442 . . . . 0.0 111.406 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.53 45.38 0.98 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.481 0.658 . . . . 0.0 110.245 176.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.417 ' HG3' ' HA ' ' A' ' 57' ' ' GLN . 23.9 mm-40 -162.33 123.68 2.64 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 124.299 1.04 . . . . 0.0 108.852 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.8 m -87.99 104.53 16.72 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.133 0.492 . . . . 0.0 110.358 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.72 105.89 3.26 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 121.041 -0.599 . . . . 0.0 111.653 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.292 0 CA-C-O 118.479 -1.178 . . . . 0.0 111.643 -179.219 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' O ' ' HG2' ' A' ' 4' ' ' GLU . 46.7 mtt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 121.455 0.645 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.06 14.56 30.23 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.858 0.837 . . . . 0.0 109.41 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.65 17.36 23.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.291 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 1' ' ' MET . 17.1 mm-40 -88.76 34.06 0.77 Allowed 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.369 0.604 . . . . 0.0 111.636 -175.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.517 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 10.0 mtpm? -142.24 -51.09 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.023 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 2.3 Cg_endo -83.38 171.72 10.98 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.094 1.863 . . . . 0.0 111.062 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -83.35 1.33 41.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.948 0.404 . . . . 0.0 111.527 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.85 171.8 7.64 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.897 0.38 . . . . 0.0 110.493 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.01 66.97 1.26 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.574 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.77 127.0 17.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.374 0.607 . . . . 0.0 111.259 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -62.29 118.24 7.17 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.532 0.682 . . . . 0.0 109.574 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -89.24 150.49 22.61 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.441 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 60.56 19.53 9.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.011 0.924 . . . . 0.0 113.31 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 t30 49.06 72.1 0.32 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.976 0.893 . . . . 0.0 109.534 -176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -78.65 174.58 11.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.525 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.54 86.7 6.31 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.805 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 38.1 p-80 -125.22 150.53 46.92 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.591 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 pt -129.77 167.9 24.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.027 0.441 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.609 ' OD1' ' HE3' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -103.69 128.37 51.04 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.61 124.94 44.63 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 83' ' ' THR . 36.0 ttpt -104.1 140.04 38.33 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.171 0.51 . . . . 0.0 111.037 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.0 t -112.86 124.71 69.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.884 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.38 126.17 40.12 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.623 0.725 . . . . 0.0 110.096 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.41 146.66 17.38 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.656 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -4.59 1.56 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.566 0.698 . . . . 0.0 112.023 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.603 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 27.6 t70 -77.65 -16.87 58.25 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.647 0.779 . . . . 0.0 110.188 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.54 -13.18 50.92 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -82.06 119.93 24.64 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.116 0.484 . . . . 0.0 110.624 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.51 137.83 28.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 111.156 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.447 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 11.3 t -144.75 151.82 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.36 137.78 46.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.447 ' CZ ' ' HB ' ' A' ' 30' ' ' VAL . 30.8 m-85 -130.55 139.48 50.46 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.406 0.622 . . . . 0.0 111.406 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.609 ' HE3' ' OD1' ' A' ' 19' ' ' ASN . 22.9 tttt -112.17 107.96 17.04 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.674 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 pt -128.89 172.18 15.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.148 0.499 . . . . 0.0 111.186 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.8 tmtt? -80.23 149.77 30.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.877 0.37 . . . . 0.0 110.294 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 20.0 tpp85 -61.31 -19.48 61.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.144 0.577 . . . . 0.0 111.574 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -107.52 -1.95 20.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.476 0.655 . . . . 0.0 109.825 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.7 m -82.24 131.52 55.9 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.917 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.94 147.4 89.17 Favored 'Trans proline' 0 C--O 1.241 0.638 0 C-N-CA 122.377 2.051 . . . . 0.0 112.151 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.84 -15.73 62.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.559 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 37.4 p -49.89 -39.78 40.78 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.198 0.599 . . . . 0.0 111.366 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.61 -53.19 60.52 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.374 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.94 -32.38 61.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.022 0.439 . . . . 0.0 111.045 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.602 ' N ' HD12 ' A' ' 43' ' ' LEU . 45.7 ttm -60.6 -50.04 75.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 110.369 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.557 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 30.0 mmtp -71.39 -42.58 68.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.429 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.636 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.48 -46.11 91.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.594 0.357 . . . . 0.0 111.898 -177.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -53.89 -49.39 68.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.992 0.425 . . . . 0.0 110.323 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.63 ' SG ' HD12 ' A' ' 58' ' ' ILE . 37.1 m -66.34 -34.32 77.7 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.27 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 45.6 mm-40 -58.14 -49.22 77.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.431 0.634 . . . . 0.0 110.992 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.636 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 5.7 ptp180 -83.99 -24.92 30.37 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -95.8 -11.61 26.62 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.93 44.86 35.4 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.973 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.4 153.22 30.25 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.379 -0.483 . . . . 0.0 110.689 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.1 m -95.75 126.14 40.81 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 120.776 0.322 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.492 ' HE3' ' HG2' ' A' ' 44' ' ' MET . 52.9 mmm -61.6 -26.71 68.15 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.417 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -82.54 -29.78 30.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 111.257 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.99 -45.64 10.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.366 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.63 HD12 ' SG ' ' A' ' 48' ' ' CYS . 8.7 pt -84.6 172.98 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 121.692 -0.63 . . . . 0.0 111.317 -177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 23.6 tpt180 -151.7 137.38 17.9 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.259 0.552 . . . . 0.0 110.351 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.405 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 8.1 m-85 -92.07 134.08 35.16 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.987 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -139.55 139.74 36.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.104 0.478 . . . . 0.0 110.509 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -145.76 137.83 25.38 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t70 67.08 24.7 9.35 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.849 0.833 . . . . 0.0 110.314 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.95 81.21 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.334 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -119.17 131.92 24.17 Favored Pre-proline 0 N--CA 1.451 -0.405 0 O-C-N 122.283 -0.54 . . . . 0.0 110.622 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -64.02 138.58 63.05 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.288 1.992 . . . . 0.0 111.295 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.7 pt -111.79 167.97 5.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.138 0.494 . . . . 0.0 111.259 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.604 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.32 158.94 39.34 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.29 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' A' ' 41' ' ' SER . 5.4 pt-20 -63.21 -9.66 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.226 0.536 . . . . 0.0 111.604 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 t -99.59 10.66 40.97 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.939 -0.475 . . . . 0.0 111.604 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.604 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -100.07 157.34 16.62 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 121.714 -0.616 . . . . 0.0 110.686 178.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.7 p -120.72 147.77 46.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.693 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 34.6 Cg_endo -63.89 -19.02 66.17 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.917 2.411 . . . . 0.0 112.35 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.59 -25.95 41.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.008 0.432 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -73.49 -55.71 5.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.398 0.618 . . . . 0.0 111.286 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.412 HD21 ' HG3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -81.61 -2.69 51.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.613 -178.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 67.31 63.31 0.44 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.014 0.912 . . . . 0.0 110.799 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.412 ' HG3' HD21 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -82.31 128.71 34.47 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.684 -178.228 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.05 164.02 16.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.952 0.406 . . . . 0.0 110.095 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.19 147.0 31.47 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.039 0.447 . . . . 0.0 110.88 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 69.17 14.83 8.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.308 1.043 . . . . 0.0 111.896 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -81.21 169.64 17.09 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 21.6 m -124.97 141.46 52.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.509 0.671 . . . . 0.0 112.564 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.36 138.17 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.243 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.04 120.45 33.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.076 0.465 . . . . 0.0 110.544 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.46 137.48 42.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.343 0.592 . . . . 0.0 111.594 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -130.97 153.84 48.78 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.729 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.603 ' OE1' ' HB2' ' A' ' 26' ' ' ASP . 2.0 mp0 -101.62 113.08 25.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.08 0.467 . . . . 0.0 111.582 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -104.47 -176.72 3.16 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.976 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 62.11 9.3 3.05 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.361 0.665 . . . . 0.0 111.045 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.3 m 53.86 69.05 0.76 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.647 0.737 . . . . 0.0 110.667 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.48 3.95 56.58 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.656 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.74 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.281 0.562 . . . . 0.0 111.556 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.95 15.33 17.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.722 0.772 . . . . 0.0 109.411 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.68 16.12 23.08 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.169 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -103.15 50.06 0.82 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.209 0.528 . . . . 0.0 111.199 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm 69.22 69.57 0.41 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.198 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.5 107.63 2.52 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.651 2.234 . . . . 0.0 111.96 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -102.57 41.37 1.24 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.944 0.878 . . . . 0.0 109.433 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.27 118.7 19.26 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.306 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.44 145.35 4.47 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.48 114.82 27.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.306 0.574 . . . . 0.0 111.069 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -112.56 140.24 47.48 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.535 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.3 p -68.22 130.82 44.05 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.12 65.49 0.51 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.826 0.822 . . . . 0.0 109.916 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -168.05 116.21 0.74 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.501 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -151.31 78.8 1.29 Allowed 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.474 0.654 . . . . 0.0 109.773 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.4 81.35 2.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 12.8 p-80 -120.33 151.6 39.01 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.0 pt -131.34 161.46 41.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.501 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -102.05 125.15 48.66 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.72 125.3 49.36 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -103.14 140.32 37.5 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.955 0.407 . . . . 0.0 110.535 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -111.19 124.14 67.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 29' ' ' VAL . . . -121.14 123.72 42.99 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.582 0.706 . . . . 0.0 110.778 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.46 139.55 14.46 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 120.111 -1.042 . . . . 0.0 111.075 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -64.06 -9.07 14.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.195 0.497 . . . . 0.0 112.33 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -83.6 -8.16 59.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.681 0.753 . . . . 0.0 109.554 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.47 -9.52 45.27 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.602 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.2 m -78.27 110.72 13.53 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 122.366 -0.491 . . . . 0.0 109.95 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 23' ' ' ALA . 61.8 t -137.27 134.72 47.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 122.087 -0.383 . . . . 0.0 110.362 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.405 HG22 ' HD3' ' A' ' 50' ' ' ARG . 21.1 t -148.64 152.7 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.471 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -108.94 142.33 39.74 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.166 -0.334 . . . . 0.0 110.603 -178.05 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -136.95 155.88 49.16 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.048 0.452 . . . . 0.0 111.229 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.501 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 44.5 mtmt -127.62 120.12 27.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.415 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 pt -136.93 170.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 110.393 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 6.2 tmtt? -73.34 147.35 44.49 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 33.7 ttm180 -64.37 -14.64 57.56 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.203 0.525 . . . . 0.0 111.665 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -110.09 1.34 18.81 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.496 0.665 . . . . 0.0 109.738 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 m -84.79 135.02 40.69 Favored Pre-proline 0 N--CA 1.444 -0.739 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.007 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.44 143.78 97.71 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.524 2.15 . . . . 0.0 112.301 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.412 HD13 ' OD2' ' A' ' 71' ' ' ASP . 43.3 mt -65.14 -16.18 63.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.609 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.451 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 55.6 p -49.46 -38.19 28.84 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.034 0.534 . . . . 0.0 111.633 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.9 mmpt? -56.25 -53.72 53.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.754 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.609 HD11 ' N ' ' A' ' 44' ' ' MET . 4.0 pp -75.59 -32.19 60.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.876 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.609 ' N ' HD11 ' A' ' 43' ' ' LEU . 58.7 mtt -59.23 -55.43 34.99 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.315 0.579 . . . . 0.0 111.208 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.524 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 41.9 mtpt -70.91 -34.41 71.51 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.197 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.65 -44.11 97.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.144 0.497 . . . . 0.0 110.136 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -58.95 -51.12 71.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.469 ' SG ' ' HG2' ' A' ' 55' ' ' MET . 17.8 p -63.15 -36.61 84.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.056 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 36.8 mt-10 -68.31 -39.06 82.13 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 11.5 ptm180 -83.53 -23.82 31.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.006 0.432 . . . . 0.0 111.376 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -95.03 -6.44 42.21 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.72 42.74 53.37 Favored Glycine 0 C--N 1.322 -0.222 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.689 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.95 156.38 28.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.228 0.537 . . . . 0.0 110.608 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 58' ' ' ILE . 45.0 m -104.8 125.91 51.34 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.341 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.469 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 97.2 mmm -59.09 -22.6 61.06 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.102 0.477 . . . . 0.0 111.89 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.457 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -83.64 -33.85 25.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.517 0.675 . . . . 0.0 110.467 -179.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.457 ' NE2' ' HB2' ' A' ' 56' ' ' ARG . 0.8 OUTLIER -90.61 -10.59 42.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.942 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 54' ' ' SER . 21.0 pt -117.74 171.89 5.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 O-C-N 121.896 -0.503 . . . . 0.0 110.788 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -151.96 138.03 18.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.973 0.416 . . . . 0.0 110.089 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.8 m-85 -93.22 139.37 30.69 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.214 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -141.16 141.18 34.14 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.239 0.542 . . . . 0.0 110.721 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -146.75 132.17 18.62 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 68.44 25.45 6.87 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.749 0.785 . . . . 0.0 110.303 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.02 -24.7 5.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.957 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -91.58 133.68 30.68 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 122.369 -0.489 . . . . 0.0 111.222 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.88 143.09 59.56 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.239 1.959 . . . . 0.0 111.385 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.8 pt -117.28 162.6 15.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.164 0.507 . . . . 0.0 111.006 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.654 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -123.47 156.88 34.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.313 -177.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.455 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 3.9 pt-20 -57.81 -14.55 6.15 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.114 0.483 . . . . 0.0 111.866 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -98.32 8.81 44.33 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 122.021 -0.424 . . . . 0.0 111.971 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.654 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -95.84 159.52 14.93 Favored 'General case' 0 C--O 1.24 0.598 0 O-C-N 121.894 -0.504 . . . . 0.0 110.372 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.3 p -121.27 144.03 38.81 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.531 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 14.4 Cg_endo -57.47 -24.82 63.24 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.032 2.488 . . . . 0.0 112.65 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.75 -26.79 57.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.21 0.529 . . . . 0.0 111.075 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -71.31 -55.71 7.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.26 0.552 . . . . 0.0 110.546 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -85.07 2.65 42.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.041 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 61.57 64.2 1.08 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.854 0.835 . . . . 0.0 112.034 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.1 ttt -82.66 128.86 34.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.131 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -84.55 154.39 22.68 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 120.86 0.362 . . . . 0.0 110.187 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -72.82 147.33 45.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.992 0.425 . . . . 0.0 110.068 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 68.91 14.11 8.86 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.694 0.798 . . . . 0.0 111.256 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -82.61 172.37 13.03 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.1 m -126.29 141.79 51.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.568 0.699 . . . . 0.0 112.704 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -103.15 139.58 23.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.107 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -97.53 121.69 39.73 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.211 0.529 . . . . 0.0 110.701 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 39.0 t -108.47 137.5 39.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.237 0.541 . . . . 0.0 111.82 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -131.36 158.19 41.39 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -101.48 111.49 23.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.167 0.508 . . . . 0.0 110.801 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.55 52.22 1.1 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.752 0.787 . . . . 0.0 111.498 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.79 74.38 3.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 m -88.1 100.48 12.98 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.261 0.553 . . . . 0.0 112.344 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.25 70.66 0.95 Allowed Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.448 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.377 0 CA-C-O 118.272 -1.293 . . . . 0.0 111.392 179.643 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 121.905 0.86 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . -145.72 -25.24 0.46 Allowed 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.187 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.49 -21.19 21.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.517 0.675 . . . . 0.0 110.79 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -90.04 -6.25 55.74 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.146 0.974 . . . . 0.0 108.499 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.478 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 46.1 tttm -78.59 -46.92 1.92 Allowed Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.699 -175.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 5' ' ' LYS . 7.1 Cg_exo -74.69 -177.93 3.72 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.136 1.891 . . . . 0.0 111.93 177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -111.37 16.41 20.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.302 0.572 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -74.89 165.73 24.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.14 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.72 -65.13 0.15 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.374 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.54 136.69 23.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.16 0.505 . . . . 0.0 110.495 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.22 173.68 11.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.845 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -150.77 11.84 0.67 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.489 0.662 . . . . 0.0 111.471 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -41.12 94.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.36 0.6 . . . . 0.0 110.5 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -143.39 100.61 3.65 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -83.78 93.51 7.97 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.249 0.547 . . . . 0.0 111.784 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.65 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 6.9 m-20 -99.78 84.41 2.91 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 13.7 p-80 -116.42 142.78 46.4 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 121.659 -0.651 . . . . 0.0 109.956 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.9 pt -128.86 159.77 40.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.294 0.569 . . . . 0.0 111.244 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.419 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -101.57 119.62 39.06 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.004 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.7 140.99 47.79 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.987 0.422 . . . . 0.0 109.862 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -115.32 139.66 49.79 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.319 0.581 . . . . 0.0 111.085 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 29' ' ' VAL . 46.4 t -112.04 124.81 69.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.676 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.39 122.95 35.02 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.479 0.656 . . . . 0.0 110.437 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.33 147.69 16.33 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.934 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -7.89 2.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -78.12 -14.61 59.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.747 0.784 . . . . 0.0 110.243 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.92 -11.78 56.04 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.2 m -78.61 118.76 21.02 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 120.945 0.402 . . . . 0.0 110.09 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.7 p -141.94 137.9 30.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.215 0.531 . . . . 0.0 111.116 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -142.93 150.96 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.419 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.1 tm0? -110.29 141.23 43.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.888 0.375 . . . . 0.0 110.374 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -135.87 147.26 48.13 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.034 0.445 . . . . 0.0 110.996 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -115.2 109.59 18.21 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.061 0.458 . . . . 0.0 110.649 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.7 pt -124.38 178.42 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 16' ' ' ASP . 22.4 tttt -89.91 159.2 17.06 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.465 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -62.25 -24.16 67.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.47 0.708 . . . . 0.0 111.884 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -105.74 -1.92 23.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.574 0.702 . . . . 0.0 109.857 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 m -83.96 132.18 49.15 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.64 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.88 149.86 86.18 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.593 2.195 . . . . 0.0 112.424 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.65 -15.6 62.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.036 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 22.3 p -49.37 -39.83 33.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.078 0.551 . . . . 0.0 111.995 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -55.5 -53.25 58.69 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.792 0.33 . . . . 0.0 111.19 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.573 HD11 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.29 -31.87 62.67 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.713 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.573 ' N ' HD11 ' A' ' 43' ' ' LEU . 57.1 mtt -59.96 -56.43 21.77 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.003 0.43 . . . . 0.0 111.596 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -67.16 -39.86 86.56 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.815 0.341 . . . . 0.0 110.499 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.45 -46.47 86.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.121 0.486 . . . . 0.0 110.582 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -57.81 -52.05 67.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.177 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.8 p -61.57 -36.79 81.65 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.059 0.457 . . . . 0.0 111.072 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -64.77 -47.98 76.19 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.959 0.409 . . . . 0.0 111.853 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 18.5 ptp180 -78.17 -24.97 47.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.83 0.348 . . . . 0.0 111.567 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -96.88 -7.63 32.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.43 45.76 22.63 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.986 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.05 159.96 23.75 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.413 -0.463 . . . . 0.0 110.547 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -106.09 126.26 51.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.645 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.443 ' CE ' ' HB3' ' A' ' 44' ' ' MET . 93.0 mmm -57.39 -28.17 62.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.414 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.71 -28.67 26.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.294 0.568 . . . . 0.0 110.839 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.696 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -83.19 -34.12 26.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.383 0.611 . . . . 0.0 110.549 -177.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.495 HG22 ' HG3' ' A' ' 88' ' ' GLN . 20.5 pt -92.94 165.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.354 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -143.36 128.69 18.87 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.909 0.385 . . . . 0.0 110.167 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -87.05 139.67 30.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.026 0.441 . . . . 0.0 110.054 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -142.14 143.12 32.85 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.115 0.483 . . . . 0.0 111.057 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -149.38 132.41 16.23 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.18 25.33 7.33 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.884 0.85 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.51 -25.57 5.01 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.156 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -91.36 138.43 25.57 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.429 -0.454 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.16 143.69 49.66 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.047 1.832 . . . . 0.0 110.981 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.547 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 12.7 pt -114.11 170.69 4.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.794 0.331 . . . . 0.0 111.116 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.427 ' C ' ' HE3' ' A' ' 44' ' ' MET . 0.5 OUTLIER -130.71 164.68 24.53 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.555 0.693 . . . . 0.0 110.921 -175.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 12.0 pt-20 -69.45 -7.67 39.94 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.39 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -102.03 6.19 40.98 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.599 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.547 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -99.21 155.04 17.69 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.918 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.5 p -120.63 152.01 55.03 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.49 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.34 -15.66 46.4 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.629 2.22 . . . . 0.0 112.165 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.56 -16.17 37.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.176 0.513 . . . . 0.0 110.829 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -80.2 -55.03 5.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.368 0.604 . . . . 0.0 111.215 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.401 HD22 ' HE2' ' A' ' 78' ' ' MET . 1.5 pt? -93.16 12.58 23.86 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.848 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 53.33 63.43 2.22 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.516 ' SD ' HD11 ' A' ' 84' ' ' ILE . 25.4 ttm -87.63 133.06 33.88 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 5.8 mm-40 -104.67 174.18 5.99 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.855 0.359 . . . . 0.0 110.636 -176.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -66.21 141.56 58.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.972 0.415 . . . . 0.0 110.693 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 69.88 15.94 7.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.625 0.77 . . . . 0.0 111.747 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -80.11 160.7 25.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -126.24 143.78 51.02 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.487 0.66 . . . . 0.0 112.645 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.516 HD11 ' SD ' ' A' ' 78' ' ' MET . 4.1 mp -108.16 138.9 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -95.05 123.97 38.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.122 0.487 . . . . 0.0 110.486 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.1 t -110.13 139.85 31.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.307 0.575 . . . . 0.0 111.448 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.414 ' HB3' ' OE1' ' A' ' 89' ' ' GLN . 73.6 m-85 -130.78 154.5 47.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.694 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.558 ' O ' ' HB3' ' A' ' 89' ' ' GLN . 1.8 mp0 -113.35 110.96 21.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.558 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 0.3 OUTLIER 165.75 96.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.349 0.595 . . . . 0.0 112.266 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -85.92 14.12 6.52 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.5 -1.375 . . . . 0.0 110.699 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -53.3 124.66 15.25 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 111.13 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.29 -93.55 0.48 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.695 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.97 0 CA-C-O 118.927 -0.929 . . . . 0.0 111.61 179.78 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 121.251 0.548 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.41 11.41 5.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.281 1.039 . . . . 0.0 108.343 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.57 39.88 0.94 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.875 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -150.48 -12.61 0.25 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.961 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.507 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 74.4 mmtt -95.56 -52.98 0.23 Allowed Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 122.038 -0.414 . . . . 0.0 111.119 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.507 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 95.9 Cg_endo -84.36 -1.11 9.66 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 121.875 1.717 . . . . 0.0 111.116 176.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt 51.66 32.61 9.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.61 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.85 115.08 2.38 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.92 -46.95 0.88 Allowed Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.6 p -126.11 102.2 9.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.857 0.837 . . . . 0.0 111.322 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -152.42 139.11 18.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.261 0.553 . . . . 0.0 111.011 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 t -136.08 -6.58 2.09 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.258 0.552 . . . . 0.0 111.053 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -51.61 134.2 29.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.735 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -97.9 27.76 4.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.898 0.856 . . . . 0.0 109.047 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -71.26 177.45 3.87 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.538 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -79.87 80.44 6.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.071 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -123.14 145.66 48.41 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 120.842 0.353 . . . . 0.0 110.202 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.2 pt -125.11 165.61 22.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 121.318 0.58 . . . . 0.0 110.881 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.431 ' ND2' ' HB2' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -100.09 135.5 41.42 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.82 126.38 30.41 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -107.19 140.08 40.61 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.245 0.545 . . . . 0.0 111.49 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.0 t -113.82 124.36 70.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.006 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.9 124.17 34.51 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.605 0.717 . . . . 0.0 110.846 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.35 151.87 19.45 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.259 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.5 pp0? -60.53 -20.22 59.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.187 0.517 . . . . 0.0 111.681 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.7 -7.44 55.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.634 0.731 . . . . 0.0 110.454 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.35 -16.07 55.57 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.686 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 m -68.76 116.73 9.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.851 0.357 . . . . 0.0 110.241 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -143.83 139.6 25.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.032 0.444 . . . . 0.0 111.423 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.2 t -145.83 151.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.22 139.91 40.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.935 0.397 . . . . 0.0 110.1 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -133.42 166.97 21.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.385 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -140.29 114.12 8.87 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.903 0.382 . . . . 0.0 110.516 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 pt -127.91 174.8 10.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.116 0.484 . . . . 0.0 110.757 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 9.7 tmtt? -87.46 149.76 24.21 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.183 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 22.7 tpp180 -54.02 -28.64 39.47 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.49 0.716 . . . . 0.0 112.376 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -105.08 -0.26 26.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.48 0.657 . . . . 0.0 110.613 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 m -85.83 133.6 41.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.181 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.99 151.87 84.33 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.502 2.135 . . . . 0.0 112.316 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.92 -15.23 61.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.943 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.519 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 25.8 p -49.28 -38.24 26.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 122.967 0.507 . . . . 0.0 111.976 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -56.35 -54.09 49.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.502 0.191 . . . . 0.0 110.845 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.635 HD11 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.96 -33.6 57.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.887 0.375 . . . . 0.0 111.629 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.635 ' N ' HD11 ' A' ' 43' ' ' LEU . 45.3 ttm -62.07 -53.27 57.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.02 0.438 . . . . 0.0 111.002 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.626 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 8.7 mmmm -70.3 -36.7 74.49 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.207 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.66 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -61.3 -45.66 93.55 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.001 -0.437 . . . . 0.0 111.05 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -56.33 -51.45 68.18 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.431 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.1 p -63.53 -35.31 80.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.107 0.48 . . . . 0.0 110.843 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.626 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 6.2 mm-40 -65.75 -43.78 87.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.009 0.433 . . . . 0.0 111.586 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.66 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 13.1 ptp180 -83.22 -20.98 33.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -96.95 -9.66 27.88 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.831 -0.543 . . . . 0.0 111.818 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.67 40.71 26.1 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.031 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.41 157.9 25.4 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.038 0.446 . . . . 0.0 110.016 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.416 ' O ' HG12 ' A' ' 58' ' ' ILE . 8.2 m -109.65 134.76 51.59 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.702 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.507 ' CE ' ' HG2' ' A' ' 44' ' ' MET . 97.1 mmm -58.76 -25.99 63.56 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.15 -24.94 27.75 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.325 0.583 . . . . 0.0 111.109 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.64 -19.34 26.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.296 0.57 . . . . 0.0 110.7 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 54' ' ' SER . 14.4 pt -120.94 174.32 5.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.095 0.474 . . . . 0.0 111.173 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -154.29 138.98 16.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.113 0.482 . . . . 0.0 109.927 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -91.87 137.3 32.48 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.227 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HG3' ' C ' ' A' ' 65' ' ' GLN . 16.3 ttm180 -136.62 134.59 37.51 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.321 0.581 . . . . 0.0 110.881 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -145.29 144.26 30.66 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 68.33 24.35 7.38 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.855 0.836 . . . . 0.0 109.447 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.34 -5.62 59.53 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.366 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.473 ' C ' ' HG3' ' A' ' 61' ' ' ARG . 5.0 pt20 -118.69 143.96 34.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 O-C-N 122.196 -0.591 . . . . 0.0 111.26 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.64 133.96 36.23 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.067 1.845 . . . . 0.0 111.145 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.594 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 12.0 pt -106.87 -177.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.92 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.86 164.53 27.36 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 121.394 0.616 . . . . 0.0 109.793 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 41' ' ' SER . 15.9 pt-20 -74.39 -9.47 58.62 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.714 0.769 . . . . 0.0 109.403 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 t -103.4 10.31 37.4 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.853 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.594 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -98.39 159.0 15.24 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.4 p -117.08 148.51 42.46 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.568 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.84 -12.17 34.06 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.798 2.332 . . . . 0.0 112.081 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.5 -28.35 23.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.125 0.488 . . . . 0.0 110.654 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -69.63 -55.32 10.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 111.685 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -88.38 9.9 21.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.002 0.429 . . . . 0.0 111.636 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 53.74 63.88 2.04 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.935 0.874 . . . . 0.0 112.735 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -78.48 129.01 34.38 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.222 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -91.19 158.11 16.8 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.431 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 4.7 p-10 -70.05 147.8 49.6 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.986 -0.446 . . . . 0.0 110.478 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 66.72 15.25 10.08 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.342 0.657 . . . . 0.0 111.733 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -79.57 167.04 21.27 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -121.83 137.48 54.76 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.659 0.742 . . . . 0.0 112.923 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.13 134.35 41.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.986 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.87 122.14 36.05 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.123 0.487 . . . . 0.0 110.471 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 40.3 t -107.68 138.38 34.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.234 0.54 . . . . 0.0 111.64 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -131.55 155.67 47.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.734 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -106.55 112.8 25.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.08 0.467 . . . . 0.0 111.192 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -103.09 47.87 0.87 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.746 0.784 . . . . 0.0 109.856 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.78 131.68 55.58 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.792 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.2 m -73.41 -59.28 2.79 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.983 0.42 . . . . 0.0 111.051 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.1 170.62 29.28 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.607 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.09 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.503 179.378 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.864 0.364 . . . . 0.0 111.223 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.26 -37.03 58.14 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.337 0.589 . . . . 0.0 110.571 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -84.76 22.27 1.38 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.475 0.655 . . . . 0.0 110.464 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -90.68 -12.8 35.67 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.224 0.535 . . . . 0.0 110.222 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 68.3 mmtt -77.86 -56.7 1.06 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.715 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 63.0 Cg_endo -85.19 107.05 1.02 Allowed 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 121.544 1.496 . . . . 0.0 111.083 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -91.8 38.05 0.98 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.292 0.568 . . . . 0.0 110.683 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -103.26 16.51 26.38 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.83 55.07 4.28 Favored Glycine 0 C--N 1.314 -0.671 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.838 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.39 145.17 36.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 120.966 0.413 . . . . 0.0 110.492 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' HD3' ' N ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -138.86 106.71 5.66 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.346 0.593 . . . . 0.0 109.765 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 p -130.25 160.71 33.04 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.309 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 54.51 50.04 16.94 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.719 0.771 . . . . 0.0 111.453 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -165.92 117.95 1.08 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.984 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -134.05 59.29 1.74 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.521 0.677 . . . . 0.0 110.334 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -82.79 81.95 8.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 6.1 p-80 -118.79 142.2 47.93 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 80' ' ' ASP . 45.2 pt -131.08 160.44 42.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.269 0.556 . . . . 0.0 110.233 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.546 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.4 OUTLIER -98.65 120.95 39.95 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.055 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.06 125.16 54.08 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -104.17 140.55 37.65 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.222 0.534 . . . . 0.0 110.596 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.75 124.21 68.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.484 ' HA ' HG21 ' A' ' 29' ' ' VAL . . . -122.31 122.44 39.08 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.549 0.69 . . . . 0.0 110.993 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.72 139.51 14.46 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.228 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -60.06 -17.07 36.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.382 0.611 . . . . 0.0 111.398 178.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.29 -6.61 58.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.751 0.786 . . . . 0.0 110.127 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.95 -11.16 48.89 Favored Glycine 0 CA--C 1.507 -0.462 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.048 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.8 m -78.6 108.08 11.73 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.153 0.502 . . . . 0.0 109.836 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.484 HG21 ' HA ' ' A' ' 23' ' ' ALA . 59.6 t -135.33 131.29 51.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 120.959 0.409 . . . . 0.0 110.112 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -141.92 150.7 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.546 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -109.5 139.38 44.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.0 110.121 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 30.4 m-85 -130.11 159.46 36.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.321 0.582 . . . . 0.0 111.263 -176.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 42.3 mtmt -131.43 113.25 13.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.302 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.6 pt -135.04 176.3 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.69 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.4 tmtt? -82.6 149.03 27.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 22.1 ttm-85 -61.87 -19.42 62.62 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -105.61 1.31 27.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.695 0.76 . . . . 0.0 109.526 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.5 m -84.99 131.9 47.38 Favored Pre-proline 0 N--CA 1.442 -0.863 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.231 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.2 145.33 88.76 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 122.633 2.222 . . . . 0.0 112.177 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.475 HD13 ' OD1' ' A' ' 71' ' ' ASP . 34.3 mt -64.93 -16.29 63.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.933 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 12.3 t -50.06 -37.19 32.29 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 122.457 0.303 . . . . 0.0 111.102 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -56.04 -53.46 56.73 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-O 120.848 0.356 . . . . 0.0 111.026 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.58 HD11 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.81 -31.87 61.83 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.529 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.58 ' N ' HD11 ' A' ' 43' ' ' LEU . 56.9 mtt -60.4 -54.56 44.1 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.927 0.394 . . . . 0.0 111.537 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 31.2 mmtp -66.71 -39.96 88.23 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.84 -47.98 83.88 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 28.0 t80 -55.22 -51.72 65.67 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.857 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.657 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.3 m -63.94 -38.53 91.44 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.568 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 40.2 mt-10 -64.09 -42.32 96.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.743 0.306 . . . . 0.0 111.356 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.2 ptp180 -80.39 -24.29 39.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.908 0.385 . . . . 0.0 111.573 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -96.0 -8.74 32.84 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.63 2.98 90.69 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.897 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.482 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 7.3 mp -80.53 158.17 25.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.615 0.722 . . . . 0.0 112.005 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.0 m -107.81 132.27 53.59 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.034 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.549 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 95.7 mmm -57.36 -31.06 65.37 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.462 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -84.35 -31.21 24.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.341 0.591 . . . . 0.0 111.126 -178.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.497 ' HG2' HE21 ' A' ' 90' ' ' GLN . 0.7 OUTLIER -84.42 -16.69 41.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.39 0.614 . . . . 0.0 110.816 -177.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.657 HD11 ' SG ' ' A' ' 48' ' ' CYS . 10.3 pt -117.81 179.17 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.369 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -156.07 132.77 10.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 120.983 0.42 . . . . 0.0 110.088 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.4 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.4 m-85 -83.54 139.32 32.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.669 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -144.11 144.24 31.5 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.218 0.532 . . . . 0.0 110.987 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -149.18 134.88 18.72 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 t70 68.44 25.04 6.98 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.535 0.683 . . . . 0.0 110.359 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.33 -24.05 6.68 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.137 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -93.69 137.55 23.19 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 122.301 -0.529 . . . . 0.0 110.803 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.3 145.54 60.15 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.038 1.825 . . . . 0.0 111.249 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 pt -113.55 160.65 12.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.982 0.42 . . . . 0.0 110.22 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.624 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -121.18 153.88 36.97 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.757 -177.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 41' ' ' SER . 10.0 pt-20 -59.72 -12.6 7.41 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.143 0.497 . . . . 0.0 111.944 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.2 t -95.82 8.12 44.44 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 120.717 0.294 . . . . 0.0 111.135 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.624 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -95.0 156.33 16.36 Favored 'General case' 0 C--O 1.244 0.78 0 O-C-N 121.89 -0.506 . . . . 0.0 110.017 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.4 p -118.12 146.64 39.72 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.613 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 18.4 Cg_endo -60.36 -22.92 73.02 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.762 2.308 . . . . 0.0 112.338 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HB3' ' HG2' ' A' ' 36' ' ' ARG . . . -78.1 -22.79 48.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.166 0.508 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -71.59 -55.27 8.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.397 0.618 . . . . 0.0 110.442 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -85.91 9.02 18.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.542 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 55.79 60.08 3.47 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.776 0.798 . . . . 0.0 112.246 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.4 mtt -84.38 141.24 31.01 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.645 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -108.76 177.35 4.8 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.121 0.486 . . . . 0.0 111.15 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.447 ' HA ' ' HB ' ' A' ' 18' ' ' ILE . 5.2 m-20 -64.54 138.27 58.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.745 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 68.82 19.42 8.37 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.678 0.791 . . . . 0.0 112.497 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -73.47 159.0 33.86 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.6 m -124.41 144.56 49.98 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.72 142.22 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.215 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.494 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 11.3 m-20 -94.83 122.5 37.53 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 110.505 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.555 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 28.7 t -109.83 136.69 45.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 O-C-N 121.886 -0.509 . . . . 0.0 111.594 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CE1' ' HB3' ' A' ' 85' ' ' ASP . 60.1 m-85 -132.73 157.61 44.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -99.12 110.72 23.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.469 0.652 . . . . 0.0 111.133 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.659 HE21 ' N ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -100.07 47.53 0.94 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.334 177.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.497 HE21 ' HG2' ' A' ' 57' ' ' GLN . 0.7 OUTLIER -116.18 122.35 44.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.178 0.513 . . . . 0.0 111.412 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.9 m -109.26 90.02 3.17 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.452 0.644 . . . . 0.0 109.709 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -117.13 117.68 3.89 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.288 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.411 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.125 179.164 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.52 55.54 2.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.11 0.481 . . . . 0.0 111.868 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.05 -15.21 61.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.199 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -60.48 -52.13 66.49 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.297 0.57 . . . . 0.0 109.541 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.553 ' O ' ' HG2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -133.98 89.68 28.66 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-O 121.779 0.8 . . . . 0.0 110.198 177.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.23 -158.42 0.08 OUTLIER 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.027 2.485 . . . . 0.0 112.38 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -86.92 34.89 0.67 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.241 0.543 . . . . 0.0 110.029 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 66.58 16.43 10.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.114 0.966 . . . . 0.0 112.3 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.21 59.63 0.62 Allowed Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.746 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.08 129.22 33.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.246 0.546 . . . . 0.0 109.687 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -155.54 140.91 17.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.385 0.612 . . . . 0.0 111.641 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -139.86 143.86 36.96 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.36 -49.19 77.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.007 0.432 . . . . 0.0 111.336 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -126.64 114.99 18.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -117.27 143.09 46.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.24 0.543 . . . . 0.0 110.807 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.576 ' OD1' ' HB3' ' A' ' 36' ' ' ARG . 0.5 OUTLIER -137.67 105.48 5.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.836 0.827 . . . . 0.0 110.494 178.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 20.0 p-80 -120.63 146.76 46.05 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.2 pt -132.95 166.79 28.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.108 0.48 . . . . 0.0 110.731 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.652 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -103.78 125.94 50.58 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.17 124.07 47.06 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 83' ' ' THR . 31.8 ttpt -103.95 140.65 37.41 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.102 0.477 . . . . 0.0 110.593 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.67 125.43 70.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.897 0.379 . . . . 0.0 110.084 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.6 121.75 27.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.533 0.682 . . . . 0.0 110.49 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.56 148.85 16.81 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 120.249 -0.976 . . . . 0.0 112.207 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -6.09 2.85 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.365 0.602 . . . . 0.0 112.294 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.92 -14.14 59.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.728 0.775 . . . . 0.0 109.845 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.6 -15.05 53.51 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.635 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.7 m -77.08 122.76 25.41 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.926 0.393 . . . . 0.0 110.63 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.28 137.83 29.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.138 0.494 . . . . 0.0 111.253 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 t -143.09 151.08 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.652 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -106.34 142.0 36.73 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.343 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -135.29 146.61 48.68 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.237 0.542 . . . . 0.0 110.461 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -121.65 114.17 20.78 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.03 0.443 . . . . 0.0 110.455 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.8 pt -134.46 177.76 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.24 0.543 . . . . 0.0 111.264 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 11.3 tmtt? -86.45 152.16 22.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.576 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 13.6 tpp180 -60.53 -19.16 56.33 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.943 0.497 . . . . 0.0 111.734 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -107.73 -3.3 19.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.55 0.691 . . . . 0.0 109.653 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -83.67 132.44 49.14 Favored Pre-proline 0 N--CA 1.441 -0.906 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.217 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.15 149.81 88.46 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.557 2.171 . . . . 0.0 112.853 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.449 HD11 ' OD2' ' A' ' 71' ' ' ASP . 28.0 mt -65.59 -13.95 60.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.065 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 p -55.13 -34.48 63.77 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.327 0.584 . . . . 0.0 110.663 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -55.93 -55.98 26.14 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.603 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.626 HD13 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -77.38 -32.73 55.11 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.626 ' N ' HD13 ' A' ' 43' ' ' LEU . 38.7 ttm -62.41 -54.01 46.53 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.067 0.46 . . . . 0.0 110.959 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 33.6 mtpt -72.37 -32.99 66.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.491 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -64.18 -43.74 94.16 Favored 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 121.92 -0.488 . . . . 0.0 110.434 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -57.39 -50.53 72.69 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.105 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 14.8 p -61.48 -36.96 81.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 0.0 110.909 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.1 mt-10 -69.02 -40.05 78.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.4 ptp180 -83.85 -24.75 30.77 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.936 -0.477 . . . . 0.0 112.167 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -95.41 -11.83 26.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.182 0.515 . . . . 0.0 111.461 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.43 41.49 13.29 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.491 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 48' ' ' CYS . 3.4 mm? -117.23 158.24 24.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.041 0.448 . . . . 0.0 110.301 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.477 ' O ' HG12 ' A' ' 58' ' ' ILE . 15.2 m -106.38 131.99 52.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.283 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.485 ' HE1' ' HG2' ' A' ' 44' ' ' MET . 85.4 mmm -55.07 -29.14 56.91 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.928 0.491 . . . . 0.0 111.817 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.554 ' HD3' ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -83.86 -28.79 27.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.4 0.619 . . . . 0.0 111.179 -177.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.43 ' HG2' ' HG3' ' A' ' 90' ' ' GLN . 0.9 OUTLIER -92.7 -7.53 46.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.117 -178.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 54' ' ' SER . 17.5 pt -125.1 170.18 15.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 120.943 0.402 . . . . 0.0 110.965 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -149.99 135.86 18.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.12 0.486 . . . . 0.0 110.164 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -89.82 137.26 32.49 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.028 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -137.28 143.02 41.94 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.258 0.551 . . . . 0.0 110.622 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -150.83 138.59 19.81 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 t70 69.79 25.35 5.08 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.605 0.716 . . . . 0.0 110.282 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.01 -1.56 79.12 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.538 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -122.73 142.92 38.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 O-C-N 122.122 -0.634 . . . . 0.0 111.409 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.04 141.89 59.59 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.503 2.135 . . . . 0.0 111.866 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 pt -117.08 172.83 4.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.102 0.477 . . . . 0.0 111.01 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.677 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.96 156.33 46.38 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.818 -178.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.58 -13.14 12.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.778 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.0 t -96.61 10.21 39.2 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 122.157 -0.339 . . . . 0.0 111.374 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.677 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.81 157.4 16.53 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.96 177.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.3 p -120.76 151.01 53.9 Favored Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.199 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.42 -18.23 52.22 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.968 2.445 . . . . 0.0 112.699 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.02 -27.15 30.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.331 0.586 . . . . 0.0 110.896 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -71.61 -55.9 6.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.478 0.656 . . . . 0.0 110.623 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -88.49 20.77 3.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.571 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 43.08 62.52 1.79 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.087 0.946 . . . . 0.0 112.662 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -78.87 122.5 26.18 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.697 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.58 156.7 30.7 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.051 0.453 . . . . 0.0 110.848 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -68.89 142.86 54.66 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.886 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 66.71 18.21 10.68 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.269 0.627 . . . . 0.0 111.437 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -81.51 171.25 14.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.976 0.417 . . . . 0.0 110.64 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 21.9 m -126.05 145.0 50.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.577 0.703 . . . . 0.0 112.352 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.03 138.74 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.283 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -94.91 121.79 36.88 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.964 0.411 . . . . 0.0 110.225 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.3 t -108.9 137.41 41.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.267 0.555 . . . . 0.0 111.757 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -130.49 151.52 50.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -101.09 112.18 24.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.074 0.464 . . . . 0.0 111.931 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -119.26 75.52 1.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.992 0.425 . . . . 0.0 110.763 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.519 ' H ' ' NE2' ' A' ' 90' ' ' GLN . 1.7 mp0 -69.31 147.71 50.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.9 0.381 . . . . 0.0 110.423 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -67.95 104.55 1.76 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.35 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.12 125.52 7.21 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.876 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.187 0 CA-C-O 118.938 -0.924 . . . . 0.0 111.461 -178.793 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.3 mtt . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 121.203 0.525 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.55 11.7 15.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.799 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -110.01 15.03 22.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.24 0.543 . . . . 0.0 110.726 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -75.15 63.5 1.31 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.938 -0.476 . . . . 0.0 111.696 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 3.5 mptp? 55.96 58.23 9.65 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.786 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.68 121.32 4.12 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.374 2.049 . . . . 0.0 112.389 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -83.6 -12.63 55.81 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.341 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 48.97 43.62 21.99 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.733 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.38 59.77 4.01 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.043 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.91 111.71 24.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.256 0.55 . . . . 0.0 110.513 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 46.76 2.6 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.579 0.704 . . . . 0.0 109.479 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -126.24 126.61 44.31 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.936 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -118.44 -178.04 3.43 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.197 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.5 m120 64.92 19.9 11.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.952 0.501 . . . . 0.0 111.43 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -92.27 126.94 37.56 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.748 0.785 . . . . 0.0 111.575 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -89.69 91.2 8.55 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.181 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -124.81 150.75 46.03 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.707 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 pt -135.37 168.05 24.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 120.896 0.379 . . . . 0.0 110.373 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.525 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -106.0 116.52 32.08 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.923 0.392 . . . . 0.0 110.311 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.66 131.68 54.14 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 83' ' ' THR . 32.5 ttpt -111.42 141.32 45.12 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.293 0.568 . . . . 0.0 111.198 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 29' ' ' VAL . 41.0 t -112.77 125.71 70.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.174 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.28 118.1 20.8 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.546 0.688 . . . . 0.0 110.658 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.33 150.47 18.55 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.009 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -11.21 8.0 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.36 0.6 . . . . 0.0 112.202 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.1 -16.82 62.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.658 0.742 . . . . 0.0 110.32 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.07 -12.99 55.87 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -78.05 122.87 26.14 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.932 0.396 . . . . 0.0 110.436 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 22' ' ' VAL . 3.1 p -144.59 137.41 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.424 0.631 . . . . 0.0 111.195 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.7 t -144.47 151.09 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.582 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.525 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -110.15 141.89 42.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.821 0.343 . . . . 0.0 110.526 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -137.06 138.77 40.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.162 0.505 . . . . 0.0 111.534 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -106.48 114.92 29.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.052 0.453 . . . . 0.0 110.51 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.1 pt -132.68 170.46 19.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.139 0.495 . . . . 0.0 110.563 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.571 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.2 tmtp? -80.41 149.24 30.23 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.571 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 9.2 tpp180 -56.83 -25.2 55.66 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -107.28 3.3 25.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.722 0.773 . . . . 0.0 109.749 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 m -81.5 131.03 59.47 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 33.7 Cg_endo -63.13 147.75 93.89 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.208 1.939 . . . . 0.0 112.152 -177.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.6 mt -64.6 -15.24 60.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 57.1 p -50.97 -38.48 51.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.096 0.558 . . . . 0.0 111.466 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 39' ' ' PRO . 12.3 mmmm -55.85 -54.45 44.45 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 44' ' ' MET . 4.3 pp -75.86 -32.27 59.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.999 0.428 . . . . 0.0 111.322 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.593 ' N ' HD13 ' A' ' 43' ' ' LEU . 37.0 ttm -61.47 -50.25 73.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.615 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 69.4 mmtt -70.38 -41.64 72.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.84 0.352 . . . . 0.0 110.094 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.16 -45.46 92.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.265 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -56.49 -50.2 72.45 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.063 0.459 . . . . 0.0 110.466 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.622 ' SG ' HD13 ' A' ' 58' ' ' ILE . 58.2 m -63.1 -38.28 90.57 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.97 0.414 . . . . 0.0 111.498 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 48.6 mt-10 -64.34 -40.22 95.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.117 0.484 . . . . 0.0 111.571 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.3 ptp180 -86.2 -23.14 26.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -98.66 -10.73 22.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.979 0.418 . . . . 0.0 112.081 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.49 43.9 14.35 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.957 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.4 mm? -119.69 157.9 27.56 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 122.307 -0.525 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.2 m -107.53 128.31 54.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.166 0.507 . . . . 0.0 111.235 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.461 ' HE1' ' HG2' ' A' ' 44' ' ' MET . 58.0 mmm -56.62 -30.57 63.41 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.548 0.739 . . . . 0.0 112.766 -177.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.597 ' N ' ' HD3' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -83.35 -28.98 28.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.47 0.652 . . . . 0.0 111.081 -176.354 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -40.18 16.49 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.88 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.622 HD13 ' SG ' ' A' ' 48' ' ' CYS . 12.8 pt -91.63 174.45 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 O-C-N 121.906 -0.496 . . . . 0.0 110.443 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -150.36 130.85 13.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.266 0.555 . . . . 0.0 110.257 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -83.02 137.04 34.28 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.848 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -136.53 143.04 43.5 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.155 0.503 . . . . 0.0 110.576 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -148.84 130.3 14.8 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 69.24 25.71 5.59 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.83 0.824 . . . . 0.0 110.199 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.91 -24.55 5.91 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.192 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -92.68 136.23 25.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 122.479 -0.424 . . . . 0.0 110.93 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -67.81 142.65 58.4 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.11 1.873 . . . . 0.0 111.387 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 pt -112.71 174.8 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.068 0.461 . . . . 0.0 110.985 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.617 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -138.27 159.16 42.78 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.135 0.493 . . . . 0.0 111.995 -176.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 11.6 pt-20 -62.56 -10.21 11.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.775 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -97.99 7.42 46.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.886 0.374 . . . . 0.0 111.396 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.617 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.29 155.94 17.24 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 121.719 -0.613 . . . . 0.0 110.594 179.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 p -120.76 146.83 44.48 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.966 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.556 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 20.2 Cg_endo -60.64 -25.31 80.61 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.778 2.319 . . . . 0.0 112.494 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 -31.66 62.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.377 0.608 . . . . 0.0 110.519 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -68.15 -55.71 11.39 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.252 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -85.12 6.92 23.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.883 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 58.73 63.15 1.74 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.958 0.885 . . . . 0.0 112.275 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.5 mtt -84.1 134.52 34.6 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.488 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -96.89 175.12 6.46 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.009 0.433 . . . . 0.0 110.146 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -77.92 147.14 35.15 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 68.51 13.63 8.98 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.13 0.572 . . . . 0.0 112.248 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.97 162.9 23.66 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 15.8 m -124.73 142.14 51.62 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.68 0.753 . . . . 0.0 113.001 -173.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.65 135.28 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.082 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -93.74 121.31 35.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.048 0.452 . . . . 0.0 110.366 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.63 138.93 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.225 0.536 . . . . 0.0 112.006 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -130.92 152.74 49.92 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.86 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.45 113.78 27.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.271 0.558 . . . . 0.0 111.91 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -105.95 -170.43 1.73 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.991 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 65.71 19.32 11.39 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.603 0.761 . . . . 0.0 111.503 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 p -84.58 -80.91 0.19 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.342 0.591 . . . . 0.0 111.167 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.27 27.18 21.57 Favored Glycine 0 C--N 1.314 -0.676 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.137 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.269 0 CA-C-O 118.31 -1.272 . . . . 0.0 111.01 -179.308 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 121.085 0.469 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.55 14.97 13.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.016 0.912 . . . . 0.0 109.434 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -81.04 5.77 15.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.626 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -97.24 41.53 1.11 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.863 0.839 . . . . 0.0 109.783 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.439 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 60.6 mttm -138.46 -50.97 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.402 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.974 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.439 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 8.0 Cg_exo -71.16 152.6 62.16 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 121.931 1.754 . . . . 0.0 112.434 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -101.99 1.4 36.58 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.144 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.35 109.22 4.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.248 0.547 . . . . 0.0 111.439 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.63 47.73 0.98 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.44 144.57 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.062 0.458 . . . . 0.0 110.651 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -138.19 148.07 44.45 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.1 p -111.31 116.34 30.83 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -154.54 170.53 21.23 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -123.58 126.28 46.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.285 0.564 . . . . 0.0 111.564 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -147.81 159.8 43.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.461 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -86.81 82.87 7.68 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.752 0.787 . . . . 0.0 110.49 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -122.04 150.4 42.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.223 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.4 pt -124.17 167.63 17.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.0 0.429 . . . . 0.0 110.061 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.466 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -106.52 124.1 49.09 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.811 0.338 . . . . 0.0 110.143 -178.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.3 125.09 49.37 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 35.5 ttpt -105.26 140.68 38.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.05 0.452 . . . . 0.0 111.004 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.4 ' O ' HG22 ' A' ' 29' ' ' VAL . 42.0 t -110.66 123.89 66.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.77 128.1 43.33 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.502 0.668 . . . . 0.0 110.514 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.39 148.86 16.52 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.692 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -5.4 2.3 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -82.54 -12.18 57.93 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.721 0.772 . . . . 0.0 110.122 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.28 -9.96 57.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.738 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.8 m -78.36 119.7 22.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 22' ' ' VAL . 4.2 p -145.48 141.22 22.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.365 0.603 . . . . 0.0 111.782 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 40.9 t -146.84 151.23 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.4 0.68 . . . . 0.0 109.174 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.466 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -110.41 141.44 43.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.931 0.396 . . . . 0.0 110.336 -179.071 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -136.54 153.58 50.96 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.067 0.46 . . . . 0.0 110.728 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 90.0 mttt -124.58 113.75 18.48 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.827 0.346 . . . . 0.0 110.246 178.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.4 pt -127.26 172.53 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.935 0.398 . . . . 0.0 110.658 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.6 tmtp? -80.91 152.04 28.28 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.477 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 9.6 tpp180 -54.67 -23.9 19.4 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -112.63 2.56 16.22 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.415 -0.803 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 m -79.49 131.65 64.42 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.562 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.33 144.82 92.12 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.636 2.224 . . . . 0.0 112.458 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.428 HD13 ' OD2' ' A' ' 71' ' ' ASP . 40.2 mt -65.01 -15.61 62.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.073 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.594 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 32.1 t -48.96 -37.82 21.19 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.643 0.377 . . . . 0.0 111.417 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -55.37 -53.29 58.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.714 0.293 . . . . 0.0 110.985 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 44' ' ' MET . 4.4 pp -75.48 -32.1 60.45 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.367 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.528 ' N ' HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -54.44 -56.74 15.63 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.3 0.571 . . . . 0.0 111.337 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 41' ' ' SER . 6.5 mmmt -71.47 -41.24 69.61 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.254 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.18 -49.01 78.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.939 0.399 . . . . 0.0 111.551 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -55.17 -51.66 65.79 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 121.029 0.443 . . . . 0.0 110.744 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.716 ' SG ' HD11 ' A' ' 58' ' ' ILE . 33.5 m -63.99 -36.68 84.78 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.869 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 41.6 mt-10 -65.86 -39.55 90.85 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.909 0.385 . . . . 0.0 111.525 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.5 ptp180 -85.96 -21.93 27.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.879 0.371 . . . . 0.0 111.707 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -96.11 -6.25 38.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.885 0.374 . . . . 0.0 111.467 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.87 41.89 71.45 Favored Glycine 0 C--N 1.321 -0.289 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.468 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 mp -115.8 153.54 31.26 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.358 0.599 . . . . 0.0 110.94 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.1 m -102.27 127.39 49.27 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.094 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.503 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 93.1 mmm -55.44 -31.98 62.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.039 0.536 . . . . 0.0 112.279 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -84.98 -28.3 25.89 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.158 0.504 . . . . 0.0 112.022 -178.081 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.714 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -91.19 -5.05 55.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.372 0.606 . . . . 0.0 110.488 -178.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.716 HD11 ' SG ' ' A' ' 48' ' ' CYS . 13.7 pt -122.71 170.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.967 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.636 ' HB2' ' NE2' ' A' ' 89' ' ' GLN . 16.0 tpp180 -143.94 138.51 28.54 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 120.875 0.369 . . . . 0.0 110.111 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -96.88 129.21 44.36 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.778 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -136.59 143.02 43.38 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.043 0.449 . . . . 0.0 110.276 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -148.38 133.45 18.24 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t70 68.21 24.56 7.5 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.675 0.75 . . . . 0.0 110.274 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.28 -21.39 6.06 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.144 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -93.11 141.73 24.44 Favored Pre-proline 0 C--N 1.317 -0.83 0 O-C-N 122.35 -0.5 . . . . 0.0 110.494 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.9 137.22 24.07 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.187 1.925 . . . . 0.0 111.649 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.8 pt -114.43 170.94 4.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.241 0.544 . . . . 0.0 110.663 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.682 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.31 155.64 46.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.025 -179.139 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 41' ' ' SER . 13.4 pt-20 -59.86 -10.17 3.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.08 0.467 . . . . 0.0 111.93 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -100.62 6.43 44.1 Favored 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 121.766 -0.583 . . . . 0.0 111.595 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.682 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -92.93 165.23 12.98 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 121.615 -0.678 . . . . 0.0 110.384 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.1 p -122.4 148.82 53.61 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.524 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.97 -20.14 58.83 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.141 2.561 . . . . 0.0 112.585 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.53 -31.54 37.02 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.052 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -67.53 -56.29 10.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.273 0.559 . . . . 0.0 110.991 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -81.84 8.73 9.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.018 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 57.69 63.08 1.91 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.587 0.708 . . . . 0.0 111.463 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.7 mtt -79.67 -165.58 0.83 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.989 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.44 169.81 15.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.55 139.51 42.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.205 0.526 . . . . 0.0 111.271 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 70.75 18.88 6.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.525 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -84.68 165.55 17.81 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 19.4 m -127.03 141.64 51.74 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.666 0.746 . . . . 0.0 112.852 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.06 140.28 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.223 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.32 121.76 38.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.11 0.481 . . . . 0.0 110.895 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.9 t -109.44 137.66 40.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.343 0.592 . . . . 0.0 111.555 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -128.71 149.55 50.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.963 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -98.14 112.17 24.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.366 0.603 . . . . 0.0 110.991 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.636 ' NE2' ' HB2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -164.55 173.98 11.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.952 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -128.07 -68.42 0.77 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.067 0.461 . . . . 0.0 110.66 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 p -98.28 75.92 2.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.134 0.492 . . . . 0.0 110.582 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.03 -50.72 3.73 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.687 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.565 0 CA-C-O 118.264 -1.298 . . . . 0.0 110.733 179.01 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.787 0.327 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.35 -38.94 13.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.257 0.551 . . . . 0.0 111.05 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.77 -6.19 47.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.576 0.703 . . . . 0.0 110.889 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -101.6 1.08 37.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.174 0.512 . . . . 0.0 110.258 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.518 ' HZ1' ' HB3' ' A' ' 5' ' ' LYS . 10.2 mtpm? -70.13 -49.65 17.86 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.789 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.81 124.4 3.94 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 121.597 1.532 . . . . 0.0 110.399 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.441 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 47.0 mmtm -99.26 7.61 45.52 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.919 -0.488 . . . . 0.0 111.149 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 57.6 30.39 18.71 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.338 0.59 . . . . 0.0 111.038 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.59 74.85 1.27 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.21 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 7' ' ' LYS . 7.3 p -70.63 127.87 33.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.489 0.662 . . . . 0.0 111.225 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 8.7 mmpt? -91.7 93.05 8.71 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.4 p -83.8 178.34 7.96 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.822 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.15 4.51 13.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.698 0.761 . . . . 0.0 109.776 178.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -151.31 166.93 29.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.573 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -138.19 96.61 3.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.578 0.704 . . . . 0.0 110.192 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -82.85 91.39 7.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.271 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -127.17 157.54 39.49 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.355 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.6 pt -140.96 165.71 19.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.99 0.424 . . . . 0.0 110.29 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.564 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -106.22 122.37 46.07 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.37 124.43 47.69 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 36.5 ttpt -100.75 145.71 28.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.02 0.438 . . . . 0.0 110.266 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' HG22 ' A' ' 29' ' ' VAL . 46.6 t -115.87 125.87 73.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.74 124.02 34.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.57 0.7 . . . . 0.0 110.893 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.99 149.0 17.46 Favored Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.472 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -63.01 -11.4 18.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.525 0.679 . . . . 0.0 111.47 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.81 -14.05 60.64 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.76 0.79 . . . . 0.0 110.062 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.84 -9.78 58.53 Favored Glycine 0 C--N 1.307 -1.067 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.902 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -79.33 117.45 20.33 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.089 0.471 . . . . 0.0 110.055 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.7 p -143.38 139.19 26.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.215 0.531 . . . . 0.0 111.455 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.462 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 48.3 t -145.91 151.16 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.564 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -104.73 142.17 35.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 36.6 m-85 -132.41 157.36 44.75 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.556 0.693 . . . . 0.0 111.301 -177.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -134.38 110.61 9.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.407 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 pt -131.45 173.8 14.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.248 0.547 . . . . 0.0 111.256 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' O ' ' HB ' ' A' ' 38' ' ' THR . 2.1 tmtp? -80.48 146.39 31.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 33.6 ttm180 -64.4 -16.75 62.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.393 0.616 . . . . 0.0 112.157 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.6 2.03 30.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.405 0.621 . . . . 0.0 110.241 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 5.6 m -88.45 133.45 36.4 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.046 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.43 146.3 93.08 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.655 2.237 . . . . 0.0 112.54 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.444 HD13 ' OD1' ' A' ' 71' ' ' ASP . 30.5 mt -65.49 -15.26 62.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.923 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 13.8 p -54.61 -33.11 59.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.271 0.558 . . . . 0.0 110.568 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -57.65 -53.95 52.43 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.676 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.585 HD11 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.08 -31.9 58.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.432 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.585 ' N ' HD11 ' A' ' 43' ' ' LEU . 58.2 mtt -57.18 -56.73 18.07 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.994 0.426 . . . . 0.0 111.549 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -71.66 -34.64 69.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.914 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -61.5 -47.03 87.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.996 0.427 . . . . 0.0 110.726 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 20.5 t80 -55.05 -50.22 69.64 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 110.49 177.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.706 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.4 m -63.27 -40.68 98.09 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.568 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 41.5 mt-10 -64.03 -34.97 79.22 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.8 ptp180 -89.66 -26.06 20.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -94.14 -16.39 23.78 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.191 0.52 . . . . 0.0 112.157 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.19 35.94 10.44 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.251 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.617 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.5 mm? -113.81 154.31 27.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.293 0.568 . . . . 0.0 110.821 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -105.17 136.97 43.68 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.548 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.497 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 92.1 mmm -63.4 -22.48 66.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.144 0.497 . . . . 0.0 111.012 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.48 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -83.67 -28.58 28.25 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.421 0.629 . . . . 0.0 110.342 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.48 ' NE2' ' HB2' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -93.67 -10.95 32.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.881 -177.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.706 HD11 ' SG ' ' A' ' 48' ' ' CYS . 7.3 pt -128.3 170.86 17.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.093 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 tpp180 -148.7 135.9 20.17 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.102 0.477 . . . . 0.0 110.291 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.2 m-85 -91.01 138.96 31.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -141.61 140.92 33.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.028 0.442 . . . . 0.0 110.72 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -146.31 134.34 21.48 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 69.53 27.49 4.85 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.907 0.86 . . . . 0.0 110.533 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.26 -6.84 49.16 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.572 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -111.43 140.56 23.17 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 122.165 -0.609 . . . . 0.0 110.826 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.11 139.19 35.08 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.269 1.98 . . . . 0.0 111.273 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.1 pt -113.15 153.62 14.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.333 0.587 . . . . 0.0 111.708 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.7 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -108.56 152.98 24.02 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.343 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.577 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 13.8 pt-20 -60.95 -14.92 25.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.178 0.513 . . . . 0.0 111.924 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -93.42 7.71 43.42 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.7 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -91.58 158.07 16.64 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 121.587 -0.695 . . . . 0.0 110.714 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.5 p -118.55 145.61 37.85 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.881 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.443 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 18.2 Cg_endo -59.14 -21.53 59.89 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.798 2.332 . . . . 0.0 112.664 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 36' ' ' ARG . . . -81.26 -19.41 43.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.029 0.443 . . . . 0.0 111.266 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -80.69 -54.67 5.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.311 0.576 . . . . 0.0 110.783 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -82.68 10.53 7.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.135 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 57.85 62.44 2.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.35 0.595 . . . . 0.0 111.123 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -83.09 121.1 26.61 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.146 0.498 . . . . 0.0 110.36 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 82' ' ' ASP . 11.4 pt-20 -80.95 159.64 24.87 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.312 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -74.78 149.19 39.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.881 0.372 . . . . 0.0 111.465 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 63.15 19.31 11.58 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.818 0.847 . . . . 0.0 112.079 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.457 ' HB2' ' HG3' ' A' ' 79' ' ' GLU . 1.7 t70 -89.28 -178.02 5.53 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.543 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 16.4 m -130.11 151.43 50.65 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.376 0.608 . . . . 0.0 112.037 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.81 137.71 42.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 123.387 0.675 . . . . 0.0 109.215 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -91.76 124.67 36.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 110.807 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 47.4 t -111.52 136.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.296 0.57 . . . . 0.0 111.795 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -126.2 144.47 50.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.12 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.455 ' HG3' HG23 ' A' ' 58' ' ' ILE . 1.5 mp0 -99.25 110.98 23.45 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.628 0.251 . . . . 0.0 110.75 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -56.7 -53.69 54.84 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.613 0.72 . . . . 0.0 110.69 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.2 125.71 27.56 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.111 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.3 p -68.99 120.67 15.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.278 0.561 . . . . 0.0 111.481 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.06 81.98 0.64 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.31 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.032 0 CA-C-O 118.583 -1.12 . . . . 0.0 111.5 179.395 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.416 ' HG2' ' OE2' ' A' ' 4' ' ' GLU . 56.5 mtt . . . . . 0 CA--C 1.507 -0.693 0 CA-C-O 121.63 0.729 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.79 -32.84 0.13 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.577 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -69.23 -26.23 64.7 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.082 0.468 . . . . 0.0 110.674 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.416 ' OE2' ' HG2' ' A' ' 1' ' ' MET . 6.2 pt-20 -66.87 -42.94 84.76 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 121.265 0.555 . . . . 0.0 110.325 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 12.8 tppt? -144.22 82.49 10.73 Favored Pre-proline 0 N--CA 1.417 -2.093 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.787 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.5 146.7 27.76 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.4 2.067 . . . . 0.0 111.661 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -112.41 48.94 0.95 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.58 119.52 9.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.918 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.04 -64.78 2.86 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.566 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.89 98.7 3.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.948 0.88 . . . . 0.0 112.439 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 11' ' ' LYS . 1.3 pptp? -160.27 144.92 14.56 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.011 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 p -71.56 91.9 1.1 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.064 0.459 . . . . 0.0 111.168 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.61 -51.17 69.69 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.53 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 56.8 70.07 0.69 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.872 0.844 . . . . 0.0 109.253 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -141.14 132.13 26.13 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.055 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -81.87 83.17 7.28 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -119.27 144.23 46.89 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.883 -0.511 . . . . 0.0 110.897 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.6 pt -125.43 167.45 19.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.113 0.482 . . . . 0.0 110.068 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.511 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -107.37 126.82 52.96 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.833 -178.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.82 125.45 48.59 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -104.48 139.72 38.98 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.872 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 40.2 t -111.82 123.21 67.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.967 0.413 . . . . 0.0 110.03 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.72 112.43 14.8 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.763 0.792 . . . . 0.0 110.751 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.95 147.7 18.7 Favored Glycine 0 C--N 1.297 -1.608 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.271 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -10.27 7.91 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.243 0.544 . . . . 0.0 112.143 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -73.36 -13.66 61.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.631 0.729 . . . . 0.0 110.315 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.8 -15.25 55.75 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.8 m -74.7 117.03 16.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.247 0.546 . . . . 0.0 110.49 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 3.3 p -142.52 136.48 27.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.397 0.618 . . . . 0.0 111.1 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -145.39 151.66 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -108.32 140.45 41.58 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -134.2 155.3 50.39 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.133 0.492 . . . . 0.0 110.945 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 90.1 mttt -128.08 111.1 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.107 0.479 . . . . 0.0 110.642 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.3 pt -127.62 173.58 12.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.029 0.442 . . . . 0.0 110.283 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.6 tmtp? -78.6 146.37 34.2 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.456 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 40.0 ttm180 -64.32 -12.75 45.14 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.334 0.588 . . . . 0.0 111.865 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -107.04 -3.38 20.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.669 0.747 . . . . 0.0 109.617 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.8 m -83.5 135.05 44.07 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.609 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.88 145.05 89.91 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.708 2.272 . . . . 0.0 112.624 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 48.5 mt -65.67 -16.84 64.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.02 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 32.6 p -54.25 -34.8 61.56 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.01 0.433 . . . . 0.0 111.061 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -57.46 -52.1 66.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.566 HD13 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.73 -32.16 62.04 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.884 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.566 ' N ' HD13 ' A' ' 43' ' ' LEU . 58.5 mtt -58.12 -53.89 53.12 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.183 0.516 . . . . 0.0 110.903 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 34.2 mmtp -66.69 -41.74 87.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.019 0.438 . . . . 0.0 110.079 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.9 -48.02 83.4 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.115 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -55.73 -49.05 74.1 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.68 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.597 ' SG ' HD12 ' A' ' 58' ' ' ILE . 62.7 m -67.2 -36.27 81.38 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 47.7 mt-10 -62.61 -39.69 94.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.093 0.473 . . . . 0.0 111.215 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 14.8 ptp180 -86.73 -25.71 24.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -93.52 -8.65 40.8 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.98 -0.45 . . . . 0.0 111.817 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.15 43.78 46.68 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.727 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.9 mp -115.91 152.89 32.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.39 0.614 . . . . 0.0 111.043 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.2 m -99.15 124.33 44.11 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.973 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.506 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 95.4 mmm -60.85 -22.33 64.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.949 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.471 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.3 OUTLIER -84.68 -32.62 23.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.482 0.658 . . . . 0.0 110.804 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.734 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -84.73 -20.66 30.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.909 -176.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.597 HD12 ' SG ' ' A' ' 48' ' ' CYS . 16.0 pt -113.02 176.17 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.231 0.539 . . . . 0.0 111.949 -177.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -149.22 140.23 22.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.407 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.435 ' CD2' ' HG2' ' A' ' 44' ' ' MET . 6.4 m-85 -94.61 129.44 41.45 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.594 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -130.55 143.58 50.85 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.538 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -150.12 136.82 19.17 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 t70 67.32 26.98 8.38 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.834 0.826 . . . . 0.0 110.815 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.38 -5.61 59.67 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.991 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -116.63 142.09 29.09 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 122.076 -0.661 . . . . 0.0 110.883 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.11 134.66 34.75 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.067 1.845 . . . . 0.0 110.799 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.706 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 12.1 pt -104.49 -177.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.137 0.494 . . . . 0.0 111.631 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.561 HD21 ' HB3' ' A' ' 71' ' ' ASP . 0.5 OUTLIER -129.39 161.63 29.88 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 121.689 0.757 . . . . 0.0 110.649 -175.132 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.1 pt-20 -67.98 -15.28 63.54 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.764 0.792 . . . . 0.0 109.583 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 t -110.01 16.49 21.85 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.706 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 1.8 p-10 -98.23 101.5 12.98 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 118.517 -1.273 . . . . 0.0 110.722 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 p -60.31 141.22 91.21 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.73 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 11.1 Cg_endo -56.39 -24.25 51.09 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.991 2.46 . . . . 0.0 112.288 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.26 -34.2 68.07 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.128 0.49 . . . . 0.0 110.647 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -64.95 -55.78 17.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.986 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.405 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 2.1 pt? -85.09 6.57 24.96 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.712 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 60.37 52.6 4.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.716 0.769 . . . . 0.0 111.499 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.76 131.64 40.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.273 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -94.94 165.75 12.29 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.028 0.442 . . . . 0.0 110.613 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -76.37 148.28 37.5 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.359 0.6 . . . . 0.0 110.553 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 65.64 14.72 9.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.768 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.62 167.21 20.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.8 m -123.04 140.77 52.68 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.03 135.93 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.191 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -94.98 118.97 32.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.064 0.459 . . . . 0.0 110.296 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.37 138.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.148 0.499 . . . . 0.0 111.793 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -128.6 150.87 50.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.952 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.425 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.1 mp0 -104.61 112.8 26.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 111.672 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.414 HE21 ' N ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -125.02 77.19 1.6 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.146 0.974 . . . . 0.0 110.348 174.43 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.464 ' HG2' ' HB3' ' A' ' 57' ' ' GLN . 70.8 mt-30 -75.06 90.06 2.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.47 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -103.17 103.91 14.0 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.088 0.471 . . . . 0.0 109.906 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.89 158.34 9.25 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.572 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.029 0 CA-C-O 118.714 -1.048 . . . . 0.0 111.299 -179.779 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.598 0.237 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.89 -66.51 0.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.98 0.419 . . . . 0.0 111.479 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -92.39 7.1 44.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.535 0.683 . . . . 0.0 110.424 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -88.9 -49.41 6.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.673 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -142.36 73.18 21.2 Favored Pre-proline 0 N--CA 1.462 0.142 0 CA-C-O 120.733 0.301 . . . . 0.0 110.831 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.95 158.37 8.71 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.529 2.153 . . . . 0.0 112.21 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -91.59 47.25 1.35 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.176 0.512 . . . . 0.0 109.95 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.21 133.71 51.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.769 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.76 142.9 6.44 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.09 124.28 28.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.191 0.519 . . . . 0.0 110.574 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -140.48 111.29 6.93 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 p -78.7 130.34 35.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.104 0.478 . . . . 0.0 110.737 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -127.69 87.71 2.66 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.406 0.622 . . . . 0.0 109.795 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -87.69 87.61 7.43 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.553 0.692 . . . . 0.0 109.68 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -105.9 144.61 32.39 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.967 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -112.6 -91.22 0.49 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.919 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 73.95 134.94 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.192 0.997 . . . . 0.0 111.16 179.497 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.7 pt -128.96 160.04 40.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.01 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.525 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.2 OUTLIER -95.72 123.87 39.49 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.478 HD23 ' SD ' ' A' ' 78' ' ' MET . 86.4 mt -122.89 125.9 46.25 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.229 0.538 . . . . 0.0 110.206 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 83' ' ' THR . 36.7 ttpt -106.82 142.82 35.85 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.283 0.563 . . . . 0.0 110.98 -178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 41.1 t -115.77 126.92 73.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.65 126.51 38.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.401 0.619 . . . . 0.0 110.526 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.51 147.35 16.61 Favored Glycine 0 C--N 1.301 -1.404 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.749 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.4 pp0? -60.64 -15.45 28.53 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 112.221 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -76.37 -11.81 59.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.926 0.87 . . . . 0.0 109.636 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.85 -11.54 45.47 Favored Glycine 0 C--N 1.318 -0.463 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.434 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -73.34 114.63 11.76 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.472 -0.428 . . . . 0.0 110.755 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 4.9 p -141.14 135.9 32.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.312 0.577 . . . . 0.0 111.367 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -145.67 151.04 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.397 -177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.525 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -109.45 138.89 45.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.016 0.436 . . . . 0.0 110.091 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 18.1 m-85 -133.39 164.17 27.72 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 121.12 0.486 . . . . 0.0 110.638 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -135.27 112.38 10.37 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 122.199 -0.313 . . . . 0.0 110.22 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 pt -126.84 168.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.946 0.403 . . . . 0.0 110.779 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 1.1 tmtp? -77.7 152.69 33.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.865 0.364 . . . . 0.0 110.391 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.419 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 10.2 tpp180 -60.96 -21.74 63.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.001 0.52 . . . . 0.0 112.071 -177.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -105.76 -2.02 23.7 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.823 -0.548 . . . . 0.0 110.099 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.7 m -82.35 132.21 53.49 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.658 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.99 147.8 85.01 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.707 2.271 . . . . 0.0 112.31 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.19 -16.12 63.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.99 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 22.7 t -49.76 -38.64 34.84 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.495 0.318 . . . . 0.0 111.079 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 6.7 mmpt? -56.55 -53.48 57.09 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -75.79 -32.33 59.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.612 ' N ' HD12 ' A' ' 43' ' ' LEU . 41.2 ttm -61.24 -50.4 73.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.891 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.532 ' HD2' ' SD ' ' A' ' 55' ' ' MET . 13.5 mmmm -70.67 -40.85 72.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.8 0.333 . . . . 0.0 110.184 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.69 -46.37 89.28 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.084 0.469 . . . . 0.0 111.444 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 24.1 t80 -55.73 -50.96 68.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.063 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.696 ' SG ' HD12 ' A' ' 58' ' ' ILE . 35.0 m -63.91 -37.32 86.97 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.032 0.444 . . . . 0.0 111.167 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -62.44 -40.39 96.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.993 0.425 . . . . 0.0 111.695 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.7 ptp180 -87.94 -21.96 24.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.843 0.354 . . . . 0.0 111.8 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -96.36 -11.35 25.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.35 7.07 85.39 Favored Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.694 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 7.2 mp -82.79 155.12 24.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.614 0.721 . . . . 0.0 112.176 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.6 m -106.15 132.82 51.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.832 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.532 ' SD ' ' HD2' ' A' ' 45' ' ' LYS . 63.7 mmm -56.18 -33.45 65.28 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -177.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -25.84 28.15 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.909 -0.495 . . . . 0.0 111.657 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.506 ' HA ' ' CG ' ' A' ' 90' ' ' GLN . 0.6 OUTLIER -84.99 -19.93 31.31 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.304 0.573 . . . . 0.0 110.85 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.696 HD12 ' SG ' ' A' ' 48' ' ' CYS . 8.4 pt -116.76 174.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.046 0.45 . . . . 0.0 110.971 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -153.81 138.8 17.25 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -92.83 137.35 32.44 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.306 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -136.94 139.37 41.49 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.301 0.572 . . . . 0.0 111.299 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -150.25 143.33 24.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 t70 67.3 24.1 9.13 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.873 0.845 . . . . 0.0 110.115 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.19 -2.44 81.42 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.391 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -121.96 142.36 36.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 122.059 -0.671 . . . . 0.0 110.887 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.97 138.69 53.57 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.012 1.808 . . . . 0.0 110.835 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.432 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 13.6 pt -112.46 172.95 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.096 0.474 . . . . 0.0 110.856 -177.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.622 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -133.76 157.98 44.49 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.079 0.466 . . . . 0.0 111.574 -177.491 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 41' ' ' SER . 17.2 pt-20 -60.4 -11.84 7.8 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.714 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -100.97 11.36 39.77 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.817 0.341 . . . . 0.0 111.582 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.622 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -99.5 157.15 16.64 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 121.721 -0.612 . . . . 0.0 109.593 177.5 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.2 p -118.51 148.06 43.29 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.704 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.86 -18.69 62.34 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.691 2.261 . . . . 0.0 112.284 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.419 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -85.9 -15.69 40.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.196 0.522 . . . . 0.0 111.193 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -82.26 -56.36 3.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.299 0.571 . . . . 0.0 110.436 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -86.8 1.98 50.45 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.221 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 62.28 61.59 1.28 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.609 0.719 . . . . 0.0 112.908 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.595 ' SD ' HD13 ' A' ' 84' ' ' ILE . 29.4 ttm -89.08 137.45 32.31 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -106.83 176.79 5.06 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.897 0.38 . . . . 0.0 110.79 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -75.3 143.52 42.91 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.169 0.509 . . . . 0.0 110.793 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 71.9 13.58 6.01 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.024 0.93 . . . . 0.0 110.855 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -80.38 161.88 24.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 22.9 m -127.34 145.84 50.66 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.342 0.591 . . . . 0.0 112.316 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.595 HD13 ' SD ' ' A' ' 78' ' ' MET . 4.0 mp -110.32 136.89 44.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.426 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -93.76 130.94 39.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.1 0.476 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 46.5 t -112.74 138.63 41.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.508 0.67 . . . . 0.0 111.854 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -134.08 163.64 29.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.361 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -111.65 112.83 24.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.814 0.34 . . . . 0.0 111.228 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.0 49.22 0.96 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.239 0.543 . . . . 0.0 111.031 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.506 ' CG ' ' HA ' ' A' ' 57' ' ' GLN . 13.8 mm100 -151.83 80.91 1.27 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.323 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.9 p -130.71 109.06 10.34 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.96 -67.32 2.21 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.678 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.724 -1.042 . . . . 0.0 112.274 179.539 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.045 0.45 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.02 -65.77 1.15 Allowed 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.039 -0.413 . . . . 0.0 110.403 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.409 ' HB3' ' CD ' ' A' ' 6' ' ' PRO . 7.7 m-20 -68.94 -42.79 76.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.089 0.471 . . . . 0.0 110.409 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 67.05 32.2 6.42 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.804 0.812 . . . . 0.0 110.558 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 59.16 68.76 1.51 Allowed Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.297 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.409 ' CD ' ' HB3' ' A' ' 3' ' ' ASP . 59.4 Cg_endo -71.59 -178.44 3.03 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.196 2.597 . . . . 0.0 112.191 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -52.06 -34.19 42.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.657 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.31 125.24 28.82 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.43 95.1 0.12 Allowed Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.803 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.51 152.36 4.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.114 0.483 . . . . 0.0 110.09 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -137.52 172.23 13.28 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -99.5 28.03 4.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.653 0.74 . . . . 0.0 110.554 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.23 -175.39 4.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.546 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -81.71 85.75 6.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.52 0.676 . . . . 0.0 109.915 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -148.27 172.19 14.77 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.375 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.97 78.8 4.45 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.347 0.594 . . . . 0.0 111.363 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -124.96 145.41 49.88 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.432 HD13 ' HB2' ' A' ' 73' ' ' PRO . 19.1 pt -132.28 167.85 25.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.285 0.564 . . . . 0.0 110.815 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.642 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -99.75 129.57 45.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.754 -179.268 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.97 126.93 45.13 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 83' ' ' THR . 35.0 ttpt -109.49 141.81 41.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.329 0.585 . . . . 0.0 111.221 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.27 127.04 70.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.167 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.18 121.95 25.75 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.661 0.743 . . . . 0.0 110.502 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.2 149.39 16.61 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.242 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -11.55 11.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.474 0.654 . . . . 0.0 112.043 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.85 -18.46 62.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.544 0.687 . . . . 0.0 110.435 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.12 -5.37 45.75 Favored Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.9 m -86.82 121.65 29.61 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.884 0.373 . . . . 0.0 110.381 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 p -144.35 138.33 23.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.366 0.603 . . . . 0.0 111.415 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -146.3 151.01 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.642 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -109.93 140.65 43.67 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -132.24 157.82 43.37 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 121.19 0.519 . . . . 0.0 111.255 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -127.82 108.55 10.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.8 pt -124.19 176.36 5.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.203 0.525 . . . . 0.0 110.73 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.3 tmtp? -85.44 149.61 25.29 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.097 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.487 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 17.6 tpp180 -53.06 -26.67 16.73 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.601 0.761 . . . . 0.0 112.576 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -111.87 6.49 19.6 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.588 -0.695 . . . . 0.0 111.748 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 m -81.64 133.93 51.7 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.0 145.07 84.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.645 2.23 . . . . 0.0 112.361 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 48.1 mt -65.2 -17.06 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.927 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.47 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 35.5 p -50.47 -37.89 40.95 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.561 0.344 . . . . 0.0 111.686 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.7 mmpt? -56.36 -52.57 64.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.755 0.312 . . . . 0.0 110.72 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.88 -31.86 61.7 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.363 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.574 ' N ' HD12 ' A' ' 43' ' ' LEU . 53.2 mtt -58.2 -54.91 41.67 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.25 0.547 . . . . 0.0 110.979 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.573 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 57.6 mmtt -65.49 -44.43 87.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.936 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.723 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -57.56 -49.04 77.67 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.071 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -54.92 -51.7 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.593 ' SG ' HD13 ' A' ' 58' ' ' ILE . 34.1 m -67.19 -35.05 78.82 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.935 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.573 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 51.4 mt-10 -66.97 -36.18 81.61 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.209 -0.307 . . . . 0.0 111.682 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.723 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -88.13 -25.81 22.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 178.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -92.25 -6.06 51.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 111.555 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.2 46.38 57.95 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.158 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.8 mp -117.36 151.51 36.86 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.224 0.535 . . . . 0.0 110.827 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 71.4 m -96.76 123.0 40.32 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.905 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.489 ' HE1' ' HB3' ' A' ' 44' ' ' MET . 92.3 mmm -56.64 -28.13 59.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.993 0.517 . . . . 0.0 111.903 -178.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -84.39 -34.87 23.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.261 0.553 . . . . 0.0 111.116 -178.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.71 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -81.66 -18.91 42.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.066 0.46 . . . . 0.0 111.338 -177.373 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.593 HD13 ' SG ' ' A' ' 48' ' ' CYS . 14.3 pt -110.57 -179.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 120.968 0.413 . . . . 0.0 110.671 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -157.31 133.3 9.49 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.173 0.511 . . . . 0.0 110.433 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.9 m-85 -85.54 135.87 33.64 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.063 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -144.79 148.21 33.8 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.997 0.427 . . . . 0.0 110.362 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -154.69 138.96 16.62 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.1 t70 65.84 25.19 11.28 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.59 0.709 . . . . 0.0 110.306 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 -26.56 5.75 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.763 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -90.94 144.62 30.38 Favored Pre-proline 0 C--N 1.327 -0.386 0 O-C-N 122.408 -0.466 . . . . 0.0 110.811 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.85 141.88 27.67 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.9 1.733 . . . . 0.0 110.338 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.653 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 6.9 pt -106.08 -179.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.832 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.473 HD21 ' HB3' ' A' ' 71' ' ' ASP . 0.4 OUTLIER -129.93 165.42 22.12 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.599 0.714 . . . . 0.0 110.714 -174.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.486 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 11.1 pt-20 -67.82 -12.94 61.65 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.943 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -118.87 16.93 13.47 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.653 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 3.6 p-10 -91.27 98.76 11.92 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.415 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 p -58.49 145.56 75.75 Favored Pre-proline 0 C--N 1.301 -1.508 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.044 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HB2' HD13 ' A' ' 18' ' ' ILE . 17.9 Cg_endo -59.57 -15.82 32.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.899 2.4 . . . . 0.0 111.58 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 36' ' ' ARG . . . -80.01 -31.1 39.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.462 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -67.54 -54.67 18.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.264 0.554 . . . . 0.0 111.657 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -84.2 7.84 17.69 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.809 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 57.66 40.49 26.56 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.508 0.671 . . . . 0.0 111.224 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.86 130.29 43.55 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.463 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.86 169.75 17.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.14 0.495 . . . . 0.0 110.417 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -79.05 145.4 33.86 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 66.28 20.24 11.04 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.447 0.699 . . . . 0.0 110.975 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.03 161.42 28.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.071 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 30.3 m -121.51 135.35 55.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.645 0.736 . . . . 0.0 112.379 -175.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.84 137.94 24.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.164 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -93.62 117.38 30.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.29 0.567 . . . . 0.0 110.85 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.82 134.89 46.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.427 0.632 . . . . 0.0 111.737 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -131.84 159.87 37.3 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.442 ' HG3' HG21 ' A' ' 58' ' ' ILE . 2.1 mp0 -101.47 111.03 23.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.139 0.495 . . . . 0.0 110.496 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.481 HE21 ' N ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -123.16 85.2 2.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.213 0.53 . . . . 0.0 110.397 178.01 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -73.48 101.02 3.41 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.373 0.606 . . . . 0.0 110.54 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -116.05 97.65 6.2 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.863 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 156.79 158.02 8.66 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.159 0 CA-C-O 118.544 -1.142 . . . . 0.0 111.672 -179.727 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 121.143 0.497 . . . . 0.0 111.5 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.82 -73.41 0.67 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.866 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' HB3' ' CG ' ' A' ' 6' ' ' PRO . 6.9 m-20 -96.91 -45.13 6.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.044 0.449 . . . . 0.0 110.287 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 32.58 54.82 0.38 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.03 1.332 . . . . 0.0 113.211 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.18 -59.48 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 72.2 Cg_endo -80.16 132.06 9.13 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.619 2.212 . . . . 0.0 114.147 -175.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 3.9 mptp? -107.86 59.4 0.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.043 175.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -69.01 105.99 2.6 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.851 -0.53 . . . . 0.0 110.71 176.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.75 -47.54 0.52 Allowed Glycine 0 CA--C 1.492 -1.393 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.5 p -77.7 157.68 5.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -137.8 129.59 28.49 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.052 0.453 . . . . 0.0 109.908 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 t -169.17 158.26 8.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.121 0.486 . . . . 0.0 110.328 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.11 10.31 16.1 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.812 0.815 . . . . 0.0 108.809 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -121.15 121.1 37.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -113.57 111.86 22.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.747 0.784 . . . . 0.0 111.67 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.44 87.88 5.05 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.643 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -124.85 147.77 48.6 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.398 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.8 pt -131.61 163.52 37.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.026 0.441 . . . . 0.0 110.19 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.522 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -97.23 141.22 30.62 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.5 mt -137.51 125.19 22.32 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 83' ' ' THR . 33.4 ttpt -108.36 140.67 41.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.243 0.544 . . . . 0.0 111.422 -176.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.5 t -114.54 127.55 71.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.847 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.61 120.37 23.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.437 0.637 . . . . 0.0 110.582 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.52 150.83 17.7 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.405 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.58 -8.94 7.27 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 112.502 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.54 -13.77 60.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.706 0.765 . . . . 0.0 109.945 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.85 -10.61 58.87 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.0 m -81.42 123.72 28.81 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.001 0.429 . . . . 0.0 110.264 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 22' ' ' VAL . 3.6 p -143.71 138.28 25.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 121.278 0.561 . . . . 0.0 110.955 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.3 t -143.04 150.8 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.595 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.522 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -107.63 137.67 45.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.087 0.47 . . . . 0.0 109.971 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 29.9 m-85 -128.15 166.44 18.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 121.382 0.61 . . . . 0.0 110.503 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -141.63 111.46 6.66 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.469 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.2 pt -131.04 176.29 9.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.395 0.616 . . . . 0.0 111.549 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.426 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 1.9 tmtp? -88.45 150.52 23.1 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.267 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.426 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 21.8 tpp180 -54.98 -27.46 44.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.944 0.898 . . . . 0.0 112.712 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -108.47 3.55 23.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.272 0.558 . . . . 0.0 111.026 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.7 m -85.16 131.81 47.32 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.195 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.52 148.7 90.62 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.508 2.139 . . . . 0.0 112.484 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.4 mt -65.61 -15.6 62.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.763 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 54.1 p -50.96 -37.91 47.43 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 122.91 0.484 . . . . 0.0 111.343 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -56.91 -53.68 55.16 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.073 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.38 -32.4 58.55 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.0 0.429 . . . . 0.0 111.317 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.62 ' N ' HD12 ' A' ' 43' ' ' LEU . 41.8 ttm -60.44 -52.12 66.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.682 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 33.1 mmtp -70.49 -37.74 74.25 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.884 0.373 . . . . 0.0 110.283 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.94 -45.4 94.84 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.92 0.391 . . . . 0.0 111.004 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 21.1 t80 -56.78 -51.92 67.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.364 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.3 p -61.63 -36.59 81.19 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.216 0.532 . . . . 0.0 110.608 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 61.6 mm-40 -67.06 -45.41 77.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.878 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.9 ptp180 -78.99 -25.59 43.37 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -93.47 -12.27 30.12 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.979 -0.45 . . . . 0.0 112.2 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.95 43.81 9.59 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.323 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.442 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.0 mm? -120.6 160.06 24.0 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.016 0.436 . . . . 0.0 110.162 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.404 ' O ' HG12 ' A' ' 58' ' ' ILE . 4.7 m -109.65 135.65 50.27 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.737 0.303 . . . . 0.0 111.013 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.427 ' HE1' ' HG2' ' A' ' 44' ' ' MET . 86.3 mmm -58.01 -27.8 63.84 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.25 -24.14 27.91 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.783 -0.573 . . . . 0.0 111.443 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.68 -14.07 32.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.25 0.548 . . . . 0.0 110.136 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.442 HG21 ' HB3' ' A' ' 53' ' ' LEU . 16.1 pt -120.5 169.94 11.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 120.944 0.402 . . . . 0.0 110.674 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -149.9 136.6 19.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -95.13 136.04 35.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.146 0.498 . . . . 0.0 110.342 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.35 142.13 37.61 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.109 0.48 . . . . 0.0 110.885 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -153.44 143.27 22.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 64.63 23.76 12.87 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.411 0.624 . . . . 0.0 110.696 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.89 -2.93 82.09 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.491 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -118.35 149.29 45.65 Favored Pre-proline 0 C--N 1.332 -0.153 0 O-C-N 122.163 -0.61 . . . . 0.0 110.376 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.47 139.81 20.98 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.846 1.697 . . . . 0.0 110.575 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.9 pt -113.46 160.73 12.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.43 0.633 . . . . 0.0 111.487 -176.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.641 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -120.2 157.14 29.71 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.424 -178.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 41' ' ' SER . 7.3 pt-20 -62.77 -9.78 10.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.994 0.426 . . . . 0.0 111.92 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.0 t -99.02 7.68 45.73 Favored 'General case' 0 N--CA 1.441 -0.916 0 O-C-N 122.036 -0.415 . . . . 0.0 111.898 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.641 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.4 OUTLIER -92.71 156.65 16.91 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 121.682 -0.636 . . . . 0.0 109.898 178.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.2 p -115.99 146.77 37.79 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.8 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.81 -12.89 33.92 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.793 2.329 . . . . 0.0 112.279 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.83 -24.49 23.7 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.326 0.584 . . . . 0.0 110.604 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -72.54 -55.33 7.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.39 0.614 . . . . 0.0 110.851 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -88.7 12.39 14.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.969 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 53.38 62.95 2.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.518 0.675 . . . . 0.0 111.576 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.84 130.15 35.09 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.683 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.48 166.88 11.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.923 0.392 . . . . 0.0 110.602 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.429 ' HB2' HD21 ' A' ' 19' ' ' ASN . 6.2 p-10 -73.06 143.74 47.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.22 0.533 . . . . 0.0 110.941 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 66.8 15.0 10.03 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.863 0.865 . . . . 0.0 112.129 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -76.98 166.63 23.07 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 18.8 m -121.68 138.21 54.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.22 135.91 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.152 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -93.6 121.58 35.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.086 0.47 . . . . 0.0 110.973 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.3 t -109.79 136.83 44.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.201 0.524 . . . . 0.0 111.613 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -129.45 151.06 50.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.089 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -106.8 111.68 24.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.054 0.454 . . . . 0.0 110.868 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 89' ' ' GLN . 0.8 OUTLIER -124.03 89.88 3.17 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 122.14 0.971 . . . . 0.0 111.741 177.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -143.63 142.26 30.96 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.7 m -63.82 -47.74 79.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 110.977 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.74 -155.97 27.62 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.487 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.026 0 CA-C-O 118.791 -1.005 . . . . 0.0 111.628 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.959 0.409 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.65 15.89 25.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -101.95 28.97 5.3 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.954 0.883 . . . . 0.0 110.429 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -121.7 125.24 46.14 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.48 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 2.5 mppt? 57.7 50.19 3.92 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -174.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 5' ' ' LYS . 95.3 Cg_endo -89.15 111.87 0.56 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.004 1.802 . . . . 0.0 110.712 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -96.45 18.38 14.12 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.412 0.625 . . . . 0.0 111.175 -177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -120.7 -155.21 0.62 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.49 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.79 36.05 6.58 Favored Glycine 0 C--N 1.316 -0.548 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.181 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.05 117.18 53.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.08 96.3 5.62 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.186 0.993 . . . . 0.0 112.881 -177.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -136.92 -66.25 0.53 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 7.0 pt-20 -142.82 122.95 13.7 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -86.17 -174.86 5.28 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.819 -0.551 . . . . 0.0 110.417 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -131.42 165.24 23.94 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.379 0.609 . . . . 0.0 110.587 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -86.49 84.27 7.46 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 16.2 p-80 -120.94 150.3 41.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.95 0.405 . . . . 0.0 110.68 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.451 HD13 HD11 ' A' ' 20' ' ' LEU . 15.9 pt -133.87 166.65 28.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.096 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.604 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -102.85 115.45 30.62 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 120.835 0.35 . . . . 0.0 110.226 -179.029 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.451 HD11 HD13 ' A' ' 18' ' ' ILE . 6.6 mp -112.55 125.66 54.49 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.431 0.634 . . . . 0.0 109.947 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 83' ' ' THR . 34.1 ttpt -105.56 146.51 29.52 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.349 0.595 . . . . 0.0 111.356 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 39.4 t -116.64 128.95 73.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.97 121.42 22.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.433 0.635 . . . . 0.0 110.489 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.0 150.31 17.1 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.839 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.46 -10.58 7.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.583 0.706 . . . . 0.0 111.86 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.534 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 21.0 t70 -71.22 -19.45 62.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.253 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.89 -13.89 49.44 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -74.94 112.34 11.08 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.796 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.3 p -139.12 131.97 37.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.281 0.563 . . . . 0.0 110.913 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.53 150.83 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.604 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -106.36 142.22 36.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.847 0.356 . . . . 0.0 110.568 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -137.29 139.0 40.64 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.133 0.492 . . . . 0.0 111.076 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.437 ' HZ1' ' HB2' ' A' ' 33' ' ' LYS . 7.7 mtmp? -106.6 113.93 27.74 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.97 -0.456 . . . . 0.0 110.028 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.3 pt -126.9 170.09 17.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.972 0.415 . . . . 0.0 110.743 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.0 tmtp? -81.4 148.04 29.51 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 11.7 tpp180 -56.26 -26.14 50.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.85 0.46 . . . . 0.0 112.032 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -102.46 -2.4 28.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.531 0.681 . . . . 0.0 110.127 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.0 m -81.33 132.07 56.93 Favored Pre-proline 0 N--CA 1.434 -1.231 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.307 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.2 148.2 88.67 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.523 2.149 . . . . 0.0 111.841 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.4 mt -64.81 -15.18 61.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.743 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 11.8 p -49.22 -37.52 23.28 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -56.57 -53.42 57.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.85 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.512 HD11 ' N ' ' A' ' 44' ' ' MET . 4.3 pp -74.44 -31.63 62.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.377 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.512 ' N ' HD11 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -53.13 -58.06 8.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.023 0.439 . . . . 0.0 111.244 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.507 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -72.38 -38.14 68.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.399 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.35 -48.17 82.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.179 0.514 . . . . 0.0 110.958 -177.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -56.51 -51.35 68.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.886 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.797 ' SG ' HD11 ' A' ' 58' ' ' ILE . 31.4 m -63.75 -36.57 84.29 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.968 0.413 . . . . 0.0 111.914 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 40.4 mt-10 -64.35 -42.27 96.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.053 0.454 . . . . 0.0 111.189 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.1 ptp180 -84.35 -19.87 32.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 0.0 111.683 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -100.75 -2.4 32.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.96 48.04 69.19 Favored Glycine 0 C--O 1.235 0.202 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.348 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.435 ' HB3' HG22 ' A' ' 58' ' ' ILE . 49.5 mt -122.69 154.53 37.95 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.067 0.46 . . . . 0.0 110.673 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.2 m -103.67 126.66 50.95 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.354 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.486 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 81.0 mmm -57.92 -26.89 62.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.035 0.534 . . . . 0.0 111.808 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -28.12 27.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.243 0.544 . . . . 0.0 111.05 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.678 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -93.01 -27.48 16.98 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.937 -177.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.797 HD11 ' SG ' ' A' ' 48' ' ' CYS . 10.0 pt -103.11 163.63 3.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 O-C-N 121.375 -0.828 . . . . 0.0 110.766 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -136.97 132.15 33.94 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.073 0.463 . . . . 0.0 110.657 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -90.32 126.98 36.04 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -138.29 144.84 40.65 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.281 0.562 . . . . 0.0 111.493 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -149.83 141.83 23.89 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 t70 64.69 25.42 13.04 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.906 0.86 . . . . 0.0 110.0 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.97 -15.38 10.52 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.521 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -100.4 135.35 20.25 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 122.184 -0.597 . . . . 0.0 110.879 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.09 131.95 24.96 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.032 1.821 . . . . 0.0 111.081 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.577 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 5.7 pt -98.75 -177.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.426 HD21 ' HB3' ' A' ' 71' ' ' ASP . 0.7 OUTLIER -133.82 166.75 21.92 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-O 121.54 0.686 . . . . 0.0 110.437 -174.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 10.3 pt-20 -78.9 -8.17 58.61 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.753 0.787 . . . . 0.0 108.964 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -107.38 16.24 24.12 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.058 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.577 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -103.81 151.55 22.94 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.9 p -115.79 150.17 44.42 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.035 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.416 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 19.3 Cg_endo -61.55 -17.0 51.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.509 2.14 . . . . 0.0 111.444 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.44 -20.48 40.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.935 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.64 -53.77 8.7 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.29 0.567 . . . . 0.0 110.468 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.91 12.25 20.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.325 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 57.33 52.78 8.31 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.244 0.545 . . . . 0.0 111.439 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.37 137.08 34.85 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -104.13 -175.61 2.85 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.949 0.404 . . . . 0.0 110.4 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.451 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 11.6 p-10 -80.0 153.86 28.59 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.352 0.596 . . . . 0.0 110.319 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 63.24 18.83 11.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.916 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.75 157.57 25.78 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 25.4 m -130.21 147.68 51.96 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.595 -0.691 . . . . 0.0 112.69 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.25 140.28 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.066 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -93.86 124.25 37.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.937 0.398 . . . . 0.0 111.033 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.5 t -109.79 139.8 31.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.261 0.553 . . . . 0.0 111.522 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -132.14 156.9 45.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.743 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.534 ' OE1' ' HB2' ' A' ' 26' ' ' ASP . 2.0 mp0 -108.79 117.42 34.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.131 0.491 . . . . 0.0 111.85 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -114.21 -171.93 2.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.016 175.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.453 ' NE2' ' HG3' ' A' ' 89' ' ' GLN . 2.0 mp0 53.14 25.09 3.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.056 0.542 . . . . 0.0 111.44 -175.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.3 m -72.33 -51.02 22.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.676 0.751 . . . . 0.0 110.393 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.44 -67.92 0.55 Allowed Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.481 0 CA-C-O 118.241 -1.311 . . . . 0.0 111.14 179.048 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 CA--C 1.506 -0.741 0 CA-C-O 121.347 0.594 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.85 59.61 1.07 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.925 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -85.21 -28.79 25.19 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.743 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -81.56 85.93 6.44 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.315 0.578 . . . . 0.0 109.903 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm 63.81 78.01 0.29 Allowed Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.064 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 7.1 Cg_endo -62.51 146.28 95.49 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.254 1.969 . . . . 0.0 110.902 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -98.96 50.83 0.96 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.687 0.755 . . . . 0.0 110.552 -175.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.404 ' HG2' ' HB2' ' A' ' 6' ' ' PRO . 48.9 mm-40 -78.35 162.57 26.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.434 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.5 112.04 0.43 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.178 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.5 t -84.8 118.9 32.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -117.29 101.27 8.29 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.542 0.686 . . . . 0.0 111.42 -179.011 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -99.7 119.24 37.8 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.035 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -59.8 -72.18 0.11 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 51.85 35.22 15.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.905 0.383 . . . . 0.0 111.755 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.597 ' OD1' ' HB3' ' A' ' 17' ' ' HIS . 8.5 p30 -143.18 175.18 10.07 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.136 0.493 . . . . 0.0 110.872 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -88.87 82.02 6.82 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 122.075 0.94 . . . . 0.0 109.441 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.597 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . 30.6 p-80 -117.96 146.69 43.81 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.195 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.401 HG13 HD23 ' A' ' 20' ' ' LEU . 34.0 pt -127.41 158.14 38.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.073 0.463 . . . . 0.0 110.389 177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.0 119.27 34.19 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.405 HD21 HG12 ' A' ' 34' ' ' ILE . 2.7 mm? -110.8 125.05 53.16 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 34.1 ttpt -104.55 139.71 39.03 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.063 0.459 . . . . 0.0 110.628 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.26 125.74 69.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.82 120.99 24.52 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.728 0.775 . . . . 0.0 110.959 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.41 146.59 18.33 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -62.61 -6.88 3.89 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.19 -4.46 59.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.735 0.779 . . . . 0.0 110.061 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.14 -10.06 56.62 Favored Glycine 0 C--N 1.316 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.57 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -74.1 113.58 11.45 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 122.753 -0.263 . . . . 0.0 110.307 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.55 137.22 28.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.461 0.648 . . . . 0.0 112.229 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.2 t -145.36 150.86 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -112.36 135.15 53.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.167 0.508 . . . . 0.0 110.569 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -126.36 166.87 16.36 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.217 0.532 . . . . 0.0 111.009 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -133.93 119.41 19.06 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.089 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.405 HG12 HD21 ' A' ' 20' ' ' LEU . 44.8 pt -134.61 170.79 18.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.073 0.463 . . . . 0.0 110.43 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.525 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.4 tmtp? -82.95 153.14 25.18 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.525 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 13.6 tpp180 -54.21 -24.45 18.46 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.109 0.564 . . . . 0.0 112.27 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -106.67 -5.06 18.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.565 0.697 . . . . 0.0 110.103 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.4 m -78.65 131.16 68.63 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.659 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.33 146.25 85.41 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.748 2.299 . . . . 0.0 112.325 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.44 -17.19 64.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.724 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.0 p -50.23 -38.96 43.13 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.76 0.424 . . . . 0.0 111.525 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.6 mmpt? -55.96 -53.33 58.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.573 HD11 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.86 -31.95 61.76 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.459 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.573 ' N ' HD11 ' A' ' 43' ' ' LEU . 53.8 mtt -60.12 -54.9 40.43 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.018 0.437 . . . . 0.0 111.41 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.542 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 11.2 mmmm -67.27 -39.01 86.01 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.227 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.78 79.77 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 111.298 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 26.4 t80 -55.33 -50.77 68.78 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.042 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 58' ' ' ILE . 35.3 m -63.96 -34.27 77.6 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.842 0.353 . . . . 0.0 111.873 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.9 mt-10 -66.57 -39.54 88.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.911 0.386 . . . . 0.0 111.376 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -86.25 -21.94 27.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.976 0.417 . . . . 0.0 111.622 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.412 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 21.5 mm-40 -96.99 0.33 48.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.021 0.439 . . . . 0.0 111.561 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.01 45.19 96.63 Favored Glycine 0 CA--C 1.512 -0.145 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.964 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.462 ' HB3' HG22 ' A' ' 58' ' ' ILE . 86.2 mt -119.41 157.58 27.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.166 0.508 . . . . 0.0 110.587 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.3 m -106.33 131.81 53.1 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.394 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.536 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 88.1 mmm -58.99 -23.37 61.8 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.253 0.549 . . . . 0.0 111.255 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.515 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.5 OUTLIER -84.66 -34.12 23.1 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.211 0.529 . . . . 0.0 111.236 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.515 ' NE2' ' HB2' ' A' ' 56' ' ' ARG . 0.8 OUTLIER -88.38 -17.1 31.26 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.992 0.425 . . . . 0.0 111.612 -176.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.773 HD12 ' SG ' ' A' ' 48' ' ' CYS . 6.3 pt -117.33 172.56 4.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.79 144.78 23.73 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.141 0.496 . . . . 0.0 110.628 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.433 ' CE2' ' HG2' ' A' ' 44' ' ' MET . 6.1 m-85 -99.37 136.61 39.07 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.744 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -137.21 141.0 42.1 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.022 0.439 . . . . 0.0 110.379 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -151.18 140.69 21.57 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t0 68.65 24.68 6.73 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.832 0.825 . . . . 0.0 110.068 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.9 -0.72 65.24 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.964 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -118.45 136.07 23.88 Favored Pre-proline 0 N--CA 1.445 -0.721 0 O-C-N 122.157 -0.614 . . . . 0.0 110.466 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.58 136.38 49.87 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.906 1.738 . . . . 0.0 110.685 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.459 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 15.0 pt -112.21 169.94 4.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.383 0.611 . . . . 0.0 111.251 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.677 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -129.9 153.52 48.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.004 -177.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.463 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.6 pt-20 -59.17 -11.13 3.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.045 0.45 . . . . 0.0 112.207 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -96.63 5.3 50.99 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 122.043 -0.41 . . . . 0.0 111.65 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.677 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -96.54 161.76 13.76 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 121.574 -0.704 . . . . 0.0 110.425 -179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.5 p -121.63 150.94 56.26 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.708 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.4 -23.15 62.13 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.955 2.437 . . . . 0.0 112.244 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -77.03 -31.67 56.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.219 0.533 . . . . 0.0 110.788 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -72.11 -55.85 6.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.565 -176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -81.96 10.07 7.15 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 56.48 62.25 2.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 111.84 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 mtt -77.75 -169.91 1.67 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.347 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -156.59 158.61 37.41 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.63 141.98 40.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.16 0.505 . . . . 0.0 110.489 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 67.87 17.49 9.67 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.945 0.898 . . . . 0.0 112.017 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.57 171.66 11.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 m -125.11 138.57 54.17 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.581 0.705 . . . . 0.0 112.665 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.51 134.78 35.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -93.9 122.06 36.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.115 0.483 . . . . 0.0 110.602 -178.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 49.7 t -109.43 138.17 38.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.325 0.583 . . . . 0.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.86 155.24 46.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.523 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.484 ' HG3' HG21 ' A' ' 58' ' ' ILE . 2.7 mp0 -108.95 112.35 24.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.704 0.287 . . . . 0.0 110.879 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.93 73.56 0.9 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.686 1.231 . . . . 0.0 111.61 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.04 97.24 8.04 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.536 176.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.4 m -53.22 -59.58 4.38 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.178 0.513 . . . . 0.0 112.008 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.0 -124.54 1.25 Allowed Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.275 0 CA-C-O 118.211 -1.327 . . . . 0.0 111.206 178.625 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 39.0 p-80 . . . . . 0 N--CA 1.441 -0.925 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 73' ' ' PRO . 33.3 pt -129.6 156.44 41.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.148 0.499 . . . . 0.0 110.658 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.467 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -96.53 113.61 25.2 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.887 -178.602 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.481 ' HG ' ' SD ' ' A' ' 78' ' ' MET . 1.5 mm? -109.57 128.58 55.31 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.094 0.473 . . . . 0.0 109.752 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 37.3 ttpt -106.66 141.89 37.19 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.127 0.489 . . . . 0.0 111.168 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 45.1 t -112.48 124.18 68.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.38 112.05 13.43 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.509 0.671 . . . . 0.0 110.81 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.26 148.68 19.07 Favored Glycine 0 C--N 1.299 -1.499 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.143 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -60.58 -11.65 7.76 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.342 0.591 . . . . 0.0 112.355 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -71.25 -18.49 62.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.601 0.715 . . . . 0.0 110.132 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.24 -10.21 50.63 Favored Glycine 0 C--N 1.316 -0.557 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.6 m -78.51 116.87 19.2 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.973 0.416 . . . . 0.0 109.982 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 3.8 p -142.34 135.49 27.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.318 0.58 . . . . 0.0 111.282 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.41 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 25.0 t -145.27 151.89 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.301 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.62 136.23 49.31 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CZ ' ' HB ' ' A' ' 30' ' ' VAL . 17.0 m-85 -131.9 133.06 44.17 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.075 0.464 . . . . 0.0 111.095 -175.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 60.7 mtpt -107.51 107.67 18.63 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.911 -0.493 . . . . 0.0 110.988 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.4 pt -121.59 173.18 7.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.227 0.536 . . . . 0.0 110.459 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.8 tmtt? -81.27 150.57 28.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.12 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 7.3 tpp180 -58.32 -20.9 46.84 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.893 0.477 . . . . 0.0 111.926 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -108.73 2.64 21.95 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.861 -0.525 . . . . 0.0 111.014 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.7 m -85.89 133.12 42.03 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.793 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.21 146.47 81.45 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.728 2.285 . . . . 0.0 112.383 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.435 HD12 ' OD2' ' A' ' 71' ' ' ASP . 31.0 mt -65.86 -16.95 64.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.941 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.4 p -50.15 -37.62 35.38 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.797 0.439 . . . . 0.0 111.365 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -57.41 -52.49 65.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.91 -31.64 61.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.336 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.562 ' N ' HD12 ' A' ' 43' ' ' LEU . 56.3 mtt -59.44 -54.7 43.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.55 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.571 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 38.0 mmtm -66.06 -41.18 91.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 109.911 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.68 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.79 -47.31 86.22 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.373 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -54.49 -49.74 69.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.597 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.559 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 75.4 m -66.28 -34.99 79.25 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 84.3 mt-10 -61.03 -44.6 97.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.188 0.518 . . . . 0.0 111.141 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.9 ptp85 -85.42 -28.22 25.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -90.8 -18.7 24.46 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.817 -0.552 . . . . 0.0 112.184 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.36 41.59 9.98 Favored Glycine 0 C--N 1.309 -0.971 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.748 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.3 mm? -114.06 153.41 29.49 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.294 -0.533 . . . . 0.0 110.806 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 75.2 m -95.7 124.11 39.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.747 0.308 . . . . 0.0 110.447 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.436 ' HE2' ' HB3' ' A' ' 44' ' ' MET . 92.0 mmm -60.11 -25.51 65.51 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.71 -28.55 26.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.299 0.571 . . . . 0.0 111.178 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 3.4 mp0 -83.17 -40.91 19.1 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.163 0.506 . . . . 0.0 110.772 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.522 HD11 ' SG ' ' A' ' 48' ' ' CYS . 13.0 pt -90.86 178.06 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.115 0.484 . . . . 0.0 110.929 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -155.43 142.66 19.34 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.874 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.411 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.7 m-85 -92.33 137.08 32.66 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.085 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -140.6 134.71 30.9 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.051 0.453 . . . . 0.0 110.028 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 78' ' ' MET . 72.3 t80 -143.81 135.53 26.23 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.04 26.43 5.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.512 0.672 . . . . 0.0 111.11 176.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.03 -6.35 71.57 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.1 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -118.4 142.61 31.65 Favored Pre-proline 0 C--N 1.319 -0.76 0 O-C-N 122.284 -0.539 . . . . 0.0 110.53 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.37 141.22 46.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.112 1.875 . . . . 0.0 111.104 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 pt -115.8 160.39 15.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.236 0.541 . . . . 0.0 110.905 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 3.4 p30 -118.97 153.31 34.84 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.566 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.463 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.7 pt-20 -60.5 -12.0 8.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.019 0.438 . . . . 0.0 112.039 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -94.15 4.83 53.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.626 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.502 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -91.84 156.7 17.32 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 121.672 -0.643 . . . . 0.0 110.395 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.7 p -119.06 148.64 45.27 Favored Pre-proline 0 N--CA 1.439 -0.981 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.838 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.46 ' HB2' HD11 ' A' ' 18' ' ' ILE . 19.6 Cg_endo -60.29 -17.48 46.96 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.705 2.27 . . . . 0.0 112.417 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.37 -16.52 32.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.095 0.474 . . . . 0.0 111.268 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -82.61 -55.68 4.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.335 0.588 . . . . 0.0 110.567 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -85.11 3.37 39.25 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.996 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 62.74 62.31 1.09 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.449 0.642 . . . . 0.0 112.455 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 84' ' ' ILE . 29.7 ttm -90.41 139.27 30.83 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -109.33 171.14 7.61 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.416 0.627 . . . . 0.0 111.705 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -65.91 141.27 58.29 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.085 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 65.47 13.95 9.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.687 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.96 170.66 15.33 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.2 m -128.55 144.21 51.11 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.519 HD11 ' SD ' ' A' ' 78' ' ' MET . 4.1 mp -104.8 133.08 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.764 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -94.15 125.57 38.86 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.31 0.576 . . . . 0.0 110.873 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 41.6 t -108.82 136.28 45.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.245 0.545 . . . . 0.0 111.147 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -128.78 153.01 47.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.034 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.436 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.6 mp0 . . . . . 0 C--N 1.321 -0.672 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 17.7 p-80 . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.6 pt -130.92 159.15 43.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.285 0.564 . . . . 0.0 110.744 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.2 OUTLIER -93.75 127.15 39.33 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.7 mt -126.49 125.59 42.33 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 83' ' ' THR . 31.9 ttpt -106.41 141.37 37.84 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.401 0.62 . . . . 0.0 111.224 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.9 t -114.15 126.88 71.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.503 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.29 121.95 27.06 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.454 0.645 . . . . 0.0 110.803 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.2 148.89 18.57 Favored Glycine 0 C--N 1.298 -1.567 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.54 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -16.49 27.34 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.262 0.553 . . . . 0.0 112.142 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -70.36 -15.7 62.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.548 0.689 . . . . 0.0 110.709 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.68 -10.9 53.29 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.566 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.533 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . 70.2 m -78.54 115.34 18.18 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.107 0.48 . . . . 0.0 110.242 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.73 135.21 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.329 0.585 . . . . 0.0 111.781 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.4 t -140.68 150.12 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.93 -177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.513 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -108.51 140.55 41.68 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.9 0.381 . . . . 0.0 110.667 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -134.81 163.45 29.79 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 110.367 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -134.85 110.31 9.09 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.3 pt -126.03 166.95 21.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.916 0.389 . . . . 0.0 110.434 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 2.1 tmtp? -74.71 147.43 41.42 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.523 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 42.7 ttm180 -65.16 -15.41 62.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.187 0.518 . . . . 0.0 111.909 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -103.11 -3.52 25.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.746 0.784 . . . . 0.0 109.079 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 m -88.99 133.55 35.2 Favored Pre-proline 0 N--CA 1.439 -1.01 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.132 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.0 150.67 87.77 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.643 2.228 . . . . 0.0 112.708 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.1 mt -65.44 -15.67 62.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.578 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 34.3 p -49.97 -37.4 32.17 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 122.768 0.427 . . . . 0.0 111.731 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 7.4 mmpt? -57.61 -52.39 65.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.242 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.44 -31.94 62.46 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.366 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.59 ' N ' HD12 ' A' ' 43' ' ' LEU . 57.7 mtt -60.98 -54.53 43.83 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 34.8 mmtp -68.54 -37.03 79.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.554 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.84 -47.94 81.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.986 0.422 . . . . 0.0 110.543 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.438 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 57.1 t80 -56.06 -51.93 66.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.343 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 p -61.09 -35.12 76.15 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.068 -0.395 . . . . 0.0 111.425 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 37.6 mt-10 -67.38 -43.27 81.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.439 . . . . 0.0 111.798 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 13.3 ptp180 -80.66 -25.89 37.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.809 0.337 . . . . 0.0 111.646 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.533 ' OE1' ' HB3' ' A' ' 28' ' ' SER . 20.5 mm-40 -93.85 -2.63 53.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.793 0.33 . . . . 0.0 111.822 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.91 91.84 Favored Glycine 0 CA--C 1.508 -0.344 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.74 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.655 ' HB3' HG21 ' A' ' 58' ' ' ILE . 84.9 mt -119.25 157.04 28.83 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.19 0.519 . . . . 0.0 110.714 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.7 m -107.12 129.51 54.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.568 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.451 ' CE ' ' HB3' ' A' ' 44' ' ' MET . 98.4 mmm -63.17 -22.47 66.89 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.164 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.06 -23.91 30.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.436 0.636 . . . . 0.0 110.422 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.85 -44.47 8.92 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.076 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.655 HG21 ' HB3' ' A' ' 53' ' ' LEU . 15.3 pt -88.52 166.83 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 O-C-N 121.661 -0.649 . . . . 0.0 110.348 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -144.43 137.85 27.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.951 0.405 . . . . 0.0 110.155 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -93.5 139.99 30.1 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.853 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -144.88 143.42 30.58 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.035 0.445 . . . . 0.0 110.291 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -152.28 135.85 16.1 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t70 67.34 25.77 8.64 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.471 0.653 . . . . 0.0 111.107 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.02 0.58 76.58 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.622 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -118.74 145.04 36.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 121.912 -0.758 . . . . 0.0 110.088 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.36 141.98 23.43 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.872 1.715 . . . . 0.0 111.166 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.8 pt -115.01 160.45 14.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.275 0.559 . . . . 0.0 111.289 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.9 p30 -121.66 155.42 35.2 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.805 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 9.8 pt-20 -61.97 -9.76 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.172 0.511 . . . . 0.0 111.738 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -97.09 9.45 42.07 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 122.054 -0.404 . . . . 0.0 111.313 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.459 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -96.57 154.58 17.19 Favored 'General case' 0 C--O 1.243 0.718 0 O-C-N 121.74 -0.6 . . . . 0.0 109.734 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.3 p -117.16 146.98 39.37 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.551 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.87 -22.48 68.61 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.649 2.233 . . . . 0.0 112.091 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -80.35 -17.25 52.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.159 0.504 . . . . 0.0 110.904 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -79.23 -54.86 5.56 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.341 0.591 . . . . 0.0 110.023 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.9 pt? -87.54 12.25 12.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.223 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 57.08 58.73 3.79 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.491 0.662 . . . . 0.0 111.55 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.61 131.77 34.57 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.726 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -97.35 167.13 11.2 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.164 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.495 ' HB2' HD22 ' A' ' 19' ' ' ASN . 4.3 p-10 -76.69 150.58 36.31 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.111 0.481 . . . . 0.0 110.82 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 67.28 13.87 9.52 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.015 0.926 . . . . 0.0 112.209 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.17 171.38 13.74 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 17.6 m -125.97 147.7 49.45 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.393 0.616 . . . . 0.0 112.354 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.3 133.66 54.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.38 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.03 121.39 31.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.235 0.541 . . . . 0.0 111.275 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.81 138.93 35.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.244 0.545 . . . . 0.0 111.384 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -128.45 150.21 50.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.489 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.452 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.7 mp0 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.284 0.564 . . . . 0.0 111.643 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 31.9 p-80 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.407 HG13 HD21 ' A' ' 20' ' ' LEU . 31.4 pt -130.63 165.1 31.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.047 0.451 . . . . 0.0 110.591 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.12 120.51 40.57 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.407 HD21 HG13 ' A' ' 18' ' ' ILE . 2.5 mm? -111.83 124.57 52.63 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 83' ' ' THR . 33.5 ttpt -104.81 142.16 35.23 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.046 0.45 . . . . 0.0 110.634 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.84 127.71 71.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 120.958 0.409 . . . . 0.0 110.112 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.18 123.38 26.95 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.491 0.662 . . . . 0.0 110.146 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.9 148.41 16.47 Favored Glycine 0 C--N 1.3 -1.437 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.986 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -7.26 4.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -82.94 -10.63 58.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.482 0.658 . . . . 0.0 109.897 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.67 -13.36 46.54 Favored Glycine 0 CA--C 1.511 -0.193 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.338 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.1 m -77.31 119.24 20.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.962 0.41 . . . . 0.0 110.678 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.81 135.31 33.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.583 0.706 . . . . 0.0 111.366 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -143.33 149.46 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 1.6 tm0? -108.0 139.77 42.15 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.106 -0.371 . . . . 0.0 110.4 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -128.43 163.7 24.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.32 0.581 . . . . 0.0 110.758 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -137.7 111.73 8.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.951 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 pt -136.44 173.33 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.323 0.582 . . . . 0.0 111.085 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 11.5 tmtt? -77.08 147.98 36.36 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.591 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.481 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 40.1 ttm180 -60.29 -18.12 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -112.59 5.11 17.68 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.372 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -83.03 133.98 47.25 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.29 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.1 140.34 83.45 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.684 2.256 . . . . 0.0 113.045 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.431 HD12 ' OD2' ' A' ' 71' ' ' ASP . 42.3 mt -65.1 -15.7 62.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.824 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 23.0 t -49.27 -39.63 31.3 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 122.615 0.366 . . . . 0.0 111.27 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.533 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -58.3 -52.46 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.617 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.6 -32.01 62.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.922 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.617 ' N ' HD12 ' A' ' 43' ' ' LEU . 38.9 ttm -61.78 -52.01 65.97 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.61 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 50.5 mmtt -68.61 -42.57 77.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.001 0.429 . . . . 0.0 110.03 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.76 -45.24 90.18 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.955 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 49.2 t80 -57.95 -52.34 65.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.455 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.531 ' SG ' ' HG2' ' A' ' 55' ' ' MET . 14.4 p -62.4 -37.62 86.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.119 0.485 . . . . 0.0 110.982 -177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 48.1 mt-10 -67.63 -37.59 82.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.987 0.422 . . . . 0.0 111.898 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.6 ptp180 -85.7 -23.41 27.41 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.104 -0.372 . . . . 0.0 111.552 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.426 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 19.6 mm-40 -97.01 -4.53 39.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.938 0.399 . . . . 0.0 111.75 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.45 54.62 Favored Glycine 0 C--N 1.322 -0.201 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.249 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.6 mp -116.65 154.43 30.56 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.156 0.503 . . . . 0.0 110.614 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.0 m -102.45 122.37 44.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.493 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.531 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 97.8 mmm -56.09 -25.48 45.67 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.516 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -83.75 -30.92 26.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.614 0.721 . . . . 0.0 109.985 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 6.3 mp0 -88.52 -24.34 22.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.256 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 54' ' ' SER . 21.9 pt -107.25 174.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 121.895 -0.503 . . . . 0.0 110.158 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -159.05 134.35 8.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.203 0.525 . . . . 0.0 110.509 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 4.1 m-85 -85.64 143.18 28.57 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.625 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.441 ' HG3' ' C ' ' A' ' 65' ' ' GLN . 26.0 ttm180 -142.1 141.78 32.74 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.066 0.46 . . . . 0.0 110.541 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -150.32 136.91 19.0 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.25 27.68 8.28 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.342 0.592 . . . . 0.0 111.207 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.4 2.08 83.28 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.239 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.441 ' C ' ' HG3' ' A' ' 61' ' ' ARG . 7.5 pt20 -125.5 144.52 48.18 Favored Pre-proline 0 C--N 1.317 -0.836 0 O-C-N 122.178 -0.601 . . . . 0.0 110.26 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.85 143.0 53.79 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.039 1.826 . . . . 0.0 111.442 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.7 pt -113.63 171.45 3.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.058 0.456 . . . . 0.0 110.552 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.511 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 1.8 p30 -131.59 155.48 47.46 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.7 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.597 ' O ' ' HB2' ' A' ' 41' ' ' SER . 12.6 pt-20 -63.02 -8.83 8.12 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.134 0.492 . . . . 0.0 111.897 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 t -99.11 9.39 43.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 121.982 -0.449 . . . . 0.0 111.293 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.511 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.4 157.74 16.21 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.789 179.1 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.6 p -123.61 151.7 64.08 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 12.2 Cg_endo -57.54 -19.85 38.71 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.76 2.307 . . . . 0.0 112.641 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.2 35.23 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.94 -0.475 . . . . 0.0 110.97 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -72.44 -56.26 5.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.186 0.517 . . . . 0.0 110.86 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 1.7 pt? -81.88 6.06 16.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.634 -178.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 56.64 64.14 1.76 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.722 0.772 . . . . 0.0 111.145 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.79 -170.69 1.12 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.258 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -147.57 149.73 33.13 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.74 143.87 47.84 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 68.3 14.93 9.28 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.228 0.611 . . . . 0.0 111.878 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -87.61 173.95 8.74 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.044 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 28.3 m -126.41 142.42 51.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.699 0.761 . . . . 0.0 112.757 -175.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.76 133.09 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.786 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -90.55 119.95 31.23 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.041 0.448 . . . . 0.0 110.623 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.27 136.7 41.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.491 0.662 . . . . 0.0 111.609 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -134.78 165.71 24.64 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.403 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.1 mp0 . . . . . 0 C--N 1.314 -0.957 0 CA-C-O 121.079 0.466 . . . . 0.0 110.196 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.667 0 CA-C-O 122.384 1.087 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 pt -116.05 158.07 16.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.19 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.79 114.49 26.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.7 mt -110.98 124.8 52.86 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 83' ' ' THR . 32.3 ttpt -102.38 136.8 41.56 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.284 0.564 . . . . 0.0 111.185 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 29' ' ' VAL . 48.2 t -112.46 125.71 69.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.226 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.15 125.84 41.86 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.44 0.638 . . . . 0.0 110.61 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.95 152.07 20.16 Favored Glycine 0 C--N 1.302 -1.354 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.018 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -19.38 38.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.227 0.513 . . . . 0.0 112.32 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.13 -22.97 63.92 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.942 0.877 . . . . 0.0 109.742 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.47 -9.3 38.28 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.486 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . 67.1 m -68.97 125.36 26.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 22' ' ' VAL . 7.1 p -146.36 145.35 19.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.24 0.543 . . . . 0.0 111.569 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.1 t -146.79 151.51 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -111.08 132.26 54.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.236 0.541 . . . . 0.0 109.879 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 32.7 m-85 -122.02 168.16 12.26 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.782 -175.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -137.58 119.67 15.51 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 pt -138.47 163.6 28.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 32.0 tttt -76.32 165.13 25.29 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.293 0.568 . . . . 0.0 111.795 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 16.0 tpp180 -71.65 -19.31 62.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.408 -177.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -105.55 -6.8 19.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.9 0.857 . . . . 0.0 108.872 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.4 m -78.19 131.75 68.48 Favored Pre-proline 0 N--CA 1.435 -1.183 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.576 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.86 148.58 86.44 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.415 2.077 . . . . 0.0 111.707 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.15 -16.48 63.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.737 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 13.2 p -50.64 -37.45 40.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.824 0.449 . . . . 0.0 112.091 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 9.4 mmpt? -55.47 -53.88 50.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.912 0.387 . . . . 0.0 110.925 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 44' ' ' MET . 4.0 pp -75.66 -32.58 60.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.325 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.64 ' N ' HD12 ' A' ' 43' ' ' LEU . 46.2 ttm -59.33 -50.32 74.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.082 0.468 . . . . 0.0 110.458 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.644 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 1.9 mmmp? -69.9 -44.24 70.1 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.001 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.64 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.54 -42.97 93.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.739 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 34.1 t80 -54.27 -51.11 65.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.882 0.372 . . . . 0.0 110.623 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 58' ' ' ILE . 23.3 m -63.66 -34.54 78.06 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.023 0.44 . . . . 0.0 111.12 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 48.9 mm-40 -63.64 -39.47 94.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.067 0.461 . . . . 0.0 111.734 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -90.68 -20.82 22.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.791 0.329 . . . . 0.0 111.862 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.486 ' OE1' ' HB3' ' A' ' 28' ' ' SER . 19.5 mm-40 -95.11 -4.57 45.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.95 9.78 85.19 Favored Glycine 0 C--O 1.236 0.279 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.76 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.41 162.46 17.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.552 0.691 . . . . 0.0 112.007 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 58' ' ' ILE . 7.3 m -114.07 136.94 52.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.87 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.448 ' SD ' ' HA ' ' A' ' 45' ' ' LYS . 68.8 mmm -60.17 -28.35 67.86 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.776 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.463 ' H ' ' HD3' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -83.39 -33.24 25.82 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.417 0.627 . . . . 0.0 110.911 -178.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.5 -20.91 46.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.395 0.616 . . . . 0.0 111.187 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.651 HD11 ' SG ' ' A' ' 48' ' ' CYS . 9.4 pt -118.15 179.72 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.134 0.492 . . . . 0.0 111.915 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -158.51 142.25 15.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.842 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -96.52 142.16 28.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.076 0.465 . . . . 0.0 111.008 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -144.18 143.15 30.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.075 0.464 . . . . 0.0 110.789 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -152.68 139.35 18.81 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.1 t70 65.47 23.97 11.89 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.828 0.823 . . . . 0.0 110.079 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.27 -23.47 8.24 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.885 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -94.68 140.14 22.5 Favored Pre-proline 0 C--N 1.322 -0.587 0 O-C-N 122.427 -0.455 . . . . 0.0 110.984 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.15 136.14 31.24 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.868 1.712 . . . . 0.0 110.623 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.605 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 10.8 pt -102.95 177.63 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.738 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.34 170.03 16.73 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.827 0.822 . . . . 0.0 111.066 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 12.0 pt-20 -73.44 -9.87 59.14 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.523 0.677 . . . . 0.0 109.708 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.2 t -107.9 10.94 28.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.211 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.605 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -99.84 155.4 17.68 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.908 178.629 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.8 p -118.53 147.87 42.91 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.329 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.12 -18.81 63.98 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.008 2.472 . . . . 0.0 112.177 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -79.65 -29.63 41.0 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.237 0.541 . . . . 0.0 110.511 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -67.85 -55.26 13.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.202 0.525 . . . . 0.0 110.825 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -88.53 12.44 14.48 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.738 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 52.28 62.81 2.51 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.724 0.773 . . . . 0.0 112.085 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.78 126.84 32.32 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.891 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.04 157.0 19.01 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -74.39 153.21 39.34 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 121.742 -0.599 . . . . 0.0 110.44 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 69.57 14.79 8.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.112 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -81.77 166.43 20.04 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.809 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 18.9 m -124.85 137.6 54.29 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.583 0.706 . . . . 0.0 112.88 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.99 140.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.659 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -95.31 117.86 31.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.089 0.471 . . . . 0.0 110.897 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -106.41 137.94 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.173 0.511 . . . . 0.0 111.414 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -129.55 155.71 45.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.899 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.987 0.422 . . . . 0.0 110.293 177.629 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 27.4 p-80 . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.17 166.98 27.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.075 0.464 . . . . 0.0 110.168 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.435 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -108.45 121.26 44.58 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.119 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.36 131.22 56.63 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 31.1 ttpt -107.81 140.66 40.56 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.072 0.463 . . . . 0.0 110.521 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 39.1 t -114.08 127.5 71.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.099 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.99 127.26 35.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.143 0.497 . . . . 0.0 110.333 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.57 153.72 16.8 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.221 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.6 pp0? -61.39 -17.74 55.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.402 0.62 . . . . 0.0 111.126 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.1 -15.1 62.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.982 0.896 . . . . 0.0 109.757 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.65 -16.1 55.11 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.796 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -70.11 118.6 13.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.049 0.452 . . . . 0.0 110.688 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.6 p -142.98 136.27 25.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.148 0.499 . . . . 0.0 111.527 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 t -146.86 151.99 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.246 0.618 . . . . 0.0 109.516 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.432 HE21 ' HB3' ' A' ' 31' ' ' GLN . 1.0 OUTLIER -110.77 141.85 43.53 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.231 -0.293 . . . . 0.0 110.497 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 24.1 m-85 -135.59 156.43 48.87 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.055 0.455 . . . . 0.0 110.826 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 48.3 mttp -125.46 110.32 13.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 110.433 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.2 pt -125.27 173.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 110.673 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 2.4 tmtp? -83.54 148.36 27.24 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -64.59 -14.51 58.18 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -107.6 -1.52 21.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.542 0.686 . . . . 0.0 109.835 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.8 m -86.73 133.54 39.46 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.679 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 151.0 85.05 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.606 2.204 . . . . 0.0 112.473 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.8 mt -65.18 -16.63 63.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.631 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 24.5 p -49.9 -37.76 32.89 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.933 0.493 . . . . 0.0 111.822 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 8.7 mmpt? -56.27 -53.56 55.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.872 0.368 . . . . 0.0 110.654 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -75.39 -31.85 60.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.47 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.572 ' N ' HD12 ' A' ' 43' ' ' LEU . 53.4 mtt -57.32 -55.99 27.64 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.793 0.33 . . . . 0.0 111.721 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -70.13 -39.19 75.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.54 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.25 -44.99 88.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.145 0.497 . . . . 0.0 110.609 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 25.0 t80 -60.17 -51.92 67.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.675 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.765 ' SG ' HD11 ' A' ' 58' ' ' ILE . 40.0 m -63.63 -34.55 78.08 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.009 0.433 . . . . 0.0 111.801 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 17.9 mm-40 -67.83 -39.38 83.88 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.051 0.453 . . . . 0.0 111.474 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.0 ptp180 -84.55 -22.54 30.06 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.917 0.389 . . . . 0.0 111.417 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.413 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 20.0 mm-40 -96.77 -3.05 43.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.253 0.549 . . . . 0.0 111.697 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.81 43.33 91.89 Favored Glycine 0 C--N 1.32 -0.351 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.349 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.538 ' HB3' HG21 ' A' ' 58' ' ' ILE . 28.6 mt -117.94 154.96 31.04 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.12 0.486 . . . . 0.0 110.594 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 75.2 m -102.03 126.51 48.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.696 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.481 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 92.7 mmm -55.5 -27.97 51.78 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.476 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -84.21 -30.76 25.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.419 0.628 . . . . 0.0 111.185 -177.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 0.8 OUTLIER -87.01 -28.88 22.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.686 -178.099 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.765 HD11 ' SG ' ' A' ' 48' ' ' CYS . 5.8 pt -105.07 177.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -157.31 141.18 16.02 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.113 0.482 . . . . 0.0 110.59 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 5.2 m-85 -91.97 141.9 28.12 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.135 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -139.81 138.79 36.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.154 0.502 . . . . 0.0 110.706 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -148.48 140.88 24.25 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 t70 67.72 23.46 8.63 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.766 0.793 . . . . 0.0 109.822 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.41 -0.24 75.98 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.26 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -119.4 138.01 26.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 O-C-N 122.206 -0.585 . . . . 0.0 110.411 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.85 141.46 71.57 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.015 1.81 . . . . 0.0 111.25 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.9 pt -114.78 167.55 7.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.86 0.362 . . . . 0.0 111.05 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.503 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.7 p30 -128.17 155.97 43.63 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.553 -177.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.3 pt-20 -60.12 -10.75 4.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 112.001 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.2 t -99.29 9.1 44.01 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 122.039 -0.413 . . . . 0.0 111.786 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.503 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -98.03 159.75 14.74 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 121.658 -0.651 . . . . 0.0 110.65 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.1 p -117.76 148.99 44.35 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.617 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.97 -19.8 69.97 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.514 2.142 . . . . 0.0 111.904 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.12 -20.95 40.31 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.005 0.431 . . . . 0.0 111.074 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -74.76 -53.86 8.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.545 0.688 . . . . 0.0 110.565 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.31 4.4 31.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.333 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 61.39 62.84 1.28 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.61 0.719 . . . . 0.0 111.832 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 mtt -79.19 126.56 30.91 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.176 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.69 157.75 18.43 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.517 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.6 147.26 49.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.859 0.361 . . . . 0.0 110.264 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 67.18 15.18 9.99 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.426 0.69 . . . . 0.0 112.167 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -82.73 168.28 17.36 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 19.1 m -125.6 140.41 52.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.842 0.83 . . . . 0.0 112.849 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.84 134.27 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.85 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.79 125.23 40.21 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.191 0.52 . . . . 0.0 111.254 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.447 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 44.0 t -108.48 137.94 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.414 0.626 . . . . 0.0 112.12 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -136.12 166.54 23.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.426 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.5 mp0 . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 121.028 0.442 . . . . 0.0 111.406 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 38.1 p-80 . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 120.847 0.356 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 pt -129.77 167.9 24.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.027 0.441 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.613 ' OD1' ' HE3' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -103.69 128.37 51.04 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.61 124.94 44.63 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 83' ' ' THR . 36.0 ttpt -104.1 140.04 38.33 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.171 0.51 . . . . 0.0 111.037 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.0 t -112.86 124.71 69.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.884 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.38 126.17 40.12 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.623 0.725 . . . . 0.0 110.096 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.41 146.66 17.38 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.656 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -4.59 1.56 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.566 0.698 . . . . 0.0 112.023 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.617 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 27.6 t70 -77.65 -16.87 58.25 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.647 0.779 . . . . 0.0 110.188 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.54 -13.18 50.92 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -82.06 119.93 24.64 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.116 0.484 . . . . 0.0 110.624 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.51 137.83 28.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 111.156 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.443 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 11.3 t -144.75 151.82 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.36 137.78 46.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.443 ' CZ ' ' HB ' ' A' ' 30' ' ' VAL . 30.8 m-85 -130.55 139.48 50.46 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.406 0.622 . . . . 0.0 111.406 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.613 ' HE3' ' OD1' ' A' ' 19' ' ' ASN . 22.9 tttt -112.17 107.96 17.04 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.674 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 pt -128.89 172.18 15.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.148 0.499 . . . . 0.0 111.186 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.8 tmtt? -80.23 149.77 30.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.877 0.37 . . . . 0.0 110.294 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 20.0 tpp85 -61.31 -19.48 61.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.144 0.577 . . . . 0.0 111.574 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -107.52 -1.95 20.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.476 0.655 . . . . 0.0 109.825 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.7 m -82.24 131.52 55.9 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.917 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.94 147.4 89.17 Favored 'Trans proline' 0 C--O 1.241 0.638 0 C-N-CA 122.377 2.051 . . . . 0.0 112.151 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.84 -15.73 62.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.549 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 37.4 p -49.89 -39.78 40.78 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.198 0.599 . . . . 0.0 111.366 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.61 -53.19 60.52 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.374 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.94 -32.38 61.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.022 0.439 . . . . 0.0 111.045 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.609 ' N ' HD12 ' A' ' 43' ' ' LEU . 45.7 ttm -60.6 -50.04 75.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 110.369 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 30.0 mmtp -71.39 -42.58 68.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.429 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.652 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.48 -46.11 91.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.594 0.357 . . . . 0.0 111.898 -177.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -53.89 -49.39 68.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.992 0.425 . . . . 0.0 110.323 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 58' ' ' ILE . 37.1 m -66.34 -34.32 77.7 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.27 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 45.6 mm-40 -58.14 -49.22 77.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.431 0.634 . . . . 0.0 110.992 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 5.7 ptp180 -83.99 -24.92 30.37 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -95.8 -11.61 26.62 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.93 44.86 35.4 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.973 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.419 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.1 mm? -114.4 153.22 30.25 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.379 -0.483 . . . . 0.0 110.689 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.4 ' O ' HG12 ' A' ' 58' ' ' ILE . 68.1 m -95.75 126.14 40.81 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 120.776 0.322 . . . . 0.0 111.03 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.451 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 52.9 mmm -61.6 -26.71 68.15 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.454 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -82.54 -29.78 30.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 111.257 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.99 -45.64 10.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.366 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 48' ' ' CYS . 8.7 pt -84.6 172.98 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 121.692 -0.63 . . . . 0.0 111.317 -177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 23.6 tpt180 -151.7 137.38 17.9 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.259 0.552 . . . . 0.0 110.351 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 8.1 m-85 -92.07 134.08 35.16 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.987 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -139.55 139.74 36.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.104 0.478 . . . . 0.0 110.509 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -145.76 137.83 25.38 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t70 67.08 24.7 9.35 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.849 0.833 . . . . 0.0 110.314 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.95 81.21 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.334 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -119.17 131.92 24.17 Favored Pre-proline 0 N--CA 1.451 -0.405 0 O-C-N 122.283 -0.54 . . . . 0.0 110.622 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -64.02 138.58 63.05 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.288 1.992 . . . . 0.0 111.295 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.7 pt -111.79 167.97 5.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.138 0.494 . . . . 0.0 111.259 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.0 p30 -131.32 158.94 39.34 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.29 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 41' ' ' SER . 5.4 pt-20 -63.21 -9.66 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.226 0.536 . . . . 0.0 111.604 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 t -99.59 10.66 40.97 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.939 -0.475 . . . . 0.0 111.604 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.461 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -100.07 157.34 16.62 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 121.714 -0.616 . . . . 0.0 110.686 178.628 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.7 p -120.72 147.77 46.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.693 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.445 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 34.6 Cg_endo -63.89 -19.02 66.17 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.917 2.411 . . . . 0.0 112.35 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.59 -25.95 41.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.008 0.432 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -73.49 -55.71 5.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.398 0.618 . . . . 0.0 111.286 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.453 HD21 ' HG3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -81.61 -2.69 51.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.613 -178.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 67.31 63.31 0.44 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.014 0.912 . . . . 0.0 110.799 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.453 ' HG3' HD21 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -82.31 128.71 34.47 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.684 -178.228 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.05 164.02 16.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.952 0.406 . . . . 0.0 110.095 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.19 147.0 31.47 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.039 0.447 . . . . 0.0 110.88 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 69.17 14.83 8.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.308 1.043 . . . . 0.0 111.896 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -81.21 169.64 17.09 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 21.6 m -124.97 141.46 52.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.509 0.671 . . . . 0.0 112.564 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.36 138.17 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.243 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.04 120.45 33.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.076 0.465 . . . . 0.0 110.544 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.46 137.48 42.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.343 0.592 . . . . 0.0 111.594 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -130.97 153.84 48.78 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.729 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.617 ' OE1' ' HB2' ' A' ' 26' ' ' ASP . 2.0 mp0 . . . . . 0 C--N 1.332 -0.168 0 CA-C-O 121.08 0.467 . . . . 0.0 111.582 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 12.8 p-80 . . . . . 0 N--CA 1.444 -0.734 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 73' ' ' PRO . 35.0 pt -131.34 161.46 41.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.509 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -102.05 125.15 48.66 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.428 HD21 HG13 ' A' ' 18' ' ' ILE . 2.6 mm? -118.72 125.3 49.36 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 33.1 ttpt -103.14 140.32 37.5 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.955 0.407 . . . . 0.0 110.535 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -111.19 124.14 67.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 29' ' ' VAL . . . -121.14 123.72 42.99 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.582 0.706 . . . . 0.0 110.778 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.46 139.55 14.46 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 120.111 -1.042 . . . . 0.0 111.075 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -64.06 -9.07 14.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.195 0.497 . . . . 0.0 112.33 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -83.6 -8.16 59.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.681 0.753 . . . . 0.0 109.554 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.47 -9.52 45.27 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.602 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.2 m -78.27 110.72 13.53 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 122.366 -0.491 . . . . 0.0 109.95 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 23' ' ' ALA . 61.8 t -137.27 134.72 47.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 122.087 -0.383 . . . . 0.0 110.362 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.416 HG11 ' HD3' ' A' ' 50' ' ' ARG . 21.1 t -148.64 152.7 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -108.94 142.33 39.74 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.166 -0.334 . . . . 0.0 110.603 -178.05 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -136.95 155.88 49.16 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.048 0.452 . . . . 0.0 111.229 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 44.5 mtmt -127.62 120.12 27.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.415 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 pt -136.93 170.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 110.393 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 6.2 tmtt? -73.34 147.35 44.49 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 33.7 ttm180 -64.37 -14.64 57.56 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.203 0.525 . . . . 0.0 111.665 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -110.09 1.34 18.81 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.496 0.665 . . . . 0.0 109.738 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 m -84.79 135.02 40.69 Favored Pre-proline 0 N--CA 1.444 -0.739 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.007 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.44 143.78 97.71 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.524 2.15 . . . . 0.0 112.301 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.402 HD12 ' OD2' ' A' ' 71' ' ' ASP . 43.3 mt -65.14 -16.18 63.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.609 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 55.6 p -49.46 -38.19 28.84 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.034 0.534 . . . . 0.0 111.633 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.407 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.9 mmpt? -56.25 -53.72 53.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.754 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 44' ' ' MET . 4.0 pp -75.59 -32.19 60.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.876 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.614 ' N ' HD12 ' A' ' 43' ' ' LEU . 58.7 mtt -59.23 -55.43 34.99 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.315 0.579 . . . . 0.0 111.208 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.511 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 41.9 mtpt -70.91 -34.41 71.51 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.197 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.65 -44.11 97.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.144 0.497 . . . . 0.0 110.136 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -58.95 -51.12 71.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' SG ' ' HG2' ' A' ' 55' ' ' MET . 17.8 p -63.15 -36.61 84.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.056 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 36.8 mt-10 -68.31 -39.06 82.13 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HG3' HE21 ' A' ' 51' ' ' GLN . 11.5 ptm180 -83.53 -23.82 31.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.006 0.432 . . . . 0.0 111.376 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.422 HE21 ' HG3' ' A' ' 50' ' ' ARG . 20.3 mm-40 -95.03 -6.44 42.21 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.72 42.74 53.37 Favored Glycine 0 C--N 1.322 -0.222 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.689 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.95 156.38 28.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.228 0.537 . . . . 0.0 110.608 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.496 ' O ' HG12 ' A' ' 58' ' ' ILE . 45.0 m -104.8 125.91 51.34 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.341 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.48 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 97.2 mmm -59.09 -22.6 61.06 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.102 0.477 . . . . 0.0 111.89 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.454 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -83.64 -33.85 25.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.517 0.675 . . . . 0.0 110.467 -179.123 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.61 -10.59 42.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.942 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 54' ' ' SER . 21.0 pt -117.74 171.89 5.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 O-C-N 121.896 -0.503 . . . . 0.0 110.788 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -151.96 138.03 18.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.973 0.416 . . . . 0.0 110.089 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.8 m-85 -93.22 139.37 30.69 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.214 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -141.16 141.18 34.14 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.239 0.542 . . . . 0.0 110.721 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -146.75 132.17 18.62 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 68.44 25.45 6.87 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.749 0.785 . . . . 0.0 110.303 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.02 -24.7 5.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.957 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -91.58 133.68 30.68 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 122.369 -0.489 . . . . 0.0 111.222 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.88 143.09 59.56 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.239 1.959 . . . . 0.0 111.385 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.8 pt -117.28 162.6 15.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.164 0.507 . . . . 0.0 111.006 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.506 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 3.1 p30 -123.47 156.88 34.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.313 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 3.9 pt-20 -57.81 -14.55 6.15 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.114 0.483 . . . . 0.0 111.866 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -98.32 8.81 44.33 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 122.021 -0.424 . . . . 0.0 111.971 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.506 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -95.84 159.52 14.93 Favored 'General case' 0 C--O 1.24 0.598 0 O-C-N 121.894 -0.504 . . . . 0.0 110.372 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.3 p -121.27 144.03 38.81 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.531 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 14.4 Cg_endo -57.47 -24.82 63.24 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.032 2.488 . . . . 0.0 112.65 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.75 -26.79 57.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.21 0.529 . . . . 0.0 111.075 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -71.31 -55.71 7.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.26 0.552 . . . . 0.0 110.546 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.437 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.0 pt? -85.07 2.65 42.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.041 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 61.57 64.2 1.08 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.854 0.835 . . . . 0.0 112.034 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.1 ttt -82.66 128.86 34.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.131 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -84.55 154.39 22.68 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 120.86 0.362 . . . . 0.0 110.187 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -72.82 147.33 45.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.992 0.425 . . . . 0.0 110.068 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 68.91 14.11 8.86 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.694 0.798 . . . . 0.0 111.256 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -82.61 172.37 13.03 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.1 m -126.29 141.79 51.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.568 0.699 . . . . 0.0 112.704 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -103.15 139.58 23.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.107 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -97.53 121.69 39.73 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.211 0.529 . . . . 0.0 110.701 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.46 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 39.0 t -108.47 137.5 39.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.237 0.541 . . . . 0.0 111.82 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -131.36 158.19 41.39 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 121.167 0.508 . . . . 0.0 110.801 178.614 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 13.7 p-80 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.9 pt -128.86 159.77 40.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.294 0.569 . . . . 0.0 111.244 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.432 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -101.57 119.62 39.06 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.004 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.7 140.99 47.79 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.987 0.422 . . . . 0.0 109.862 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -115.32 139.66 49.79 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.319 0.581 . . . . 0.0 111.085 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 29' ' ' VAL . 46.4 t -112.04 124.81 69.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.676 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.39 122.95 35.02 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.479 0.656 . . . . 0.0 110.437 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.33 147.69 16.33 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.934 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -7.89 2.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -78.12 -14.61 59.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.747 0.784 . . . . 0.0 110.243 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.92 -11.78 56.04 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.2 m -78.61 118.76 21.02 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 120.945 0.402 . . . . 0.0 110.09 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.7 p -141.94 137.9 30.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.215 0.531 . . . . 0.0 111.116 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -142.93 150.96 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.44 HE21 ' HB3' ' A' ' 31' ' ' GLN . 1.1 tm0? -110.29 141.23 43.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.888 0.375 . . . . 0.0 110.374 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -135.87 147.26 48.13 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.034 0.445 . . . . 0.0 110.996 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -115.2 109.59 18.21 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.061 0.458 . . . . 0.0 110.649 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.7 pt -124.38 178.42 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 22.4 tttt -89.91 159.2 17.06 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.465 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -62.25 -24.16 67.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.47 0.708 . . . . 0.0 111.884 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -105.74 -1.92 23.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.574 0.702 . . . . 0.0 109.857 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 m -83.96 132.18 49.15 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.64 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.88 149.86 86.18 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.593 2.195 . . . . 0.0 112.424 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.65 -15.6 62.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.036 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 22.3 p -49.37 -39.83 33.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.078 0.551 . . . . 0.0 111.995 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -55.5 -53.25 58.69 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.792 0.33 . . . . 0.0 111.19 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.29 -31.87 62.67 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.713 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.577 ' N ' HD12 ' A' ' 43' ' ' LEU . 57.1 mtt -59.96 -56.43 21.77 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.003 0.43 . . . . 0.0 111.596 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -67.16 -39.86 86.56 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.815 0.341 . . . . 0.0 110.499 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.45 -46.47 86.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.121 0.486 . . . . 0.0 110.582 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -57.81 -52.05 67.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.177 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.8 p -61.57 -36.79 81.65 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.059 0.457 . . . . 0.0 111.072 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -64.77 -47.98 76.19 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.959 0.409 . . . . 0.0 111.853 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 18.5 ptp180 -78.17 -24.97 47.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.83 0.348 . . . . 0.0 111.567 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -96.88 -7.63 32.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.43 45.76 22.63 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.986 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.1 mm? -120.05 159.96 23.75 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.413 -0.463 . . . . 0.0 110.547 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.8 m -106.09 126.26 51.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.645 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.457 ' CE ' ' HB3' ' A' ' 44' ' ' MET . 93.0 mmm -57.39 -28.17 62.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.71 -28.67 26.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.294 0.568 . . . . 0.0 110.839 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 5.1 mp0 -83.19 -34.12 26.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.383 0.611 . . . . 0.0 110.549 -177.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.512 HG22 ' HG3' ' A' ' 88' ' ' GLN . 20.5 pt -92.94 165.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.354 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 20.1 tpt180 -143.36 128.69 18.87 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.909 0.385 . . . . 0.0 110.167 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -87.05 139.67 30.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.026 0.441 . . . . 0.0 110.054 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -142.14 143.12 32.85 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.115 0.483 . . . . 0.0 111.057 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -149.38 132.41 16.23 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.18 25.33 7.33 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.884 0.85 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.51 -25.57 5.01 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.156 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -91.36 138.43 25.57 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.429 -0.454 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.16 143.69 49.66 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.047 1.832 . . . . 0.0 110.981 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.552 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 12.7 pt -114.11 170.69 4.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.794 0.331 . . . . 0.0 111.116 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.427 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.5 OUTLIER -130.71 164.68 24.53 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.555 0.693 . . . . 0.0 110.921 -175.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 12.0 pt-20 -69.45 -7.67 39.94 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.39 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 68' ' ' ASN . 10.0 t -102.03 6.19 40.98 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.599 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.552 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -99.21 155.04 17.69 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.918 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.5 p -120.63 152.01 55.03 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.49 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.34 -15.66 46.4 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.629 2.22 . . . . 0.0 112.165 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.56 -16.17 37.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.176 0.513 . . . . 0.0 110.829 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -80.2 -55.03 5.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.368 0.604 . . . . 0.0 111.215 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.5 pt? -93.16 12.58 23.86 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.848 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 53.33 63.43 2.22 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 84' ' ' ILE . 25.4 ttm -87.63 133.06 33.88 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 5.8 mm-40 -104.67 174.18 5.99 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.855 0.359 . . . . 0.0 110.636 -176.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -66.21 141.56 58.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.972 0.415 . . . . 0.0 110.693 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 69.88 15.94 7.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.625 0.77 . . . . 0.0 111.747 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -80.11 160.7 25.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -126.24 143.78 51.02 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.487 0.66 . . . . 0.0 112.645 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.519 HD11 ' SD ' ' A' ' 78' ' ' MET . 4.1 mp -108.16 138.9 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -95.05 123.97 38.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.122 0.487 . . . . 0.0 110.486 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.423 HG12 HE22 ' A' ' 88' ' ' GLN . 44.1 t -110.13 139.85 31.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.307 0.575 . . . . 0.0 111.448 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -130.78 154.5 47.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.694 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.512 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.8 mp0 . . . . . 0 C--N 1.326 -0.443 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 28.2 p-80 . . . . . 0 N--CA 1.444 -0.732 0 CA-C-O 120.842 0.353 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.2 pt -125.11 165.61 22.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 121.318 0.58 . . . . 0.0 110.881 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -100.09 135.5 41.42 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.178 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.82 126.38 30.41 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -107.19 140.08 40.61 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.245 0.545 . . . . 0.0 111.49 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 29' ' ' VAL . 45.0 t -113.82 124.36 70.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.006 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.9 124.17 34.51 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.605 0.717 . . . . 0.0 110.846 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.35 151.87 19.45 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.259 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.5 pp0? -60.53 -20.22 59.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.187 0.517 . . . . 0.0 111.681 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.7 -7.44 55.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.634 0.731 . . . . 0.0 110.454 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.35 -16.07 55.57 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.686 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 m -68.76 116.73 9.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.851 0.357 . . . . 0.0 110.241 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.9 p -143.83 139.6 25.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.032 0.444 . . . . 0.0 111.423 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.2 t -145.83 151.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.463 HE21 ' HB3' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -107.22 139.91 40.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.935 0.397 . . . . 0.0 110.1 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -133.42 166.97 21.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.385 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -140.29 114.12 8.87 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.903 0.382 . . . . 0.0 110.516 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 pt -127.91 174.8 10.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.116 0.484 . . . . 0.0 110.757 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.7 tmtt? -87.46 149.76 24.21 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.183 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.425 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 22.7 tpp180 -54.02 -28.64 39.47 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.49 0.716 . . . . 0.0 112.376 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -105.08 -0.26 26.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.48 0.657 . . . . 0.0 110.613 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 m -85.83 133.6 41.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.181 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.99 151.87 84.33 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.502 2.135 . . . . 0.0 112.316 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.92 -15.23 61.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.943 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 25.8 p -49.28 -38.24 26.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 122.967 0.507 . . . . 0.0 111.976 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -56.35 -54.09 49.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.502 0.191 . . . . 0.0 110.845 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.96 -33.6 57.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.887 0.375 . . . . 0.0 111.629 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.644 ' N ' HD12 ' A' ' 43' ' ' LEU . 45.3 ttm -62.07 -53.27 57.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.02 0.438 . . . . 0.0 111.002 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.646 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 8.7 mmmm -70.3 -36.7 74.49 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.207 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.664 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -61.3 -45.66 93.55 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.001 -0.437 . . . . 0.0 111.05 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -56.33 -51.45 68.18 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.431 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.1 p -63.53 -35.31 80.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.107 0.48 . . . . 0.0 110.843 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 6.2 mm-40 -65.75 -43.78 87.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.009 0.433 . . . . 0.0 111.586 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 13.1 ptp180 -83.22 -20.98 33.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -96.95 -9.66 27.88 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.831 -0.543 . . . . 0.0 111.818 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.67 40.71 26.1 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.031 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.412 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.1 mm? -117.41 157.9 25.4 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.038 0.446 . . . . 0.0 110.016 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.424 ' O ' HG12 ' A' ' 58' ' ' ILE . 8.2 m -109.65 134.76 51.59 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.702 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.519 ' HE1' ' HG2' ' A' ' 44' ' ' MET . 97.1 mmm -58.76 -25.99 63.56 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.42 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -85.15 -24.94 27.75 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.325 0.583 . . . . 0.0 111.109 178.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.64 -19.34 26.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.296 0.57 . . . . 0.0 110.7 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 54' ' ' SER . 14.4 pt -120.94 174.32 5.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.095 0.474 . . . . 0.0 111.173 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 59' ' ' ARG . 9.0 tpt180 -154.29 138.98 16.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.113 0.482 . . . . 0.0 109.927 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -91.87 137.3 32.48 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.227 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HG3' ' C ' ' A' ' 65' ' ' GLN . 16.3 ttm180 -136.62 134.59 37.51 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.321 0.581 . . . . 0.0 110.881 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -145.29 144.26 30.66 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 68.33 24.35 7.38 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.855 0.836 . . . . 0.0 109.447 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.34 -5.62 59.53 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.366 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.481 ' C ' ' HG3' ' A' ' 61' ' ' ARG . 5.0 pt20 -118.69 143.96 34.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 O-C-N 122.196 -0.591 . . . . 0.0 111.26 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.64 133.96 36.23 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.067 1.845 . . . . 0.0 111.145 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.6 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 12.0 pt -106.87 -177.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.92 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.86 164.53 27.36 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 121.394 0.616 . . . . 0.0 109.793 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 41' ' ' SER . 15.9 pt-20 -74.39 -9.47 58.62 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.714 0.769 . . . . 0.0 109.403 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 t -103.4 10.31 37.4 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.853 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.6 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -98.39 159.0 15.24 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.706 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.4 p -117.08 148.51 42.46 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.568 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.84 -12.17 34.06 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.798 2.332 . . . . 0.0 112.081 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.5 -28.35 23.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.125 0.488 . . . . 0.0 110.654 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -69.63 -55.32 10.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 111.685 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -88.38 9.9 21.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.002 0.429 . . . . 0.0 111.636 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 53.74 63.88 2.04 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.935 0.874 . . . . 0.0 112.735 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -78.48 129.01 34.38 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.222 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -91.19 158.11 16.8 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.436 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 4.7 p-10 -70.05 147.8 49.6 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.986 -0.446 . . . . 0.0 110.478 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' HG2' HD22 ' A' ' 19' ' ' ASN . 5.7 mm-40 66.72 15.25 10.08 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.342 0.657 . . . . 0.0 111.733 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -79.57 167.04 21.27 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -121.83 137.48 54.76 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.659 0.742 . . . . 0.0 112.923 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.13 134.35 41.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.986 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.87 122.14 36.05 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.123 0.487 . . . . 0.0 110.471 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 40.3 t -107.68 138.38 34.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.234 0.54 . . . . 0.0 111.64 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -131.55 155.67 47.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.734 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.419 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.6 mp0 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.08 0.467 . . . . 0.0 111.192 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 6.1 p-80 . . . . . 0 CA--C 1.504 -0.826 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 80' ' ' ASP . 45.2 pt -131.08 160.44 42.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.269 0.556 . . . . 0.0 110.233 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.561 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.4 OUTLIER -98.65 120.95 39.95 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.055 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.06 125.16 54.08 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -104.17 140.55 37.65 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.222 0.534 . . . . 0.0 110.596 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.75 124.21 68.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' A' ' 29' ' ' VAL . . . -122.31 122.44 39.08 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.549 0.69 . . . . 0.0 110.993 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.72 139.51 14.46 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.228 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -60.06 -17.07 36.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.382 0.611 . . . . 0.0 111.398 178.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.29 -6.61 58.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.751 0.786 . . . . 0.0 110.127 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.95 -11.16 48.89 Favored Glycine 0 CA--C 1.507 -0.462 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.048 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.8 m -78.6 108.08 11.73 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.153 0.502 . . . . 0.0 109.836 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 23' ' ' ALA . 59.6 t -135.33 131.29 51.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 120.959 0.409 . . . . 0.0 110.112 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -141.92 150.7 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.561 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -109.5 139.38 44.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.0 110.121 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 30.4 m-85 -130.11 159.46 36.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.321 0.582 . . . . 0.0 111.263 -176.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 42.3 mtmt -131.43 113.25 13.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.302 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.6 pt -135.04 176.3 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.69 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.4 tmtt? -82.6 149.03 27.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.488 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 22.1 ttm-85 -61.87 -19.42 62.62 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -105.61 1.31 27.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.695 0.76 . . . . 0.0 109.526 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.5 m -84.99 131.9 47.38 Favored Pre-proline 0 N--CA 1.442 -0.863 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.231 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.2 145.33 88.76 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 122.633 2.222 . . . . 0.0 112.177 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.47 HD12 ' OD1' ' A' ' 71' ' ' ASP . 34.3 mt -64.93 -16.29 63.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.933 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.526 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 12.3 t -50.06 -37.19 32.29 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 122.457 0.303 . . . . 0.0 111.102 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.439 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -56.04 -53.46 56.73 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-O 120.848 0.356 . . . . 0.0 111.026 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.81 -31.87 61.83 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.529 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.584 ' N ' HD12 ' A' ' 43' ' ' LEU . 56.9 mtt -60.4 -54.56 44.1 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.927 0.394 . . . . 0.0 111.537 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 41' ' ' SER . 31.2 mmtp -66.71 -39.96 88.23 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.84 -47.98 83.88 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 28.0 t80 -55.22 -51.72 65.67 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.857 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.631 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.3 m -63.94 -38.53 91.44 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.568 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 40.2 mt-10 -64.09 -42.32 96.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.743 0.306 . . . . 0.0 111.356 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.2 ptp180 -80.39 -24.29 39.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.908 0.385 . . . . 0.0 111.573 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -96.0 -8.74 32.84 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.63 2.98 90.69 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.897 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 7.3 mp -80.53 158.17 25.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.615 0.722 . . . . 0.0 112.005 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.0 m -107.81 132.27 53.59 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.034 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.431 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 95.7 mmm -57.36 -31.06 65.37 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -84.35 -31.21 24.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.341 0.591 . . . . 0.0 111.126 -178.023 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 0.7 OUTLIER -84.42 -16.69 41.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.39 0.614 . . . . 0.0 110.816 -177.405 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.631 HD11 ' SG ' ' A' ' 48' ' ' CYS . 10.3 pt -117.81 179.17 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.369 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -156.07 132.77 10.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 120.983 0.42 . . . . 0.0 110.088 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.401 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.4 m-85 -83.54 139.32 32.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.669 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -144.11 144.24 31.5 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.218 0.532 . . . . 0.0 110.987 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -149.18 134.88 18.72 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 t70 68.44 25.04 6.98 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.535 0.683 . . . . 0.0 110.359 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.33 -24.05 6.68 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.137 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -93.69 137.55 23.19 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 122.301 -0.529 . . . . 0.0 110.803 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.3 145.54 60.15 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.038 1.825 . . . . 0.0 111.249 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 pt -113.55 160.65 12.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.982 0.42 . . . . 0.0 110.22 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.6 p30 -121.18 153.88 36.97 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.757 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 41' ' ' SER . 10.0 pt-20 -59.72 -12.6 7.41 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.143 0.497 . . . . 0.0 111.944 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.2 t -95.82 8.12 44.44 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 120.717 0.294 . . . . 0.0 111.135 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.489 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -95.0 156.33 16.36 Favored 'General case' 0 C--O 1.244 0.78 0 O-C-N 121.89 -0.506 . . . . 0.0 110.017 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.4 p -118.12 146.64 39.72 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.613 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 18.4 Cg_endo -60.36 -22.92 73.02 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.762 2.308 . . . . 0.0 112.338 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.488 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -78.1 -22.79 48.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.166 0.508 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -71.59 -55.27 8.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.397 0.618 . . . . 0.0 110.442 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.3 pt? -85.91 9.02 18.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.542 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 55.79 60.08 3.47 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.776 0.798 . . . . 0.0 112.246 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.4 mtt -84.38 141.24 31.01 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.645 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -108.76 177.35 4.8 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.121 0.486 . . . . 0.0 111.15 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 18' ' ' ILE . 5.2 m-20 -64.54 138.27 58.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.745 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 68.82 19.42 8.37 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.678 0.791 . . . . 0.0 112.497 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -73.47 159.0 33.86 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.6 m -124.41 144.56 49.98 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.72 142.22 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.215 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 11.3 m-20 -94.83 122.5 37.53 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 110.505 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.563 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 28.7 t -109.83 136.69 45.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 O-C-N 121.886 -0.509 . . . . 0.0 111.594 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 85' ' ' ASP . 60.1 m-85 -132.73 157.61 44.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.469 0.652 . . . . 0.0 111.133 179.348 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 20.0 p-80 . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.2 pt -132.95 166.79 28.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.108 0.48 . . . . 0.0 110.731 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.658 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -103.78 125.94 50.58 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.17 124.07 47.06 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' THR . 31.8 ttpt -103.95 140.65 37.41 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.102 0.477 . . . . 0.0 110.593 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 29' ' ' VAL . 47.6 t -113.67 125.43 70.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.897 0.379 . . . . 0.0 110.084 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.6 121.75 27.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.533 0.682 . . . . 0.0 110.49 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.56 148.85 16.81 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 120.249 -0.976 . . . . 0.0 112.207 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -6.09 2.85 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.365 0.602 . . . . 0.0 112.294 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.92 -14.14 59.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.728 0.775 . . . . 0.0 109.845 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.6 -15.05 53.51 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.635 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.7 m -77.08 122.76 25.41 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.926 0.393 . . . . 0.0 110.63 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 22' ' ' VAL . 4.2 p -142.28 137.83 29.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.138 0.494 . . . . 0.0 111.253 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 t -143.09 151.08 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.658 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -106.34 142.0 36.73 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.343 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -135.29 146.61 48.68 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.237 0.542 . . . . 0.0 110.461 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -121.65 114.17 20.78 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.03 0.443 . . . . 0.0 110.455 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.8 pt -134.46 177.76 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.24 0.543 . . . . 0.0 111.264 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.484 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 11.3 tmtt? -86.45 152.16 22.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.484 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 13.6 tpp180 -60.53 -19.16 56.33 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.943 0.497 . . . . 0.0 111.734 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -107.73 -3.3 19.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.55 0.691 . . . . 0.0 109.653 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -83.67 132.44 49.14 Favored Pre-proline 0 N--CA 1.441 -0.906 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.217 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.15 149.81 88.46 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.557 2.171 . . . . 0.0 112.853 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.453 HD12 ' OD2' ' A' ' 71' ' ' ASP . 28.0 mt -65.59 -13.95 60.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.065 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 p -55.13 -34.48 63.77 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.327 0.584 . . . . 0.0 110.663 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -55.93 -55.98 26.14 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.603 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -77.38 -32.73 55.11 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.632 ' N ' HD12 ' A' ' 43' ' ' LEU . 38.7 ttm -62.41 -54.01 46.53 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.067 0.46 . . . . 0.0 110.959 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 33.6 mtpt -72.37 -32.99 66.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.491 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -64.18 -43.74 94.16 Favored 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 121.92 -0.488 . . . . 0.0 110.434 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -57.39 -50.53 72.69 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.105 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 14.8 p -61.48 -36.96 81.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 0.0 110.909 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.1 mt-10 -69.02 -40.05 78.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.4 ptp180 -83.85 -24.75 30.77 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.936 -0.477 . . . . 0.0 112.167 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -95.41 -11.83 26.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.182 0.515 . . . . 0.0 111.461 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.43 41.49 13.29 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.491 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.484 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.4 mm? -117.23 158.24 24.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.041 0.448 . . . . 0.0 110.301 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 58' ' ' ILE . 15.2 m -106.38 131.99 52.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.283 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 85.4 mmm -55.07 -29.14 56.91 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.928 0.491 . . . . 0.0 111.817 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.528 ' HD3' ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -83.86 -28.79 27.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.4 0.619 . . . . 0.0 111.179 -177.671 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.7 -7.53 46.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.117 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.484 HG21 ' HB3' ' A' ' 53' ' ' LEU . 17.5 pt -125.1 170.18 15.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 120.943 0.402 . . . . 0.0 110.965 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -149.99 135.86 18.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.12 0.486 . . . . 0.0 110.164 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -89.82 137.26 32.49 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.028 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -137.28 143.02 41.94 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.258 0.551 . . . . 0.0 110.622 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -150.83 138.59 19.81 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 t70 69.79 25.35 5.08 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.605 0.716 . . . . 0.0 110.282 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.01 -1.56 79.12 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.538 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -122.73 142.92 38.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 O-C-N 122.122 -0.634 . . . . 0.0 111.409 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.04 141.89 59.59 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.503 2.135 . . . . 0.0 111.866 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 pt -117.08 172.83 4.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.102 0.477 . . . . 0.0 111.01 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 4.0 p30 -131.96 156.33 46.38 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.818 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.58 -13.14 12.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.778 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.0 t -96.61 10.21 39.2 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 122.157 -0.339 . . . . 0.0 111.374 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.81 157.4 16.53 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.96 177.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.3 p -120.76 151.01 53.9 Favored Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.199 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.42 -18.23 52.22 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.968 2.445 . . . . 0.0 112.699 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.02 -27.15 30.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.331 0.586 . . . . 0.0 110.896 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -71.61 -55.9 6.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.478 0.656 . . . . 0.0 110.623 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.489 HD11 ' HE3' ' A' ' 78' ' ' MET . 1.6 pt? -88.49 20.77 3.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.571 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 43.08 62.52 1.79 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.087 0.946 . . . . 0.0 112.662 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.489 ' HE3' HD11 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -78.87 122.5 26.18 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.697 -178.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.58 156.7 30.7 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.051 0.453 . . . . 0.0 110.848 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -68.89 142.86 54.66 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.886 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 66.71 18.21 10.68 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.269 0.627 . . . . 0.0 111.437 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -81.51 171.25 14.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.976 0.417 . . . . 0.0 110.64 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 21.9 m -126.05 145.0 50.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.577 0.703 . . . . 0.0 112.352 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.03 138.74 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.283 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -94.91 121.79 36.88 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.964 0.411 . . . . 0.0 110.225 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.3 t -108.9 137.41 41.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.267 0.555 . . . . 0.0 111.757 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -130.49 151.52 50.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.406 HE21 HG22 ' A' ' 58' ' ' ILE . 1.8 mp0 . . . . . 0 C--N 1.321 -0.632 0 CA-C-O 121.074 0.464 . . . . 0.0 111.931 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.788 0.327 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 pt -135.37 168.05 24.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 120.896 0.379 . . . . 0.0 110.373 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.539 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -106.0 116.52 32.08 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.923 0.392 . . . . 0.0 110.311 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.66 131.68 54.14 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 83' ' ' THR . 32.5 ttpt -111.42 141.32 45.12 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.293 0.568 . . . . 0.0 111.198 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 29' ' ' VAL . 41.0 t -112.77 125.71 70.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.174 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.28 118.1 20.8 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.546 0.688 . . . . 0.0 110.658 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.33 150.47 18.55 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.009 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -11.21 8.0 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.36 0.6 . . . . 0.0 112.202 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.1 -16.82 62.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.658 0.742 . . . . 0.0 110.32 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.07 -12.99 55.87 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -78.05 122.87 26.14 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.932 0.396 . . . . 0.0 110.436 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 22' ' ' VAL . 3.1 p -144.59 137.41 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.424 0.631 . . . . 0.0 111.195 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.7 t -144.47 151.09 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.582 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.539 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -110.15 141.89 42.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.821 0.343 . . . . 0.0 110.526 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -137.06 138.77 40.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.162 0.505 . . . . 0.0 111.534 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -106.48 114.92 29.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.052 0.453 . . . . 0.0 110.51 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.1 pt -132.68 170.46 19.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.139 0.495 . . . . 0.0 110.563 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.579 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.2 tmtp? -80.41 149.24 30.23 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.579 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 9.2 tpp180 -56.83 -25.2 55.66 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -107.28 3.3 25.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.722 0.773 . . . . 0.0 109.749 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 m -81.5 131.03 59.47 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.452 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 33.7 Cg_endo -63.13 147.75 93.89 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.208 1.939 . . . . 0.0 112.152 -177.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.4 HD12 ' OD2' ' A' ' 71' ' ' ASP . 39.6 mt -64.6 -15.24 60.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 57.1 p -50.97 -38.48 51.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.096 0.558 . . . . 0.0 111.466 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 39' ' ' PRO . 12.3 mmmm -55.85 -54.45 44.45 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 44' ' ' MET . 4.3 pp -75.86 -32.27 59.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.999 0.428 . . . . 0.0 111.322 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.6 ' N ' HD12 ' A' ' 43' ' ' LEU . 37.0 ttm -61.47 -50.25 73.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.615 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 69.4 mmtt -70.38 -41.64 72.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.84 0.352 . . . . 0.0 110.094 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.16 -45.46 92.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.265 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -56.49 -50.2 72.45 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.063 0.459 . . . . 0.0 110.466 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.596 ' SG ' HD11 ' A' ' 58' ' ' ILE . 58.2 m -63.1 -38.28 90.57 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.97 0.414 . . . . 0.0 111.498 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 48.6 mt-10 -64.34 -40.22 95.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.117 0.484 . . . . 0.0 111.571 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.3 ptp180 -86.2 -23.14 26.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -98.66 -10.73 22.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.979 0.418 . . . . 0.0 112.081 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.49 43.9 14.35 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.957 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.4 mm? -119.69 157.9 27.56 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 122.307 -0.525 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.2 m -107.53 128.31 54.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.166 0.507 . . . . 0.0 111.235 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.445 ' SD ' ' HD3' ' A' ' 45' ' ' LYS . 58.0 mmm -56.62 -30.57 63.41 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.548 0.739 . . . . 0.0 112.766 -177.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.556 ' HD3' ' N ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -83.35 -28.98 28.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.47 0.652 . . . . 0.0 111.081 -176.354 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -40.18 16.49 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.88 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.596 HD11 ' SG ' ' A' ' 48' ' ' CYS . 12.8 pt -91.63 174.45 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 O-C-N 121.906 -0.496 . . . . 0.0 110.443 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -150.36 130.85 13.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.266 0.555 . . . . 0.0 110.257 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -83.02 137.04 34.28 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.848 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 43.3 ttm180 -136.53 143.04 43.5 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.155 0.503 . . . . 0.0 110.576 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -148.84 130.3 14.8 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 69.24 25.71 5.59 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.83 0.824 . . . . 0.0 110.199 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.91 -24.55 5.91 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.192 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -92.68 136.23 25.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 122.479 -0.424 . . . . 0.0 110.93 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 35.2 Cg_endo -67.81 142.65 58.4 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.11 1.873 . . . . 0.0 111.387 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 pt -112.71 174.8 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.068 0.461 . . . . 0.0 110.985 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.8 p30 -138.27 159.16 42.78 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.135 0.493 . . . . 0.0 111.995 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 11.6 pt-20 -62.56 -10.21 11.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.775 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -97.99 7.42 46.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.886 0.374 . . . . 0.0 111.396 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.462 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.29 155.94 17.24 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 121.719 -0.613 . . . . 0.0 110.594 179.472 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 p -120.76 146.83 44.48 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.966 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.555 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 20.2 Cg_endo -60.64 -25.31 80.61 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.778 2.319 . . . . 0.0 112.494 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 -31.66 62.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.377 0.608 . . . . 0.0 110.519 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -68.15 -55.71 11.39 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.252 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 1.6 pt? -85.12 6.92 23.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.883 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 58.73 63.15 1.74 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.958 0.885 . . . . 0.0 112.275 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.5 mtt -84.1 134.52 34.6 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.488 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -96.89 175.12 6.46 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.009 0.433 . . . . 0.0 110.146 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -77.92 147.14 35.15 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 68.51 13.63 8.98 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.13 0.572 . . . . 0.0 112.248 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.97 162.9 23.66 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 15.8 m -124.73 142.14 51.62 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.68 0.753 . . . . 0.0 113.001 -173.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.65 135.28 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.082 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -93.74 121.31 35.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.048 0.452 . . . . 0.0 110.366 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.63 138.93 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.225 0.536 . . . . 0.0 112.006 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -130.92 152.74 49.92 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.86 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 121.271 0.558 . . . . 0.0 111.91 -179.237 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 28.7 p-80 . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.4 pt -124.17 167.63 17.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.0 0.429 . . . . 0.0 110.061 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -106.52 124.1 49.09 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.811 0.338 . . . . 0.0 110.143 -178.794 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.3 125.09 49.37 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 35.5 ttpt -105.26 140.68 38.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.05 0.452 . . . . 0.0 111.004 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.66 123.89 66.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.77 128.1 43.33 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.502 0.668 . . . . 0.0 110.514 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.39 148.86 16.52 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.692 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -5.4 2.3 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -82.54 -12.18 57.93 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.721 0.772 . . . . 0.0 110.122 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.28 -9.96 57.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.738 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.8 m -78.36 119.7 22.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -145.48 141.22 22.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.365 0.603 . . . . 0.0 111.782 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 40.9 t -146.84 151.23 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.4 0.68 . . . . 0.0 109.174 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -110.41 141.44 43.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.931 0.396 . . . . 0.0 110.336 -179.071 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -136.54 153.58 50.96 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.067 0.46 . . . . 0.0 110.728 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 90.0 mttt -124.58 113.75 18.48 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.827 0.346 . . . . 0.0 110.246 178.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 46.4 pt -127.26 172.53 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.935 0.398 . . . . 0.0 110.658 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.6 tmtp? -80.91 152.04 28.28 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.487 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 9.6 tpp180 -54.67 -23.9 19.4 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -112.63 2.56 16.22 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.415 -0.803 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 m -79.49 131.65 64.42 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.562 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.33 144.82 92.12 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.636 2.224 . . . . 0.0 112.458 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.422 HD12 ' OD2' ' A' ' 71' ' ' ASP . 40.2 mt -65.01 -15.61 62.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.073 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.612 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 32.1 t -48.96 -37.82 21.19 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.643 0.377 . . . . 0.0 111.417 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -55.37 -53.29 58.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.714 0.293 . . . . 0.0 110.985 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 44' ' ' MET . 4.4 pp -75.48 -32.1 60.45 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.367 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.538 ' N ' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -54.44 -56.74 15.63 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.3 0.571 . . . . 0.0 111.337 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 41' ' ' SER . 6.5 mmmt -71.47 -41.24 69.61 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.254 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.18 -49.01 78.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.939 0.399 . . . . 0.0 111.551 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 29.2 t80 -55.17 -51.66 65.79 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 121.029 0.443 . . . . 0.0 110.744 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.698 ' SG ' HD11 ' A' ' 58' ' ' ILE . 33.5 m -63.99 -36.68 84.78 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.869 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 41.6 mt-10 -65.86 -39.55 90.85 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.909 0.385 . . . . 0.0 111.525 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.5 ptp180 -85.96 -21.93 27.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.879 0.371 . . . . 0.0 111.707 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.404 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 20.1 mm-40 -96.11 -6.25 38.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.885 0.374 . . . . 0.0 111.467 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.87 41.89 71.45 Favored Glycine 0 C--N 1.321 -0.289 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.468 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 mp -115.8 153.54 31.26 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.358 0.599 . . . . 0.0 110.94 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.1 m -102.27 127.39 49.27 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.094 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.414 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 93.1 mmm -55.44 -31.98 62.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.039 0.536 . . . . 0.0 112.279 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.479 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -84.98 -28.3 25.89 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.158 0.504 . . . . 0.0 112.022 -178.081 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 8.3 mp0 -91.19 -5.05 55.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.372 0.606 . . . . 0.0 110.488 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.698 HD11 ' SG ' ' A' ' 48' ' ' CYS . 13.7 pt -122.71 170.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.967 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -143.94 138.51 28.54 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 120.875 0.369 . . . . 0.0 110.111 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -96.88 129.21 44.36 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.778 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -136.59 143.02 43.38 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.043 0.449 . . . . 0.0 110.276 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -148.38 133.45 18.24 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t70 68.21 24.56 7.5 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.675 0.75 . . . . 0.0 110.274 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.28 -21.39 6.06 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.144 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -93.11 141.73 24.44 Favored Pre-proline 0 C--N 1.317 -0.83 0 O-C-N 122.35 -0.5 . . . . 0.0 110.494 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.9 137.22 24.07 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.187 1.925 . . . . 0.0 111.649 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.8 pt -114.43 170.94 4.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.241 0.544 . . . . 0.0 110.663 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.543 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 4.8 p30 -131.31 155.64 46.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.025 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 41' ' ' SER . 13.4 pt-20 -59.86 -10.17 3.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.08 0.467 . . . . 0.0 111.93 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -100.62 6.43 44.1 Favored 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 121.766 -0.583 . . . . 0.0 111.595 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.543 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -92.93 165.23 12.98 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 121.615 -0.678 . . . . 0.0 110.384 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.1 p -122.4 148.82 53.61 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.524 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.97 -20.14 58.83 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.141 2.561 . . . . 0.0 112.585 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.53 -31.54 37.02 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.052 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -67.53 -56.29 10.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.273 0.559 . . . . 0.0 110.991 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -81.84 8.73 9.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.018 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 57.69 63.08 1.91 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.587 0.708 . . . . 0.0 111.463 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.7 mtt -79.67 -165.58 0.83 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.989 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.44 169.81 15.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.55 139.51 42.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.205 0.526 . . . . 0.0 111.271 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 70.75 18.88 6.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.525 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -84.68 165.55 17.81 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 19.4 m -127.03 141.64 51.74 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.666 0.746 . . . . 0.0 112.852 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.06 140.28 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.223 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.32 121.76 38.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.11 0.481 . . . . 0.0 110.895 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.9 t -109.44 137.66 40.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.343 0.592 . . . . 0.0 111.555 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -128.71 149.55 50.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.963 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.429 HE21 HG22 ' A' ' 58' ' ' ILE . 2.0 mp0 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.366 0.603 . . . . 0.0 110.991 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 . . . . . 0 N--CA 1.447 -0.61 0 CA-C-O 120.719 0.295 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.443 HD11 ' HB2' ' A' ' 73' ' ' PRO . 23.6 pt -140.96 165.71 19.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.99 0.424 . . . . 0.0 110.29 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.579 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -106.22 122.37 46.07 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.37 124.43 47.69 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 36.5 ttpt -100.75 145.71 28.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.02 0.438 . . . . 0.0 110.266 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 29' ' ' VAL . 46.6 t -115.87 125.87 73.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.74 124.02 34.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.57 0.7 . . . . 0.0 110.893 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.99 149.0 17.46 Favored Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.472 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -63.01 -11.4 18.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.525 0.679 . . . . 0.0 111.47 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.81 -14.05 60.64 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.76 0.79 . . . . 0.0 110.062 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.84 -9.78 58.53 Favored Glycine 0 C--N 1.307 -1.067 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.902 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -79.33 117.45 20.33 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.089 0.471 . . . . 0.0 110.055 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.7 p -143.38 139.19 26.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.215 0.531 . . . . 0.0 111.455 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 48.3 t -145.91 151.16 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.579 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -104.73 142.17 35.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 36.6 m-85 -132.41 157.36 44.75 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.556 0.693 . . . . 0.0 111.301 -177.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -134.38 110.61 9.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.407 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 pt -131.45 173.8 14.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.248 0.547 . . . . 0.0 111.256 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HD3' ' H ' ' A' ' 37' ' ' HIS . 2.1 tmtp? -80.48 146.39 31.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.491 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 33.6 ttm180 -64.4 -16.75 62.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.393 0.616 . . . . 0.0 112.157 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.425 ' H ' ' HD3' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -104.6 2.03 30.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.405 0.621 . . . . 0.0 110.241 177.718 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 5.6 m -88.45 133.45 36.4 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.046 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.43 146.3 93.08 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.655 2.237 . . . . 0.0 112.54 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.436 HD12 ' OD1' ' A' ' 71' ' ' ASP . 30.5 mt -65.49 -15.26 62.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.923 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 13.8 p -54.61 -33.11 59.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.271 0.558 . . . . 0.0 110.568 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -57.65 -53.95 52.43 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.676 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.08 -31.9 58.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.432 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.59 ' N ' HD12 ' A' ' 43' ' ' LEU . 58.2 mtt -57.18 -56.73 18.07 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.994 0.426 . . . . 0.0 111.549 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 41' ' ' SER . 0.4 OUTLIER -71.66 -34.64 69.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.914 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -61.5 -47.03 87.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.996 0.427 . . . . 0.0 110.726 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 20.5 t80 -55.05 -50.22 69.64 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 110.49 177.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.649 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.4 m -63.27 -40.68 98.09 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.568 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 41.5 mt-10 -64.03 -34.97 79.22 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.8 ptp180 -89.66 -26.06 20.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -94.14 -16.39 23.78 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.191 0.52 . . . . 0.0 112.157 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.19 35.94 10.44 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.251 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.635 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.5 mm? -113.81 154.31 27.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.293 0.568 . . . . 0.0 110.821 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -105.17 136.97 43.68 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.548 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.1 mmm -63.4 -22.48 66.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.144 0.497 . . . . 0.0 111.012 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.496 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -83.67 -28.58 28.25 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.421 0.629 . . . . 0.0 110.342 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.496 ' NE2' ' HB2' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -93.67 -10.95 32.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.881 -177.11 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.649 HD11 ' SG ' ' A' ' 48' ' ' CYS . 7.3 pt -128.3 170.86 17.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.093 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 tpp180 -148.7 135.9 20.17 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.102 0.477 . . . . 0.0 110.291 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.2 m-85 -91.01 138.96 31.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -141.61 140.92 33.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.028 0.442 . . . . 0.0 110.72 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -146.31 134.34 21.48 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 69.53 27.49 4.85 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.907 0.86 . . . . 0.0 110.533 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.26 -6.84 49.16 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.572 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -111.43 140.56 23.17 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 122.165 -0.609 . . . . 0.0 110.826 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.11 139.19 35.08 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.269 1.98 . . . . 0.0 111.273 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.1 pt -113.15 153.62 14.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.333 0.587 . . . . 0.0 111.708 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.568 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 3.3 p30 -108.56 152.98 24.02 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.343 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.571 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 13.8 pt-20 -60.95 -14.92 25.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.178 0.513 . . . . 0.0 111.924 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -93.42 7.71 43.42 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.568 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -91.58 158.07 16.64 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 121.587 -0.695 . . . . 0.0 110.714 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.5 p -118.55 145.61 37.85 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.881 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.449 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 18.2 Cg_endo -59.14 -21.53 59.89 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.798 2.332 . . . . 0.0 112.664 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -81.26 -19.41 43.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.029 0.443 . . . . 0.0 111.266 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -80.69 -54.67 5.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.311 0.576 . . . . 0.0 110.783 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 2.0 pt? -82.68 10.53 7.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.135 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 57.85 62.44 2.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.35 0.595 . . . . 0.0 111.123 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -83.09 121.1 26.61 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.146 0.498 . . . . 0.0 110.36 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HG3' ' HB2' ' A' ' 82' ' ' ASP . 11.4 pt-20 -80.95 159.64 24.87 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.312 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -74.78 149.19 39.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.881 0.372 . . . . 0.0 111.465 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 63.15 19.31 11.58 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.818 0.847 . . . . 0.0 112.079 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.492 ' HB2' ' HG3' ' A' ' 79' ' ' GLU . 1.7 t70 -89.28 -178.02 5.53 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.543 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 16.4 m -130.11 151.43 50.65 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.376 0.608 . . . . 0.0 112.037 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.81 137.71 42.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 123.387 0.675 . . . . 0.0 109.215 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -91.76 124.67 36.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 110.807 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.422 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 47.4 t -111.52 136.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.296 0.57 . . . . 0.0 111.795 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -126.2 144.47 50.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.12 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.482 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.5 mp0 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 120.628 0.251 . . . . 0.0 110.75 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 22.1 p-80 . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.922 0.391 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.415 HD11 ' HB2' ' A' ' 73' ' ' PRO . 27.6 pt -125.43 167.45 19.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.113 0.482 . . . . 0.0 110.068 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.516 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -107.37 126.82 52.96 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.833 -178.839 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.82 125.45 48.59 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -104.48 139.72 38.98 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.872 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 40.2 t -111.82 123.21 67.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.967 0.413 . . . . 0.0 110.03 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.72 112.43 14.8 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.763 0.792 . . . . 0.0 110.751 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.95 147.7 18.7 Favored Glycine 0 C--N 1.297 -1.608 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.271 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -10.27 7.91 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.243 0.544 . . . . 0.0 112.143 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.403 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 9.3 t70 -73.36 -13.66 61.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.631 0.729 . . . . 0.0 110.315 177.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.8 -15.25 55.75 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.8 m -74.7 117.03 16.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.247 0.546 . . . . 0.0 110.49 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 3.3 p -142.52 136.48 27.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.397 0.618 . . . . 0.0 111.1 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -145.39 151.66 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.475 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -108.32 140.45 41.58 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -134.2 155.3 50.39 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.133 0.492 . . . . 0.0 110.945 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.516 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 90.1 mttt -128.08 111.1 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.107 0.479 . . . . 0.0 110.642 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.3 pt -127.62 173.58 12.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.029 0.442 . . . . 0.0 110.283 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.6 tmtp? -78.6 146.37 34.2 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.462 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 40.0 ttm180 -64.32 -12.75 45.14 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.334 0.588 . . . . 0.0 111.865 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.427 ' H ' ' HD3' ' A' ' 35' ' ' LYS . 37.8 t-80 -107.04 -3.38 20.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.669 0.747 . . . . 0.0 109.617 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.8 m -83.5 135.05 44.07 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.609 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.88 145.05 89.91 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.708 2.272 . . . . 0.0 112.624 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 48.5 mt -65.67 -16.84 64.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.02 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 32.6 p -54.25 -34.8 61.56 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.01 0.433 . . . . 0.0 111.061 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -57.46 -52.1 66.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.73 -32.16 62.04 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.884 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.577 ' N ' HD12 ' A' ' 43' ' ' LEU . 58.5 mtt -58.12 -53.89 53.12 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.183 0.516 . . . . 0.0 110.903 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 34.2 mmtp -66.69 -41.74 87.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.019 0.438 . . . . 0.0 110.079 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.9 -48.02 83.4 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.115 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -55.73 -49.05 74.1 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.68 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.7 m -67.2 -36.27 81.38 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 47.7 mt-10 -62.61 -39.69 94.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.093 0.473 . . . . 0.0 111.215 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 14.8 ptp180 -86.73 -25.71 24.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -93.52 -8.65 40.8 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.98 -0.45 . . . . 0.0 111.817 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.15 43.78 46.68 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.727 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.9 mp -115.91 152.89 32.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.39 0.614 . . . . 0.0 111.043 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.2 m -99.15 124.33 44.11 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.973 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 95.4 mmm -60.85 -22.33 64.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.949 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.483 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -84.68 -32.62 23.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.482 0.658 . . . . 0.0 110.804 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 4.9 mp0 -84.73 -20.66 30.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.909 -176.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.588 HD11 ' SG ' ' A' ' 48' ' ' CYS . 16.0 pt -113.02 176.17 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.231 0.539 . . . . 0.0 111.949 -177.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -149.22 140.23 22.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.407 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 44' ' ' MET . 6.4 m-85 -94.61 129.44 41.45 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.594 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -130.55 143.58 50.85 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.538 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -150.12 136.82 19.17 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 t70 67.32 26.98 8.38 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.834 0.826 . . . . 0.0 110.815 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.38 -5.61 59.67 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.991 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -116.63 142.09 29.09 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 122.076 -0.661 . . . . 0.0 110.883 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.11 134.66 34.75 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.067 1.845 . . . . 0.0 110.799 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.709 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 12.1 pt -104.49 -177.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.137 0.494 . . . . 0.0 111.631 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.39 161.63 29.88 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 121.689 0.757 . . . . 0.0 110.649 -175.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.49 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.1 pt-20 -67.98 -15.28 63.54 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.764 0.792 . . . . 0.0 109.583 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 t -110.01 16.49 21.85 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.709 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 1.8 p-10 -98.23 101.5 12.98 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 118.517 -1.273 . . . . 0.0 110.722 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 p -60.31 141.22 91.21 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.73 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 11.1 Cg_endo -56.39 -24.25 51.09 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.991 2.46 . . . . 0.0 112.288 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -72.26 -34.2 68.07 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.128 0.49 . . . . 0.0 110.647 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -64.95 -55.78 17.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.986 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 2.1 pt? -85.09 6.57 24.96 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.712 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 60.37 52.6 4.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.716 0.769 . . . . 0.0 111.499 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.76 131.64 40.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.273 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -94.94 165.75 12.29 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.028 0.442 . . . . 0.0 110.613 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.41 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 9.9 p-10 -76.37 148.28 37.5 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.359 0.6 . . . . 0.0 110.553 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 65.64 14.72 9.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.768 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.62 167.21 20.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.8 m -123.04 140.77 52.68 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.03 135.93 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.191 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -94.98 118.97 32.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.064 0.459 . . . . 0.0 110.296 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.37 138.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.148 0.499 . . . . 0.0 111.793 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -128.6 150.87 50.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.952 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.439 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.1 mp0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 111.672 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 121.78 0.8 . . . . 0.0 111.16 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.506 HD12 HD21 ' A' ' 20' ' ' LEU . 24.7 pt -128.96 160.04 40.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.01 178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.544 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.2 OUTLIER -95.72 123.87 39.49 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.538 HD22 ' SD ' ' A' ' 78' ' ' MET . 86.4 mt -122.89 125.9 46.25 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.229 0.538 . . . . 0.0 110.206 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 83' ' ' THR . 36.7 ttpt -106.82 142.82 35.85 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.283 0.563 . . . . 0.0 110.98 -178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 41.1 t -115.77 126.92 73.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.65 126.51 38.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.401 0.619 . . . . 0.0 110.526 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.51 147.35 16.61 Favored Glycine 0 C--N 1.301 -1.404 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.749 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.4 pp0? -60.64 -15.45 28.53 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 112.221 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -76.37 -11.81 59.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.926 0.87 . . . . 0.0 109.636 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.85 -11.54 45.47 Favored Glycine 0 C--N 1.318 -0.463 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.434 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -73.34 114.63 11.76 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.472 -0.428 . . . . 0.0 110.755 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 4.9 p -141.14 135.9 32.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.312 0.577 . . . . 0.0 111.367 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -145.67 151.04 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.397 -177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.544 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -109.45 138.89 45.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.016 0.436 . . . . 0.0 110.091 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 18.1 m-85 -133.39 164.17 27.72 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 121.12 0.486 . . . . 0.0 110.638 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -135.27 112.38 10.37 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 122.199 -0.313 . . . . 0.0 110.22 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 pt -126.84 168.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.946 0.403 . . . . 0.0 110.779 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 1.1 tmtp? -77.7 152.69 33.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.865 0.364 . . . . 0.0 110.391 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 10.2 tpp180 -60.96 -21.74 63.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.001 0.52 . . . . 0.0 112.071 -177.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -105.76 -2.02 23.7 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.823 -0.548 . . . . 0.0 110.099 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.7 m -82.35 132.21 53.49 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.658 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.99 147.8 85.01 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.707 2.271 . . . . 0.0 112.31 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.19 -16.12 63.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.99 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 22.7 t -49.76 -38.64 34.84 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.495 0.318 . . . . 0.0 111.079 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 6.7 mmpt? -56.55 -53.48 57.09 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -75.79 -32.33 59.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.619 ' N ' HD12 ' A' ' 43' ' ' LEU . 41.2 ttm -61.24 -50.4 73.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.891 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.54 ' HD2' ' SD ' ' A' ' 55' ' ' MET . 13.5 mmmm -70.67 -40.85 72.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.8 0.333 . . . . 0.0 110.184 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.69 -46.37 89.28 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.084 0.469 . . . . 0.0 111.444 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 24.1 t80 -55.73 -50.96 68.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.063 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.663 ' SG ' HD11 ' A' ' 58' ' ' ILE . 35.0 m -63.91 -37.32 86.97 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.032 0.444 . . . . 0.0 111.167 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -62.44 -40.39 96.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.993 0.425 . . . . 0.0 111.695 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.7 ptp180 -87.94 -21.96 24.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.843 0.354 . . . . 0.0 111.8 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -96.36 -11.35 25.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.35 7.07 85.39 Favored Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.694 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 7.2 mp -82.79 155.12 24.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.614 0.721 . . . . 0.0 112.176 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.402 ' O ' HG12 ' A' ' 58' ' ' ILE . 27.6 m -106.15 132.82 51.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.832 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.54 ' SD ' ' HD2' ' A' ' 45' ' ' LYS . 63.7 mmm -56.18 -33.45 65.28 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -177.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -25.84 28.15 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.909 -0.495 . . . . 0.0 111.657 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.99 -19.93 31.31 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.304 0.573 . . . . 0.0 110.85 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.663 HD11 ' SG ' ' A' ' 48' ' ' CYS . 8.4 pt -116.76 174.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.046 0.45 . . . . 0.0 110.971 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -153.81 138.8 17.25 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -92.83 137.35 32.44 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.306 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -136.94 139.37 41.49 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.301 0.572 . . . . 0.0 111.299 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -150.25 143.33 24.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 t70 67.3 24.1 9.13 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.873 0.845 . . . . 0.0 110.115 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.19 -2.44 81.42 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.391 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -121.96 142.36 36.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 122.059 -0.671 . . . . 0.0 110.887 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.97 138.69 53.57 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.012 1.808 . . . . 0.0 110.835 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.44 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 13.6 pt -112.46 172.95 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.096 0.474 . . . . 0.0 110.856 -177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.5 p30 -133.76 157.98 44.49 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.079 0.466 . . . . 0.0 111.574 -177.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' SER . 17.2 pt-20 -60.4 -11.84 7.8 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.714 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -100.97 11.36 39.77 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.817 0.341 . . . . 0.0 111.582 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.478 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -99.5 157.15 16.64 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 121.721 -0.612 . . . . 0.0 109.593 177.5 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.2 p -118.51 148.06 43.29 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.704 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.86 -18.69 62.34 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.691 2.261 . . . . 0.0 112.284 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.483 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -85.9 -15.69 40.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.196 0.522 . . . . 0.0 111.193 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -82.26 -56.36 3.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.299 0.571 . . . . 0.0 110.436 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -86.8 1.98 50.45 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.221 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 62.28 61.59 1.28 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.609 0.719 . . . . 0.0 112.908 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.601 ' SD ' HD11 ' A' ' 84' ' ' ILE . 29.4 ttm -89.08 137.45 32.31 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -106.83 176.79 5.06 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.897 0.38 . . . . 0.0 110.79 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -75.3 143.52 42.91 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.169 0.509 . . . . 0.0 110.793 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 71.9 13.58 6.01 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.024 0.93 . . . . 0.0 110.855 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -80.38 161.88 24.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 22.9 m -127.34 145.84 50.66 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.342 0.591 . . . . 0.0 112.316 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.601 HD11 ' SD ' ' A' ' 78' ' ' MET . 4.0 mp -110.32 136.89 44.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.426 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -93.76 130.94 39.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.1 0.476 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 46.5 t -112.74 138.63 41.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.508 0.67 . . . . 0.0 111.854 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -134.08 163.64 29.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.361 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--N 1.323 -0.569 0 CA-C-O 120.814 0.34 . . . . 0.0 111.228 179.116 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 . . . . . 0 N--CA 1.446 -0.666 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.513 HD11 ' HB2' ' A' ' 73' ' ' PRO . 19.1 pt -132.28 167.85 25.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.285 0.564 . . . . 0.0 110.815 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.66 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -99.75 129.57 45.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.754 -179.268 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.415 HD23 HG12 ' A' ' 34' ' ' ILE . 3.1 mm? -125.97 126.93 45.13 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 83' ' ' THR . 35.0 ttpt -109.49 141.81 41.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.329 0.585 . . . . 0.0 111.221 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.27 127.04 70.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.167 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.18 121.95 25.75 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.661 0.743 . . . . 0.0 110.502 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.2 149.39 16.61 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.242 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -11.55 11.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.474 0.654 . . . . 0.0 112.043 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.85 -18.46 62.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.544 0.687 . . . . 0.0 110.435 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.12 -5.37 45.75 Favored Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.9 m -86.82 121.65 29.61 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.884 0.373 . . . . 0.0 110.381 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 p -144.35 138.33 23.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.366 0.603 . . . . 0.0 111.415 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -146.3 151.01 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.66 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -109.93 140.65 43.67 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.513 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -132.24 157.82 43.37 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 121.19 0.519 . . . . 0.0 111.255 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -127.82 108.55 10.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.415 HG12 HD23 ' A' ' 20' ' ' LEU . 46.8 pt -124.19 176.36 5.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.203 0.525 . . . . 0.0 110.73 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.3 tmtp? -85.44 149.61 25.29 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.097 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.495 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 17.6 tpp180 -53.06 -26.67 16.73 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.601 0.761 . . . . 0.0 112.576 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -111.87 6.49 19.6 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.588 -0.695 . . . . 0.0 111.748 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 m -81.64 133.93 51.7 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.0 145.07 84.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.645 2.23 . . . . 0.0 112.361 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 48.1 mt -65.2 -17.06 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.927 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 35.5 p -50.47 -37.89 40.95 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.561 0.344 . . . . 0.0 111.686 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.7 mmpt? -56.36 -52.57 64.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.755 0.312 . . . . 0.0 110.72 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.88 -31.86 61.7 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.363 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.576 ' N ' HD12 ' A' ' 43' ' ' LEU . 53.2 mtt -58.2 -54.91 41.67 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.25 0.547 . . . . 0.0 110.979 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 57.6 mmtt -65.49 -44.43 87.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.936 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.728 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -57.56 -49.04 77.67 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.071 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -54.92 -51.7 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.584 ' SG ' HD11 ' A' ' 58' ' ' ILE . 34.1 m -67.19 -35.05 78.82 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.935 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 51.4 mt-10 -66.97 -36.18 81.61 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.209 -0.307 . . . . 0.0 111.682 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.728 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -88.13 -25.81 22.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 178.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -92.25 -6.06 51.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 111.555 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.2 46.38 57.95 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.158 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.8 mp -117.36 151.51 36.86 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.224 0.535 . . . . 0.0 110.827 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 71.4 m -96.76 123.0 40.32 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.905 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.3 mmm -56.64 -28.13 59.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.993 0.517 . . . . 0.0 111.903 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.476 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -84.39 -34.87 23.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.261 0.553 . . . . 0.0 111.116 -178.506 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 4.8 mp0 -81.66 -18.91 42.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.066 0.46 . . . . 0.0 111.338 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.584 HD11 ' SG ' ' A' ' 48' ' ' CYS . 14.3 pt -110.57 -179.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 120.968 0.413 . . . . 0.0 110.671 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 59' ' ' ARG . 10.0 tpt180 -157.31 133.3 9.49 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.173 0.511 . . . . 0.0 110.433 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.9 m-85 -85.54 135.87 33.64 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.063 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -144.79 148.21 33.8 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.997 0.427 . . . . 0.0 110.362 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -154.69 138.96 16.62 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.1 t70 65.84 25.19 11.28 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.59 0.709 . . . . 0.0 110.306 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 -26.56 5.75 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.763 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -90.94 144.62 30.38 Favored Pre-proline 0 C--N 1.327 -0.386 0 O-C-N 122.408 -0.466 . . . . 0.0 110.811 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.85 141.88 27.67 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.9 1.733 . . . . 0.0 110.338 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.654 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 6.9 pt -106.08 -179.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.832 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.93 165.42 22.12 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.599 0.714 . . . . 0.0 110.714 -174.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 11.1 pt-20 -67.82 -12.94 61.65 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.943 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -118.87 16.93 13.47 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.654 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 3.6 p-10 -91.27 98.76 11.92 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.415 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 p -58.49 145.56 75.75 Favored Pre-proline 0 C--N 1.301 -1.508 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.044 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.513 ' HB2' HD11 ' A' ' 18' ' ' ILE . 17.9 Cg_endo -59.57 -15.82 32.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.899 2.4 . . . . 0.0 111.58 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.465 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -80.01 -31.1 39.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.462 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -67.54 -54.67 18.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.264 0.554 . . . . 0.0 111.657 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.3 pt? -84.2 7.84 17.69 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.809 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 57.66 40.49 26.56 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.508 0.671 . . . . 0.0 111.224 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.86 130.29 43.55 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.463 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.86 169.75 17.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.14 0.495 . . . . 0.0 110.417 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -79.05 145.4 33.86 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 66.28 20.24 11.04 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.447 0.699 . . . . 0.0 110.975 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.03 161.42 28.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.071 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 30.3 m -121.51 135.35 55.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.645 0.736 . . . . 0.0 112.379 -175.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.84 137.94 24.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.164 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -93.62 117.38 30.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.29 0.567 . . . . 0.0 110.85 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.82 134.89 46.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.427 0.632 . . . . 0.0 111.737 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -131.84 159.87 37.3 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.463 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.1 mp0 . . . . . 0 C--N 1.318 -0.778 0 CA-C-O 121.139 0.495 . . . . 0.0 110.496 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 23.4 p-80 . . . . . 0 N--CA 1.44 -0.938 0 CA-C-O 120.769 0.318 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.8 pt -131.61 163.52 37.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.026 0.441 . . . . 0.0 110.19 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.539 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -97.23 141.22 30.62 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.5 mt -137.51 125.19 22.32 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 83' ' ' THR . 33.4 ttpt -108.36 140.67 41.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.243 0.544 . . . . 0.0 111.422 -176.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.5 t -114.54 127.55 71.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.847 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.61 120.37 23.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.437 0.637 . . . . 0.0 110.582 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.52 150.83 17.7 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.405 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.58 -8.94 7.27 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 112.502 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.54 -13.77 60.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.706 0.765 . . . . 0.0 109.945 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.85 -10.61 58.87 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.0 m -81.42 123.72 28.81 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.001 0.429 . . . . 0.0 110.264 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 22' ' ' VAL . 3.6 p -143.71 138.28 25.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 121.278 0.561 . . . . 0.0 110.955 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.3 t -143.04 150.8 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.595 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.539 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -107.63 137.67 45.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.087 0.47 . . . . 0.0 109.971 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 29.9 m-85 -128.15 166.44 18.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 121.382 0.61 . . . . 0.0 110.503 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -141.63 111.46 6.66 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.469 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.2 pt -131.04 176.29 9.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.395 0.616 . . . . 0.0 111.549 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 1.9 tmtp? -88.45 150.52 23.1 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.267 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.431 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 21.8 tpp180 -54.98 -27.46 44.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.944 0.898 . . . . 0.0 112.712 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -108.47 3.55 23.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.272 0.558 . . . . 0.0 111.026 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.7 m -85.16 131.81 47.32 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.195 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.52 148.7 90.62 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.508 2.139 . . . . 0.0 112.484 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.4 mt -65.61 -15.6 62.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.763 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 54.1 p -50.96 -37.91 47.43 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 122.91 0.484 . . . . 0.0 111.343 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -56.91 -53.68 55.16 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.073 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.38 -32.4 58.55 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.0 0.429 . . . . 0.0 111.317 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.626 ' N ' HD12 ' A' ' 43' ' ' LEU . 41.8 ttm -60.44 -52.12 66.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.682 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 33.1 mmtp -70.49 -37.74 74.25 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.884 0.373 . . . . 0.0 110.283 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.94 -45.4 94.84 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.92 0.391 . . . . 0.0 111.004 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 21.1 t80 -56.78 -51.92 67.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.364 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.3 p -61.63 -36.59 81.19 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.216 0.532 . . . . 0.0 110.608 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 61.6 mm-40 -67.06 -45.41 77.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.878 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.9 ptp180 -78.99 -25.59 43.37 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -93.47 -12.27 30.12 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.979 -0.45 . . . . 0.0 112.2 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.95 43.81 9.59 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.323 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.515 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.0 mm? -120.6 160.06 24.0 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.016 0.436 . . . . 0.0 110.162 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.406 ' O ' HG12 ' A' ' 58' ' ' ILE . 4.7 m -109.65 135.65 50.27 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.737 0.303 . . . . 0.0 111.013 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.424 ' CE ' ' HG2' ' A' ' 44' ' ' MET . 86.3 mmm -58.01 -27.8 63.84 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.459 ' H ' ' HD3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -85.25 -24.14 27.91 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.783 -0.573 . . . . 0.0 111.443 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.68 -14.07 32.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.25 0.548 . . . . 0.0 110.136 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 53' ' ' LEU . 16.1 pt -120.5 169.94 11.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 120.944 0.402 . . . . 0.0 110.674 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -149.9 136.6 19.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -95.13 136.04 35.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.146 0.498 . . . . 0.0 110.342 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.35 142.13 37.61 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.109 0.48 . . . . 0.0 110.885 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -153.44 143.27 22.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 64.63 23.76 12.87 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.411 0.624 . . . . 0.0 110.696 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.89 -2.93 82.09 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.491 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -118.35 149.29 45.65 Favored Pre-proline 0 C--N 1.332 -0.153 0 O-C-N 122.163 -0.61 . . . . 0.0 110.376 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.47 139.81 20.98 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.846 1.697 . . . . 0.0 110.575 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.9 pt -113.46 160.73 12.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.43 0.633 . . . . 0.0 111.487 -176.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.8 p30 -120.2 157.14 29.71 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.424 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 7.3 pt-20 -62.77 -9.78 10.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.994 0.426 . . . . 0.0 111.92 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.0 t -99.02 7.68 45.73 Favored 'General case' 0 N--CA 1.441 -0.916 0 O-C-N 122.036 -0.415 . . . . 0.0 111.898 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.502 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.4 OUTLIER -92.71 156.65 16.91 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 121.682 -0.636 . . . . 0.0 109.898 178.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.2 p -115.99 146.77 37.79 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.8 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.81 -12.89 33.92 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.793 2.329 . . . . 0.0 112.279 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.83 -24.49 23.7 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.326 0.584 . . . . 0.0 110.604 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -72.54 -55.33 7.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.39 0.614 . . . . 0.0 110.851 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -88.7 12.39 14.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.969 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 53.38 62.95 2.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.518 0.675 . . . . 0.0 111.576 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.84 130.15 35.09 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.683 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.48 166.88 11.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.923 0.392 . . . . 0.0 110.602 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -73.06 143.74 47.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.22 0.533 . . . . 0.0 110.941 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 66.8 15.0 10.03 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.863 0.865 . . . . 0.0 112.129 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -76.98 166.63 23.07 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 18.8 m -121.68 138.21 54.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.22 135.91 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.152 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -93.6 121.58 35.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.086 0.47 . . . . 0.0 110.973 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.3 t -109.79 136.83 44.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.201 0.524 . . . . 0.0 111.613 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -129.45 151.06 50.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.089 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--N 1.326 -0.437 0 CA-C-O 121.054 0.454 . . . . 0.0 110.868 178.112 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 16.2 p-80 . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.95 0.405 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 20' ' ' LEU . 15.9 pt -133.87 166.65 28.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.096 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.617 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -102.85 115.45 30.62 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 120.835 0.35 . . . . 0.0 110.226 -179.029 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.558 HD11 HD12 ' A' ' 18' ' ' ILE . 6.6 mp -112.55 125.66 54.49 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.431 0.634 . . . . 0.0 109.947 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 83' ' ' THR . 34.1 ttpt -105.56 146.51 29.52 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.349 0.595 . . . . 0.0 111.356 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 39.4 t -116.64 128.95 73.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.97 121.42 22.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.433 0.635 . . . . 0.0 110.489 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.0 150.31 17.1 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.839 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.46 -10.58 7.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.583 0.706 . . . . 0.0 111.86 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.546 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 21.0 t70 -71.22 -19.45 62.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.253 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.89 -13.89 49.44 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -74.94 112.34 11.08 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.796 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.3 p -139.12 131.97 37.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.281 0.563 . . . . 0.0 110.913 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.53 150.83 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.617 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -106.36 142.22 36.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.847 0.356 . . . . 0.0 110.568 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -137.29 139.0 40.64 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.133 0.492 . . . . 0.0 111.076 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -106.6 113.93 27.74 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.97 -0.456 . . . . 0.0 110.028 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.3 pt -126.9 170.09 17.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.972 0.415 . . . . 0.0 110.743 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 2.0 tmtp? -81.4 148.04 29.51 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.431 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 11.7 tpp180 -56.26 -26.14 50.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.85 0.46 . . . . 0.0 112.032 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -102.46 -2.4 28.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.531 0.681 . . . . 0.0 110.127 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.0 m -81.33 132.07 56.93 Favored Pre-proline 0 N--CA 1.434 -1.231 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.307 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.2 148.2 88.67 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.523 2.149 . . . . 0.0 111.841 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.4 mt -64.81 -15.18 61.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.743 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.49 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 11.8 p -49.22 -37.52 23.28 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 6.7 mmpt? -56.57 -53.42 57.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.85 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 44' ' ' MET . 4.3 pp -74.44 -31.63 62.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.377 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.522 ' N ' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -53.13 -58.06 8.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.023 0.439 . . . . 0.0 111.244 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -72.38 -38.14 68.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.399 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.35 -48.17 82.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.179 0.514 . . . . 0.0 110.958 -177.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -56.51 -51.35 68.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.886 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.784 ' SG ' HD11 ' A' ' 58' ' ' ILE . 31.4 m -63.75 -36.57 84.29 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.968 0.413 . . . . 0.0 111.914 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 40.4 mt-10 -64.35 -42.27 96.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.053 0.454 . . . . 0.0 111.189 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.1 ptp180 -84.35 -19.87 32.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 0.0 111.683 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -100.75 -2.4 32.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.96 48.04 69.19 Favored Glycine 0 C--O 1.235 0.202 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.348 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 58' ' ' ILE . 49.5 mt -122.69 154.53 37.95 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.067 0.46 . . . . 0.0 110.673 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.2 m -103.67 126.66 50.95 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.354 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.41 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 81.0 mmm -57.92 -26.89 62.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.035 0.534 . . . . 0.0 111.808 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.15 -28.12 27.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.243 0.544 . . . . 0.0 111.05 -178.738 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.414 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 5.0 mp0 -93.01 -27.48 16.98 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.937 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.784 HD11 ' SG ' ' A' ' 48' ' ' CYS . 10.0 pt -103.11 163.63 3.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 O-C-N 121.375 -0.828 . . . . 0.0 110.766 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -136.97 132.15 33.94 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.073 0.463 . . . . 0.0 110.657 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -90.32 126.98 36.04 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -138.29 144.84 40.65 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.281 0.562 . . . . 0.0 111.493 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -149.83 141.83 23.89 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 t70 64.69 25.42 13.04 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.906 0.86 . . . . 0.0 110.0 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.97 -15.38 10.52 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.521 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -100.4 135.35 20.25 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 122.184 -0.597 . . . . 0.0 110.879 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.09 131.95 24.96 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.032 1.821 . . . . 0.0 111.081 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.581 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 5.7 pt -98.75 -177.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.82 166.75 21.92 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-O 121.54 0.686 . . . . 0.0 110.437 -174.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 10.3 pt-20 -78.9 -8.17 58.61 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.753 0.787 . . . . 0.0 108.964 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -107.38 16.24 24.12 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.058 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.581 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -103.81 151.55 22.94 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.69 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.9 p -115.79 150.17 44.42 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.035 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HB3' HD21 ' A' ' 20' ' ' LEU . 19.3 Cg_endo -61.55 -17.0 51.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.509 2.14 . . . . 0.0 111.444 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.44 -20.48 40.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.935 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.64 -53.77 8.7 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.29 0.567 . . . . 0.0 110.468 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.54 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.9 pt? -90.91 12.25 20.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.325 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 57.33 52.78 8.31 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.244 0.545 . . . . 0.0 111.439 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.37 137.08 34.85 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -104.13 -175.61 2.85 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.949 0.404 . . . . 0.0 110.4 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.46 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 11.6 p-10 -80.0 153.86 28.59 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.352 0.596 . . . . 0.0 110.319 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 63.24 18.83 11.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.916 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.75 157.57 25.78 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 25.4 m -130.21 147.68 51.96 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.595 -0.691 . . . . 0.0 112.69 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.25 140.28 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.066 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -93.86 124.25 37.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.937 0.398 . . . . 0.0 111.033 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.5 t -109.79 139.8 31.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.261 0.553 . . . . 0.0 111.522 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -132.14 156.9 45.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.743 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.546 ' OE1' ' HB2' ' A' ' 26' ' ' ASP . 2.0 mp0 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 121.131 0.491 . . . . 0.0 111.85 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.445 HG13 HD21 ' A' ' 20' ' ' LEU . 34.0 pt -127.41 158.14 38.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.073 0.463 . . . . 0.0 110.389 177.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.0 119.27 34.19 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.445 HD21 HG13 ' A' ' 18' ' ' ILE . 2.7 mm? -110.8 125.05 53.16 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 34.1 ttpt -104.55 139.71 39.03 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.063 0.459 . . . . 0.0 110.628 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.26 125.74 69.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.82 120.99 24.52 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.728 0.775 . . . . 0.0 110.959 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA2' ' HB ' ' A' ' 86' ' ' VAL . . . -97.41 146.59 18.33 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -62.61 -6.88 3.89 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.19 -4.46 59.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.735 0.779 . . . . 0.0 110.061 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.14 -10.06 56.62 Favored Glycine 0 C--N 1.316 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.57 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -74.1 113.58 11.45 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 122.753 -0.263 . . . . 0.0 110.307 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.55 137.22 28.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.461 0.648 . . . . 0.0 112.229 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.2 t -145.36 150.86 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 1.5 tm0? -112.36 135.15 53.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.167 0.508 . . . . 0.0 110.569 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -126.36 166.87 16.36 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.217 0.532 . . . . 0.0 111.009 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -133.93 119.41 19.06 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.089 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.422 HG12 HD23 ' A' ' 20' ' ' LEU . 44.8 pt -134.61 170.79 18.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.073 0.463 . . . . 0.0 110.43 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.4 tmtp? -82.95 153.14 25.18 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 13.6 tpp180 -54.21 -24.45 18.46 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.109 0.564 . . . . 0.0 112.27 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -106.67 -5.06 18.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.565 0.697 . . . . 0.0 110.103 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.4 m -78.65 131.16 68.63 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.659 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.33 146.25 85.41 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.748 2.299 . . . . 0.0 112.325 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.44 -17.19 64.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.724 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 30.0 p -50.23 -38.96 43.13 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.76 0.424 . . . . 0.0 111.525 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.6 mmpt? -55.96 -53.33 58.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.86 -31.95 61.76 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.459 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.579 ' N ' HD12 ' A' ' 43' ' ' LEU . 53.8 mtt -60.12 -54.9 40.43 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.018 0.437 . . . . 0.0 111.41 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 11.2 mmmm -67.27 -39.01 86.01 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.227 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.78 79.77 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 111.298 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.432 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 26.4 t80 -55.33 -50.77 68.78 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.042 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.76 ' SG ' HD11 ' A' ' 58' ' ' ILE . 35.3 m -63.96 -34.27 77.6 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.842 0.353 . . . . 0.0 111.873 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.9 mt-10 -66.57 -39.54 88.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.911 0.386 . . . . 0.0 111.376 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -86.25 -21.94 27.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.976 0.417 . . . . 0.0 111.622 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.432 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 21.5 mm-40 -96.99 0.33 48.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.021 0.439 . . . . 0.0 111.561 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.01 45.19 96.63 Favored Glycine 0 CA--C 1.512 -0.145 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.964 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.644 ' HB3' HG21 ' A' ' 58' ' ' ILE . 86.2 mt -119.41 157.58 27.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.166 0.508 . . . . 0.0 110.587 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 58' ' ' ILE . 36.3 m -106.33 131.81 53.1 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.394 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 88.1 mmm -58.99 -23.37 61.8 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.253 0.549 . . . . 0.0 111.255 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.44 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.5 OUTLIER -84.66 -34.12 23.1 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.211 0.529 . . . . 0.0 111.236 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 0.6 OUTLIER -88.38 -17.1 31.26 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.992 0.425 . . . . 0.0 111.612 -176.229 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.76 HD11 ' SG ' ' A' ' 48' ' ' CYS . 6.3 pt -117.33 172.56 4.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -152.79 144.78 23.73 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.141 0.496 . . . . 0.0 110.628 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CE2' ' HG2' ' A' ' 44' ' ' MET . 6.1 m-85 -99.37 136.61 39.07 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.744 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -137.21 141.0 42.1 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.022 0.439 . . . . 0.0 110.379 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -151.18 140.69 21.57 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t0 68.65 24.68 6.73 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.832 0.825 . . . . 0.0 110.068 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.9 -0.72 65.24 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.964 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -118.45 136.07 23.88 Favored Pre-proline 0 N--CA 1.445 -0.721 0 O-C-N 122.157 -0.614 . . . . 0.0 110.466 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.58 136.38 49.87 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.906 1.738 . . . . 0.0 110.685 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.466 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 15.0 pt -112.21 169.94 4.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.383 0.611 . . . . 0.0 111.251 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.524 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.7 p30 -129.9 153.52 48.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.004 -177.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.6 pt-20 -59.17 -11.13 3.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.045 0.45 . . . . 0.0 112.207 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -96.63 5.3 50.99 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 122.043 -0.41 . . . . 0.0 111.65 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.524 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -96.54 161.76 13.76 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 121.574 -0.704 . . . . 0.0 110.425 -179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.5 p -121.63 150.94 56.26 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.708 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 18.5 Cg_endo -58.4 -23.15 62.13 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.955 2.437 . . . . 0.0 112.244 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.576 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -77.03 -31.67 56.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.219 0.533 . . . . 0.0 110.788 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -72.11 -55.85 6.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.565 -176.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.432 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 1.5 pt? -81.96 10.07 7.15 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 56.48 62.25 2.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 111.84 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 mtt -77.75 -169.91 1.67 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.347 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -156.59 158.61 37.41 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.63 141.98 40.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.16 0.505 . . . . 0.0 110.489 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 67.87 17.49 9.67 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.945 0.898 . . . . 0.0 112.017 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.57 171.66 11.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 m -125.11 138.57 54.17 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.581 0.705 . . . . 0.0 112.665 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.51 134.78 35.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -93.9 122.06 36.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.115 0.483 . . . . 0.0 110.602 -178.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 49.7 t -109.43 138.17 38.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.325 0.583 . . . . 0.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.86 155.24 46.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.523 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.536 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.7 mp0 . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 120.704 0.287 . . . . 0.0 110.879 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 120.794 0.331 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.18 -53.82 1.04 Allowed 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -112.71 -10.58 13.61 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.367 0.604 . . . . 0.0 112.028 -176.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -109.69 -34.19 6.55 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.227 0.536 . . . . 0.0 109.662 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -150.76 71.42 8.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.325 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -75.14 153.67 41.27 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.343 2.029 . . . . 0.0 111.62 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -69.65 -15.86 63.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.032 0.444 . . . . 0.0 111.454 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -72.86 -72.39 0.25 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.878 0.847 . . . . 0.0 110.082 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.29 -54.4 3.9 Favored Glycine 0 C--N 1.291 -1.937 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.115 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.33 152.15 4.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 120.939 0.4 . . . . 0.0 110.348 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.545 ' N ' ' HE3' ' A' ' 11' ' ' LYS . 0.8 OUTLIER -66.12 173.61 3.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.016 0.436 . . . . 0.0 110.854 178.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 m -71.74 93.15 1.25 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.801 0.81 . . . . 0.0 110.501 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -93.34 151.38 19.81 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.386 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -82.02 166.56 19.68 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -79.77 73.96 6.49 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.883 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.427 ' OD2' ' HB3' ' A' ' 36' ' ' ARG . 2.6 p-10 -107.2 91.28 3.59 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 122.344 1.069 . . . . 0.0 108.725 171.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 39.0 p-80 -118.73 150.53 39.62 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.506 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 73' ' ' PRO . 33.3 pt -129.6 156.44 41.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.148 0.499 . . . . 0.0 110.658 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.467 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -96.53 113.61 25.2 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.887 -178.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.481 ' HG ' ' SD ' ' A' ' 78' ' ' MET . 1.5 mm? -109.57 128.58 55.31 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.094 0.473 . . . . 0.0 109.752 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 37.3 ttpt -106.66 141.89 37.19 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.127 0.489 . . . . 0.0 111.168 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 45.1 t -112.48 124.18 68.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.38 112.05 13.43 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.509 0.671 . . . . 0.0 110.81 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.26 148.68 19.07 Favored Glycine 0 C--N 1.299 -1.499 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.143 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -60.58 -11.65 7.76 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.342 0.591 . . . . 0.0 112.355 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -71.25 -18.49 62.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.601 0.715 . . . . 0.0 110.132 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.24 -10.21 50.63 Favored Glycine 0 C--N 1.316 -0.557 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.6 m -78.51 116.87 19.2 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.973 0.416 . . . . 0.0 109.982 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 3.8 p -142.34 135.49 27.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.318 0.58 . . . . 0.0 111.282 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.41 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 25.0 t -145.27 151.89 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.301 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.62 136.23 49.31 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CZ ' ' HB ' ' A' ' 30' ' ' VAL . 17.0 m-85 -131.9 133.06 44.17 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.075 0.464 . . . . 0.0 111.095 -175.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 60.7 mtpt -107.51 107.67 18.63 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.911 -0.493 . . . . 0.0 110.988 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.4 pt -121.59 173.18 7.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.227 0.536 . . . . 0.0 110.459 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.8 tmtt? -81.27 150.57 28.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.12 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.427 ' HB3' ' OD2' ' A' ' 16' ' ' ASP . 7.3 tpp180 -58.32 -20.9 46.84 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.893 0.477 . . . . 0.0 111.926 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -108.73 2.64 21.95 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.861 -0.525 . . . . 0.0 111.014 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.7 m -85.89 133.12 42.03 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.793 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.21 146.47 81.45 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.728 2.285 . . . . 0.0 112.383 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.435 HD12 ' OD2' ' A' ' 71' ' ' ASP . 31.0 mt -65.86 -16.95 64.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.941 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.4 p -50.15 -37.62 35.38 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.797 0.439 . . . . 0.0 111.365 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -57.41 -52.49 65.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.91 -31.64 61.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.336 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.562 ' N ' HD12 ' A' ' 43' ' ' LEU . 56.3 mtt -59.44 -54.7 43.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.55 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.571 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 38.0 mmtm -66.06 -41.18 91.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 109.911 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.68 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.79 -47.31 86.22 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.373 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -54.49 -49.74 69.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.597 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.559 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 75.4 m -66.28 -34.99 79.25 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 84.3 mt-10 -61.03 -44.6 97.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.188 0.518 . . . . 0.0 111.141 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.9 ptp85 -85.42 -28.22 25.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -90.8 -18.7 24.46 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.817 -0.552 . . . . 0.0 112.184 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.36 41.59 9.98 Favored Glycine 0 C--N 1.309 -0.971 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.748 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.3 mm? -114.06 153.41 29.49 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.294 -0.533 . . . . 0.0 110.806 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 75.2 m -95.7 124.11 39.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.747 0.308 . . . . 0.0 110.447 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.436 ' HE2' ' HB3' ' A' ' 44' ' ' MET . 92.0 mmm -60.11 -25.51 65.51 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.71 -28.55 26.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.299 0.571 . . . . 0.0 111.178 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 3.4 mp0 -83.17 -40.91 19.1 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.163 0.506 . . . . 0.0 110.772 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.522 HD11 ' SG ' ' A' ' 48' ' ' CYS . 13.0 pt -90.86 178.06 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.115 0.484 . . . . 0.0 110.929 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.494 ' HB3' HE22 ' A' ' 89' ' ' GLN . 21.8 tpt180 -155.43 142.66 19.34 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.874 177.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.411 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.7 m-85 -92.33 137.08 32.66 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.085 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -140.6 134.71 30.9 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.051 0.453 . . . . 0.0 110.028 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 78' ' ' MET . 72.3 t80 -143.81 135.53 26.23 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.04 26.43 5.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.512 0.672 . . . . 0.0 111.11 176.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.03 -6.35 71.57 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.1 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -118.4 142.61 31.65 Favored Pre-proline 0 C--N 1.319 -0.76 0 O-C-N 122.284 -0.539 . . . . 0.0 110.53 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.37 141.22 46.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.112 1.875 . . . . 0.0 111.104 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 pt -115.8 160.39 15.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.236 0.541 . . . . 0.0 110.905 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 3.4 p30 -118.97 153.31 34.84 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.566 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.463 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.7 pt-20 -60.5 -12.0 8.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.019 0.438 . . . . 0.0 112.039 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -94.15 4.83 53.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.626 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.502 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -91.84 156.7 17.32 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 121.672 -0.643 . . . . 0.0 110.395 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.7 p -119.06 148.64 45.27 Favored Pre-proline 0 N--CA 1.439 -0.981 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.838 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.46 ' HB2' HD11 ' A' ' 18' ' ' ILE . 19.6 Cg_endo -60.29 -17.48 46.96 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.705 2.27 . . . . 0.0 112.417 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.37 -16.52 32.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.095 0.474 . . . . 0.0 111.268 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -82.61 -55.68 4.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.335 0.588 . . . . 0.0 110.567 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -85.11 3.37 39.25 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.996 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 62.74 62.31 1.09 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.449 0.642 . . . . 0.0 112.455 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 84' ' ' ILE . 29.7 ttm -90.41 139.27 30.83 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -109.33 171.14 7.61 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.416 0.627 . . . . 0.0 111.705 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -65.91 141.27 58.29 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.085 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 65.47 13.95 9.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.687 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.96 170.66 15.33 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.2 m -128.55 144.21 51.11 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.519 HD11 ' SD ' ' A' ' 78' ' ' MET . 4.1 mp -104.8 133.08 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.764 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -94.15 125.57 38.86 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.31 0.576 . . . . 0.0 110.873 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 41.6 t -108.82 136.28 45.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.245 0.545 . . . . 0.0 111.147 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -128.78 153.01 47.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.034 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.436 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.6 mp0 -102.75 111.07 23.22 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.494 HE22 ' HB3' ' A' ' 59' ' ' ARG . 20.6 mp0 -59.01 -57.47 12.92 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.582 0.706 . . . . 0.0 110.762 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -83.73 -170.21 2.95 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.082 175.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -81.77 -173.15 4.28 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.874 0.368 . . . . 0.0 111.424 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.87 -17.99 0.1 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.392 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.766 0 CA-C-O 118.938 -0.923 . . . . 0.0 111.584 179.506 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 121.469 0.652 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.5 20.78 2.2 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.15 23.13 6.82 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.776 -175.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -76.97 -59.62 2.7 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.922 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.567 ' O ' ' HG2' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -159.37 82.27 2.47 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 121.927 0.87 . . . . 0.0 110.82 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.97 148.5 35.5 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.265 1.977 . . . . 0.0 110.625 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HD3' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -143.77 40.61 1.41 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.54 174.92 6.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.68 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.44 -11.66 16.38 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.671 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.55 120.5 10.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.299 -0.45 . . . . 0.0 110.067 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -127.29 22.35 6.57 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.614 0.721 . . . . 0.0 111.025 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -85.17 80.83 9.08 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.763 0.792 . . . . 0.0 110.436 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -93.6 96.28 9.75 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.86 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -131.43 42.06 3.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.842 0.83 . . . . 0.0 109.825 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -157.76 167.08 31.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.176 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.38 82.1 7.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.876 0.37 . . . . 0.0 110.237 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 17.7 p-80 -124.68 151.78 44.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.6 pt -130.92 159.15 43.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.285 0.564 . . . . 0.0 110.744 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.2 OUTLIER -93.75 127.15 39.33 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.7 mt -126.49 125.59 42.33 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 83' ' ' THR . 31.9 ttpt -106.41 141.37 37.84 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.401 0.62 . . . . 0.0 111.224 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.9 t -114.15 126.88 71.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.503 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.29 121.95 27.06 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.454 0.645 . . . . 0.0 110.803 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.2 148.89 18.57 Favored Glycine 0 C--N 1.298 -1.567 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.54 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -16.49 27.34 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.262 0.553 . . . . 0.0 112.142 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -70.36 -15.7 62.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.548 0.689 . . . . 0.0 110.709 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.68 -10.9 53.29 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.566 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.533 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . 70.2 m -78.54 115.34 18.18 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.107 0.48 . . . . 0.0 110.242 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.73 135.21 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.329 0.585 . . . . 0.0 111.781 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.4 t -140.68 150.12 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.93 -177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.513 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -108.51 140.55 41.68 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.9 0.381 . . . . 0.0 110.667 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -134.81 163.45 29.79 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 110.367 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -134.85 110.31 9.09 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.3 pt -126.03 166.95 21.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.916 0.389 . . . . 0.0 110.434 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 2.1 tmtp? -74.71 147.43 41.42 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.523 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 42.7 ttm180 -65.16 -15.41 62.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.187 0.518 . . . . 0.0 111.909 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -103.11 -3.52 25.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.746 0.784 . . . . 0.0 109.079 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 m -88.99 133.55 35.2 Favored Pre-proline 0 N--CA 1.439 -1.01 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.132 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.0 150.67 87.77 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.643 2.228 . . . . 0.0 112.708 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.1 mt -65.44 -15.67 62.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.578 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 34.3 p -49.97 -37.4 32.17 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 122.768 0.427 . . . . 0.0 111.731 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 7.4 mmpt? -57.61 -52.39 65.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.242 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.44 -31.94 62.46 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.366 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.59 ' N ' HD12 ' A' ' 43' ' ' LEU . 57.7 mtt -60.98 -54.53 43.83 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 34.8 mmtp -68.54 -37.03 79.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.554 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.84 -47.94 81.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.986 0.422 . . . . 0.0 110.543 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.438 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 57.1 t80 -56.06 -51.93 66.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.343 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 p -61.09 -35.12 76.15 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.068 -0.395 . . . . 0.0 111.425 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 37.6 mt-10 -67.38 -43.27 81.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.439 . . . . 0.0 111.798 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 13.3 ptp180 -80.66 -25.89 37.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.809 0.337 . . . . 0.0 111.646 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.533 ' OE1' ' HB3' ' A' ' 28' ' ' SER . 20.5 mm-40 -93.85 -2.63 53.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.793 0.33 . . . . 0.0 111.822 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.91 91.84 Favored Glycine 0 CA--C 1.508 -0.344 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.74 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.655 ' HB3' HG21 ' A' ' 58' ' ' ILE . 84.9 mt -119.25 157.04 28.83 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.19 0.519 . . . . 0.0 110.714 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.7 m -107.12 129.51 54.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.568 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.451 ' CE ' ' HB3' ' A' ' 44' ' ' MET . 98.4 mmm -63.17 -22.47 66.89 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.164 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.06 -23.91 30.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.436 0.636 . . . . 0.0 110.422 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.85 -44.47 8.92 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.076 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.655 HG21 ' HB3' ' A' ' 53' ' ' LEU . 15.3 pt -88.52 166.83 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 O-C-N 121.661 -0.649 . . . . 0.0 110.348 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -144.43 137.85 27.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.951 0.405 . . . . 0.0 110.155 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -93.5 139.99 30.1 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.853 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -144.88 143.42 30.58 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.035 0.445 . . . . 0.0 110.291 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -152.28 135.85 16.1 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t70 67.34 25.77 8.64 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.471 0.653 . . . . 0.0 111.107 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.02 0.58 76.58 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.622 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -118.74 145.04 36.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 121.912 -0.758 . . . . 0.0 110.088 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.36 141.98 23.43 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.872 1.715 . . . . 0.0 111.166 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.8 pt -115.01 160.45 14.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.275 0.559 . . . . 0.0 111.289 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.9 p30 -121.66 155.42 35.2 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.805 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 9.8 pt-20 -61.97 -9.76 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.172 0.511 . . . . 0.0 111.738 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -97.09 9.45 42.07 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 122.054 -0.404 . . . . 0.0 111.313 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.459 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -96.57 154.58 17.19 Favored 'General case' 0 C--O 1.243 0.718 0 O-C-N 121.74 -0.6 . . . . 0.0 109.734 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.3 p -117.16 146.98 39.37 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.551 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.87 -22.48 68.61 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.649 2.233 . . . . 0.0 112.091 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -80.35 -17.25 52.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.159 0.504 . . . . 0.0 110.904 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -79.23 -54.86 5.56 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.341 0.591 . . . . 0.0 110.023 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.9 pt? -87.54 12.25 12.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.223 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 57.08 58.73 3.79 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.491 0.662 . . . . 0.0 111.55 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.61 131.77 34.57 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.726 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -97.35 167.13 11.2 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.164 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.495 ' HB2' HD22 ' A' ' 19' ' ' ASN . 4.3 p-10 -76.69 150.58 36.31 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.111 0.481 . . . . 0.0 110.82 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 67.28 13.87 9.52 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.015 0.926 . . . . 0.0 112.209 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.17 171.38 13.74 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 17.6 m -125.97 147.7 49.45 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.393 0.616 . . . . 0.0 112.354 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.3 133.66 54.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.38 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.03 121.39 31.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.235 0.541 . . . . 0.0 111.275 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.81 138.93 35.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.244 0.545 . . . . 0.0 111.384 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.545 ' HB2' HE22 ' A' ' 89' ' ' GLN . 67.7 m-85 -128.45 150.21 50.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.489 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.452 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.7 mp0 -101.86 112.69 25.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.284 0.564 . . . . 0.0 111.643 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.545 HE22 ' HB2' ' A' ' 87' ' ' PHE . 26.6 mp0 -99.93 -176.12 3.16 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 60.43 21.33 10.97 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.331 0.653 . . . . 0.0 109.99 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 m 58.86 65.46 1.22 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.736 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.01 -20.87 77.2 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.498 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.462 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.385 178.863 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.713 0.292 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.407 ' O ' ' HE3' ' A' ' 11' ' ' LYS . . . 65.58 27.62 11.48 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.474 0.71 . . . . 0.0 111.293 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -136.45 18.76 3.13 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.853 0.835 . . . . 0.0 109.621 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -83.77 27.52 0.63 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.614 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 68.48 56.51 0.65 Allowed Pre-proline 0 N--CA 1.466 0.375 0 C-N-CA 123.394 0.677 . . . . 0.0 110.564 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.68 161.84 44.66 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.541 2.16 . . . . 0.0 111.713 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -86.09 -13.19 47.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.197 0.522 . . . . 0.0 111.09 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -121.77 132.93 54.88 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.96 56.08 18.32 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.874 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.21 38.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 122.005 0.907 . . . . 0.0 110.571 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.491 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER 49.21 34.47 6.13 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.016 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 p -113.09 -84.73 0.59 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.825 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.72 160.74 42.41 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.368 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 62.95 43.58 6.65 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.857 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -67.62 174.62 3.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.442 0.639 . . . . 0.0 111.651 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.13 85.74 5.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.272 1.034 . . . . 0.0 110.743 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 31.9 p-80 -121.03 143.87 48.83 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.126 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.407 HG13 HD21 ' A' ' 20' ' ' LEU . 31.4 pt -130.63 165.1 31.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.047 0.451 . . . . 0.0 110.591 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.12 120.51 40.57 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.407 HD21 HG13 ' A' ' 18' ' ' ILE . 2.5 mm? -111.83 124.57 52.63 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 83' ' ' THR . 33.5 ttpt -104.81 142.16 35.23 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.046 0.45 . . . . 0.0 110.634 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.84 127.71 71.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 120.958 0.409 . . . . 0.0 110.112 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.18 123.38 26.95 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.491 0.662 . . . . 0.0 110.146 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.9 148.41 16.47 Favored Glycine 0 C--N 1.3 -1.437 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.986 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -7.26 4.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -82.94 -10.63 58.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.482 0.658 . . . . 0.0 109.897 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.67 -13.36 46.54 Favored Glycine 0 CA--C 1.511 -0.193 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.338 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.1 m -77.31 119.24 20.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.962 0.41 . . . . 0.0 110.678 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.81 135.31 33.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.583 0.706 . . . . 0.0 111.366 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -143.33 149.46 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 1.6 tm0? -108.0 139.77 42.15 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.106 -0.371 . . . . 0.0 110.4 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -128.43 163.7 24.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.32 0.581 . . . . 0.0 110.758 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -137.7 111.73 8.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.951 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 pt -136.44 173.33 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.323 0.582 . . . . 0.0 111.085 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 11.5 tmtt? -77.08 147.98 36.36 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.591 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.481 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 40.1 ttm180 -60.29 -18.12 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -112.59 5.11 17.68 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.372 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -83.03 133.98 47.25 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.29 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.1 140.34 83.45 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.684 2.256 . . . . 0.0 113.045 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.431 HD12 ' OD2' ' A' ' 71' ' ' ASP . 42.3 mt -65.1 -15.7 62.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.824 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 23.0 t -49.27 -39.63 31.3 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 122.615 0.366 . . . . 0.0 111.27 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.533 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -58.3 -52.46 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.617 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.6 -32.01 62.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.922 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.617 ' N ' HD12 ' A' ' 43' ' ' LEU . 38.9 ttm -61.78 -52.01 65.97 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.61 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 50.5 mmtt -68.61 -42.57 77.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.001 0.429 . . . . 0.0 110.03 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.76 -45.24 90.18 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.955 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 49.2 t80 -57.95 -52.34 65.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.455 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.531 ' SG ' ' HG2' ' A' ' 55' ' ' MET . 14.4 p -62.4 -37.62 86.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.119 0.485 . . . . 0.0 110.982 -177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 48.1 mt-10 -67.63 -37.59 82.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.987 0.422 . . . . 0.0 111.898 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.6 ptp180 -85.7 -23.41 27.41 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.104 -0.372 . . . . 0.0 111.552 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.426 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 19.6 mm-40 -97.01 -4.53 39.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.938 0.399 . . . . 0.0 111.75 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.45 54.62 Favored Glycine 0 C--N 1.322 -0.201 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.249 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.6 mp -116.65 154.43 30.56 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.156 0.503 . . . . 0.0 110.614 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.0 m -102.45 122.37 44.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.493 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.531 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 97.8 mmm -56.09 -25.48 45.67 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.516 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -83.75 -30.92 26.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.614 0.721 . . . . 0.0 109.985 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 6.3 mp0 -88.52 -24.34 22.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.256 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 54' ' ' SER . 21.9 pt -107.25 174.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 121.895 -0.503 . . . . 0.0 110.158 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.487 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 1.9 tpp180 -159.05 134.35 8.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.203 0.525 . . . . 0.0 110.509 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 4.1 m-85 -85.64 143.18 28.57 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.625 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.441 ' HG3' ' C ' ' A' ' 65' ' ' GLN . 26.0 ttm180 -142.1 141.78 32.74 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.066 0.46 . . . . 0.0 110.541 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -150.32 136.91 19.0 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.25 27.68 8.28 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.342 0.592 . . . . 0.0 111.207 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.4 2.08 83.28 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.239 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.441 ' C ' ' HG3' ' A' ' 61' ' ' ARG . 7.5 pt20 -125.5 144.52 48.18 Favored Pre-proline 0 C--N 1.317 -0.836 0 O-C-N 122.178 -0.601 . . . . 0.0 110.26 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.85 143.0 53.79 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.039 1.826 . . . . 0.0 111.442 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.7 pt -113.63 171.45 3.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.058 0.456 . . . . 0.0 110.552 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.511 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 1.8 p30 -131.59 155.48 47.46 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.7 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.597 ' O ' ' HB2' ' A' ' 41' ' ' SER . 12.6 pt-20 -63.02 -8.83 8.12 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.134 0.492 . . . . 0.0 111.897 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 t -99.11 9.39 43.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 121.982 -0.449 . . . . 0.0 111.293 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.511 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.4 157.74 16.21 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.789 179.1 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.6 p -123.61 151.7 64.08 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 12.2 Cg_endo -57.54 -19.85 38.71 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.76 2.307 . . . . 0.0 112.641 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.2 35.23 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.94 -0.475 . . . . 0.0 110.97 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -72.44 -56.26 5.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.186 0.517 . . . . 0.0 110.86 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 1.7 pt? -81.88 6.06 16.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.634 -178.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 56.64 64.14 1.76 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.722 0.772 . . . . 0.0 111.145 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.79 -170.69 1.12 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.258 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -147.57 149.73 33.13 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.74 143.87 47.84 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 68.3 14.93 9.28 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.228 0.611 . . . . 0.0 111.878 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -87.61 173.95 8.74 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.044 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 28.3 m -126.41 142.42 51.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.699 0.761 . . . . 0.0 112.757 -175.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.76 133.09 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.786 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -90.55 119.95 31.23 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.041 0.448 . . . . 0.0 110.623 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.27 136.7 41.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.491 0.662 . . . . 0.0 111.609 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -134.78 165.71 24.64 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.403 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.1 mp0 -107.54 110.86 22.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.079 0.466 . . . . 0.0 110.196 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.487 ' NE2' ' HB3' ' A' ' 59' ' ' ARG . 2.0 mp0 -110.25 70.28 0.72 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.39 0.614 . . . . 0.0 110.877 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -86.87 -27.82 23.22 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.7 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.4 p -81.46 -70.82 0.51 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.223 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.06 26.88 0.02 OUTLIER Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.857 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.82 0 CA-C-O 119.16 -0.8 . . . . 0.0 111.479 179.7 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.963 0.411 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.05 -5.13 42.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.56 0.695 . . . . 0.0 110.599 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -80.53 -21.41 41.85 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.972 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -78.94 -36.68 41.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.463 0.649 . . . . 0.0 109.408 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -151.59 87.97 4.37 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-O 121.605 0.717 . . . . 0.0 111.962 178.15 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.0 -177.02 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.497 2.132 . . . . 0.0 111.392 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -82.04 -34.38 29.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -78.33 130.06 35.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.971 0.415 . . . . 0.0 110.564 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.16 -30.46 34.34 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.725 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -63.26 119.26 6.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.522 0.677 . . . . 0.0 110.413 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -101.74 89.89 3.83 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.564 0.697 . . . . 0.0 111.117 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -103.42 42.03 1.21 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 122.195 0.998 . . . . 0.0 109.446 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -165.46 -173.67 2.88 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.48 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -138.7 131.6 29.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.136 0.493 . . . . 0.0 110.986 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.605 ' OD1' ' HE3' ' A' ' 35' ' ' LYS . 50.0 t30 -124.37 132.92 53.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.369 0.604 . . . . 0.0 110.29 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -105.35 -85.75 0.48 Allowed 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.791 0.805 . . . . 0.0 109.098 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 72.92 104.41 0.07 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.418 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 pt -116.05 158.07 16.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.19 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.79 114.49 26.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.7 mt -110.98 124.8 52.86 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 83' ' ' THR . 32.3 ttpt -102.38 136.8 41.56 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.284 0.564 . . . . 0.0 111.185 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 29' ' ' VAL . 48.2 t -112.46 125.71 69.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.226 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.15 125.84 41.86 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.44 0.638 . . . . 0.0 110.61 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.95 152.07 20.16 Favored Glycine 0 C--N 1.302 -1.354 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.018 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -19.38 38.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.227 0.513 . . . . 0.0 112.32 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.13 -22.97 63.92 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.942 0.877 . . . . 0.0 109.742 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.47 -9.3 38.28 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.486 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . 67.1 m -68.97 125.36 26.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 22' ' ' VAL . 7.1 p -146.36 145.35 19.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.24 0.543 . . . . 0.0 111.569 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.1 t -146.79 151.51 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -111.08 132.26 54.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.236 0.541 . . . . 0.0 109.879 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 32.7 m-85 -122.02 168.16 12.26 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.782 -175.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -137.58 119.67 15.51 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 pt -138.47 163.6 28.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 32.0 tttt -76.32 165.13 25.29 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.293 0.568 . . . . 0.0 111.795 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 16.0 tpp180 -71.65 -19.31 62.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.408 -177.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -105.55 -6.8 19.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.9 0.857 . . . . 0.0 108.872 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.4 m -78.19 131.75 68.48 Favored Pre-proline 0 N--CA 1.435 -1.183 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.576 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.86 148.58 86.44 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.415 2.077 . . . . 0.0 111.707 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.15 -16.48 63.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.737 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 13.2 p -50.64 -37.45 40.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.824 0.449 . . . . 0.0 112.091 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 9.4 mmpt? -55.47 -53.88 50.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.912 0.387 . . . . 0.0 110.925 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 44' ' ' MET . 4.0 pp -75.66 -32.58 60.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.325 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.64 ' N ' HD12 ' A' ' 43' ' ' LEU . 46.2 ttm -59.33 -50.32 74.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.082 0.468 . . . . 0.0 110.458 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.644 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 1.9 mmmp? -69.9 -44.24 70.1 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.001 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.64 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.54 -42.97 93.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.739 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 34.1 t80 -54.27 -51.11 65.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.882 0.372 . . . . 0.0 110.623 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 58' ' ' ILE . 23.3 m -63.66 -34.54 78.06 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.023 0.44 . . . . 0.0 111.12 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 48.9 mm-40 -63.64 -39.47 94.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.067 0.461 . . . . 0.0 111.734 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -90.68 -20.82 22.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.791 0.329 . . . . 0.0 111.862 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.486 ' OE1' ' HB3' ' A' ' 28' ' ' SER . 19.5 mm-40 -95.11 -4.57 45.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.95 9.78 85.19 Favored Glycine 0 C--O 1.236 0.279 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.76 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.41 162.46 17.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.552 0.691 . . . . 0.0 112.007 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 58' ' ' ILE . 7.3 m -114.07 136.94 52.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.87 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.448 ' SD ' ' HA ' ' A' ' 45' ' ' LYS . 68.8 mmm -60.17 -28.35 67.86 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.776 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -83.39 -33.24 25.82 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.417 0.627 . . . . 0.0 110.911 -178.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.5 -20.91 46.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.395 0.616 . . . . 0.0 111.187 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.651 HD11 ' SG ' ' A' ' 48' ' ' CYS . 9.4 pt -118.15 179.72 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.134 0.492 . . . . 0.0 111.915 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -158.51 142.25 15.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.842 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -96.52 142.16 28.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.076 0.465 . . . . 0.0 111.008 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -144.18 143.15 30.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.075 0.464 . . . . 0.0 110.789 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -152.68 139.35 18.81 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.1 t70 65.47 23.97 11.89 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.828 0.823 . . . . 0.0 110.079 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.27 -23.47 8.24 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.885 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -94.68 140.14 22.5 Favored Pre-proline 0 C--N 1.322 -0.587 0 O-C-N 122.427 -0.455 . . . . 0.0 110.984 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.15 136.14 31.24 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.868 1.712 . . . . 0.0 110.623 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.605 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 10.8 pt -102.95 177.63 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.738 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.34 170.03 16.73 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.827 0.822 . . . . 0.0 111.066 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 12.0 pt-20 -73.44 -9.87 59.14 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.523 0.677 . . . . 0.0 109.708 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.2 t -107.9 10.94 28.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.211 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.605 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -99.84 155.4 17.68 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.908 178.629 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.8 p -118.53 147.87 42.91 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.329 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.12 -18.81 63.98 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.008 2.472 . . . . 0.0 112.177 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -79.65 -29.63 41.0 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.237 0.541 . . . . 0.0 110.511 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -67.85 -55.26 13.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.202 0.525 . . . . 0.0 110.825 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -88.53 12.44 14.48 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.738 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 52.28 62.81 2.51 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.724 0.773 . . . . 0.0 112.085 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.78 126.84 32.32 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.891 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.04 157.0 19.01 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -74.39 153.21 39.34 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 121.742 -0.599 . . . . 0.0 110.44 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 69.57 14.79 8.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.112 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -81.77 166.43 20.04 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.809 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 18.9 m -124.85 137.6 54.29 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.583 0.706 . . . . 0.0 112.88 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.99 140.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.659 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -95.31 117.86 31.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.089 0.471 . . . . 0.0 110.897 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -106.41 137.94 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.173 0.511 . . . . 0.0 111.414 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -129.55 155.71 45.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.899 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -102.14 111.74 24.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.987 0.422 . . . . 0.0 110.293 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -111.12 63.51 0.61 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.521 0.677 . . . . 0.0 111.126 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -131.49 83.82 2.13 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.1 m -73.67 110.94 8.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.227 0.537 . . . . 0.0 112.215 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.49 -122.64 5.13 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.925 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.449 179.133 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.105 0.479 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.98 1.19 55.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.795 0.807 . . . . 0.0 110.328 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -88.8 17.89 5.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.576 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.87 -48.98 27.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.524 0.678 . . . . 0.0 109.363 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -135.06 81.4 45.3 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-O 121.504 0.669 . . . . 0.0 111.692 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.1 144.23 29.67 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 123.254 2.636 . . . . 0.0 112.381 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -89.76 57.81 4.02 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.768 0.794 . . . . 0.0 109.404 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -75.38 142.5 43.1 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.635 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.93 39.83 32.15 Favored Glycine 0 CA--C 1.505 -0.587 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.342 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.45 146.93 6.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 120.922 0.391 . . . . 0.0 110.743 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -145.58 161.89 38.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.176 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.1 p -132.69 139.21 47.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.189 0.519 . . . . 0.0 112.147 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -140.68 117.0 10.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 57.44 85.76 0.08 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.745 0.783 . . . . 0.0 111.424 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -151.73 143.02 23.37 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.631 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.656 ' OD2' ' HD2' ' A' ' 36' ' ' ARG . 1.9 t70 -88.68 85.74 6.85 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.591 0.71 . . . . 0.0 109.334 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 27.4 p-80 -119.28 146.48 45.22 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.507 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.17 166.98 27.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.075 0.464 . . . . 0.0 110.168 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.435 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -108.45 121.26 44.58 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.119 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.36 131.22 56.63 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 31.1 ttpt -107.81 140.66 40.56 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.072 0.463 . . . . 0.0 110.521 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 39.1 t -114.08 127.5 71.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.099 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.99 127.26 35.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.143 0.497 . . . . 0.0 110.333 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.57 153.72 16.8 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.221 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.6 pp0? -61.39 -17.74 55.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.402 0.62 . . . . 0.0 111.126 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.1 -15.1 62.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.982 0.896 . . . . 0.0 109.757 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.65 -16.1 55.11 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.796 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -70.11 118.6 13.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.049 0.452 . . . . 0.0 110.688 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.6 p -142.98 136.27 25.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.148 0.499 . . . . 0.0 111.527 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 t -146.86 151.99 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.246 0.618 . . . . 0.0 109.516 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.432 HE21 ' HB3' ' A' ' 31' ' ' GLN . 1.0 OUTLIER -110.77 141.85 43.53 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.231 -0.293 . . . . 0.0 110.497 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 24.1 m-85 -135.59 156.43 48.87 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.055 0.455 . . . . 0.0 110.826 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 48.3 mttp -125.46 110.32 13.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 110.433 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.2 pt -125.27 173.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 110.673 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 2.4 tmtp? -83.54 148.36 27.24 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.656 ' HD2' ' OD2' ' A' ' 16' ' ' ASP . 28.7 ttm180 -64.59 -14.51 58.18 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -107.6 -1.52 21.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.542 0.686 . . . . 0.0 109.835 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.8 m -86.73 133.54 39.46 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.679 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 151.0 85.05 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.606 2.204 . . . . 0.0 112.473 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.8 mt -65.18 -16.63 63.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.631 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 24.5 p -49.9 -37.76 32.89 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.933 0.493 . . . . 0.0 111.822 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 8.7 mmpt? -56.27 -53.56 55.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.872 0.368 . . . . 0.0 110.654 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -75.39 -31.85 60.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.47 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.572 ' N ' HD12 ' A' ' 43' ' ' LEU . 53.4 mtt -57.32 -55.99 27.64 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.793 0.33 . . . . 0.0 111.721 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -70.13 -39.19 75.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.54 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.25 -44.99 88.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.145 0.497 . . . . 0.0 110.609 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 25.0 t80 -60.17 -51.92 67.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.675 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.765 ' SG ' HD11 ' A' ' 58' ' ' ILE . 40.0 m -63.63 -34.55 78.08 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.009 0.433 . . . . 0.0 111.801 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 17.9 mm-40 -67.83 -39.38 83.88 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.051 0.453 . . . . 0.0 111.474 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.0 ptp180 -84.55 -22.54 30.06 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.917 0.389 . . . . 0.0 111.417 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.413 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 20.0 mm-40 -96.77 -3.05 43.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.253 0.549 . . . . 0.0 111.697 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.81 43.33 91.89 Favored Glycine 0 C--N 1.32 -0.351 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.349 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.538 ' HB3' HG21 ' A' ' 58' ' ' ILE . 28.6 mt -117.94 154.96 31.04 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.12 0.486 . . . . 0.0 110.594 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 75.2 m -102.03 126.51 48.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.696 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.481 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 92.7 mmm -55.5 -27.97 51.78 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.476 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -84.21 -30.76 25.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.419 0.628 . . . . 0.0 111.185 -177.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 0.8 OUTLIER -87.01 -28.88 22.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.686 -178.099 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.765 HD11 ' SG ' ' A' ' 48' ' ' CYS . 5.8 pt -105.07 177.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -157.31 141.18 16.02 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.113 0.482 . . . . 0.0 110.59 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 5.2 m-85 -91.97 141.9 28.12 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.135 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -139.81 138.79 36.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.154 0.502 . . . . 0.0 110.706 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -148.48 140.88 24.25 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 t70 67.72 23.46 8.63 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.766 0.793 . . . . 0.0 109.822 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.41 -0.24 75.98 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.26 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -119.4 138.01 26.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 O-C-N 122.206 -0.585 . . . . 0.0 110.411 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.85 141.46 71.57 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.015 1.81 . . . . 0.0 111.25 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.9 pt -114.78 167.55 7.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.86 0.362 . . . . 0.0 111.05 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.503 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.7 p30 -128.17 155.97 43.63 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.553 -177.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.3 pt-20 -60.12 -10.75 4.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 112.001 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.2 t -99.29 9.1 44.01 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 122.039 -0.413 . . . . 0.0 111.786 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.503 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -98.03 159.75 14.74 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 121.658 -0.651 . . . . 0.0 110.65 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.1 p -117.76 148.99 44.35 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.617 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.97 -19.8 69.97 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.514 2.142 . . . . 0.0 111.904 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.12 -20.95 40.31 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.005 0.431 . . . . 0.0 111.074 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -74.76 -53.86 8.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.545 0.688 . . . . 0.0 110.565 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.31 4.4 31.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.333 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 61.39 62.84 1.28 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.61 0.719 . . . . 0.0 111.832 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 mtt -79.19 126.56 30.91 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.176 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.69 157.75 18.43 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.517 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.6 147.26 49.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.859 0.361 . . . . 0.0 110.264 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 67.18 15.18 9.99 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.426 0.69 . . . . 0.0 112.167 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -82.73 168.28 17.36 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 19.1 m -125.6 140.41 52.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.842 0.83 . . . . 0.0 112.849 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.84 134.27 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.85 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.79 125.23 40.21 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.191 0.52 . . . . 0.0 111.254 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.447 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 44.0 t -108.48 137.94 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.414 0.626 . . . . 0.0 112.12 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -136.12 166.54 23.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.426 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.5 mp0 -112.3 112.78 24.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.028 0.442 . . . . 0.0 111.406 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.53 45.38 0.98 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.481 0.658 . . . . 0.0 110.245 176.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.446 ' HG3' ' HA ' ' A' ' 57' ' ' GLN . 23.9 mm-40 -162.33 123.68 2.64 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 124.299 1.04 . . . . 0.0 108.852 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.8 m -87.99 104.53 16.72 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.133 0.492 . . . . 0.0 110.358 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.72 105.89 3.26 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 121.041 -0.599 . . . . 0.0 111.653 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.292 0 CA-C-O 118.479 -1.178 . . . . 0.0 111.643 -179.219 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.442 ' O ' ' HG2' ' A' ' 4' ' ' GLU . 46.7 mtt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 121.455 0.645 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.06 14.56 30.23 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.858 0.837 . . . . 0.0 109.41 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.65 17.36 23.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.291 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.497 ' HG3' HG21 ' A' ' 38' ' ' THR . 17.1 mm-40 -88.76 34.06 0.77 Allowed 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.369 0.604 . . . . 0.0 111.636 -175.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.546 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 10.0 mtpm? -142.24 -51.09 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.023 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 2.3 Cg_endo -83.38 171.72 10.98 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.094 1.863 . . . . 0.0 111.062 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -83.35 1.33 41.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.948 0.404 . . . . 0.0 111.527 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.85 171.8 7.64 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.897 0.38 . . . . 0.0 110.493 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.01 66.97 1.26 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.574 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.77 127.0 17.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.374 0.607 . . . . 0.0 111.259 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -62.29 118.24 7.17 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.532 0.682 . . . . 0.0 109.574 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.434 HG22 ' HG3' ' A' ' 13' ' ' GLU . 2.5 m -89.24 150.49 22.61 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.441 -172.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' HG3' HG22 ' A' ' 12' ' ' THR . 31.0 mt-10 60.56 19.53 9.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.011 0.924 . . . . 0.0 113.31 176.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 t30 49.06 72.1 0.32 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.976 0.893 . . . . 0.0 109.534 -176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -78.65 174.58 11.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.525 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.54 86.7 6.31 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.805 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 38.1 p-80 -125.22 150.53 46.92 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.591 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 pt -129.77 167.9 24.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.027 0.441 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.613 ' OD1' ' HE3' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -103.69 128.37 51.04 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.61 124.94 44.63 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 83' ' ' THR . 36.0 ttpt -104.1 140.04 38.33 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.171 0.51 . . . . 0.0 111.037 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.0 t -112.86 124.71 69.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.884 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.38 126.17 40.12 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.623 0.725 . . . . 0.0 110.096 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.41 146.66 17.38 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.656 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -4.59 1.56 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.566 0.698 . . . . 0.0 112.023 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.617 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 27.6 t70 -77.65 -16.87 58.25 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.647 0.779 . . . . 0.0 110.188 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.54 -13.18 50.92 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -82.06 119.93 24.64 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.116 0.484 . . . . 0.0 110.624 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.51 137.83 28.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 111.156 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.443 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 11.3 t -144.75 151.82 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.36 137.78 46.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.443 ' CZ ' ' HB ' ' A' ' 30' ' ' VAL . 30.8 m-85 -130.55 139.48 50.46 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.406 0.622 . . . . 0.0 111.406 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.613 ' HE3' ' OD1' ' A' ' 19' ' ' ASN . 22.9 tttt -112.17 107.96 17.04 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.674 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 pt -128.89 172.18 15.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.148 0.499 . . . . 0.0 111.186 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.8 tmtt? -80.23 149.77 30.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.877 0.37 . . . . 0.0 110.294 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 20.0 tpp85 -61.31 -19.48 61.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.144 0.577 . . . . 0.0 111.574 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -107.52 -1.95 20.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.476 0.655 . . . . 0.0 109.825 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.497 HG21 ' HG3' ' A' ' 4' ' ' GLU . 6.7 m -82.24 131.52 55.9 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.917 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.94 147.4 89.17 Favored 'Trans proline' 0 C--O 1.241 0.638 0 C-N-CA 122.377 2.051 . . . . 0.0 112.151 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.84 -15.73 62.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.549 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 37.4 p -49.89 -39.78 40.78 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.198 0.599 . . . . 0.0 111.366 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.61 -53.19 60.52 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.374 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.94 -32.38 61.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.022 0.439 . . . . 0.0 111.045 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.609 ' N ' HD12 ' A' ' 43' ' ' LEU . 45.7 ttm -60.6 -50.04 75.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 110.369 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 30.0 mmtp -71.39 -42.58 68.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.429 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.652 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.48 -46.11 91.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.594 0.357 . . . . 0.0 111.898 -177.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -53.89 -49.39 68.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.992 0.425 . . . . 0.0 110.323 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 58' ' ' ILE . 37.1 m -66.34 -34.32 77.7 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.27 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 45.6 mm-40 -58.14 -49.22 77.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.431 0.634 . . . . 0.0 110.992 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 5.7 ptp180 -83.99 -24.92 30.37 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -95.8 -11.61 26.62 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.93 44.86 35.4 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.973 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.419 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.1 mm? -114.4 153.22 30.25 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.379 -0.483 . . . . 0.0 110.689 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.4 ' O ' HG12 ' A' ' 58' ' ' ILE . 68.1 m -95.75 126.14 40.81 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 120.776 0.322 . . . . 0.0 111.03 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.451 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 52.9 mmm -61.6 -26.71 68.15 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.454 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -82.54 -29.78 30.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 111.257 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.99 -45.64 10.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.366 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 48' ' ' CYS . 8.7 pt -84.6 172.98 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 121.692 -0.63 . . . . 0.0 111.317 -177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 23.6 tpt180 -151.7 137.38 17.9 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.259 0.552 . . . . 0.0 110.351 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 8.1 m-85 -92.07 134.08 35.16 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.987 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -139.55 139.74 36.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.104 0.478 . . . . 0.0 110.509 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -145.76 137.83 25.38 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t70 67.08 24.7 9.35 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.849 0.833 . . . . 0.0 110.314 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.95 81.21 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.334 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -119.17 131.92 24.17 Favored Pre-proline 0 N--CA 1.451 -0.405 0 O-C-N 122.283 -0.54 . . . . 0.0 110.622 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -64.02 138.58 63.05 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.288 1.992 . . . . 0.0 111.295 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.7 pt -111.79 167.97 5.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.138 0.494 . . . . 0.0 111.259 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.0 p30 -131.32 158.94 39.34 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.29 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 41' ' ' SER . 5.4 pt-20 -63.21 -9.66 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.226 0.536 . . . . 0.0 111.604 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 t -99.59 10.66 40.97 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.939 -0.475 . . . . 0.0 111.604 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.461 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -100.07 157.34 16.62 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 121.714 -0.616 . . . . 0.0 110.686 178.628 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.7 p -120.72 147.77 46.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.693 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.445 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 34.6 Cg_endo -63.89 -19.02 66.17 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.917 2.411 . . . . 0.0 112.35 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.59 -25.95 41.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.008 0.432 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -73.49 -55.71 5.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.398 0.618 . . . . 0.0 111.286 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.453 HD21 ' HG3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -81.61 -2.69 51.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.613 -178.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 67.31 63.31 0.44 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.014 0.912 . . . . 0.0 110.799 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.453 ' HG3' HD21 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -82.31 128.71 34.47 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.684 -178.228 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.05 164.02 16.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.952 0.406 . . . . 0.0 110.095 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.19 147.0 31.47 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.039 0.447 . . . . 0.0 110.88 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 69.17 14.83 8.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.308 1.043 . . . . 0.0 111.896 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -81.21 169.64 17.09 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 21.6 m -124.97 141.46 52.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.509 0.671 . . . . 0.0 112.564 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.36 138.17 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.243 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.04 120.45 33.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.076 0.465 . . . . 0.0 110.544 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.46 137.48 42.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.343 0.592 . . . . 0.0 111.594 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -130.97 153.84 48.78 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.729 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.617 ' OE1' ' HB2' ' A' ' 26' ' ' ASP . 2.0 mp0 -101.62 113.08 25.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.08 0.467 . . . . 0.0 111.582 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -104.47 -176.72 3.16 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.976 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 62.11 9.3 3.05 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.361 0.665 . . . . 0.0 111.045 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.3 m 53.86 69.05 0.76 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.647 0.737 . . . . 0.0 110.667 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.48 3.95 56.58 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.656 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.74 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.281 0.562 . . . . 0.0 111.556 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.95 15.33 17.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.722 0.772 . . . . 0.0 109.411 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.68 16.12 23.08 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.169 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -103.15 50.06 0.82 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.209 0.528 . . . . 0.0 111.199 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm 69.22 69.57 0.41 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.198 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.5 107.63 2.52 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.651 2.234 . . . . 0.0 111.96 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -102.57 41.37 1.24 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.944 0.878 . . . . 0.0 109.433 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.27 118.7 19.26 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.306 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.44 145.35 4.47 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.48 114.82 27.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.306 0.574 . . . . 0.0 111.069 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -112.56 140.24 47.48 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.535 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.3 p -68.22 130.82 44.05 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.12 65.49 0.51 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.826 0.822 . . . . 0.0 109.916 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -168.05 116.21 0.74 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.501 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -151.31 78.8 1.29 Allowed 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.474 0.654 . . . . 0.0 109.773 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.4 81.35 2.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 12.8 p-80 -120.33 151.6 39.01 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 73' ' ' PRO . 35.0 pt -131.34 161.46 41.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.509 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -102.05 125.15 48.66 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.428 HD21 HG13 ' A' ' 18' ' ' ILE . 2.6 mm? -118.72 125.3 49.36 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 33.1 ttpt -103.14 140.32 37.5 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.955 0.407 . . . . 0.0 110.535 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -111.19 124.14 67.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 29' ' ' VAL . . . -121.14 123.72 42.99 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.582 0.706 . . . . 0.0 110.778 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.46 139.55 14.46 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 120.111 -1.042 . . . . 0.0 111.075 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -64.06 -9.07 14.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.195 0.497 . . . . 0.0 112.33 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -83.6 -8.16 59.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.681 0.753 . . . . 0.0 109.554 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.47 -9.52 45.27 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.602 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.2 m -78.27 110.72 13.53 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 122.366 -0.491 . . . . 0.0 109.95 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 23' ' ' ALA . 61.8 t -137.27 134.72 47.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 122.087 -0.383 . . . . 0.0 110.362 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.416 HG11 ' HD3' ' A' ' 50' ' ' ARG . 21.1 t -148.64 152.7 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -108.94 142.33 39.74 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.166 -0.334 . . . . 0.0 110.603 -178.05 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -136.95 155.88 49.16 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.048 0.452 . . . . 0.0 111.229 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 44.5 mtmt -127.62 120.12 27.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.415 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 pt -136.93 170.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 110.393 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 6.2 tmtt? -73.34 147.35 44.49 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 33.7 ttm180 -64.37 -14.64 57.56 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.203 0.525 . . . . 0.0 111.665 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -110.09 1.34 18.81 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.496 0.665 . . . . 0.0 109.738 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 m -84.79 135.02 40.69 Favored Pre-proline 0 N--CA 1.444 -0.739 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.007 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.44 143.78 97.71 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.524 2.15 . . . . 0.0 112.301 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.402 HD12 ' OD2' ' A' ' 71' ' ' ASP . 43.3 mt -65.14 -16.18 63.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.609 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 55.6 p -49.46 -38.19 28.84 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.034 0.534 . . . . 0.0 111.633 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.9 mmpt? -56.25 -53.72 53.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.754 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 44' ' ' MET . 4.0 pp -75.59 -32.19 60.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.876 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.614 ' N ' HD12 ' A' ' 43' ' ' LEU . 58.7 mtt -59.23 -55.43 34.99 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.315 0.579 . . . . 0.0 111.208 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 41.9 mtpt -70.91 -34.41 71.51 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.197 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.65 -44.11 97.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.144 0.497 . . . . 0.0 110.136 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -58.95 -51.12 71.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.48 ' SG ' ' HG2' ' A' ' 55' ' ' MET . 17.8 p -63.15 -36.61 84.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.056 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 36.8 mt-10 -68.31 -39.06 82.13 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HG3' HE21 ' A' ' 51' ' ' GLN . 11.5 ptm180 -83.53 -23.82 31.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.006 0.432 . . . . 0.0 111.376 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.422 HE21 ' HG3' ' A' ' 50' ' ' ARG . 20.3 mm-40 -95.03 -6.44 42.21 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.72 42.74 53.37 Favored Glycine 0 C--N 1.322 -0.222 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.689 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.95 156.38 28.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.228 0.537 . . . . 0.0 110.608 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.496 ' O ' HG12 ' A' ' 58' ' ' ILE . 45.0 m -104.8 125.91 51.34 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.341 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.48 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 97.2 mmm -59.09 -22.6 61.06 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.102 0.477 . . . . 0.0 111.89 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.454 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -83.64 -33.85 25.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.517 0.675 . . . . 0.0 110.467 -179.123 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.61 -10.59 42.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.942 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 54' ' ' SER . 21.0 pt -117.74 171.89 5.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 O-C-N 121.896 -0.503 . . . . 0.0 110.788 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -151.96 138.03 18.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.973 0.416 . . . . 0.0 110.089 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.8 m-85 -93.22 139.37 30.69 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.214 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -141.16 141.18 34.14 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.239 0.542 . . . . 0.0 110.721 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -146.75 132.17 18.62 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 68.44 25.45 6.87 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.749 0.785 . . . . 0.0 110.303 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.02 -24.7 5.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.957 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -91.58 133.68 30.68 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 122.369 -0.489 . . . . 0.0 111.222 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.88 143.09 59.56 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.239 1.959 . . . . 0.0 111.385 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.8 pt -117.28 162.6 15.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.164 0.507 . . . . 0.0 111.006 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.506 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 3.1 p30 -123.47 156.88 34.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.313 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 3.9 pt-20 -57.81 -14.55 6.15 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.114 0.483 . . . . 0.0 111.866 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -98.32 8.81 44.33 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 122.021 -0.424 . . . . 0.0 111.971 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.506 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -95.84 159.52 14.93 Favored 'General case' 0 C--O 1.24 0.598 0 O-C-N 121.894 -0.504 . . . . 0.0 110.372 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.3 p -121.27 144.03 38.81 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.531 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 14.4 Cg_endo -57.47 -24.82 63.24 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.032 2.488 . . . . 0.0 112.65 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.75 -26.79 57.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.21 0.529 . . . . 0.0 111.075 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -71.31 -55.71 7.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.26 0.552 . . . . 0.0 110.546 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.437 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.0 pt? -85.07 2.65 42.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.041 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 61.57 64.2 1.08 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.854 0.835 . . . . 0.0 112.034 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.1 ttt -82.66 128.86 34.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.131 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -84.55 154.39 22.68 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 120.86 0.362 . . . . 0.0 110.187 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -72.82 147.33 45.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.992 0.425 . . . . 0.0 110.068 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 68.91 14.11 8.86 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.694 0.798 . . . . 0.0 111.256 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -82.61 172.37 13.03 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.1 m -126.29 141.79 51.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.568 0.699 . . . . 0.0 112.704 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -103.15 139.58 23.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.107 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -97.53 121.69 39.73 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.211 0.529 . . . . 0.0 110.701 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.46 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 39.0 t -108.47 137.5 39.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.237 0.541 . . . . 0.0 111.82 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -131.36 158.19 41.39 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -101.48 111.49 23.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.167 0.508 . . . . 0.0 110.801 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -97.55 52.22 1.1 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.752 0.787 . . . . 0.0 111.498 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.79 74.38 3.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 m -88.1 100.48 12.98 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.261 0.553 . . . . 0.0 112.344 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.25 70.66 0.95 Allowed Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.448 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.377 0 CA-C-O 118.272 -1.293 . . . . 0.0 111.392 179.643 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 121.905 0.86 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . -145.72 -25.24 0.46 Allowed 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.187 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.49 -21.19 21.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.517 0.675 . . . . 0.0 110.79 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -90.04 -6.25 55.74 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.146 0.974 . . . . 0.0 108.499 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 46.1 tttm -78.59 -46.92 1.92 Allowed Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.699 -175.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 5' ' ' LYS . 7.1 Cg_exo -74.69 -177.93 3.72 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.136 1.891 . . . . 0.0 111.93 177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -111.37 16.41 20.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.302 0.572 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -74.89 165.73 24.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.14 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.72 -65.13 0.15 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.374 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.54 136.69 23.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.16 0.505 . . . . 0.0 110.495 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.22 173.68 11.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.845 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -150.77 11.84 0.67 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.489 0.662 . . . . 0.0 111.471 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -41.12 94.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.36 0.6 . . . . 0.0 110.5 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -143.39 100.61 3.65 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -83.78 93.51 7.97 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.249 0.547 . . . . 0.0 111.784 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.673 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 6.9 m-20 -99.78 84.41 2.91 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 13.7 p-80 -116.42 142.78 46.4 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 121.659 -0.651 . . . . 0.0 109.956 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.9 pt -128.86 159.77 40.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.294 0.569 . . . . 0.0 111.244 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.432 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -101.57 119.62 39.06 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.004 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.7 140.99 47.79 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.987 0.422 . . . . 0.0 109.862 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -115.32 139.66 49.79 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.319 0.581 . . . . 0.0 111.085 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 29' ' ' VAL . 46.4 t -112.04 124.81 69.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.676 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.39 122.95 35.02 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.479 0.656 . . . . 0.0 110.437 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.33 147.69 16.33 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.934 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -7.89 2.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -78.12 -14.61 59.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.747 0.784 . . . . 0.0 110.243 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.92 -11.78 56.04 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.2 m -78.61 118.76 21.02 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 120.945 0.402 . . . . 0.0 110.09 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.7 p -141.94 137.9 30.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.215 0.531 . . . . 0.0 111.116 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -142.93 150.96 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.44 HE21 ' HB3' ' A' ' 31' ' ' GLN . 1.1 tm0? -110.29 141.23 43.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.888 0.375 . . . . 0.0 110.374 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -135.87 147.26 48.13 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.034 0.445 . . . . 0.0 110.996 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -115.2 109.59 18.21 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.061 0.458 . . . . 0.0 110.649 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.7 pt -124.38 178.42 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.673 ' HG2' ' O ' ' A' ' 16' ' ' ASP . 22.4 tttt -89.91 159.2 17.06 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.465 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -62.25 -24.16 67.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.47 0.708 . . . . 0.0 111.884 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -105.74 -1.92 23.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.574 0.702 . . . . 0.0 109.857 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 m -83.96 132.18 49.15 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.64 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.88 149.86 86.18 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.593 2.195 . . . . 0.0 112.424 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.65 -15.6 62.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.036 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 22.3 p -49.37 -39.83 33.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.078 0.551 . . . . 0.0 111.995 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -55.5 -53.25 58.69 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.792 0.33 . . . . 0.0 111.19 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.29 -31.87 62.67 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.713 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.577 ' N ' HD12 ' A' ' 43' ' ' LEU . 57.1 mtt -59.96 -56.43 21.77 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.003 0.43 . . . . 0.0 111.596 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -67.16 -39.86 86.56 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.815 0.341 . . . . 0.0 110.499 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.45 -46.47 86.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.121 0.486 . . . . 0.0 110.582 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -57.81 -52.05 67.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.177 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.8 p -61.57 -36.79 81.65 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.059 0.457 . . . . 0.0 111.072 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -64.77 -47.98 76.19 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.959 0.409 . . . . 0.0 111.853 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 18.5 ptp180 -78.17 -24.97 47.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.83 0.348 . . . . 0.0 111.567 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -96.88 -7.63 32.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.43 45.76 22.63 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.986 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.1 mm? -120.05 159.96 23.75 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.413 -0.463 . . . . 0.0 110.547 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.8 m -106.09 126.26 51.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.645 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.457 ' CE ' ' HB3' ' A' ' 44' ' ' MET . 93.0 mmm -57.39 -28.17 62.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.71 -28.67 26.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.294 0.568 . . . . 0.0 110.839 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 5.1 mp0 -83.19 -34.12 26.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.383 0.611 . . . . 0.0 110.549 -177.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.512 HG22 ' HG3' ' A' ' 88' ' ' GLN . 20.5 pt -92.94 165.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.354 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 20.1 tpt180 -143.36 128.69 18.87 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.909 0.385 . . . . 0.0 110.167 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -87.05 139.67 30.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.026 0.441 . . . . 0.0 110.054 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -142.14 143.12 32.85 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.115 0.483 . . . . 0.0 111.057 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -149.38 132.41 16.23 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.18 25.33 7.33 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.884 0.85 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.51 -25.57 5.01 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.156 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -91.36 138.43 25.57 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.429 -0.454 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.16 143.69 49.66 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.047 1.832 . . . . 0.0 110.981 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.552 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 12.7 pt -114.11 170.69 4.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.794 0.331 . . . . 0.0 111.116 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.427 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.5 OUTLIER -130.71 164.68 24.53 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.555 0.693 . . . . 0.0 110.921 -175.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 12.0 pt-20 -69.45 -7.67 39.94 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.39 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 68' ' ' ASN . 10.0 t -102.03 6.19 40.98 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.599 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.552 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -99.21 155.04 17.69 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.918 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.5 p -120.63 152.01 55.03 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.49 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.34 -15.66 46.4 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.629 2.22 . . . . 0.0 112.165 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.56 -16.17 37.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.176 0.513 . . . . 0.0 110.829 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -80.2 -55.03 5.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.368 0.604 . . . . 0.0 111.215 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.5 pt? -93.16 12.58 23.86 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.848 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 53.33 63.43 2.22 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 84' ' ' ILE . 25.4 ttm -87.63 133.06 33.88 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 5.8 mm-40 -104.67 174.18 5.99 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.855 0.359 . . . . 0.0 110.636 -176.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -66.21 141.56 58.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.972 0.415 . . . . 0.0 110.693 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 69.88 15.94 7.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.625 0.77 . . . . 0.0 111.747 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -80.11 160.7 25.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -126.24 143.78 51.02 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.487 0.66 . . . . 0.0 112.645 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.519 HD11 ' SD ' ' A' ' 78' ' ' MET . 4.1 mp -108.16 138.9 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -95.05 123.97 38.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.122 0.487 . . . . 0.0 110.486 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.423 HG12 HE22 ' A' ' 88' ' ' GLN . 44.1 t -110.13 139.85 31.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.307 0.575 . . . . 0.0 111.448 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.436 ' HB3' ' OE1' ' A' ' 89' ' ' GLN . 73.6 m-85 -130.78 154.5 47.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.694 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 89' ' ' GLN . 1.8 mp0 -113.35 110.96 21.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 0.3 OUTLIER 165.75 96.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.349 0.595 . . . . 0.0 112.266 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -85.92 14.12 6.52 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.5 -1.375 . . . . 0.0 110.699 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -53.3 124.66 15.25 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 111.13 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.29 -93.55 0.48 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.695 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.97 0 CA-C-O 118.927 -0.929 . . . . 0.0 111.61 179.78 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 121.251 0.548 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.41 11.41 5.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.281 1.039 . . . . 0.0 108.343 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.57 39.88 0.94 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.875 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -150.48 -12.61 0.25 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.961 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 74.4 mmtt -95.56 -52.98 0.23 Allowed Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 122.038 -0.414 . . . . 0.0 111.119 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.536 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 95.9 Cg_endo -84.36 -1.11 9.66 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 121.875 1.717 . . . . 0.0 111.116 176.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 7' ' ' LYS . 50.8 mmtt 51.66 32.61 9.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.61 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.85 115.08 2.38 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.92 -46.95 0.88 Allowed Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.6 p -126.11 102.2 9.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.857 0.837 . . . . 0.0 111.322 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -152.42 139.11 18.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.261 0.553 . . . . 0.0 111.011 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 t -136.08 -6.58 2.09 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.258 0.552 . . . . 0.0 111.053 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -51.61 134.2 29.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.735 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -97.9 27.76 4.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.898 0.856 . . . . 0.0 109.047 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -71.26 177.45 3.87 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.538 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -79.87 80.44 6.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.071 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 28.2 p-80 -123.14 145.66 48.41 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 120.842 0.353 . . . . 0.0 110.202 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.2 pt -125.11 165.61 22.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 121.318 0.58 . . . . 0.0 110.881 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -100.09 135.5 41.42 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.178 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.82 126.38 30.41 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -107.19 140.08 40.61 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.245 0.545 . . . . 0.0 111.49 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 29' ' ' VAL . 45.0 t -113.82 124.36 70.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.006 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.9 124.17 34.51 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.605 0.717 . . . . 0.0 110.846 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.35 151.87 19.45 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.259 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.5 pp0? -60.53 -20.22 59.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.187 0.517 . . . . 0.0 111.681 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.7 -7.44 55.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.634 0.731 . . . . 0.0 110.454 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.35 -16.07 55.57 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.686 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 m -68.76 116.73 9.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.851 0.357 . . . . 0.0 110.241 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.9 p -143.83 139.6 25.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.032 0.444 . . . . 0.0 111.423 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.2 t -145.83 151.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.463 HE21 ' HB3' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -107.22 139.91 40.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.935 0.397 . . . . 0.0 110.1 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -133.42 166.97 21.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.385 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -140.29 114.12 8.87 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.903 0.382 . . . . 0.0 110.516 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 pt -127.91 174.8 10.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.116 0.484 . . . . 0.0 110.757 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.7 tmtt? -87.46 149.76 24.21 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.183 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.425 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 22.7 tpp180 -54.02 -28.64 39.47 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.49 0.716 . . . . 0.0 112.376 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -105.08 -0.26 26.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.48 0.657 . . . . 0.0 110.613 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 m -85.83 133.6 41.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.181 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.99 151.87 84.33 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.502 2.135 . . . . 0.0 112.316 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.92 -15.23 61.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.943 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 25.8 p -49.28 -38.24 26.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 122.967 0.507 . . . . 0.0 111.976 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -56.35 -54.09 49.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.502 0.191 . . . . 0.0 110.845 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.96 -33.6 57.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.887 0.375 . . . . 0.0 111.629 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.644 ' N ' HD12 ' A' ' 43' ' ' LEU . 45.3 ttm -62.07 -53.27 57.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.02 0.438 . . . . 0.0 111.002 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.646 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 8.7 mmmm -70.3 -36.7 74.49 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.207 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.664 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -61.3 -45.66 93.55 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.001 -0.437 . . . . 0.0 111.05 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -56.33 -51.45 68.18 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.431 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.1 p -63.53 -35.31 80.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.107 0.48 . . . . 0.0 110.843 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 6.2 mm-40 -65.75 -43.78 87.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.009 0.433 . . . . 0.0 111.586 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 13.1 ptp180 -83.22 -20.98 33.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -96.95 -9.66 27.88 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.831 -0.543 . . . . 0.0 111.818 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.67 40.71 26.1 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.031 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.412 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.1 mm? -117.41 157.9 25.4 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.038 0.446 . . . . 0.0 110.016 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.424 ' O ' HG12 ' A' ' 58' ' ' ILE . 8.2 m -109.65 134.76 51.59 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.702 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.519 ' HE1' ' HG2' ' A' ' 44' ' ' MET . 97.1 mmm -58.76 -25.99 63.56 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.42 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -85.15 -24.94 27.75 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.325 0.583 . . . . 0.0 111.109 178.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.64 -19.34 26.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.296 0.57 . . . . 0.0 110.7 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 54' ' ' SER . 14.4 pt -120.94 174.32 5.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.095 0.474 . . . . 0.0 111.173 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 59' ' ' ARG . 9.0 tpt180 -154.29 138.98 16.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.113 0.482 . . . . 0.0 109.927 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -91.87 137.3 32.48 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.227 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HG3' ' C ' ' A' ' 65' ' ' GLN . 16.3 ttm180 -136.62 134.59 37.51 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.321 0.581 . . . . 0.0 110.881 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -145.29 144.26 30.66 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 68.33 24.35 7.38 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.855 0.836 . . . . 0.0 109.447 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.34 -5.62 59.53 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.366 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.481 ' C ' ' HG3' ' A' ' 61' ' ' ARG . 5.0 pt20 -118.69 143.96 34.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 O-C-N 122.196 -0.591 . . . . 0.0 111.26 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.64 133.96 36.23 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.067 1.845 . . . . 0.0 111.145 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.6 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 12.0 pt -106.87 -177.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.92 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.86 164.53 27.36 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 121.394 0.616 . . . . 0.0 109.793 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 41' ' ' SER . 15.9 pt-20 -74.39 -9.47 58.62 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.714 0.769 . . . . 0.0 109.403 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 t -103.4 10.31 37.4 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.853 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.6 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -98.39 159.0 15.24 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.706 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.4 p -117.08 148.51 42.46 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.568 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.84 -12.17 34.06 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.798 2.332 . . . . 0.0 112.081 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.5 -28.35 23.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.125 0.488 . . . . 0.0 110.654 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -69.63 -55.32 10.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 111.685 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -88.38 9.9 21.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.002 0.429 . . . . 0.0 111.636 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 53.74 63.88 2.04 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.935 0.874 . . . . 0.0 112.735 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -78.48 129.01 34.38 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.222 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -91.19 158.11 16.8 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 4.7 p-10 -70.05 147.8 49.6 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.986 -0.446 . . . . 0.0 110.478 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.4 ' HG2' HD22 ' A' ' 19' ' ' ASN . 5.7 mm-40 66.72 15.25 10.08 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.342 0.657 . . . . 0.0 111.733 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -79.57 167.04 21.27 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -121.83 137.48 54.76 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.659 0.742 . . . . 0.0 112.923 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.13 134.35 41.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.986 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.87 122.14 36.05 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.123 0.487 . . . . 0.0 110.471 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 40.3 t -107.68 138.38 34.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.234 0.54 . . . . 0.0 111.64 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.611 ' HB2' HE22 ' A' ' 89' ' ' GLN . 62.0 m-85 -131.55 155.67 47.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.734 -178.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.419 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.6 mp0 -106.55 112.8 25.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.08 0.467 . . . . 0.0 111.192 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.611 HE22 ' HB2' ' A' ' 87' ' ' PHE . 25.8 mp0 -103.09 47.87 0.87 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.746 0.784 . . . . 0.0 109.856 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -112.78 131.68 55.58 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.792 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.2 m -73.41 -59.28 2.79 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.983 0.42 . . . . 0.0 111.051 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.1 170.62 29.28 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.607 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.09 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.503 179.378 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.864 0.364 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.26 -37.03 58.14 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.337 0.589 . . . . 0.0 110.571 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -84.76 22.27 1.38 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.475 0.655 . . . . 0.0 110.464 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -90.68 -12.8 35.67 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.224 0.535 . . . . 0.0 110.222 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.583 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 68.3 mmtt -77.86 -56.7 1.06 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.715 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 63.0 Cg_endo -85.19 107.05 1.02 Allowed 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 121.544 1.496 . . . . 0.0 111.083 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -91.8 38.05 0.98 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.292 0.568 . . . . 0.0 110.683 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -103.26 16.51 26.38 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.83 55.07 4.28 Favored Glycine 0 C--N 1.314 -0.671 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.838 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.39 145.17 36.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 120.966 0.413 . . . . 0.0 110.492 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -138.86 106.71 5.66 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.346 0.593 . . . . 0.0 109.765 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 p -130.25 160.71 33.04 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.309 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 54.51 50.04 16.94 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.719 0.771 . . . . 0.0 111.453 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -165.92 117.95 1.08 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.984 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -134.05 59.29 1.74 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.521 0.677 . . . . 0.0 110.334 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -82.79 81.95 8.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 6.1 p-80 -118.79 142.2 47.93 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 80' ' ' ASP . 45.2 pt -131.08 160.44 42.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.269 0.556 . . . . 0.0 110.233 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.561 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.4 OUTLIER -98.65 120.95 39.95 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.055 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.06 125.16 54.08 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -104.17 140.55 37.65 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.222 0.534 . . . . 0.0 110.596 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.75 124.21 68.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' A' ' 29' ' ' VAL . . . -122.31 122.44 39.08 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.549 0.69 . . . . 0.0 110.993 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.72 139.51 14.46 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.228 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -60.06 -17.07 36.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.382 0.611 . . . . 0.0 111.398 178.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.29 -6.61 58.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.751 0.786 . . . . 0.0 110.127 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.95 -11.16 48.89 Favored Glycine 0 CA--C 1.507 -0.462 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.048 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.8 m -78.6 108.08 11.73 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.153 0.502 . . . . 0.0 109.836 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 23' ' ' ALA . 59.6 t -135.33 131.29 51.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 120.959 0.409 . . . . 0.0 110.112 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -141.92 150.7 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.561 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -109.5 139.38 44.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.0 110.121 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 30.4 m-85 -130.11 159.46 36.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.321 0.582 . . . . 0.0 111.263 -176.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 42.3 mtmt -131.43 113.25 13.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.302 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.6 pt -135.04 176.3 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.69 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.4 tmtt? -82.6 149.03 27.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.488 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 22.1 ttm-85 -61.87 -19.42 62.62 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -105.61 1.31 27.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.695 0.76 . . . . 0.0 109.526 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.5 m -84.99 131.9 47.38 Favored Pre-proline 0 N--CA 1.442 -0.863 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.231 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.2 145.33 88.76 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 122.633 2.222 . . . . 0.0 112.177 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.47 HD12 ' OD1' ' A' ' 71' ' ' ASP . 34.3 mt -64.93 -16.29 63.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.933 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.526 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 12.3 t -50.06 -37.19 32.29 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 122.457 0.303 . . . . 0.0 111.102 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.439 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -56.04 -53.46 56.73 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-O 120.848 0.356 . . . . 0.0 111.026 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.81 -31.87 61.83 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.529 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.584 ' N ' HD12 ' A' ' 43' ' ' LEU . 56.9 mtt -60.4 -54.56 44.1 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.927 0.394 . . . . 0.0 111.537 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 41' ' ' SER . 31.2 mmtp -66.71 -39.96 88.23 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.84 -47.98 83.88 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 28.0 t80 -55.22 -51.72 65.67 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.857 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.631 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.3 m -63.94 -38.53 91.44 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.568 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 40.2 mt-10 -64.09 -42.32 96.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.743 0.306 . . . . 0.0 111.356 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.2 ptp180 -80.39 -24.29 39.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.908 0.385 . . . . 0.0 111.573 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -96.0 -8.74 32.84 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.63 2.98 90.69 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.897 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 7.3 mp -80.53 158.17 25.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.615 0.722 . . . . 0.0 112.005 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.0 m -107.81 132.27 53.59 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.034 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.431 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 95.7 mmm -57.36 -31.06 65.37 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -84.35 -31.21 24.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.341 0.591 . . . . 0.0 111.126 -178.023 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 0.7 OUTLIER -84.42 -16.69 41.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.39 0.614 . . . . 0.0 110.816 -177.405 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.631 HD11 ' SG ' ' A' ' 48' ' ' CYS . 10.3 pt -117.81 179.17 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.369 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -156.07 132.77 10.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 120.983 0.42 . . . . 0.0 110.088 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.401 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.4 m-85 -83.54 139.32 32.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.669 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -144.11 144.24 31.5 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.218 0.532 . . . . 0.0 110.987 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -149.18 134.88 18.72 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 t70 68.44 25.04 6.98 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.535 0.683 . . . . 0.0 110.359 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.33 -24.05 6.68 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.137 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -93.69 137.55 23.19 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 122.301 -0.529 . . . . 0.0 110.803 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.3 145.54 60.15 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.038 1.825 . . . . 0.0 111.249 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 pt -113.55 160.65 12.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.982 0.42 . . . . 0.0 110.22 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.6 p30 -121.18 153.88 36.97 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.757 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 41' ' ' SER . 10.0 pt-20 -59.72 -12.6 7.41 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.143 0.497 . . . . 0.0 111.944 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.2 t -95.82 8.12 44.44 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 120.717 0.294 . . . . 0.0 111.135 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.489 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -95.0 156.33 16.36 Favored 'General case' 0 C--O 1.244 0.78 0 O-C-N 121.89 -0.506 . . . . 0.0 110.017 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.4 p -118.12 146.64 39.72 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.613 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 18.4 Cg_endo -60.36 -22.92 73.02 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.762 2.308 . . . . 0.0 112.338 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.488 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -78.1 -22.79 48.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.166 0.508 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -71.59 -55.27 8.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.397 0.618 . . . . 0.0 110.442 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.3 pt? -85.91 9.02 18.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.542 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 55.79 60.08 3.47 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.776 0.798 . . . . 0.0 112.246 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.4 mtt -84.38 141.24 31.01 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.645 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -108.76 177.35 4.8 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.121 0.486 . . . . 0.0 111.15 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 18' ' ' ILE . 5.2 m-20 -64.54 138.27 58.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.745 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 68.82 19.42 8.37 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.678 0.791 . . . . 0.0 112.497 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -73.47 159.0 33.86 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.6 m -124.41 144.56 49.98 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.72 142.22 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.215 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 11.3 m-20 -94.83 122.5 37.53 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 110.505 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.563 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 28.7 t -109.83 136.69 45.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 O-C-N 121.886 -0.509 . . . . 0.0 111.594 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 85' ' ' ASP . 60.1 m-85 -132.73 157.61 44.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -99.12 110.72 23.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.469 0.652 . . . . 0.0 111.133 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -100.07 47.53 0.94 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.334 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -116.18 122.35 44.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.178 0.513 . . . . 0.0 111.412 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.9 m -109.26 90.02 3.17 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.452 0.644 . . . . 0.0 109.709 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -117.13 117.68 3.89 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.288 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.411 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.125 179.164 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.52 55.54 2.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.11 0.481 . . . . 0.0 111.868 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.05 -15.21 61.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.199 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -60.48 -52.13 66.49 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.297 0.57 . . . . 0.0 109.541 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -133.98 89.68 28.66 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-O 121.779 0.8 . . . . 0.0 110.198 177.097 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.23 -158.42 0.08 OUTLIER 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.027 2.485 . . . . 0.0 112.38 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -86.92 34.89 0.67 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.241 0.543 . . . . 0.0 110.029 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 66.58 16.43 10.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.114 0.966 . . . . 0.0 112.3 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.21 59.63 0.62 Allowed Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.746 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.08 129.22 33.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.246 0.546 . . . . 0.0 109.687 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -155.54 140.91 17.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.385 0.612 . . . . 0.0 111.641 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -139.86 143.86 36.96 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.36 -49.19 77.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.007 0.432 . . . . 0.0 111.336 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -126.64 114.99 18.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -117.27 143.09 46.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.24 0.543 . . . . 0.0 110.807 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.59 ' OD1' ' HB3' ' A' ' 36' ' ' ARG . 0.5 OUTLIER -137.67 105.48 5.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.836 0.827 . . . . 0.0 110.494 178.062 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 20.0 p-80 -120.63 146.76 46.05 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.2 pt -132.95 166.79 28.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.108 0.48 . . . . 0.0 110.731 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.658 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -103.78 125.94 50.58 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.17 124.07 47.06 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' THR . 31.8 ttpt -103.95 140.65 37.41 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.102 0.477 . . . . 0.0 110.593 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 29' ' ' VAL . 47.6 t -113.67 125.43 70.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.897 0.379 . . . . 0.0 110.084 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.6 121.75 27.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.533 0.682 . . . . 0.0 110.49 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.56 148.85 16.81 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 120.249 -0.976 . . . . 0.0 112.207 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -6.09 2.85 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.365 0.602 . . . . 0.0 112.294 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.92 -14.14 59.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.728 0.775 . . . . 0.0 109.845 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.6 -15.05 53.51 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.635 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.7 m -77.08 122.76 25.41 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.926 0.393 . . . . 0.0 110.63 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 22' ' ' VAL . 4.2 p -142.28 137.83 29.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.138 0.494 . . . . 0.0 111.253 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 t -143.09 151.08 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.658 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -106.34 142.0 36.73 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.343 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -135.29 146.61 48.68 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.237 0.542 . . . . 0.0 110.461 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -121.65 114.17 20.78 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.03 0.443 . . . . 0.0 110.455 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.8 pt -134.46 177.76 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.24 0.543 . . . . 0.0 111.264 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.523 ' HE2' ' H ' ' A' ' 16' ' ' ASP . 11.3 tmtt? -86.45 152.16 22.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.59 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 13.6 tpp180 -60.53 -19.16 56.33 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.943 0.497 . . . . 0.0 111.734 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -107.73 -3.3 19.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.55 0.691 . . . . 0.0 109.653 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -83.67 132.44 49.14 Favored Pre-proline 0 N--CA 1.441 -0.906 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.217 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.15 149.81 88.46 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.557 2.171 . . . . 0.0 112.853 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.453 HD12 ' OD2' ' A' ' 71' ' ' ASP . 28.0 mt -65.59 -13.95 60.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.065 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 p -55.13 -34.48 63.77 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.327 0.584 . . . . 0.0 110.663 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -55.93 -55.98 26.14 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.603 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -77.38 -32.73 55.11 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.632 ' N ' HD12 ' A' ' 43' ' ' LEU . 38.7 ttm -62.41 -54.01 46.53 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.067 0.46 . . . . 0.0 110.959 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 33.6 mtpt -72.37 -32.99 66.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.491 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -64.18 -43.74 94.16 Favored 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 121.92 -0.488 . . . . 0.0 110.434 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -57.39 -50.53 72.69 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.105 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 14.8 p -61.48 -36.96 81.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 0.0 110.909 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.1 mt-10 -69.02 -40.05 78.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.4 ptp180 -83.85 -24.75 30.77 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.936 -0.477 . . . . 0.0 112.167 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -95.41 -11.83 26.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.182 0.515 . . . . 0.0 111.461 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.43 41.49 13.29 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.491 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.484 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.4 mm? -117.23 158.24 24.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.041 0.448 . . . . 0.0 110.301 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 58' ' ' ILE . 15.2 m -106.38 131.99 52.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.283 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 85.4 mmm -55.07 -29.14 56.91 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.928 0.491 . . . . 0.0 111.817 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.528 ' HD3' ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -83.86 -28.79 27.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.4 0.619 . . . . 0.0 111.179 -177.671 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.468 ' HG2' ' HG3' ' A' ' 90' ' ' GLN . 0.9 OUTLIER -92.7 -7.53 46.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.117 -178.365 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.484 HG21 ' HB3' ' A' ' 53' ' ' LEU . 17.5 pt -125.1 170.18 15.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 120.943 0.402 . . . . 0.0 110.965 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -149.99 135.86 18.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.12 0.486 . . . . 0.0 110.164 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -89.82 137.26 32.49 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.028 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -137.28 143.02 41.94 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.258 0.551 . . . . 0.0 110.622 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -150.83 138.59 19.81 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 t70 69.79 25.35 5.08 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.605 0.716 . . . . 0.0 110.282 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.01 -1.56 79.12 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.538 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -122.73 142.92 38.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 O-C-N 122.122 -0.634 . . . . 0.0 111.409 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.04 141.89 59.59 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.503 2.135 . . . . 0.0 111.866 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 pt -117.08 172.83 4.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.102 0.477 . . . . 0.0 111.01 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 4.0 p30 -131.96 156.33 46.38 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.818 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.58 -13.14 12.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.778 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.0 t -96.61 10.21 39.2 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 122.157 -0.339 . . . . 0.0 111.374 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.81 157.4 16.53 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.96 177.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.3 p -120.76 151.01 53.9 Favored Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.199 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.42 -18.23 52.22 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.968 2.445 . . . . 0.0 112.699 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.02 -27.15 30.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.331 0.586 . . . . 0.0 110.896 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -71.61 -55.9 6.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.478 0.656 . . . . 0.0 110.623 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.489 HD11 ' HE3' ' A' ' 78' ' ' MET . 1.6 pt? -88.49 20.77 3.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.571 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 43.08 62.52 1.79 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.087 0.946 . . . . 0.0 112.662 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.489 ' HE3' HD11 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -78.87 122.5 26.18 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.697 -178.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.58 156.7 30.7 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.051 0.453 . . . . 0.0 110.848 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -68.89 142.86 54.66 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.886 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 66.71 18.21 10.68 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.269 0.627 . . . . 0.0 111.437 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -81.51 171.25 14.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.976 0.417 . . . . 0.0 110.64 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 21.9 m -126.05 145.0 50.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.577 0.703 . . . . 0.0 112.352 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.03 138.74 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.283 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -94.91 121.79 36.88 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.964 0.411 . . . . 0.0 110.225 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.3 t -108.9 137.41 41.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.267 0.555 . . . . 0.0 111.757 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -130.49 151.52 50.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.406 HE21 HG22 ' A' ' 58' ' ' ILE . 1.8 mp0 -101.09 112.18 24.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.074 0.464 . . . . 0.0 111.931 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -119.26 75.52 1.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.992 0.425 . . . . 0.0 110.763 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.568 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 1.7 mp0 -69.31 147.71 50.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.9 0.381 . . . . 0.0 110.423 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -67.95 104.55 1.76 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.35 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.12 125.52 7.21 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.876 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.187 0 CA-C-O 118.938 -0.924 . . . . 0.0 111.461 -178.793 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.3 mtt . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 121.203 0.525 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.55 11.7 15.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.799 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -110.01 15.03 22.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.24 0.543 . . . . 0.0 110.726 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -75.15 63.5 1.31 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.938 -0.476 . . . . 0.0 111.696 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 5' ' ' LYS . 3.5 mptp? 55.96 58.23 9.65 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.786 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.68 121.32 4.12 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.374 2.049 . . . . 0.0 112.389 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -83.6 -12.63 55.81 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.341 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 48.97 43.62 21.99 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.733 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.38 59.77 4.01 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.043 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.91 111.71 24.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.256 0.55 . . . . 0.0 110.513 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 46.76 2.6 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.579 0.704 . . . . 0.0 109.479 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -126.24 126.61 44.31 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.936 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -118.44 -178.04 3.43 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.197 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 64.92 19.9 11.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.952 0.501 . . . . 0.0 111.43 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -92.27 126.94 37.56 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.748 0.785 . . . . 0.0 111.575 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -89.69 91.2 8.55 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.181 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -124.81 150.75 46.03 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.707 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 pt -135.37 168.05 24.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 120.896 0.379 . . . . 0.0 110.373 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.539 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -106.0 116.52 32.08 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.923 0.392 . . . . 0.0 110.311 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.66 131.68 54.14 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 83' ' ' THR . 32.5 ttpt -111.42 141.32 45.12 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.293 0.568 . . . . 0.0 111.198 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 29' ' ' VAL . 41.0 t -112.77 125.71 70.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.174 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.28 118.1 20.8 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.546 0.688 . . . . 0.0 110.658 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.33 150.47 18.55 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.009 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -11.21 8.0 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.36 0.6 . . . . 0.0 112.202 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.1 -16.82 62.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.658 0.742 . . . . 0.0 110.32 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.07 -12.99 55.87 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -78.05 122.87 26.14 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.932 0.396 . . . . 0.0 110.436 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 22' ' ' VAL . 3.1 p -144.59 137.41 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.424 0.631 . . . . 0.0 111.195 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.7 t -144.47 151.09 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.582 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.539 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -110.15 141.89 42.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.821 0.343 . . . . 0.0 110.526 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -137.06 138.77 40.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.162 0.505 . . . . 0.0 111.534 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -106.48 114.92 29.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.052 0.453 . . . . 0.0 110.51 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.1 pt -132.68 170.46 19.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.139 0.495 . . . . 0.0 110.563 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.579 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.2 tmtp? -80.41 149.24 30.23 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.579 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 9.2 tpp180 -56.83 -25.2 55.66 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -107.28 3.3 25.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.722 0.773 . . . . 0.0 109.749 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 m -81.5 131.03 59.47 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.452 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 33.7 Cg_endo -63.13 147.75 93.89 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.208 1.939 . . . . 0.0 112.152 -177.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.4 HD12 ' OD2' ' A' ' 71' ' ' ASP . 39.6 mt -64.6 -15.24 60.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 57.1 p -50.97 -38.48 51.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.096 0.558 . . . . 0.0 111.466 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 39' ' ' PRO . 12.3 mmmm -55.85 -54.45 44.45 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 44' ' ' MET . 4.3 pp -75.86 -32.27 59.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.999 0.428 . . . . 0.0 111.322 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.6 ' N ' HD12 ' A' ' 43' ' ' LEU . 37.0 ttm -61.47 -50.25 73.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.615 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 69.4 mmtt -70.38 -41.64 72.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.84 0.352 . . . . 0.0 110.094 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.16 -45.46 92.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.265 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -56.49 -50.2 72.45 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.063 0.459 . . . . 0.0 110.466 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.596 ' SG ' HD11 ' A' ' 58' ' ' ILE . 58.2 m -63.1 -38.28 90.57 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.97 0.414 . . . . 0.0 111.498 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 48.6 mt-10 -64.34 -40.22 95.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.117 0.484 . . . . 0.0 111.571 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.3 ptp180 -86.2 -23.14 26.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -98.66 -10.73 22.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.979 0.418 . . . . 0.0 112.081 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.49 43.9 14.35 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.957 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.4 mm? -119.69 157.9 27.56 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 122.307 -0.525 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.2 m -107.53 128.31 54.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.166 0.507 . . . . 0.0 111.235 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.445 ' SD ' ' HD3' ' A' ' 45' ' ' LYS . 58.0 mmm -56.62 -30.57 63.41 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.548 0.739 . . . . 0.0 112.766 -177.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.556 ' HD3' ' N ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -83.35 -28.98 28.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.47 0.652 . . . . 0.0 111.081 -176.354 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -40.18 16.49 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.88 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.596 HD11 ' SG ' ' A' ' 48' ' ' CYS . 12.8 pt -91.63 174.45 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 O-C-N 121.906 -0.496 . . . . 0.0 110.443 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -150.36 130.85 13.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.266 0.555 . . . . 0.0 110.257 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -83.02 137.04 34.28 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.848 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 43.3 ttm180 -136.53 143.04 43.5 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.155 0.503 . . . . 0.0 110.576 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -148.84 130.3 14.8 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 69.24 25.71 5.59 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.83 0.824 . . . . 0.0 110.199 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.91 -24.55 5.91 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.192 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -92.68 136.23 25.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 122.479 -0.424 . . . . 0.0 110.93 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 35.2 Cg_endo -67.81 142.65 58.4 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.11 1.873 . . . . 0.0 111.387 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 pt -112.71 174.8 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.068 0.461 . . . . 0.0 110.985 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.8 p30 -138.27 159.16 42.78 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.135 0.493 . . . . 0.0 111.995 -176.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 11.6 pt-20 -62.56 -10.21 11.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.775 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -97.99 7.42 46.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.886 0.374 . . . . 0.0 111.396 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.462 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.29 155.94 17.24 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 121.719 -0.613 . . . . 0.0 110.594 179.472 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 p -120.76 146.83 44.48 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.966 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.555 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 20.2 Cg_endo -60.64 -25.31 80.61 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.778 2.319 . . . . 0.0 112.494 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 -31.66 62.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.377 0.608 . . . . 0.0 110.519 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -68.15 -55.71 11.39 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.252 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 1.6 pt? -85.12 6.92 23.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.883 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 58.73 63.15 1.74 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.958 0.885 . . . . 0.0 112.275 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.5 mtt -84.1 134.52 34.6 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.488 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -96.89 175.12 6.46 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.009 0.433 . . . . 0.0 110.146 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -77.92 147.14 35.15 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 68.51 13.63 8.98 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.13 0.572 . . . . 0.0 112.248 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.97 162.9 23.66 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 15.8 m -124.73 142.14 51.62 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.68 0.753 . . . . 0.0 113.001 -173.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.65 135.28 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.082 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -93.74 121.31 35.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.048 0.452 . . . . 0.0 110.366 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.63 138.93 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.225 0.536 . . . . 0.0 112.006 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -130.92 152.74 49.92 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.86 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.45 113.78 27.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.271 0.558 . . . . 0.0 111.91 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -105.95 -170.43 1.73 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.991 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 65.71 19.32 11.39 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.603 0.761 . . . . 0.0 111.503 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 p -84.58 -80.91 0.19 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.342 0.591 . . . . 0.0 111.167 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.27 27.18 21.57 Favored Glycine 0 C--N 1.314 -0.676 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.137 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.269 0 CA-C-O 118.31 -1.272 . . . . 0.0 111.01 -179.308 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 121.085 0.469 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.55 14.97 13.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.016 0.912 . . . . 0.0 109.434 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -81.04 5.77 15.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.626 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -97.24 41.53 1.11 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.863 0.839 . . . . 0.0 109.783 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.511 ' H ' ' CD ' ' A' ' 6' ' ' PRO . 60.6 mttm -138.46 -50.97 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.402 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.974 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.511 ' CD ' ' H ' ' A' ' 5' ' ' LYS . 8.0 Cg_exo -71.16 152.6 62.16 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 121.931 1.754 . . . . 0.0 112.434 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -101.99 1.4 36.58 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.144 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.35 109.22 4.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.248 0.547 . . . . 0.0 111.439 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.63 47.73 0.98 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.44 144.57 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.062 0.458 . . . . 0.0 110.651 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -138.19 148.07 44.45 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.1 p -111.31 116.34 30.83 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -154.54 170.53 21.23 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -123.58 126.28 46.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.285 0.564 . . . . 0.0 111.564 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -147.81 159.8 43.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.461 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -86.81 82.87 7.68 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.752 0.787 . . . . 0.0 110.49 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 28.7 p-80 -122.04 150.4 42.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.223 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.4 pt -124.17 167.63 17.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.0 0.429 . . . . 0.0 110.061 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -106.52 124.1 49.09 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.811 0.338 . . . . 0.0 110.143 -178.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.3 125.09 49.37 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 35.5 ttpt -105.26 140.68 38.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.05 0.452 . . . . 0.0 111.004 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.66 123.89 66.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.77 128.1 43.33 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.502 0.668 . . . . 0.0 110.514 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.39 148.86 16.52 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.692 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -5.4 2.3 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -82.54 -12.18 57.93 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.721 0.772 . . . . 0.0 110.122 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.28 -9.96 57.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.738 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.8 m -78.36 119.7 22.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -145.48 141.22 22.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.365 0.603 . . . . 0.0 111.782 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 40.9 t -146.84 151.23 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.4 0.68 . . . . 0.0 109.174 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -110.41 141.44 43.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.931 0.396 . . . . 0.0 110.336 -179.071 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -136.54 153.58 50.96 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.067 0.46 . . . . 0.0 110.728 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 90.0 mttt -124.58 113.75 18.48 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.827 0.346 . . . . 0.0 110.246 178.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 46.4 pt -127.26 172.53 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.935 0.398 . . . . 0.0 110.658 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.6 tmtp? -80.91 152.04 28.28 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.487 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 9.6 tpp180 -54.67 -23.9 19.4 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -112.63 2.56 16.22 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.415 -0.803 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 m -79.49 131.65 64.42 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.562 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.33 144.82 92.12 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.636 2.224 . . . . 0.0 112.458 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.422 HD12 ' OD2' ' A' ' 71' ' ' ASP . 40.2 mt -65.01 -15.61 62.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.073 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.612 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 32.1 t -48.96 -37.82 21.19 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.643 0.377 . . . . 0.0 111.417 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -55.37 -53.29 58.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.714 0.293 . . . . 0.0 110.985 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 44' ' ' MET . 4.4 pp -75.48 -32.1 60.45 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.367 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.538 ' N ' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -54.44 -56.74 15.63 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.3 0.571 . . . . 0.0 111.337 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 41' ' ' SER . 6.5 mmmt -71.47 -41.24 69.61 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.254 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.18 -49.01 78.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.939 0.399 . . . . 0.0 111.551 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 29.2 t80 -55.17 -51.66 65.79 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 121.029 0.443 . . . . 0.0 110.744 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.698 ' SG ' HD11 ' A' ' 58' ' ' ILE . 33.5 m -63.99 -36.68 84.78 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.869 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 41.6 mt-10 -65.86 -39.55 90.85 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.909 0.385 . . . . 0.0 111.525 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.5 ptp180 -85.96 -21.93 27.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.879 0.371 . . . . 0.0 111.707 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.404 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 20.1 mm-40 -96.11 -6.25 38.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.885 0.374 . . . . 0.0 111.467 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.87 41.89 71.45 Favored Glycine 0 C--N 1.321 -0.289 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.468 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 mp -115.8 153.54 31.26 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.358 0.599 . . . . 0.0 110.94 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.1 m -102.27 127.39 49.27 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.094 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.414 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 93.1 mmm -55.44 -31.98 62.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.039 0.536 . . . . 0.0 112.279 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.479 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -84.98 -28.3 25.89 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.158 0.504 . . . . 0.0 112.022 -178.081 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 8.3 mp0 -91.19 -5.05 55.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.372 0.606 . . . . 0.0 110.488 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.698 HD11 ' SG ' ' A' ' 48' ' ' CYS . 13.7 pt -122.71 170.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.967 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.653 ' HB2' ' NE2' ' A' ' 89' ' ' GLN . 16.0 tpp180 -143.94 138.51 28.54 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 120.875 0.369 . . . . 0.0 110.111 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -96.88 129.21 44.36 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.778 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -136.59 143.02 43.38 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.043 0.449 . . . . 0.0 110.276 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -148.38 133.45 18.24 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t70 68.21 24.56 7.5 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.675 0.75 . . . . 0.0 110.274 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.28 -21.39 6.06 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.144 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -93.11 141.73 24.44 Favored Pre-proline 0 C--N 1.317 -0.83 0 O-C-N 122.35 -0.5 . . . . 0.0 110.494 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.9 137.22 24.07 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.187 1.925 . . . . 0.0 111.649 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.8 pt -114.43 170.94 4.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.241 0.544 . . . . 0.0 110.663 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.543 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 4.8 p30 -131.31 155.64 46.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.025 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 41' ' ' SER . 13.4 pt-20 -59.86 -10.17 3.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.08 0.467 . . . . 0.0 111.93 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -100.62 6.43 44.1 Favored 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 121.766 -0.583 . . . . 0.0 111.595 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.543 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -92.93 165.23 12.98 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 121.615 -0.678 . . . . 0.0 110.384 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.1 p -122.4 148.82 53.61 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.524 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.97 -20.14 58.83 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.141 2.561 . . . . 0.0 112.585 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.53 -31.54 37.02 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.052 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -67.53 -56.29 10.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.273 0.559 . . . . 0.0 110.991 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -81.84 8.73 9.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.018 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 57.69 63.08 1.91 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.587 0.708 . . . . 0.0 111.463 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.7 mtt -79.67 -165.58 0.83 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.989 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.44 169.81 15.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.55 139.51 42.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.205 0.526 . . . . 0.0 111.271 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 70.75 18.88 6.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.525 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -84.68 165.55 17.81 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 19.4 m -127.03 141.64 51.74 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.666 0.746 . . . . 0.0 112.852 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.06 140.28 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.223 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.32 121.76 38.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.11 0.481 . . . . 0.0 110.895 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.9 t -109.44 137.66 40.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.343 0.592 . . . . 0.0 111.555 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -128.71 149.55 50.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.963 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.429 HE21 HG22 ' A' ' 58' ' ' ILE . 2.0 mp0 -98.14 112.17 24.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.366 0.603 . . . . 0.0 110.991 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.653 ' NE2' ' HB2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -164.55 173.98 11.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.952 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -128.07 -68.42 0.77 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.067 0.461 . . . . 0.0 110.66 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 p -98.28 75.92 2.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.134 0.492 . . . . 0.0 110.582 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.03 -50.72 3.73 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.687 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.565 0 CA-C-O 118.264 -1.298 . . . . 0.0 110.733 179.01 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.787 0.327 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.35 -38.94 13.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.257 0.551 . . . . 0.0 111.05 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.77 -6.19 47.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.576 0.703 . . . . 0.0 110.889 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -101.6 1.08 37.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.174 0.512 . . . . 0.0 110.258 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.404 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 10.2 mtpm? -70.13 -49.65 17.86 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.789 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 86.5 Cg_endo -82.81 124.4 3.94 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 121.597 1.532 . . . . 0.0 110.399 175.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 47.0 mmtm -99.26 7.61 45.52 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.919 -0.488 . . . . 0.0 111.149 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 57.6 30.39 18.71 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.338 0.59 . . . . 0.0 111.038 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.59 74.85 1.27 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.21 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.451 ' HB ' ' CB ' ' A' ' 7' ' ' LYS . 7.3 p -70.63 127.87 33.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.489 0.662 . . . . 0.0 111.225 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.596 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 8.7 mmpt? -91.7 93.05 8.71 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.4 p -83.8 178.34 7.96 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.822 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.15 4.51 13.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.698 0.761 . . . . 0.0 109.776 178.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -151.31 166.93 29.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.573 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -138.19 96.61 3.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.578 0.704 . . . . 0.0 110.192 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -82.85 91.39 7.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.271 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -127.17 157.54 39.49 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.355 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.443 HD11 ' HB2' ' A' ' 73' ' ' PRO . 23.6 pt -140.96 165.71 19.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.99 0.424 . . . . 0.0 110.29 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.579 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -106.22 122.37 46.07 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.37 124.43 47.69 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 36.5 ttpt -100.75 145.71 28.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.02 0.438 . . . . 0.0 110.266 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 29' ' ' VAL . 46.6 t -115.87 125.87 73.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.74 124.02 34.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.57 0.7 . . . . 0.0 110.893 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.99 149.0 17.46 Favored Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.472 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -63.01 -11.4 18.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.525 0.679 . . . . 0.0 111.47 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.81 -14.05 60.64 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.76 0.79 . . . . 0.0 110.062 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.84 -9.78 58.53 Favored Glycine 0 C--N 1.307 -1.067 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.902 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -79.33 117.45 20.33 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.089 0.471 . . . . 0.0 110.055 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.7 p -143.38 139.19 26.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.215 0.531 . . . . 0.0 111.455 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 48.3 t -145.91 151.16 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.579 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -104.73 142.17 35.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 36.6 m-85 -132.41 157.36 44.75 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.556 0.693 . . . . 0.0 111.301 -177.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -134.38 110.61 9.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.407 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 pt -131.45 173.8 14.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.248 0.547 . . . . 0.0 111.256 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HD3' ' H ' ' A' ' 37' ' ' HIS . 2.1 tmtp? -80.48 146.39 31.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.491 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 33.6 ttm180 -64.4 -16.75 62.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.393 0.616 . . . . 0.0 112.157 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.425 ' H ' ' HD3' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -104.6 2.03 30.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.405 0.621 . . . . 0.0 110.241 177.718 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 5.6 m -88.45 133.45 36.4 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.046 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.43 146.3 93.08 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.655 2.237 . . . . 0.0 112.54 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.436 HD12 ' OD1' ' A' ' 71' ' ' ASP . 30.5 mt -65.49 -15.26 62.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.923 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 13.8 p -54.61 -33.11 59.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.271 0.558 . . . . 0.0 110.568 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -57.65 -53.95 52.43 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.676 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.08 -31.9 58.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.432 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.59 ' N ' HD12 ' A' ' 43' ' ' LEU . 58.2 mtt -57.18 -56.73 18.07 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.994 0.426 . . . . 0.0 111.549 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 41' ' ' SER . 0.4 OUTLIER -71.66 -34.64 69.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.914 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -61.5 -47.03 87.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.996 0.427 . . . . 0.0 110.726 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 20.5 t80 -55.05 -50.22 69.64 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 110.49 177.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.649 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.4 m -63.27 -40.68 98.09 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.568 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 41.5 mt-10 -64.03 -34.97 79.22 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.8 ptp180 -89.66 -26.06 20.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -94.14 -16.39 23.78 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.191 0.52 . . . . 0.0 112.157 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.19 35.94 10.44 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.251 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.635 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.5 mm? -113.81 154.31 27.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.293 0.568 . . . . 0.0 110.821 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -105.17 136.97 43.68 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.548 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.1 mmm -63.4 -22.48 66.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.144 0.497 . . . . 0.0 111.012 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.496 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -83.67 -28.58 28.25 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.421 0.629 . . . . 0.0 110.342 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.496 ' NE2' ' HB2' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -93.67 -10.95 32.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.881 -177.11 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.649 HD11 ' SG ' ' A' ' 48' ' ' CYS . 7.3 pt -128.3 170.86 17.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.093 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 tpp180 -148.7 135.9 20.17 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.102 0.477 . . . . 0.0 110.291 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.2 m-85 -91.01 138.96 31.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -141.61 140.92 33.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.028 0.442 . . . . 0.0 110.72 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -146.31 134.34 21.48 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 69.53 27.49 4.85 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.907 0.86 . . . . 0.0 110.533 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.26 -6.84 49.16 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.572 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -111.43 140.56 23.17 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 122.165 -0.609 . . . . 0.0 110.826 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.11 139.19 35.08 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.269 1.98 . . . . 0.0 111.273 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.1 pt -113.15 153.62 14.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.333 0.587 . . . . 0.0 111.708 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.568 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 3.3 p30 -108.56 152.98 24.02 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.343 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.571 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 13.8 pt-20 -60.95 -14.92 25.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.178 0.513 . . . . 0.0 111.924 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -93.42 7.71 43.42 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.568 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -91.58 158.07 16.64 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 121.587 -0.695 . . . . 0.0 110.714 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.5 p -118.55 145.61 37.85 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.881 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.449 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 18.2 Cg_endo -59.14 -21.53 59.89 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.798 2.332 . . . . 0.0 112.664 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -81.26 -19.41 43.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.029 0.443 . . . . 0.0 111.266 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -80.69 -54.67 5.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.311 0.576 . . . . 0.0 110.783 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 2.0 pt? -82.68 10.53 7.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.135 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 57.85 62.44 2.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.35 0.595 . . . . 0.0 111.123 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -83.09 121.1 26.61 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.146 0.498 . . . . 0.0 110.36 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HG3' ' HB2' ' A' ' 82' ' ' ASP . 11.4 pt-20 -80.95 159.64 24.87 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.312 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -74.78 149.19 39.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.881 0.372 . . . . 0.0 111.465 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 63.15 19.31 11.58 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.818 0.847 . . . . 0.0 112.079 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.492 ' HB2' ' HG3' ' A' ' 79' ' ' GLU . 1.7 t70 -89.28 -178.02 5.53 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.543 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 16.4 m -130.11 151.43 50.65 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.376 0.608 . . . . 0.0 112.037 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.81 137.71 42.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 123.387 0.675 . . . . 0.0 109.215 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -91.76 124.67 36.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 110.807 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.422 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 47.4 t -111.52 136.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.296 0.57 . . . . 0.0 111.795 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -126.2 144.47 50.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.12 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.482 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.5 mp0 -99.25 110.98 23.45 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.628 0.251 . . . . 0.0 110.75 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -56.7 -53.69 54.84 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.613 0.72 . . . . 0.0 110.69 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.2 125.71 27.56 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.111 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.3 p -68.99 120.67 15.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.278 0.561 . . . . 0.0 111.481 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.06 81.98 0.64 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.31 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.032 0 CA-C-O 118.583 -1.12 . . . . 0.0 111.5 179.395 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HG2' ' OE2' ' A' ' 4' ' ' GLU . 56.5 mtt . . . . . 0 CA--C 1.507 -0.693 0 CA-C-O 121.63 0.729 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.79 -32.84 0.13 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.577 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -69.23 -26.23 64.7 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.082 0.468 . . . . 0.0 110.674 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.407 ' OE2' ' HG2' ' A' ' 1' ' ' MET . 6.2 pt-20 -66.87 -42.94 84.76 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 121.265 0.555 . . . . 0.0 110.325 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 12.8 tppt? -144.22 82.49 10.73 Favored Pre-proline 0 N--CA 1.417 -2.093 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.787 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.5 146.7 27.76 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.4 2.067 . . . . 0.0 111.661 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -112.41 48.94 0.95 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.58 119.52 9.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.918 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.04 -64.78 2.86 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.566 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.89 98.7 3.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.948 0.88 . . . . 0.0 112.439 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 11' ' ' LYS . 1.3 pptp? -160.27 144.92 14.56 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.011 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 p -71.56 91.9 1.1 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.064 0.459 . . . . 0.0 111.168 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.61 -51.17 69.69 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.53 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 56.8 70.07 0.69 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.872 0.844 . . . . 0.0 109.253 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -141.14 132.13 26.13 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.055 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.437 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 6.4 m-20 -81.87 83.17 7.28 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 22.1 p-80 -119.27 144.23 46.89 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.883 -0.511 . . . . 0.0 110.897 -177.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.415 HD11 ' HB2' ' A' ' 73' ' ' PRO . 27.6 pt -125.43 167.45 19.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.113 0.482 . . . . 0.0 110.068 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.516 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -107.37 126.82 52.96 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.833 -178.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.82 125.45 48.59 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -104.48 139.72 38.98 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.872 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 40.2 t -111.82 123.21 67.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.967 0.413 . . . . 0.0 110.03 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.72 112.43 14.8 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.763 0.792 . . . . 0.0 110.751 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.95 147.7 18.7 Favored Glycine 0 C--N 1.297 -1.608 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.271 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -10.27 7.91 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.243 0.544 . . . . 0.0 112.143 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.403 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 9.3 t70 -73.36 -13.66 61.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.631 0.729 . . . . 0.0 110.315 177.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.8 -15.25 55.75 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.8 m -74.7 117.03 16.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.247 0.546 . . . . 0.0 110.49 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 3.3 p -142.52 136.48 27.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.397 0.618 . . . . 0.0 111.1 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -145.39 151.66 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.475 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -108.32 140.45 41.58 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -134.2 155.3 50.39 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.133 0.492 . . . . 0.0 110.945 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.516 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 90.1 mttt -128.08 111.1 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.107 0.479 . . . . 0.0 110.642 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.3 pt -127.62 173.58 12.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.029 0.442 . . . . 0.0 110.283 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.6 tmtp? -78.6 146.37 34.2 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.462 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 40.0 ttm180 -64.32 -12.75 45.14 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.334 0.588 . . . . 0.0 111.865 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.427 ' H ' ' HD3' ' A' ' 35' ' ' LYS . 37.8 t-80 -107.04 -3.38 20.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.669 0.747 . . . . 0.0 109.617 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.8 m -83.5 135.05 44.07 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.609 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.88 145.05 89.91 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.708 2.272 . . . . 0.0 112.624 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 48.5 mt -65.67 -16.84 64.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.02 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 32.6 p -54.25 -34.8 61.56 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.01 0.433 . . . . 0.0 111.061 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -57.46 -52.1 66.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.73 -32.16 62.04 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.884 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.577 ' N ' HD12 ' A' ' 43' ' ' LEU . 58.5 mtt -58.12 -53.89 53.12 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.183 0.516 . . . . 0.0 110.903 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 34.2 mmtp -66.69 -41.74 87.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.019 0.438 . . . . 0.0 110.079 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.9 -48.02 83.4 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.115 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -55.73 -49.05 74.1 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.68 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.7 m -67.2 -36.27 81.38 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 47.7 mt-10 -62.61 -39.69 94.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.093 0.473 . . . . 0.0 111.215 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 14.8 ptp180 -86.73 -25.71 24.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -93.52 -8.65 40.8 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.98 -0.45 . . . . 0.0 111.817 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.15 43.78 46.68 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.727 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.9 mp -115.91 152.89 32.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.39 0.614 . . . . 0.0 111.043 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.2 m -99.15 124.33 44.11 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.973 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 95.4 mmm -60.85 -22.33 64.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.949 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.483 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -84.68 -32.62 23.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.482 0.658 . . . . 0.0 110.804 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 4.9 mp0 -84.73 -20.66 30.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.909 -176.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.588 HD11 ' SG ' ' A' ' 48' ' ' CYS . 16.0 pt -113.02 176.17 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.231 0.539 . . . . 0.0 111.949 -177.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -149.22 140.23 22.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.407 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 44' ' ' MET . 6.4 m-85 -94.61 129.44 41.45 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.594 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -130.55 143.58 50.85 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.538 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -150.12 136.82 19.17 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 t70 67.32 26.98 8.38 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.834 0.826 . . . . 0.0 110.815 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.38 -5.61 59.67 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.991 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -116.63 142.09 29.09 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 122.076 -0.661 . . . . 0.0 110.883 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.11 134.66 34.75 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.067 1.845 . . . . 0.0 110.799 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.709 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 12.1 pt -104.49 -177.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.137 0.494 . . . . 0.0 111.631 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.39 161.63 29.88 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 121.689 0.757 . . . . 0.0 110.649 -175.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.49 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.1 pt-20 -67.98 -15.28 63.54 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.764 0.792 . . . . 0.0 109.583 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 t -110.01 16.49 21.85 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.709 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 1.8 p-10 -98.23 101.5 12.98 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 118.517 -1.273 . . . . 0.0 110.722 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 p -60.31 141.22 91.21 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.73 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 11.1 Cg_endo -56.39 -24.25 51.09 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.991 2.46 . . . . 0.0 112.288 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -72.26 -34.2 68.07 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.128 0.49 . . . . 0.0 110.647 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -64.95 -55.78 17.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.986 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 2.1 pt? -85.09 6.57 24.96 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.712 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 60.37 52.6 4.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.716 0.769 . . . . 0.0 111.499 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.76 131.64 40.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.273 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -94.94 165.75 12.29 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.028 0.442 . . . . 0.0 110.613 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.41 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 9.9 p-10 -76.37 148.28 37.5 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.359 0.6 . . . . 0.0 110.553 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 65.64 14.72 9.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.768 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.62 167.21 20.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.8 m -123.04 140.77 52.68 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.03 135.93 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.191 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -94.98 118.97 32.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.064 0.459 . . . . 0.0 110.296 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.37 138.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.148 0.499 . . . . 0.0 111.793 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -128.6 150.87 50.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.952 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.439 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.1 mp0 -104.61 112.8 26.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 111.672 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.441 ' N ' HE21 ' A' ' 89' ' ' GLN . 0.0 OUTLIER -125.02 77.19 1.6 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.146 0.974 . . . . 0.0 110.348 174.43 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.491 ' HG2' ' HB3' ' A' ' 57' ' ' GLN . 70.8 mt-30 -75.06 90.06 2.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.47 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -103.17 103.91 14.0 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.088 0.471 . . . . 0.0 109.906 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.89 158.34 9.25 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.572 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.029 0 CA-C-O 118.714 -1.048 . . . . 0.0 111.299 -179.779 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.598 0.237 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.89 -66.51 0.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.98 0.419 . . . . 0.0 111.479 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -92.39 7.1 44.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.535 0.683 . . . . 0.0 110.424 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -88.9 -49.41 6.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.673 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -142.36 73.18 21.2 Favored Pre-proline 0 N--CA 1.462 0.142 0 CA-C-O 120.733 0.301 . . . . 0.0 110.831 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.95 158.37 8.71 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.529 2.153 . . . . 0.0 112.21 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -91.59 47.25 1.35 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.176 0.512 . . . . 0.0 109.95 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.21 133.71 51.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.769 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.76 142.9 6.44 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.09 124.28 28.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.191 0.519 . . . . 0.0 110.574 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -140.48 111.29 6.93 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 p -78.7 130.34 35.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.104 0.478 . . . . 0.0 110.737 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -127.69 87.71 2.66 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.406 0.622 . . . . 0.0 109.795 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -87.69 87.61 7.43 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.553 0.692 . . . . 0.0 109.68 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -105.9 144.61 32.39 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.967 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -112.6 -91.22 0.49 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.919 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 73.95 134.94 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.192 0.997 . . . . 0.0 111.16 179.497 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.506 HD12 HD21 ' A' ' 20' ' ' LEU . 24.7 pt -128.96 160.04 40.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.01 178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.544 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.2 OUTLIER -95.72 123.87 39.49 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.538 HD22 ' SD ' ' A' ' 78' ' ' MET . 86.4 mt -122.89 125.9 46.25 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.229 0.538 . . . . 0.0 110.206 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 83' ' ' THR . 36.7 ttpt -106.82 142.82 35.85 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.283 0.563 . . . . 0.0 110.98 -178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 41.1 t -115.77 126.92 73.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.65 126.51 38.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.401 0.619 . . . . 0.0 110.526 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.51 147.35 16.61 Favored Glycine 0 C--N 1.301 -1.404 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.749 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.4 pp0? -60.64 -15.45 28.53 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 112.221 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -76.37 -11.81 59.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.926 0.87 . . . . 0.0 109.636 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.85 -11.54 45.47 Favored Glycine 0 C--N 1.318 -0.463 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.434 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -73.34 114.63 11.76 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.472 -0.428 . . . . 0.0 110.755 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 4.9 p -141.14 135.9 32.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.312 0.577 . . . . 0.0 111.367 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -145.67 151.04 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.397 -177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.544 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -109.45 138.89 45.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.016 0.436 . . . . 0.0 110.091 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 18.1 m-85 -133.39 164.17 27.72 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 121.12 0.486 . . . . 0.0 110.638 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -135.27 112.38 10.37 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 122.199 -0.313 . . . . 0.0 110.22 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 pt -126.84 168.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.946 0.403 . . . . 0.0 110.779 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 1.1 tmtp? -77.7 152.69 33.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.865 0.364 . . . . 0.0 110.391 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 10.2 tpp180 -60.96 -21.74 63.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.001 0.52 . . . . 0.0 112.071 -177.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -105.76 -2.02 23.7 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.823 -0.548 . . . . 0.0 110.099 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.7 m -82.35 132.21 53.49 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.658 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.99 147.8 85.01 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.707 2.271 . . . . 0.0 112.31 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.19 -16.12 63.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.99 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 22.7 t -49.76 -38.64 34.84 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.495 0.318 . . . . 0.0 111.079 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 6.7 mmpt? -56.55 -53.48 57.09 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -75.79 -32.33 59.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.619 ' N ' HD12 ' A' ' 43' ' ' LEU . 41.2 ttm -61.24 -50.4 73.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.891 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.54 ' HD2' ' SD ' ' A' ' 55' ' ' MET . 13.5 mmmm -70.67 -40.85 72.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.8 0.333 . . . . 0.0 110.184 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.69 -46.37 89.28 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.084 0.469 . . . . 0.0 111.444 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 24.1 t80 -55.73 -50.96 68.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.063 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.663 ' SG ' HD11 ' A' ' 58' ' ' ILE . 35.0 m -63.91 -37.32 86.97 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.032 0.444 . . . . 0.0 111.167 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -62.44 -40.39 96.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.993 0.425 . . . . 0.0 111.695 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.7 ptp180 -87.94 -21.96 24.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.843 0.354 . . . . 0.0 111.8 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -96.36 -11.35 25.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.35 7.07 85.39 Favored Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.694 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 7.2 mp -82.79 155.12 24.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.614 0.721 . . . . 0.0 112.176 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.402 ' O ' HG12 ' A' ' 58' ' ' ILE . 27.6 m -106.15 132.82 51.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.832 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.54 ' SD ' ' HD2' ' A' ' 45' ' ' LYS . 63.7 mmm -56.18 -33.45 65.28 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -177.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -25.84 28.15 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.909 -0.495 . . . . 0.0 111.657 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.518 ' HA ' ' CG ' ' A' ' 90' ' ' GLN . 0.6 OUTLIER -84.99 -19.93 31.31 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.304 0.573 . . . . 0.0 110.85 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.663 HD11 ' SG ' ' A' ' 48' ' ' CYS . 8.4 pt -116.76 174.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.046 0.45 . . . . 0.0 110.971 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -153.81 138.8 17.25 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -92.83 137.35 32.44 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.306 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -136.94 139.37 41.49 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.301 0.572 . . . . 0.0 111.299 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -150.25 143.33 24.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 t70 67.3 24.1 9.13 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.873 0.845 . . . . 0.0 110.115 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.19 -2.44 81.42 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.391 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -121.96 142.36 36.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 122.059 -0.671 . . . . 0.0 110.887 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.97 138.69 53.57 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.012 1.808 . . . . 0.0 110.835 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.44 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 13.6 pt -112.46 172.95 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.096 0.474 . . . . 0.0 110.856 -177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.5 p30 -133.76 157.98 44.49 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.079 0.466 . . . . 0.0 111.574 -177.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' SER . 17.2 pt-20 -60.4 -11.84 7.8 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.714 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -100.97 11.36 39.77 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.817 0.341 . . . . 0.0 111.582 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.478 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -99.5 157.15 16.64 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 121.721 -0.612 . . . . 0.0 109.593 177.5 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.2 p -118.51 148.06 43.29 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.704 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.86 -18.69 62.34 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.691 2.261 . . . . 0.0 112.284 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.483 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -85.9 -15.69 40.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.196 0.522 . . . . 0.0 111.193 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -82.26 -56.36 3.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.299 0.571 . . . . 0.0 110.436 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -86.8 1.98 50.45 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.221 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 62.28 61.59 1.28 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.609 0.719 . . . . 0.0 112.908 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.601 ' SD ' HD11 ' A' ' 84' ' ' ILE . 29.4 ttm -89.08 137.45 32.31 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -106.83 176.79 5.06 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.897 0.38 . . . . 0.0 110.79 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -75.3 143.52 42.91 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.169 0.509 . . . . 0.0 110.793 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 71.9 13.58 6.01 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.024 0.93 . . . . 0.0 110.855 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -80.38 161.88 24.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 22.9 m -127.34 145.84 50.66 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.342 0.591 . . . . 0.0 112.316 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.601 HD11 ' SD ' ' A' ' 78' ' ' MET . 4.0 mp -110.32 136.89 44.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.426 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -93.76 130.94 39.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.1 0.476 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 46.5 t -112.74 138.63 41.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.508 0.67 . . . . 0.0 111.854 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -134.08 163.64 29.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.361 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -111.65 112.83 24.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.814 0.34 . . . . 0.0 111.228 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.0 49.22 0.96 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.239 0.543 . . . . 0.0 111.031 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.518 ' CG ' ' HA ' ' A' ' 57' ' ' GLN . 83.1 mm-40 -151.83 80.91 1.27 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.323 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.9 p -130.71 109.06 10.34 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.96 -67.32 2.21 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.678 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.724 -1.042 . . . . 0.0 112.274 179.539 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.045 0.45 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.02 -65.77 1.15 Allowed 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.039 -0.413 . . . . 0.0 110.403 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.459 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 7.7 m-20 -68.94 -42.79 76.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.089 0.471 . . . . 0.0 110.409 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 67.05 32.2 6.42 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.804 0.812 . . . . 0.0 110.558 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 59.16 68.76 1.51 Allowed Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.297 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 59.4 Cg_endo -71.59 -178.44 3.03 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.196 2.597 . . . . 0.0 112.191 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -52.06 -34.19 42.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.657 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.31 125.24 28.82 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.43 95.1 0.12 Allowed Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.803 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.51 152.36 4.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.114 0.483 . . . . 0.0 110.09 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -137.52 172.23 13.28 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -99.5 28.03 4.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.653 0.74 . . . . 0.0 110.554 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.23 -175.39 4.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.546 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -81.71 85.75 6.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.52 0.676 . . . . 0.0 109.915 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -148.27 172.19 14.77 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.375 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.97 78.8 4.45 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.347 0.594 . . . . 0.0 111.363 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -124.96 145.41 49.88 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.513 HD11 ' HB2' ' A' ' 73' ' ' PRO . 19.1 pt -132.28 167.85 25.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.285 0.564 . . . . 0.0 110.815 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.66 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -99.75 129.57 45.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.754 -179.268 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.415 HD23 HG12 ' A' ' 34' ' ' ILE . 3.1 mm? -125.97 126.93 45.13 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 83' ' ' THR . 35.0 ttpt -109.49 141.81 41.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.329 0.585 . . . . 0.0 111.221 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.27 127.04 70.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.167 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.18 121.95 25.75 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.661 0.743 . . . . 0.0 110.502 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.2 149.39 16.61 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.242 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -11.55 11.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.474 0.654 . . . . 0.0 112.043 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.85 -18.46 62.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.544 0.687 . . . . 0.0 110.435 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.12 -5.37 45.75 Favored Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.9 m -86.82 121.65 29.61 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.884 0.373 . . . . 0.0 110.381 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 p -144.35 138.33 23.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.366 0.603 . . . . 0.0 111.415 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -146.3 151.01 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.66 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -109.93 140.65 43.67 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.513 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -132.24 157.82 43.37 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 121.19 0.519 . . . . 0.0 111.255 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -127.82 108.55 10.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.415 HG12 HD23 ' A' ' 20' ' ' LEU . 46.8 pt -124.19 176.36 5.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.203 0.525 . . . . 0.0 110.73 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.3 tmtp? -85.44 149.61 25.29 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.097 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.495 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 17.6 tpp180 -53.06 -26.67 16.73 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.601 0.761 . . . . 0.0 112.576 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -111.87 6.49 19.6 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.588 -0.695 . . . . 0.0 111.748 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 m -81.64 133.93 51.7 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.0 145.07 84.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.645 2.23 . . . . 0.0 112.361 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 48.1 mt -65.2 -17.06 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.927 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 35.5 p -50.47 -37.89 40.95 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.561 0.344 . . . . 0.0 111.686 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.7 mmpt? -56.36 -52.57 64.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.755 0.312 . . . . 0.0 110.72 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.88 -31.86 61.7 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.363 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.576 ' N ' HD12 ' A' ' 43' ' ' LEU . 53.2 mtt -58.2 -54.91 41.67 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.25 0.547 . . . . 0.0 110.979 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 57.6 mmtt -65.49 -44.43 87.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.936 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.728 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -57.56 -49.04 77.67 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.071 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -54.92 -51.7 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.584 ' SG ' HD11 ' A' ' 58' ' ' ILE . 34.1 m -67.19 -35.05 78.82 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.935 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 51.4 mt-10 -66.97 -36.18 81.61 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.209 -0.307 . . . . 0.0 111.682 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.728 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -88.13 -25.81 22.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 178.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -92.25 -6.06 51.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 111.555 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.2 46.38 57.95 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.158 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.8 mp -117.36 151.51 36.86 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.224 0.535 . . . . 0.0 110.827 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 71.4 m -96.76 123.0 40.32 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.905 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.3 mmm -56.64 -28.13 59.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.993 0.517 . . . . 0.0 111.903 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.476 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -84.39 -34.87 23.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.261 0.553 . . . . 0.0 111.116 -178.506 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 4.8 mp0 -81.66 -18.91 42.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.066 0.46 . . . . 0.0 111.338 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.584 HD11 ' SG ' ' A' ' 48' ' ' CYS . 14.3 pt -110.57 -179.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 120.968 0.413 . . . . 0.0 110.671 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 59' ' ' ARG . 10.0 tpt180 -157.31 133.3 9.49 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.173 0.511 . . . . 0.0 110.433 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.9 m-85 -85.54 135.87 33.64 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.063 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -144.79 148.21 33.8 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.997 0.427 . . . . 0.0 110.362 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -154.69 138.96 16.62 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.1 t70 65.84 25.19 11.28 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.59 0.709 . . . . 0.0 110.306 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 -26.56 5.75 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.763 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -90.94 144.62 30.38 Favored Pre-proline 0 C--N 1.327 -0.386 0 O-C-N 122.408 -0.466 . . . . 0.0 110.811 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.85 141.88 27.67 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.9 1.733 . . . . 0.0 110.338 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.654 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 6.9 pt -106.08 -179.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.832 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.93 165.42 22.12 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.599 0.714 . . . . 0.0 110.714 -174.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 11.1 pt-20 -67.82 -12.94 61.65 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.943 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -118.87 16.93 13.47 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.654 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 3.6 p-10 -91.27 98.76 11.92 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.415 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 p -58.49 145.56 75.75 Favored Pre-proline 0 C--N 1.301 -1.508 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.044 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.513 ' HB2' HD11 ' A' ' 18' ' ' ILE . 17.9 Cg_endo -59.57 -15.82 32.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.899 2.4 . . . . 0.0 111.58 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.465 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -80.01 -31.1 39.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.462 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -67.54 -54.67 18.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.264 0.554 . . . . 0.0 111.657 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.3 pt? -84.2 7.84 17.69 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.809 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 57.66 40.49 26.56 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.508 0.671 . . . . 0.0 111.224 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.86 130.29 43.55 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.463 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.86 169.75 17.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.14 0.495 . . . . 0.0 110.417 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -79.05 145.4 33.86 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 66.28 20.24 11.04 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.447 0.699 . . . . 0.0 110.975 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.03 161.42 28.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.071 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 30.3 m -121.51 135.35 55.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.645 0.736 . . . . 0.0 112.379 -175.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.84 137.94 24.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.164 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -93.62 117.38 30.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.29 0.567 . . . . 0.0 110.85 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.82 134.89 46.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.427 0.632 . . . . 0.0 111.737 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -131.84 159.87 37.3 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.463 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.1 mp0 -101.47 111.03 23.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.139 0.495 . . . . 0.0 110.496 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -123.16 85.2 2.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.213 0.53 . . . . 0.0 110.397 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -73.48 101.02 3.41 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.373 0.606 . . . . 0.0 110.54 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -116.05 97.65 6.2 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.863 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 156.79 158.02 8.66 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.159 0 CA-C-O 118.544 -1.142 . . . . 0.0 111.672 -179.727 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 121.143 0.497 . . . . 0.0 111.5 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.82 -73.41 0.67 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.866 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.432 ' HB3' ' CG ' ' A' ' 6' ' ' PRO . 6.9 m-20 -96.91 -45.13 6.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.044 0.449 . . . . 0.0 110.287 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 32.58 54.82 0.38 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.03 1.332 . . . . 0.0 113.211 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.18 -59.48 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 72.2 Cg_endo -80.16 132.06 9.13 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.619 2.212 . . . . 0.0 114.147 -175.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 3.9 mptp? -107.86 59.4 0.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.043 175.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' OE1' ' HB2' ' A' ' 6' ' ' PRO . 4.4 mp0 -69.01 105.99 2.6 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.851 -0.53 . . . . 0.0 110.71 176.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.75 -47.54 0.52 Allowed Glycine 0 CA--C 1.492 -1.393 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.5 p -77.7 157.68 5.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -137.8 129.59 28.49 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.052 0.453 . . . . 0.0 109.908 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 t -169.17 158.26 8.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.121 0.486 . . . . 0.0 110.328 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.11 10.31 16.1 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.812 0.815 . . . . 0.0 108.809 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -121.15 121.1 37.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -113.57 111.86 22.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.747 0.784 . . . . 0.0 111.67 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.44 87.88 5.05 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.643 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 23.4 p-80 -124.85 147.77 48.6 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.398 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.8 pt -131.61 163.52 37.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.026 0.441 . . . . 0.0 110.19 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.539 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -97.23 141.22 30.62 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.5 mt -137.51 125.19 22.32 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 83' ' ' THR . 33.4 ttpt -108.36 140.67 41.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.243 0.544 . . . . 0.0 111.422 -176.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.5 t -114.54 127.55 71.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.847 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.61 120.37 23.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.437 0.637 . . . . 0.0 110.582 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.52 150.83 17.7 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.405 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.58 -8.94 7.27 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 112.502 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.54 -13.77 60.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.706 0.765 . . . . 0.0 109.945 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.85 -10.61 58.87 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.0 m -81.42 123.72 28.81 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.001 0.429 . . . . 0.0 110.264 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 22' ' ' VAL . 3.6 p -143.71 138.28 25.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 121.278 0.561 . . . . 0.0 110.955 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.3 t -143.04 150.8 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.595 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.539 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -107.63 137.67 45.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.087 0.47 . . . . 0.0 109.971 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 29.9 m-85 -128.15 166.44 18.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 121.382 0.61 . . . . 0.0 110.503 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -141.63 111.46 6.66 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.469 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.2 pt -131.04 176.29 9.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.395 0.616 . . . . 0.0 111.549 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 1.9 tmtp? -88.45 150.52 23.1 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.267 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.431 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 21.8 tpp180 -54.98 -27.46 44.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.944 0.898 . . . . 0.0 112.712 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -108.47 3.55 23.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.272 0.558 . . . . 0.0 111.026 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.7 m -85.16 131.81 47.32 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.195 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.52 148.7 90.62 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.508 2.139 . . . . 0.0 112.484 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.4 mt -65.61 -15.6 62.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.763 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 54.1 p -50.96 -37.91 47.43 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 122.91 0.484 . . . . 0.0 111.343 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -56.91 -53.68 55.16 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.073 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.38 -32.4 58.55 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.0 0.429 . . . . 0.0 111.317 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.626 ' N ' HD12 ' A' ' 43' ' ' LEU . 41.8 ttm -60.44 -52.12 66.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.682 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 33.1 mmtp -70.49 -37.74 74.25 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.884 0.373 . . . . 0.0 110.283 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.94 -45.4 94.84 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.92 0.391 . . . . 0.0 111.004 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 21.1 t80 -56.78 -51.92 67.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.364 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.3 p -61.63 -36.59 81.19 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.216 0.532 . . . . 0.0 110.608 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 61.6 mm-40 -67.06 -45.41 77.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.878 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.9 ptp180 -78.99 -25.59 43.37 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -93.47 -12.27 30.12 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.979 -0.45 . . . . 0.0 112.2 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.95 43.81 9.59 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.323 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.515 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.0 mm? -120.6 160.06 24.0 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.016 0.436 . . . . 0.0 110.162 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.406 ' O ' HG12 ' A' ' 58' ' ' ILE . 4.7 m -109.65 135.65 50.27 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.737 0.303 . . . . 0.0 111.013 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.424 ' CE ' ' HG2' ' A' ' 44' ' ' MET . 86.3 mmm -58.01 -27.8 63.84 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.459 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -85.25 -24.14 27.91 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.783 -0.573 . . . . 0.0 111.443 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.68 -14.07 32.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.25 0.548 . . . . 0.0 110.136 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 53' ' ' LEU . 16.1 pt -120.5 169.94 11.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 120.944 0.402 . . . . 0.0 110.674 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.564 ' HB3' HE22 ' A' ' 89' ' ' GLN . 5.6 tpp180 -149.9 136.6 19.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -95.13 136.04 35.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.146 0.498 . . . . 0.0 110.342 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.35 142.13 37.61 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.109 0.48 . . . . 0.0 110.885 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -153.44 143.27 22.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 64.63 23.76 12.87 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.411 0.624 . . . . 0.0 110.696 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.89 -2.93 82.09 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.491 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -118.35 149.29 45.65 Favored Pre-proline 0 C--N 1.332 -0.153 0 O-C-N 122.163 -0.61 . . . . 0.0 110.376 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.47 139.81 20.98 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.846 1.697 . . . . 0.0 110.575 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.9 pt -113.46 160.73 12.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.43 0.633 . . . . 0.0 111.487 -176.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.8 p30 -120.2 157.14 29.71 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.424 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 7.3 pt-20 -62.77 -9.78 10.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.994 0.426 . . . . 0.0 111.92 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.0 t -99.02 7.68 45.73 Favored 'General case' 0 N--CA 1.441 -0.916 0 O-C-N 122.036 -0.415 . . . . 0.0 111.898 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.502 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.4 OUTLIER -92.71 156.65 16.91 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 121.682 -0.636 . . . . 0.0 109.898 178.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.2 p -115.99 146.77 37.79 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.8 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.81 -12.89 33.92 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.793 2.329 . . . . 0.0 112.279 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.83 -24.49 23.7 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.326 0.584 . . . . 0.0 110.604 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -72.54 -55.33 7.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.39 0.614 . . . . 0.0 110.851 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -88.7 12.39 14.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.969 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 53.38 62.95 2.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.518 0.675 . . . . 0.0 111.576 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.84 130.15 35.09 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.683 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.48 166.88 11.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.923 0.392 . . . . 0.0 110.602 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -73.06 143.74 47.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.22 0.533 . . . . 0.0 110.941 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 66.8 15.0 10.03 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.863 0.865 . . . . 0.0 112.129 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -76.98 166.63 23.07 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 18.8 m -121.68 138.21 54.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.22 135.91 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.152 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -93.6 121.58 35.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.086 0.47 . . . . 0.0 110.973 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.3 t -109.79 136.83 44.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.201 0.524 . . . . 0.0 111.613 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -129.45 151.06 50.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.089 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -106.8 111.68 24.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.054 0.454 . . . . 0.0 110.868 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.564 HE22 ' HB3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -124.03 89.88 3.17 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 122.14 0.971 . . . . 0.0 111.741 177.053 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -143.63 142.26 30.96 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.7 m -63.82 -47.74 79.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 110.977 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.74 -155.97 27.62 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.487 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.026 0 CA-C-O 118.791 -1.005 . . . . 0.0 111.628 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.959 0.409 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.65 15.89 25.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -101.95 28.97 5.3 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.954 0.883 . . . . 0.0 110.429 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -121.7 125.24 46.14 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 2.5 mppt? 57.7 50.19 3.92 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -174.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 5' ' ' LYS . 95.3 Cg_endo -89.15 111.87 0.56 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.004 1.802 . . . . 0.0 110.712 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -96.45 18.38 14.12 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.412 0.625 . . . . 0.0 111.175 -177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -120.7 -155.21 0.62 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.49 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.79 36.05 6.58 Favored Glycine 0 C--N 1.316 -0.548 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.181 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.05 117.18 53.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HD3' ' H ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -115.08 96.3 5.62 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.186 0.993 . . . . 0.0 112.881 -177.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -136.92 -66.25 0.53 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 7.0 pt-20 -142.82 122.95 13.7 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -86.17 -174.86 5.28 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.819 -0.551 . . . . 0.0 110.417 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -131.42 165.24 23.94 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.379 0.609 . . . . 0.0 110.587 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -86.49 84.27 7.46 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 16.2 p-80 -120.94 150.3 41.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.95 0.405 . . . . 0.0 110.68 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 20' ' ' LEU . 15.9 pt -133.87 166.65 28.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.096 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.617 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -102.85 115.45 30.62 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 120.835 0.35 . . . . 0.0 110.226 -179.029 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.558 HD11 HD12 ' A' ' 18' ' ' ILE . 6.6 mp -112.55 125.66 54.49 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.431 0.634 . . . . 0.0 109.947 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 83' ' ' THR . 34.1 ttpt -105.56 146.51 29.52 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.349 0.595 . . . . 0.0 111.356 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 39.4 t -116.64 128.95 73.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.97 121.42 22.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.433 0.635 . . . . 0.0 110.489 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.0 150.31 17.1 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.839 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.46 -10.58 7.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.583 0.706 . . . . 0.0 111.86 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.546 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 21.0 t70 -71.22 -19.45 62.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.253 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.89 -13.89 49.44 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -74.94 112.34 11.08 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.796 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.3 p -139.12 131.97 37.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.281 0.563 . . . . 0.0 110.913 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.53 150.83 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.617 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -106.36 142.22 36.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.847 0.356 . . . . 0.0 110.568 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -137.29 139.0 40.64 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.133 0.492 . . . . 0.0 111.076 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' HB2' ' HZ2' ' A' ' 33' ' ' LYS . 7.7 mtmp? -106.6 113.93 27.74 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.97 -0.456 . . . . 0.0 110.028 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.3 pt -126.9 170.09 17.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.972 0.415 . . . . 0.0 110.743 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 2.0 tmtp? -81.4 148.04 29.51 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.431 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 11.7 tpp180 -56.26 -26.14 50.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.85 0.46 . . . . 0.0 112.032 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -102.46 -2.4 28.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.531 0.681 . . . . 0.0 110.127 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.0 m -81.33 132.07 56.93 Favored Pre-proline 0 N--CA 1.434 -1.231 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.307 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.2 148.2 88.67 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.523 2.149 . . . . 0.0 111.841 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.4 mt -64.81 -15.18 61.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.743 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.49 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 11.8 p -49.22 -37.52 23.28 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 6.7 mmpt? -56.57 -53.42 57.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.85 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 44' ' ' MET . 4.3 pp -74.44 -31.63 62.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.377 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.522 ' N ' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -53.13 -58.06 8.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.023 0.439 . . . . 0.0 111.244 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -72.38 -38.14 68.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.399 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.35 -48.17 82.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.179 0.514 . . . . 0.0 110.958 -177.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -56.51 -51.35 68.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.886 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.784 ' SG ' HD11 ' A' ' 58' ' ' ILE . 31.4 m -63.75 -36.57 84.29 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.968 0.413 . . . . 0.0 111.914 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 40.4 mt-10 -64.35 -42.27 96.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.053 0.454 . . . . 0.0 111.189 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.1 ptp180 -84.35 -19.87 32.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 0.0 111.683 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -100.75 -2.4 32.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.96 48.04 69.19 Favored Glycine 0 C--O 1.235 0.202 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.348 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 58' ' ' ILE . 49.5 mt -122.69 154.53 37.95 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.067 0.46 . . . . 0.0 110.673 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.2 m -103.67 126.66 50.95 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.354 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.41 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 81.0 mmm -57.92 -26.89 62.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.035 0.534 . . . . 0.0 111.808 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.15 -28.12 27.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.243 0.544 . . . . 0.0 111.05 -178.738 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.614 ' O ' ' HG2' ' A' ' 89' ' ' GLN . 5.0 mp0 -93.01 -27.48 16.98 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.937 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.784 HD11 ' SG ' ' A' ' 48' ' ' CYS . 10.0 pt -103.11 163.63 3.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 O-C-N 121.375 -0.828 . . . . 0.0 110.766 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -136.97 132.15 33.94 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.073 0.463 . . . . 0.0 110.657 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -90.32 126.98 36.04 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -138.29 144.84 40.65 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.281 0.562 . . . . 0.0 111.493 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -149.83 141.83 23.89 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 t70 64.69 25.42 13.04 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.906 0.86 . . . . 0.0 110.0 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.97 -15.38 10.52 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.521 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -100.4 135.35 20.25 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 122.184 -0.597 . . . . 0.0 110.879 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.09 131.95 24.96 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.032 1.821 . . . . 0.0 111.081 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.581 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 5.7 pt -98.75 -177.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.82 166.75 21.92 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-O 121.54 0.686 . . . . 0.0 110.437 -174.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 10.3 pt-20 -78.9 -8.17 58.61 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.753 0.787 . . . . 0.0 108.964 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -107.38 16.24 24.12 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.058 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.581 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -103.81 151.55 22.94 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.69 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.9 p -115.79 150.17 44.42 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.035 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HB3' HD21 ' A' ' 20' ' ' LEU . 19.3 Cg_endo -61.55 -17.0 51.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.509 2.14 . . . . 0.0 111.444 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.44 -20.48 40.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.935 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.64 -53.77 8.7 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.29 0.567 . . . . 0.0 110.468 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.54 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.9 pt? -90.91 12.25 20.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.325 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 57.33 52.78 8.31 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.244 0.545 . . . . 0.0 111.439 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.37 137.08 34.85 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -104.13 -175.61 2.85 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.949 0.404 . . . . 0.0 110.4 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.46 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 11.6 p-10 -80.0 153.86 28.59 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.352 0.596 . . . . 0.0 110.319 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 63.24 18.83 11.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.916 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.75 157.57 25.78 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 25.4 m -130.21 147.68 51.96 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.595 -0.691 . . . . 0.0 112.69 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.25 140.28 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.066 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -93.86 124.25 37.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.937 0.398 . . . . 0.0 111.033 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.5 t -109.79 139.8 31.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.261 0.553 . . . . 0.0 111.522 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -132.14 156.9 45.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.743 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.546 ' OE1' ' HB2' ' A' ' 26' ' ' ASP . 2.0 mp0 -108.79 117.42 34.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.131 0.491 . . . . 0.0 111.85 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -114.21 -171.93 2.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.016 175.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.471 ' NE2' ' HG3' ' A' ' 89' ' ' GLN . 2.0 mp0 53.14 25.09 3.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.056 0.542 . . . . 0.0 111.44 -175.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.3 m -72.33 -51.02 22.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.676 0.751 . . . . 0.0 110.393 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.44 -67.92 0.55 Allowed Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.481 0 CA-C-O 118.241 -1.311 . . . . 0.0 111.14 179.048 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 CA--C 1.506 -0.741 0 CA-C-O 121.347 0.594 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.85 59.61 1.07 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.925 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -85.21 -28.79 25.19 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.743 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -81.56 85.93 6.44 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.315 0.578 . . . . 0.0 109.903 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm 63.81 78.01 0.29 Allowed Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.064 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 7.1 Cg_endo -62.51 146.28 95.49 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.254 1.969 . . . . 0.0 110.902 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -98.96 50.83 0.96 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.687 0.755 . . . . 0.0 110.552 -175.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 6' ' ' PRO . 48.9 mm-40 -78.35 162.57 26.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.434 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.5 112.04 0.43 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.178 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.5 t -84.8 118.9 32.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -117.29 101.27 8.29 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.542 0.686 . . . . 0.0 111.42 -179.011 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -99.7 119.24 37.8 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.035 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -59.8 -72.18 0.11 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 51.85 35.22 15.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.905 0.383 . . . . 0.0 111.755 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.6 ' OD1' ' HB3' ' A' ' 17' ' ' HIS . 8.5 p30 -143.18 175.18 10.07 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.136 0.493 . . . . 0.0 110.872 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -88.87 82.02 6.82 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 122.075 0.94 . . . . 0.0 109.441 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.6 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . 30.6 p-80 -117.96 146.69 43.81 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.195 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.445 HG13 HD21 ' A' ' 20' ' ' LEU . 34.0 pt -127.41 158.14 38.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.073 0.463 . . . . 0.0 110.389 177.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.0 119.27 34.19 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD21 HG13 ' A' ' 18' ' ' ILE . 2.7 mm? -110.8 125.05 53.16 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 34.1 ttpt -104.55 139.71 39.03 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.063 0.459 . . . . 0.0 110.628 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.26 125.74 69.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.82 120.99 24.52 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.728 0.775 . . . . 0.0 110.959 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA2' ' HB ' ' A' ' 86' ' ' VAL . . . -97.41 146.59 18.33 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -62.61 -6.88 3.89 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.19 -4.46 59.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.735 0.779 . . . . 0.0 110.061 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.14 -10.06 56.62 Favored Glycine 0 C--N 1.316 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.57 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -74.1 113.58 11.45 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 122.753 -0.263 . . . . 0.0 110.307 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.55 137.22 28.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.461 0.648 . . . . 0.0 112.229 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.2 t -145.36 150.86 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 1.5 tm0? -112.36 135.15 53.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.167 0.508 . . . . 0.0 110.569 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -126.36 166.87 16.36 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.217 0.532 . . . . 0.0 111.009 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -133.93 119.41 19.06 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.089 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.422 HG12 HD23 ' A' ' 20' ' ' LEU . 44.8 pt -134.61 170.79 18.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.073 0.463 . . . . 0.0 110.43 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.4 tmtp? -82.95 153.14 25.18 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 13.6 tpp180 -54.21 -24.45 18.46 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.109 0.564 . . . . 0.0 112.27 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -106.67 -5.06 18.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.565 0.697 . . . . 0.0 110.103 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.4 m -78.65 131.16 68.63 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.659 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.33 146.25 85.41 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.748 2.299 . . . . 0.0 112.325 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.44 -17.19 64.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.724 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 30.0 p -50.23 -38.96 43.13 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.76 0.424 . . . . 0.0 111.525 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.6 mmpt? -55.96 -53.33 58.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.86 -31.95 61.76 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.459 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.579 ' N ' HD12 ' A' ' 43' ' ' LEU . 53.8 mtt -60.12 -54.9 40.43 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.018 0.437 . . . . 0.0 111.41 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 11.2 mmmm -67.27 -39.01 86.01 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.227 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.78 79.77 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 111.298 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 26.4 t80 -55.33 -50.77 68.78 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.042 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.76 ' SG ' HD11 ' A' ' 58' ' ' ILE . 35.3 m -63.96 -34.27 77.6 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.842 0.353 . . . . 0.0 111.873 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.9 mt-10 -66.57 -39.54 88.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.911 0.386 . . . . 0.0 111.376 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -86.25 -21.94 27.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.976 0.417 . . . . 0.0 111.622 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.432 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 21.5 mm-40 -96.99 0.33 48.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.021 0.439 . . . . 0.0 111.561 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.01 45.19 96.63 Favored Glycine 0 CA--C 1.512 -0.145 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.964 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.644 ' HB3' HG21 ' A' ' 58' ' ' ILE . 86.2 mt -119.41 157.58 27.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.166 0.508 . . . . 0.0 110.587 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 58' ' ' ILE . 36.3 m -106.33 131.81 53.1 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.394 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 88.1 mmm -58.99 -23.37 61.8 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.253 0.549 . . . . 0.0 111.255 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.44 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.5 OUTLIER -84.66 -34.12 23.1 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.211 0.529 . . . . 0.0 111.236 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 0.6 OUTLIER -88.38 -17.1 31.26 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.992 0.425 . . . . 0.0 111.612 -176.229 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.76 HD11 ' SG ' ' A' ' 48' ' ' CYS . 6.3 pt -117.33 172.56 4.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -152.79 144.78 23.73 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.141 0.496 . . . . 0.0 110.628 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CE2' ' HG2' ' A' ' 44' ' ' MET . 6.1 m-85 -99.37 136.61 39.07 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.744 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -137.21 141.0 42.1 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.022 0.439 . . . . 0.0 110.379 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -151.18 140.69 21.57 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t0 68.65 24.68 6.73 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.832 0.825 . . . . 0.0 110.068 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.9 -0.72 65.24 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.964 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -118.45 136.07 23.88 Favored Pre-proline 0 N--CA 1.445 -0.721 0 O-C-N 122.157 -0.614 . . . . 0.0 110.466 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.58 136.38 49.87 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.906 1.738 . . . . 0.0 110.685 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.466 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 15.0 pt -112.21 169.94 4.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.383 0.611 . . . . 0.0 111.251 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.524 ' OD1' ' HB3' ' A' ' 71' ' ' ASP . 2.7 p30 -129.9 153.52 48.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.004 -177.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.6 pt-20 -59.17 -11.13 3.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.045 0.45 . . . . 0.0 112.207 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -96.63 5.3 50.99 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 122.043 -0.41 . . . . 0.0 111.65 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.524 ' HB3' ' OD1' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -96.54 161.76 13.76 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 121.574 -0.704 . . . . 0.0 110.425 -179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.5 p -121.63 150.94 56.26 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.708 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 18.5 Cg_endo -58.4 -23.15 62.13 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.955 2.437 . . . . 0.0 112.244 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.576 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -77.03 -31.67 56.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.219 0.533 . . . . 0.0 110.788 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -72.11 -55.85 6.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.565 -176.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.432 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 1.5 pt? -81.96 10.07 7.15 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 56.48 62.25 2.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 111.84 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 mtt -77.75 -169.91 1.67 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.347 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -156.59 158.61 37.41 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.63 141.98 40.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.16 0.505 . . . . 0.0 110.489 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 67.87 17.49 9.67 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.945 0.898 . . . . 0.0 112.017 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.57 171.66 11.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 m -125.11 138.57 54.17 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.581 0.705 . . . . 0.0 112.665 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.51 134.78 35.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -93.9 122.06 36.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.115 0.483 . . . . 0.0 110.602 -178.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 49.7 t -109.43 138.17 38.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.325 0.583 . . . . 0.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.86 155.24 46.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.523 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.536 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.7 mp0 -108.95 112.35 24.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.704 0.287 . . . . 0.0 110.879 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.93 73.56 0.9 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.686 1.231 . . . . 0.0 111.61 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.04 97.24 8.04 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.536 176.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.4 m -53.22 -59.58 4.38 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.178 0.513 . . . . 0.0 112.008 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.0 -124.54 1.25 Allowed Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.275 0 CA-C-O 118.211 -1.327 . . . . 0.0 111.206 178.625 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 39.0 p-80 . . . . . 0 N--CA 1.441 -0.925 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 73' ' ' PRO . 33.3 pt -129.6 156.44 41.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.148 0.499 . . . . 0.0 110.658 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.467 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -96.53 113.61 25.2 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.887 -178.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.481 ' HG ' ' SD ' ' A' ' 78' ' ' MET . 1.5 mm? -109.57 128.58 55.31 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.094 0.473 . . . . 0.0 109.752 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 37.3 ttpt -106.66 141.89 37.19 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.127 0.489 . . . . 0.0 111.168 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 45.1 t -112.48 124.18 68.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.38 112.05 13.43 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.509 0.671 . . . . 0.0 110.81 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.26 148.68 19.07 Favored Glycine 0 C--N 1.299 -1.499 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.143 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -60.58 -11.65 7.76 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.342 0.591 . . . . 0.0 112.355 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -71.25 -18.49 62.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.601 0.715 . . . . 0.0 110.132 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.24 -10.21 50.63 Favored Glycine 0 C--N 1.316 -0.557 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.6 m -78.51 116.87 19.2 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.973 0.416 . . . . 0.0 109.982 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 3.8 p -142.34 135.49 27.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.318 0.58 . . . . 0.0 111.282 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.41 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 25.0 t -145.27 151.89 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.301 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.62 136.23 49.31 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CZ ' ' HB ' ' A' ' 30' ' ' VAL . 17.0 m-85 -131.9 133.06 44.17 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.075 0.464 . . . . 0.0 111.095 -175.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 60.7 mtpt -107.51 107.67 18.63 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.911 -0.493 . . . . 0.0 110.988 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.4 pt -121.59 173.18 7.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.227 0.536 . . . . 0.0 110.459 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.8 tmtt? -81.27 150.57 28.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.12 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 7.3 tpp180 -58.32 -20.9 46.84 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.893 0.477 . . . . 0.0 111.926 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -108.73 2.64 21.95 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.861 -0.525 . . . . 0.0 111.014 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.7 m -85.89 133.12 42.03 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.793 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.21 146.47 81.45 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.728 2.285 . . . . 0.0 112.383 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.435 HD12 ' OD2' ' A' ' 71' ' ' ASP . 31.0 mt -65.86 -16.95 64.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.941 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.4 p -50.15 -37.62 35.38 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.797 0.439 . . . . 0.0 111.365 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -57.41 -52.49 65.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.91 -31.64 61.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.336 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.562 ' N ' HD12 ' A' ' 43' ' ' LEU . 56.3 mtt -59.44 -54.7 43.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.55 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.571 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 38.0 mmtm -66.06 -41.18 91.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 109.911 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.68 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.79 -47.31 86.22 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.373 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -54.49 -49.74 69.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.597 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.559 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 75.4 m -66.28 -34.99 79.25 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 84.3 mt-10 -61.03 -44.6 97.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.188 0.518 . . . . 0.0 111.141 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.9 ptp85 -85.42 -28.22 25.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -90.8 -18.7 24.46 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.817 -0.552 . . . . 0.0 112.184 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.36 41.59 9.98 Favored Glycine 0 C--N 1.309 -0.971 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.748 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.3 mm? -114.06 153.41 29.49 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.294 -0.533 . . . . 0.0 110.806 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 75.2 m -95.7 124.11 39.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.747 0.308 . . . . 0.0 110.447 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.436 ' HE2' ' HB3' ' A' ' 44' ' ' MET . 92.0 mmm -60.11 -25.51 65.51 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.71 -28.55 26.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.299 0.571 . . . . 0.0 111.178 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.723 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -83.17 -40.91 19.1 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.163 0.506 . . . . 0.0 110.772 -178.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.522 HD11 ' SG ' ' A' ' 48' ' ' CYS . 13.0 pt -90.86 178.06 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.115 0.484 . . . . 0.0 110.929 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -155.43 142.66 19.34 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.874 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.411 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.7 m-85 -92.33 137.08 32.66 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.085 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -140.6 134.71 30.9 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.051 0.453 . . . . 0.0 110.028 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 78' ' ' MET . 72.3 t80 -143.81 135.53 26.23 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.04 26.43 5.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.512 0.672 . . . . 0.0 111.11 176.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.03 -6.35 71.57 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.1 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -118.4 142.61 31.65 Favored Pre-proline 0 C--N 1.319 -0.76 0 O-C-N 122.284 -0.539 . . . . 0.0 110.53 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.37 141.22 46.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.112 1.875 . . . . 0.0 111.104 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 pt -115.8 160.39 15.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.236 0.541 . . . . 0.0 110.905 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.649 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -118.97 153.31 34.84 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.566 -178.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.463 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.7 pt-20 -60.5 -12.0 8.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.019 0.438 . . . . 0.0 112.039 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -94.15 4.83 53.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.626 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.649 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -91.84 156.7 17.32 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 121.672 -0.643 . . . . 0.0 110.395 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.7 p -119.06 148.64 45.27 Favored Pre-proline 0 N--CA 1.439 -0.981 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.838 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.46 ' HB2' HD11 ' A' ' 18' ' ' ILE . 19.6 Cg_endo -60.29 -17.48 46.96 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.705 2.27 . . . . 0.0 112.417 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.37 -16.52 32.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.095 0.474 . . . . 0.0 111.268 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -82.61 -55.68 4.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.335 0.588 . . . . 0.0 110.567 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -85.11 3.37 39.25 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.996 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 62.74 62.31 1.09 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.449 0.642 . . . . 0.0 112.455 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 84' ' ' ILE . 29.7 ttm -90.41 139.27 30.83 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -109.33 171.14 7.61 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.416 0.627 . . . . 0.0 111.705 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -65.91 141.27 58.29 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.085 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 65.47 13.95 9.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.687 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.96 170.66 15.33 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.2 m -128.55 144.21 51.11 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.519 HD11 ' SD ' ' A' ' 78' ' ' MET . 4.1 mp -104.8 133.08 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.764 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -94.15 125.57 38.86 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.31 0.576 . . . . 0.0 110.873 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 41.6 t -108.82 136.28 45.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.245 0.545 . . . . 0.0 111.147 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -128.78 153.01 47.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.034 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.436 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.6 mp0 . . . . . 0 C--N 1.321 -0.672 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 17.7 p-80 . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.6 pt -130.92 159.15 43.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.285 0.564 . . . . 0.0 110.744 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.2 OUTLIER -93.75 127.15 39.33 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.7 mt -126.49 125.59 42.33 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 83' ' ' THR . 31.9 ttpt -106.41 141.37 37.84 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.401 0.62 . . . . 0.0 111.224 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.9 t -114.15 126.88 71.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.503 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.29 121.95 27.06 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.454 0.645 . . . . 0.0 110.803 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.2 148.89 18.57 Favored Glycine 0 C--N 1.298 -1.567 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.54 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -16.49 27.34 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.262 0.553 . . . . 0.0 112.142 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -70.36 -15.7 62.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.548 0.689 . . . . 0.0 110.709 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.68 -10.9 53.29 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.566 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.533 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . 70.2 m -78.54 115.34 18.18 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.107 0.48 . . . . 0.0 110.242 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.73 135.21 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.329 0.585 . . . . 0.0 111.781 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.4 t -140.68 150.12 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.93 -177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.513 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -108.51 140.55 41.68 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.9 0.381 . . . . 0.0 110.667 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -134.81 163.45 29.79 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 110.367 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -134.85 110.31 9.09 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.3 pt -126.03 166.95 21.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.916 0.389 . . . . 0.0 110.434 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 2.1 tmtp? -74.71 147.43 41.42 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.523 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 42.7 ttm180 -65.16 -15.41 62.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.187 0.518 . . . . 0.0 111.909 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -103.11 -3.52 25.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.746 0.784 . . . . 0.0 109.079 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 m -88.99 133.55 35.2 Favored Pre-proline 0 N--CA 1.439 -1.01 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.132 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.0 150.67 87.77 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.643 2.228 . . . . 0.0 112.708 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.1 mt -65.44 -15.67 62.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.578 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 34.3 p -49.97 -37.4 32.17 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 122.768 0.427 . . . . 0.0 111.731 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 7.4 mmpt? -57.61 -52.39 65.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.242 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.44 -31.94 62.46 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.366 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.59 ' N ' HD12 ' A' ' 43' ' ' LEU . 57.7 mtt -60.98 -54.53 43.83 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 34.8 mmtp -68.54 -37.03 79.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.554 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.84 -47.94 81.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.986 0.422 . . . . 0.0 110.543 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.438 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 57.1 t80 -56.06 -51.93 66.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.343 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 p -61.09 -35.12 76.15 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.068 -0.395 . . . . 0.0 111.425 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 37.6 mt-10 -67.38 -43.27 81.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.439 . . . . 0.0 111.798 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 13.3 ptp180 -80.66 -25.89 37.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.809 0.337 . . . . 0.0 111.646 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.533 ' OE1' ' HB3' ' A' ' 28' ' ' SER . 20.5 mm-40 -93.85 -2.63 53.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.793 0.33 . . . . 0.0 111.822 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.91 91.84 Favored Glycine 0 CA--C 1.508 -0.344 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.74 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.655 ' HB3' HG21 ' A' ' 58' ' ' ILE . 84.9 mt -119.25 157.04 28.83 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.19 0.519 . . . . 0.0 110.714 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.7 m -107.12 129.51 54.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.568 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.451 ' CE ' ' HB3' ' A' ' 44' ' ' MET . 98.4 mmm -63.17 -22.47 66.89 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.164 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.06 -23.91 30.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.436 0.636 . . . . 0.0 110.422 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.85 -44.47 8.92 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.076 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.655 HG21 ' HB3' ' A' ' 53' ' ' LEU . 15.3 pt -88.52 166.83 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 O-C-N 121.661 -0.649 . . . . 0.0 110.348 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -144.43 137.85 27.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.951 0.405 . . . . 0.0 110.155 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -93.5 139.99 30.1 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.853 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -144.88 143.42 30.58 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.035 0.445 . . . . 0.0 110.291 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -152.28 135.85 16.1 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t70 67.34 25.77 8.64 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.471 0.653 . . . . 0.0 111.107 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.02 0.58 76.58 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.622 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -118.74 145.04 36.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 121.912 -0.758 . . . . 0.0 110.088 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.36 141.98 23.43 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.872 1.715 . . . . 0.0 111.166 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.8 pt -115.01 160.45 14.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.275 0.559 . . . . 0.0 111.289 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.611 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -121.66 155.42 35.2 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.805 -178.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 9.8 pt-20 -61.97 -9.76 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.172 0.511 . . . . 0.0 111.738 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -97.09 9.45 42.07 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 122.054 -0.404 . . . . 0.0 111.313 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.611 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -96.57 154.58 17.19 Favored 'General case' 0 C--O 1.243 0.718 0 O-C-N 121.74 -0.6 . . . . 0.0 109.734 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.3 p -117.16 146.98 39.37 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.551 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.87 -22.48 68.61 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.649 2.233 . . . . 0.0 112.091 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -80.35 -17.25 52.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.159 0.504 . . . . 0.0 110.904 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -79.23 -54.86 5.56 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.341 0.591 . . . . 0.0 110.023 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.9 pt? -87.54 12.25 12.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.223 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 57.08 58.73 3.79 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.491 0.662 . . . . 0.0 111.55 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.61 131.77 34.57 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.726 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -97.35 167.13 11.2 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.164 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.495 ' HB2' HD22 ' A' ' 19' ' ' ASN . 4.3 p-10 -76.69 150.58 36.31 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.111 0.481 . . . . 0.0 110.82 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 67.28 13.87 9.52 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.015 0.926 . . . . 0.0 112.209 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.17 171.38 13.74 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 17.6 m -125.97 147.7 49.45 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.393 0.616 . . . . 0.0 112.354 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.3 133.66 54.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.38 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.03 121.39 31.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.235 0.541 . . . . 0.0 111.275 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.81 138.93 35.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.244 0.545 . . . . 0.0 111.384 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -128.45 150.21 50.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.489 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.452 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.7 mp0 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.284 0.564 . . . . 0.0 111.643 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 31.9 p-80 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.407 HG13 HD21 ' A' ' 20' ' ' LEU . 31.4 pt -130.63 165.1 31.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.047 0.451 . . . . 0.0 110.591 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.12 120.51 40.57 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.407 HD21 HG13 ' A' ' 18' ' ' ILE . 2.5 mm? -111.83 124.57 52.63 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 83' ' ' THR . 33.5 ttpt -104.81 142.16 35.23 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.046 0.45 . . . . 0.0 110.634 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.84 127.71 71.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 120.958 0.409 . . . . 0.0 110.112 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.18 123.38 26.95 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.491 0.662 . . . . 0.0 110.146 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.9 148.41 16.47 Favored Glycine 0 C--N 1.3 -1.437 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.986 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -7.26 4.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -82.94 -10.63 58.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.482 0.658 . . . . 0.0 109.897 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.67 -13.36 46.54 Favored Glycine 0 CA--C 1.511 -0.193 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.338 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.1 m -77.31 119.24 20.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.962 0.41 . . . . 0.0 110.678 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.81 135.31 33.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.583 0.706 . . . . 0.0 111.366 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -143.33 149.46 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.41 ' C ' HE21 ' A' ' 31' ' ' GLN . 0.0 OUTLIER -108.0 139.77 42.15 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.106 -0.371 . . . . 0.0 110.4 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -128.43 163.7 24.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.32 0.581 . . . . 0.0 110.758 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -137.7 111.73 8.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.951 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 pt -136.44 173.33 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.323 0.582 . . . . 0.0 111.085 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 11.5 tmtt? -77.08 147.98 36.36 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.591 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.481 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 40.1 ttm180 -60.29 -18.12 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -112.59 5.11 17.68 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.372 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -83.03 133.98 47.25 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.29 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.1 140.34 83.45 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.684 2.256 . . . . 0.0 113.045 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.431 HD12 ' OD2' ' A' ' 71' ' ' ASP . 42.3 mt -65.1 -15.7 62.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.824 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 23.0 t -49.27 -39.63 31.3 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 122.615 0.366 . . . . 0.0 111.27 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.533 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -58.3 -52.46 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.617 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.6 -32.01 62.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.922 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.617 ' N ' HD12 ' A' ' 43' ' ' LEU . 38.9 ttm -61.78 -52.01 65.97 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.61 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 50.5 mmtt -68.61 -42.57 77.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.001 0.429 . . . . 0.0 110.03 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.76 -45.24 90.18 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.955 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 49.2 t80 -57.95 -52.34 65.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.455 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.531 ' SG ' ' HG2' ' A' ' 55' ' ' MET . 14.4 p -62.4 -37.62 86.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.119 0.485 . . . . 0.0 110.982 -177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 48.1 mt-10 -67.63 -37.59 82.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.987 0.422 . . . . 0.0 111.898 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.6 ptp180 -85.7 -23.41 27.41 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.104 -0.372 . . . . 0.0 111.552 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.426 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 19.6 mm-40 -97.01 -4.53 39.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.938 0.399 . . . . 0.0 111.75 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.45 54.62 Favored Glycine 0 C--N 1.322 -0.201 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.249 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.6 mp -116.65 154.43 30.56 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.156 0.503 . . . . 0.0 110.614 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.0 m -102.45 122.37 44.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.493 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.531 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 97.8 mmm -56.09 -25.48 45.67 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.516 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -83.75 -30.92 26.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.614 0.721 . . . . 0.0 109.985 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.759 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -88.52 -24.34 22.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.256 -177.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 54' ' ' SER . 21.9 pt -107.25 174.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 121.895 -0.503 . . . . 0.0 110.158 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -159.05 134.35 8.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.203 0.525 . . . . 0.0 110.509 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 4.1 m-85 -85.64 143.18 28.57 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.625 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.441 ' HG3' ' C ' ' A' ' 65' ' ' GLN . 26.0 ttm180 -142.1 141.78 32.74 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.066 0.46 . . . . 0.0 110.541 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -150.32 136.91 19.0 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.25 27.68 8.28 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.342 0.592 . . . . 0.0 111.207 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.4 2.08 83.28 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.239 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.441 ' C ' ' HG3' ' A' ' 61' ' ' ARG . 7.5 pt20 -125.5 144.52 48.18 Favored Pre-proline 0 C--N 1.317 -0.836 0 O-C-N 122.178 -0.601 . . . . 0.0 110.26 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.85 143.0 53.79 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.039 1.826 . . . . 0.0 111.442 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.7 pt -113.63 171.45 3.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.058 0.456 . . . . 0.0 110.552 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.661 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.59 155.48 47.46 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.7 -177.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.597 ' O ' ' HB2' ' A' ' 41' ' ' SER . 12.6 pt-20 -63.02 -8.83 8.12 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.134 0.492 . . . . 0.0 111.897 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 t -99.11 9.39 43.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 121.982 -0.449 . . . . 0.0 111.293 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.661 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.4 157.74 16.21 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.789 179.1 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.6 p -123.61 151.7 64.08 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 12.2 Cg_endo -57.54 -19.85 38.71 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.76 2.307 . . . . 0.0 112.641 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.2 35.23 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.94 -0.475 . . . . 0.0 110.97 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -72.44 -56.26 5.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.186 0.517 . . . . 0.0 110.86 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 1.7 pt? -81.88 6.06 16.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.634 -178.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 56.64 64.14 1.76 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.722 0.772 . . . . 0.0 111.145 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.79 -170.69 1.12 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.258 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -147.57 149.73 33.13 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.74 143.87 47.84 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 68.3 14.93 9.28 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.228 0.611 . . . . 0.0 111.878 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -87.61 173.95 8.74 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.044 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 28.3 m -126.41 142.42 51.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.699 0.761 . . . . 0.0 112.757 -175.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.76 133.09 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.786 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -90.55 119.95 31.23 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.041 0.448 . . . . 0.0 110.623 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.27 136.7 41.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.491 0.662 . . . . 0.0 111.609 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -134.78 165.71 24.64 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.403 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.1 mp0 . . . . . 0 C--N 1.314 -0.957 0 CA-C-O 121.079 0.466 . . . . 0.0 110.196 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.667 0 CA-C-O 122.384 1.087 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 pt -116.05 158.07 16.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.19 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.424 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -96.79 114.49 26.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.7 mt -110.98 124.8 52.86 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 83' ' ' THR . 32.3 ttpt -102.38 136.8 41.56 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.284 0.564 . . . . 0.0 111.185 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 29' ' ' VAL . 48.2 t -112.46 125.71 69.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.226 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.15 125.84 41.86 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.44 0.638 . . . . 0.0 110.61 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.95 152.07 20.16 Favored Glycine 0 C--N 1.302 -1.354 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.018 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -19.38 38.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.227 0.513 . . . . 0.0 112.32 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.13 -22.97 63.92 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.942 0.877 . . . . 0.0 109.742 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.47 -9.3 38.28 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.486 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . 67.1 m -68.97 125.36 26.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 22' ' ' VAL . 7.1 p -146.36 145.35 19.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.24 0.543 . . . . 0.0 111.569 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.1 t -146.79 151.51 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.424 ' NE2' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -111.08 132.26 54.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.236 0.541 . . . . 0.0 109.879 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 32.7 m-85 -122.02 168.16 12.26 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.782 -175.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -137.58 119.67 15.51 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 pt -138.47 163.6 28.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 32.0 tttt -76.32 165.13 25.29 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.293 0.568 . . . . 0.0 111.795 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 16.0 tpp180 -71.65 -19.31 62.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.408 -177.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -105.55 -6.8 19.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.9 0.857 . . . . 0.0 108.872 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.4 m -78.19 131.75 68.48 Favored Pre-proline 0 N--CA 1.435 -1.183 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.576 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.86 148.58 86.44 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.415 2.077 . . . . 0.0 111.707 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.15 -16.48 63.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.737 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 13.2 p -50.64 -37.45 40.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.824 0.449 . . . . 0.0 112.091 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 9.4 mmpt? -55.47 -53.88 50.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.912 0.387 . . . . 0.0 110.925 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 44' ' ' MET . 4.0 pp -75.66 -32.58 60.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.325 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.64 ' N ' HD12 ' A' ' 43' ' ' LEU . 46.2 ttm -59.33 -50.32 74.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.082 0.468 . . . . 0.0 110.458 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.644 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 1.9 mmmp? -69.9 -44.24 70.1 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.001 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.64 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.54 -42.97 93.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.739 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 34.1 t80 -54.27 -51.11 65.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.882 0.372 . . . . 0.0 110.623 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 58' ' ' ILE . 23.3 m -63.66 -34.54 78.06 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.023 0.44 . . . . 0.0 111.12 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 48.9 mm-40 -63.64 -39.47 94.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.067 0.461 . . . . 0.0 111.734 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -90.68 -20.82 22.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.791 0.329 . . . . 0.0 111.862 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.486 ' OE1' ' HB3' ' A' ' 28' ' ' SER . 19.5 mm-40 -95.11 -4.57 45.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.95 9.78 85.19 Favored Glycine 0 C--O 1.236 0.279 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.76 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.41 162.46 17.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.552 0.691 . . . . 0.0 112.007 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 58' ' ' ILE . 7.3 m -114.07 136.94 52.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.87 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.448 ' SD ' ' HA ' ' A' ' 45' ' ' LYS . 68.8 mmm -60.17 -28.35 67.86 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.776 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -83.39 -33.24 25.82 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.417 0.627 . . . . 0.0 110.911 -178.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.5 -20.91 46.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.395 0.616 . . . . 0.0 111.187 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.651 HD11 ' SG ' ' A' ' 48' ' ' CYS . 9.4 pt -118.15 179.72 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.134 0.492 . . . . 0.0 111.915 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -158.51 142.25 15.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.842 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -96.52 142.16 28.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.076 0.465 . . . . 0.0 111.008 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -144.18 143.15 30.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.075 0.464 . . . . 0.0 110.789 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -152.68 139.35 18.81 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.1 t70 65.47 23.97 11.89 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.828 0.823 . . . . 0.0 110.079 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.27 -23.47 8.24 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.885 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -94.68 140.14 22.5 Favored Pre-proline 0 C--N 1.322 -0.587 0 O-C-N 122.427 -0.455 . . . . 0.0 110.984 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.15 136.14 31.24 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.868 1.712 . . . . 0.0 110.623 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.605 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 10.8 pt -102.95 177.63 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.738 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.34 170.03 16.73 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.827 0.822 . . . . 0.0 111.066 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 12.0 pt-20 -73.44 -9.87 59.14 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.523 0.677 . . . . 0.0 109.708 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.2 t -107.9 10.94 28.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.211 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.605 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -99.84 155.4 17.68 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.908 178.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.8 p -118.53 147.87 42.91 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.329 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.12 -18.81 63.98 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.008 2.472 . . . . 0.0 112.177 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -79.65 -29.63 41.0 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.237 0.541 . . . . 0.0 110.511 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -67.85 -55.26 13.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.202 0.525 . . . . 0.0 110.825 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -88.53 12.44 14.48 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.738 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 52.28 62.81 2.51 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.724 0.773 . . . . 0.0 112.085 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.78 126.84 32.32 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.891 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.04 157.0 19.01 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -74.39 153.21 39.34 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 121.742 -0.599 . . . . 0.0 110.44 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 69.57 14.79 8.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.112 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -81.77 166.43 20.04 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.809 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 18.9 m -124.85 137.6 54.29 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.583 0.706 . . . . 0.0 112.88 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.99 140.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.659 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -95.31 117.86 31.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.089 0.471 . . . . 0.0 110.897 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -106.41 137.94 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.173 0.511 . . . . 0.0 111.414 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -129.55 155.71 45.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.899 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.987 0.422 . . . . 0.0 110.293 177.629 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 27.4 p-80 . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.17 166.98 27.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.075 0.464 . . . . 0.0 110.168 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.435 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -108.45 121.26 44.58 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.36 131.22 56.63 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 31.1 ttpt -107.81 140.66 40.56 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.072 0.463 . . . . 0.0 110.521 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 39.1 t -114.08 127.5 71.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.099 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.99 127.26 35.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.143 0.497 . . . . 0.0 110.333 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.57 153.72 16.8 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.221 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.6 pp0? -61.39 -17.74 55.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.402 0.62 . . . . 0.0 111.126 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.1 -15.1 62.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.982 0.896 . . . . 0.0 109.757 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.65 -16.1 55.11 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.796 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -70.11 118.6 13.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.049 0.452 . . . . 0.0 110.688 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.6 p -142.98 136.27 25.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.148 0.499 . . . . 0.0 111.527 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 t -146.86 151.99 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.246 0.618 . . . . 0.0 109.516 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.432 HE21 ' HB3' ' A' ' 31' ' ' GLN . 1.0 OUTLIER -110.77 141.85 43.53 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.231 -0.293 . . . . 0.0 110.497 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 24.1 m-85 -135.59 156.43 48.87 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.055 0.455 . . . . 0.0 110.826 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 48.3 mttp -125.46 110.32 13.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 110.433 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.2 pt -125.27 173.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 110.673 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 2.4 tmtp? -83.54 148.36 27.24 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -64.59 -14.51 58.18 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -107.6 -1.52 21.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.542 0.686 . . . . 0.0 109.835 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.8 m -86.73 133.54 39.46 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.679 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 151.0 85.05 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.606 2.204 . . . . 0.0 112.473 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.8 mt -65.18 -16.63 63.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.631 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 24.5 p -49.9 -37.76 32.89 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.933 0.493 . . . . 0.0 111.822 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 8.7 mmpt? -56.27 -53.56 55.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.872 0.368 . . . . 0.0 110.654 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -75.39 -31.85 60.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.47 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.572 ' N ' HD12 ' A' ' 43' ' ' LEU . 53.4 mtt -57.32 -55.99 27.64 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.793 0.33 . . . . 0.0 111.721 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -70.13 -39.19 75.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.54 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.25 -44.99 88.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.145 0.497 . . . . 0.0 110.609 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 25.0 t80 -60.17 -51.92 67.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.675 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.765 ' SG ' HD11 ' A' ' 58' ' ' ILE . 40.0 m -63.63 -34.55 78.08 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.009 0.433 . . . . 0.0 111.801 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 17.9 mm-40 -67.83 -39.38 83.88 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.051 0.453 . . . . 0.0 111.474 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.0 ptp180 -84.55 -22.54 30.06 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.917 0.389 . . . . 0.0 111.417 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.413 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 20.0 mm-40 -96.77 -3.05 43.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.253 0.549 . . . . 0.0 111.697 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.81 43.33 91.89 Favored Glycine 0 C--N 1.32 -0.351 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.349 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.538 ' HB3' HG21 ' A' ' 58' ' ' ILE . 28.6 mt -117.94 154.96 31.04 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.12 0.486 . . . . 0.0 110.594 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 75.2 m -102.03 126.51 48.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.696 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.481 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 92.7 mmm -55.5 -27.97 51.78 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.476 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -84.21 -30.76 25.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.419 0.628 . . . . 0.0 111.185 -177.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 0.8 OUTLIER -87.01 -28.88 22.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.686 -178.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.765 HD11 ' SG ' ' A' ' 48' ' ' CYS . 5.8 pt -105.07 177.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -157.31 141.18 16.02 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.113 0.482 . . . . 0.0 110.59 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 5.2 m-85 -91.97 141.9 28.12 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.135 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -139.81 138.79 36.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.154 0.502 . . . . 0.0 110.706 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -148.48 140.88 24.25 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 t70 67.72 23.46 8.63 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.766 0.793 . . . . 0.0 109.822 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.41 -0.24 75.98 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.26 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -119.4 138.01 26.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 O-C-N 122.206 -0.585 . . . . 0.0 110.411 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.85 141.46 71.57 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.015 1.81 . . . . 0.0 111.25 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.9 pt -114.78 167.55 7.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.86 0.362 . . . . 0.0 111.05 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.669 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -128.17 155.97 43.63 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.553 -177.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.3 pt-20 -60.12 -10.75 4.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 112.001 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.2 t -99.29 9.1 44.01 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 122.039 -0.413 . . . . 0.0 111.786 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.669 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -98.03 159.75 14.74 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 121.658 -0.651 . . . . 0.0 110.65 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.1 p -117.76 148.99 44.35 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.617 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.97 -19.8 69.97 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.514 2.142 . . . . 0.0 111.904 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.12 -20.95 40.31 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.005 0.431 . . . . 0.0 111.074 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -74.76 -53.86 8.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.545 0.688 . . . . 0.0 110.565 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.31 4.4 31.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.333 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 61.39 62.84 1.28 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.61 0.719 . . . . 0.0 111.832 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 mtt -79.19 126.56 30.91 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.176 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.69 157.75 18.43 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.517 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.6 147.26 49.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.859 0.361 . . . . 0.0 110.264 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 67.18 15.18 9.99 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.426 0.69 . . . . 0.0 112.167 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -82.73 168.28 17.36 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 19.1 m -125.6 140.41 52.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.842 0.83 . . . . 0.0 112.849 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.84 134.27 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.85 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.79 125.23 40.21 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.191 0.52 . . . . 0.0 111.254 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.447 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 44.0 t -108.48 137.94 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.414 0.626 . . . . 0.0 112.12 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -136.12 166.54 23.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.426 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.5 mp0 . . . . . 0 C--N 1.322 -0.601 0 CA-C-O 121.028 0.442 . . . . 0.0 111.406 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 38.1 p-80 . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 120.847 0.356 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 pt -129.77 167.9 24.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.027 0.441 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.613 ' OD1' ' HE3' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -103.69 128.37 51.04 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.61 124.94 44.63 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 83' ' ' THR . 36.0 ttpt -104.1 140.04 38.33 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.171 0.51 . . . . 0.0 111.037 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.0 t -112.86 124.71 69.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.884 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.38 126.17 40.12 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.623 0.725 . . . . 0.0 110.096 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.41 146.66 17.38 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.656 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -4.59 1.56 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.566 0.698 . . . . 0.0 112.023 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.617 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 27.6 t70 -77.65 -16.87 58.25 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.647 0.779 . . . . 0.0 110.188 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.54 -13.18 50.92 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -82.06 119.93 24.64 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.116 0.484 . . . . 0.0 110.624 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.51 137.83 28.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 111.156 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.443 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 11.3 t -144.75 151.82 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.36 137.78 46.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.443 ' CZ ' ' HB ' ' A' ' 30' ' ' VAL . 30.8 m-85 -130.55 139.48 50.46 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.406 0.622 . . . . 0.0 111.406 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.613 ' HE3' ' OD1' ' A' ' 19' ' ' ASN . 22.9 tttt -112.17 107.96 17.04 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.674 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 pt -128.89 172.18 15.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.148 0.499 . . . . 0.0 111.186 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.8 tmtt? -80.23 149.77 30.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.877 0.37 . . . . 0.0 110.294 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 20.0 tpp85 -61.31 -19.48 61.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.144 0.577 . . . . 0.0 111.574 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -107.52 -1.95 20.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.476 0.655 . . . . 0.0 109.825 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.7 m -82.24 131.52 55.9 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.917 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.94 147.4 89.17 Favored 'Trans proline' 0 C--O 1.241 0.638 0 C-N-CA 122.377 2.051 . . . . 0.0 112.151 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.84 -15.73 62.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.549 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 37.4 p -49.89 -39.78 40.78 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.198 0.599 . . . . 0.0 111.366 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.61 -53.19 60.52 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.374 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.94 -32.38 61.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.022 0.439 . . . . 0.0 111.045 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.609 ' N ' HD12 ' A' ' 43' ' ' LEU . 45.7 ttm -60.6 -50.04 75.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 110.369 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 30.0 mmtp -71.39 -42.58 68.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.429 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.652 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.48 -46.11 91.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.594 0.357 . . . . 0.0 111.898 -177.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -53.89 -49.39 68.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.992 0.425 . . . . 0.0 110.323 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 58' ' ' ILE . 37.1 m -66.34 -34.32 77.7 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.27 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 45.6 mm-40 -58.14 -49.22 77.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.431 0.634 . . . . 0.0 110.992 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 5.7 ptp180 -83.99 -24.92 30.37 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -95.8 -11.61 26.62 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.93 44.86 35.4 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.973 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.419 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.1 mm? -114.4 153.22 30.25 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.379 -0.483 . . . . 0.0 110.689 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.4 ' O ' HG12 ' A' ' 58' ' ' ILE . 68.1 m -95.75 126.14 40.81 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 120.776 0.322 . . . . 0.0 111.03 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.451 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 52.9 mmm -61.6 -26.71 68.15 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.454 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -82.54 -29.78 30.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 111.257 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.99 -45.64 10.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.366 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 48' ' ' CYS . 8.7 pt -84.6 172.98 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 121.692 -0.63 . . . . 0.0 111.317 -177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 23.6 tpt180 -151.7 137.38 17.9 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.259 0.552 . . . . 0.0 110.351 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 8.1 m-85 -92.07 134.08 35.16 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.987 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -139.55 139.74 36.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.104 0.478 . . . . 0.0 110.509 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -145.76 137.83 25.38 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t70 67.08 24.7 9.35 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.849 0.833 . . . . 0.0 110.314 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.95 81.21 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.334 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -119.17 131.92 24.17 Favored Pre-proline 0 N--CA 1.451 -0.405 0 O-C-N 122.283 -0.54 . . . . 0.0 110.622 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -64.02 138.58 63.05 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.288 1.992 . . . . 0.0 111.295 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.7 pt -111.79 167.97 5.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.138 0.494 . . . . 0.0 111.259 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.623 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.32 158.94 39.34 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.29 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 41' ' ' SER . 5.4 pt-20 -63.21 -9.66 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.226 0.536 . . . . 0.0 111.604 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 t -99.59 10.66 40.97 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.939 -0.475 . . . . 0.0 111.604 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.623 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -100.07 157.34 16.62 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 121.714 -0.616 . . . . 0.0 110.686 178.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.7 p -120.72 147.77 46.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.693 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.445 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 34.6 Cg_endo -63.89 -19.02 66.17 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.917 2.411 . . . . 0.0 112.35 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.59 -25.95 41.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.008 0.432 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -73.49 -55.71 5.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.398 0.618 . . . . 0.0 111.286 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.453 HD21 ' HG3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -81.61 -2.69 51.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.613 -178.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 67.31 63.31 0.44 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.014 0.912 . . . . 0.0 110.799 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.453 ' HG3' HD21 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -82.31 128.71 34.47 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.684 -178.228 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.05 164.02 16.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.952 0.406 . . . . 0.0 110.095 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.19 147.0 31.47 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.039 0.447 . . . . 0.0 110.88 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 69.17 14.83 8.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.308 1.043 . . . . 0.0 111.896 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -81.21 169.64 17.09 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 21.6 m -124.97 141.46 52.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.509 0.671 . . . . 0.0 112.564 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.36 138.17 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.243 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.04 120.45 33.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.076 0.465 . . . . 0.0 110.544 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.46 137.48 42.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.343 0.592 . . . . 0.0 111.594 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -130.97 153.84 48.78 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.729 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.617 ' OE1' ' HB2' ' A' ' 26' ' ' ASP . 2.0 mp0 . . . . . 0 C--N 1.332 -0.168 0 CA-C-O 121.08 0.467 . . . . 0.0 111.582 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 12.8 p-80 . . . . . 0 N--CA 1.444 -0.734 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 73' ' ' PRO . 35.0 pt -131.34 161.46 41.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.509 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -102.05 125.15 48.66 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.428 HD21 HG13 ' A' ' 18' ' ' ILE . 2.6 mm? -118.72 125.3 49.36 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 33.1 ttpt -103.14 140.32 37.5 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.955 0.407 . . . . 0.0 110.535 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -111.19 124.14 67.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 29' ' ' VAL . . . -121.14 123.72 42.99 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.582 0.706 . . . . 0.0 110.778 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.46 139.55 14.46 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 120.111 -1.042 . . . . 0.0 111.075 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -64.06 -9.07 14.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.195 0.497 . . . . 0.0 112.33 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -83.6 -8.16 59.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.681 0.753 . . . . 0.0 109.554 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.47 -9.52 45.27 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.602 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.2 m -78.27 110.72 13.53 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 122.366 -0.491 . . . . 0.0 109.95 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 23' ' ' ALA . 61.8 t -137.27 134.72 47.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 122.087 -0.383 . . . . 0.0 110.362 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.416 HG11 ' HD3' ' A' ' 50' ' ' ARG . 21.1 t -148.64 152.7 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -108.94 142.33 39.74 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.166 -0.334 . . . . 0.0 110.603 -178.05 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -136.95 155.88 49.16 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.048 0.452 . . . . 0.0 111.229 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 44.5 mtmt -127.62 120.12 27.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.415 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 pt -136.93 170.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 110.393 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 6.2 tmtt? -73.34 147.35 44.49 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 33.7 ttm180 -64.37 -14.64 57.56 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.203 0.525 . . . . 0.0 111.665 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -110.09 1.34 18.81 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.496 0.665 . . . . 0.0 109.738 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 m -84.79 135.02 40.69 Favored Pre-proline 0 N--CA 1.444 -0.739 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.007 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.44 143.78 97.71 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.524 2.15 . . . . 0.0 112.301 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.402 HD12 ' OD2' ' A' ' 71' ' ' ASP . 43.3 mt -65.14 -16.18 63.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.609 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 55.6 p -49.46 -38.19 28.84 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.034 0.534 . . . . 0.0 111.633 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.407 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.9 mmpt? -56.25 -53.72 53.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.754 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 44' ' ' MET . 4.0 pp -75.59 -32.19 60.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.876 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.614 ' N ' HD12 ' A' ' 43' ' ' LEU . 58.7 mtt -59.23 -55.43 34.99 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.315 0.579 . . . . 0.0 111.208 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.511 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 41.9 mtpt -70.91 -34.41 71.51 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.197 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.65 -44.11 97.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.144 0.497 . . . . 0.0 110.136 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -58.95 -51.12 71.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' SG ' ' HG2' ' A' ' 55' ' ' MET . 17.8 p -63.15 -36.61 84.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.056 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 36.8 mt-10 -68.31 -39.06 82.13 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HG3' HE21 ' A' ' 51' ' ' GLN . 11.5 ptm180 -83.53 -23.82 31.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.006 0.432 . . . . 0.0 111.376 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.422 HE21 ' HG3' ' A' ' 50' ' ' ARG . 20.3 mm-40 -95.03 -6.44 42.21 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.72 42.74 53.37 Favored Glycine 0 C--N 1.322 -0.222 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.689 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.95 156.38 28.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.228 0.537 . . . . 0.0 110.608 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.496 ' O ' HG12 ' A' ' 58' ' ' ILE . 45.0 m -104.8 125.91 51.34 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.341 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.48 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 97.2 mmm -59.09 -22.6 61.06 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.102 0.477 . . . . 0.0 111.89 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.473 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -83.64 -33.85 25.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.517 0.675 . . . . 0.0 110.467 -179.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.473 ' NE2' ' HB2' ' A' ' 56' ' ' ARG . 0.8 OUTLIER -90.61 -10.59 42.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.942 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 54' ' ' SER . 21.0 pt -117.74 171.89 5.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 O-C-N 121.896 -0.503 . . . . 0.0 110.788 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -151.96 138.03 18.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.973 0.416 . . . . 0.0 110.089 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.8 m-85 -93.22 139.37 30.69 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.214 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -141.16 141.18 34.14 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.239 0.542 . . . . 0.0 110.721 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -146.75 132.17 18.62 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 68.44 25.45 6.87 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.749 0.785 . . . . 0.0 110.303 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.02 -24.7 5.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.957 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -91.58 133.68 30.68 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 122.369 -0.489 . . . . 0.0 111.222 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.88 143.09 59.56 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.239 1.959 . . . . 0.0 111.385 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.8 pt -117.28 162.6 15.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.164 0.507 . . . . 0.0 111.006 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.665 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -123.47 156.88 34.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.313 -177.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 3.9 pt-20 -57.81 -14.55 6.15 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.114 0.483 . . . . 0.0 111.866 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -98.32 8.81 44.33 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 122.021 -0.424 . . . . 0.0 111.971 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.665 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -95.84 159.52 14.93 Favored 'General case' 0 C--O 1.24 0.598 0 O-C-N 121.894 -0.504 . . . . 0.0 110.372 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.3 p -121.27 144.03 38.81 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.531 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 14.4 Cg_endo -57.47 -24.82 63.24 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.032 2.488 . . . . 0.0 112.65 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.75 -26.79 57.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.21 0.529 . . . . 0.0 111.075 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -71.31 -55.71 7.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.26 0.552 . . . . 0.0 110.546 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.437 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.0 pt? -85.07 2.65 42.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.041 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 61.57 64.2 1.08 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.854 0.835 . . . . 0.0 112.034 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.1 ttt -82.66 128.86 34.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.131 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -84.55 154.39 22.68 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 120.86 0.362 . . . . 0.0 110.187 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -72.82 147.33 45.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.992 0.425 . . . . 0.0 110.068 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 68.91 14.11 8.86 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.694 0.798 . . . . 0.0 111.256 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -82.61 172.37 13.03 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.1 m -126.29 141.79 51.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.568 0.699 . . . . 0.0 112.704 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -103.15 139.58 23.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.107 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -97.53 121.69 39.73 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.211 0.529 . . . . 0.0 110.701 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.46 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 39.0 t -108.47 137.5 39.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.237 0.541 . . . . 0.0 111.82 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -131.36 158.19 41.39 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 121.167 0.508 . . . . 0.0 110.801 178.614 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 13.7 p-80 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.9 pt -128.86 159.77 40.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.294 0.569 . . . . 0.0 111.244 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.432 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -101.57 119.62 39.06 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.004 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.7 140.99 47.79 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.987 0.422 . . . . 0.0 109.862 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -115.32 139.66 49.79 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.319 0.581 . . . . 0.0 111.085 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 29' ' ' VAL . 46.4 t -112.04 124.81 69.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.676 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.39 122.95 35.02 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.479 0.656 . . . . 0.0 110.437 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.33 147.69 16.33 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.934 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -7.89 2.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -78.12 -14.61 59.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.747 0.784 . . . . 0.0 110.243 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.92 -11.78 56.04 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.2 m -78.61 118.76 21.02 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 120.945 0.402 . . . . 0.0 110.09 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.7 p -141.94 137.9 30.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.215 0.531 . . . . 0.0 111.116 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -142.93 150.96 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.44 HE21 ' HB3' ' A' ' 31' ' ' GLN . 1.1 tm0? -110.29 141.23 43.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.888 0.375 . . . . 0.0 110.374 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -135.87 147.26 48.13 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.034 0.445 . . . . 0.0 110.996 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -115.2 109.59 18.21 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.061 0.458 . . . . 0.0 110.649 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.7 pt -124.38 178.42 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 22.4 tttt -89.91 159.2 17.06 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.465 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -62.25 -24.16 67.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.47 0.708 . . . . 0.0 111.884 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -105.74 -1.92 23.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.574 0.702 . . . . 0.0 109.857 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 m -83.96 132.18 49.15 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.64 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.88 149.86 86.18 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.593 2.195 . . . . 0.0 112.424 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.65 -15.6 62.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.036 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 22.3 p -49.37 -39.83 33.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.078 0.551 . . . . 0.0 111.995 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -55.5 -53.25 58.69 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.792 0.33 . . . . 0.0 111.19 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.29 -31.87 62.67 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.713 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.577 ' N ' HD12 ' A' ' 43' ' ' LEU . 57.1 mtt -59.96 -56.43 21.77 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.003 0.43 . . . . 0.0 111.596 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -67.16 -39.86 86.56 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.815 0.341 . . . . 0.0 110.499 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.45 -46.47 86.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.121 0.486 . . . . 0.0 110.582 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -57.81 -52.05 67.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.177 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.8 p -61.57 -36.79 81.65 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.059 0.457 . . . . 0.0 111.072 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -64.77 -47.98 76.19 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.959 0.409 . . . . 0.0 111.853 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 18.5 ptp180 -78.17 -24.97 47.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.83 0.348 . . . . 0.0 111.567 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -96.88 -7.63 32.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.43 45.76 22.63 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.986 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.1 mm? -120.05 159.96 23.75 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.413 -0.463 . . . . 0.0 110.547 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.8 m -106.09 126.26 51.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.645 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.457 ' CE ' ' HB3' ' A' ' 44' ' ' MET . 93.0 mmm -57.39 -28.17 62.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.71 -28.67 26.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.294 0.568 . . . . 0.0 110.839 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.749 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -83.19 -34.12 26.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.383 0.611 . . . . 0.0 110.549 -177.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.512 HG22 ' HG3' ' A' ' 88' ' ' GLN . 20.5 pt -92.94 165.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.354 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 20.1 tpt180 -143.36 128.69 18.87 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.909 0.385 . . . . 0.0 110.167 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -87.05 139.67 30.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.026 0.441 . . . . 0.0 110.054 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -142.14 143.12 32.85 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.115 0.483 . . . . 0.0 111.057 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -149.38 132.41 16.23 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.18 25.33 7.33 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.884 0.85 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.51 -25.57 5.01 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.156 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -91.36 138.43 25.57 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.429 -0.454 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.16 143.69 49.66 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.047 1.832 . . . . 0.0 110.981 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.552 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 12.7 pt -114.11 170.69 4.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.794 0.331 . . . . 0.0 111.116 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.427 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.5 OUTLIER -130.71 164.68 24.53 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.555 0.693 . . . . 0.0 110.921 -175.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 12.0 pt-20 -69.45 -7.67 39.94 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.39 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 68' ' ' ASN . 10.0 t -102.03 6.19 40.98 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.599 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.552 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -99.21 155.04 17.69 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.918 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.5 p -120.63 152.01 55.03 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.49 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.34 -15.66 46.4 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.629 2.22 . . . . 0.0 112.165 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.56 -16.17 37.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.176 0.513 . . . . 0.0 110.829 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -80.2 -55.03 5.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.368 0.604 . . . . 0.0 111.215 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.5 pt? -93.16 12.58 23.86 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.848 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 53.33 63.43 2.22 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 84' ' ' ILE . 25.4 ttm -87.63 133.06 33.88 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 5.8 mm-40 -104.67 174.18 5.99 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.855 0.359 . . . . 0.0 110.636 -176.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -66.21 141.56 58.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.972 0.415 . . . . 0.0 110.693 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 69.88 15.94 7.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.625 0.77 . . . . 0.0 111.747 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -80.11 160.7 25.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -126.24 143.78 51.02 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.487 0.66 . . . . 0.0 112.645 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.519 HD11 ' SD ' ' A' ' 78' ' ' MET . 4.1 mp -108.16 138.9 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -95.05 123.97 38.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.122 0.487 . . . . 0.0 110.486 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.423 HG12 HE22 ' A' ' 88' ' ' GLN . 44.1 t -110.13 139.85 31.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.307 0.575 . . . . 0.0 111.448 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -130.78 154.5 47.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.694 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.512 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.8 mp0 . . . . . 0 C--N 1.326 -0.443 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 28.2 p-80 . . . . . 0 N--CA 1.444 -0.732 0 CA-C-O 120.842 0.353 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.2 pt -125.11 165.61 22.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 121.318 0.58 . . . . 0.0 110.881 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -100.09 135.5 41.42 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.82 126.38 30.41 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -107.19 140.08 40.61 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.245 0.545 . . . . 0.0 111.49 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 29' ' ' VAL . 45.0 t -113.82 124.36 70.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.006 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.9 124.17 34.51 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.605 0.717 . . . . 0.0 110.846 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.35 151.87 19.45 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.259 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.5 pp0? -60.53 -20.22 59.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.187 0.517 . . . . 0.0 111.681 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.7 -7.44 55.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.634 0.731 . . . . 0.0 110.454 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.35 -16.07 55.57 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.686 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 m -68.76 116.73 9.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.851 0.357 . . . . 0.0 110.241 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.9 p -143.83 139.6 25.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.032 0.444 . . . . 0.0 111.423 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.2 t -145.83 151.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.463 HE21 ' HB3' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -107.22 139.91 40.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.935 0.397 . . . . 0.0 110.1 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -133.42 166.97 21.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.385 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -140.29 114.12 8.87 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.903 0.382 . . . . 0.0 110.516 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 pt -127.91 174.8 10.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.116 0.484 . . . . 0.0 110.757 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.7 tmtt? -87.46 149.76 24.21 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.183 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.425 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 22.7 tpp180 -54.02 -28.64 39.47 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.49 0.716 . . . . 0.0 112.376 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -105.08 -0.26 26.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.48 0.657 . . . . 0.0 110.613 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 m -85.83 133.6 41.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.181 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.99 151.87 84.33 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.502 2.135 . . . . 0.0 112.316 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.92 -15.23 61.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.943 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 25.8 p -49.28 -38.24 26.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 122.967 0.507 . . . . 0.0 111.976 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -56.35 -54.09 49.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.502 0.191 . . . . 0.0 110.845 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.96 -33.6 57.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.887 0.375 . . . . 0.0 111.629 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.644 ' N ' HD12 ' A' ' 43' ' ' LEU . 45.3 ttm -62.07 -53.27 57.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.02 0.438 . . . . 0.0 111.002 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.646 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 8.7 mmmm -70.3 -36.7 74.49 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.207 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.664 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -61.3 -45.66 93.55 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.001 -0.437 . . . . 0.0 111.05 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -56.33 -51.45 68.18 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.431 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.1 p -63.53 -35.31 80.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.107 0.48 . . . . 0.0 110.843 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 6.2 mm-40 -65.75 -43.78 87.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.009 0.433 . . . . 0.0 111.586 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 13.1 ptp180 -83.22 -20.98 33.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -96.95 -9.66 27.88 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.831 -0.543 . . . . 0.0 111.818 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.67 40.71 26.1 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.031 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.412 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.1 mm? -117.41 157.9 25.4 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.038 0.446 . . . . 0.0 110.016 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.424 ' O ' HG12 ' A' ' 58' ' ' ILE . 8.2 m -109.65 134.76 51.59 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.702 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.519 ' HE1' ' HG2' ' A' ' 44' ' ' MET . 97.1 mmm -58.76 -25.99 63.56 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.42 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -85.15 -24.94 27.75 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.325 0.583 . . . . 0.0 111.109 178.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.64 -19.34 26.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.296 0.57 . . . . 0.0 110.7 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 54' ' ' SER . 14.4 pt -120.94 174.32 5.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.095 0.474 . . . . 0.0 111.173 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 59' ' ' ARG . 9.0 tpt180 -154.29 138.98 16.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.113 0.482 . . . . 0.0 109.927 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -91.87 137.3 32.48 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.227 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HG3' ' C ' ' A' ' 65' ' ' GLN . 16.3 ttm180 -136.62 134.59 37.51 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.321 0.581 . . . . 0.0 110.881 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -145.29 144.26 30.66 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 68.33 24.35 7.38 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.855 0.836 . . . . 0.0 109.447 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.34 -5.62 59.53 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.366 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.481 ' C ' ' HG3' ' A' ' 61' ' ' ARG . 5.0 pt20 -118.69 143.96 34.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 O-C-N 122.196 -0.591 . . . . 0.0 111.26 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.64 133.96 36.23 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.067 1.845 . . . . 0.0 111.145 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.6 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 12.0 pt -106.87 -177.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.92 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.86 164.53 27.36 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 121.394 0.616 . . . . 0.0 109.793 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 41' ' ' SER . 15.9 pt-20 -74.39 -9.47 58.62 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.714 0.769 . . . . 0.0 109.403 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 t -103.4 10.31 37.4 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.853 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.6 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -98.39 159.0 15.24 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.4 p -117.08 148.51 42.46 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.568 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.84 -12.17 34.06 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.798 2.332 . . . . 0.0 112.081 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.5 -28.35 23.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.125 0.488 . . . . 0.0 110.654 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -69.63 -55.32 10.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 111.685 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -88.38 9.9 21.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.002 0.429 . . . . 0.0 111.636 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 53.74 63.88 2.04 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.935 0.874 . . . . 0.0 112.735 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -78.48 129.01 34.38 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.222 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -91.19 158.11 16.8 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.436 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 4.7 p-10 -70.05 147.8 49.6 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.986 -0.446 . . . . 0.0 110.478 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' HG2' HD22 ' A' ' 19' ' ' ASN . 5.7 mm-40 66.72 15.25 10.08 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.342 0.657 . . . . 0.0 111.733 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -79.57 167.04 21.27 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -121.83 137.48 54.76 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.659 0.742 . . . . 0.0 112.923 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.13 134.35 41.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.986 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.87 122.14 36.05 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.123 0.487 . . . . 0.0 110.471 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 40.3 t -107.68 138.38 34.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.234 0.54 . . . . 0.0 111.64 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -131.55 155.67 47.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.734 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.419 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.6 mp0 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.08 0.467 . . . . 0.0 111.192 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 6.1 p-80 . . . . . 0 CA--C 1.504 -0.826 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 80' ' ' ASP . 45.2 pt -131.08 160.44 42.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.269 0.556 . . . . 0.0 110.233 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.561 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.4 OUTLIER -98.65 120.95 39.95 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.055 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.06 125.16 54.08 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -104.17 140.55 37.65 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.222 0.534 . . . . 0.0 110.596 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.75 124.21 68.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' A' ' 29' ' ' VAL . . . -122.31 122.44 39.08 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.549 0.69 . . . . 0.0 110.993 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.72 139.51 14.46 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.228 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -60.06 -17.07 36.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.382 0.611 . . . . 0.0 111.398 178.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.29 -6.61 58.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.751 0.786 . . . . 0.0 110.127 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.95 -11.16 48.89 Favored Glycine 0 CA--C 1.507 -0.462 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.048 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.8 m -78.6 108.08 11.73 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.153 0.502 . . . . 0.0 109.836 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 23' ' ' ALA . 59.6 t -135.33 131.29 51.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 120.959 0.409 . . . . 0.0 110.112 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -141.92 150.7 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.561 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -109.5 139.38 44.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.0 110.121 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 30.4 m-85 -130.11 159.46 36.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.321 0.582 . . . . 0.0 111.263 -176.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 42.3 mtmt -131.43 113.25 13.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.302 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.6 pt -135.04 176.3 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.69 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.4 tmtt? -82.6 149.03 27.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.488 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 22.1 ttm-85 -61.87 -19.42 62.62 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -105.61 1.31 27.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.695 0.76 . . . . 0.0 109.526 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.5 m -84.99 131.9 47.38 Favored Pre-proline 0 N--CA 1.442 -0.863 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.231 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.2 145.33 88.76 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 122.633 2.222 . . . . 0.0 112.177 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.47 HD12 ' OD1' ' A' ' 71' ' ' ASP . 34.3 mt -64.93 -16.29 63.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.933 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.526 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 12.3 t -50.06 -37.19 32.29 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 122.457 0.303 . . . . 0.0 111.102 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.439 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -56.04 -53.46 56.73 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-O 120.848 0.356 . . . . 0.0 111.026 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.81 -31.87 61.83 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.529 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.584 ' N ' HD12 ' A' ' 43' ' ' LEU . 56.9 mtt -60.4 -54.56 44.1 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.927 0.394 . . . . 0.0 111.537 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 41' ' ' SER . 31.2 mmtp -66.71 -39.96 88.23 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.84 -47.98 83.88 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 28.0 t80 -55.22 -51.72 65.67 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.857 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.631 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.3 m -63.94 -38.53 91.44 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.568 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 40.2 mt-10 -64.09 -42.32 96.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.743 0.306 . . . . 0.0 111.356 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.2 ptp180 -80.39 -24.29 39.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.908 0.385 . . . . 0.0 111.573 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -96.0 -8.74 32.84 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.63 2.98 90.69 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.897 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 7.3 mp -80.53 158.17 25.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.615 0.722 . . . . 0.0 112.005 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.0 m -107.81 132.27 53.59 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.034 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.431 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 95.7 mmm -57.36 -31.06 65.37 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -84.35 -31.21 24.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.341 0.591 . . . . 0.0 111.126 -178.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 0.7 OUTLIER -84.42 -16.69 41.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.39 0.614 . . . . 0.0 110.816 -177.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.631 HD11 ' SG ' ' A' ' 48' ' ' CYS . 10.3 pt -117.81 179.17 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.369 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -156.07 132.77 10.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 120.983 0.42 . . . . 0.0 110.088 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.401 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.4 m-85 -83.54 139.32 32.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.669 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -144.11 144.24 31.5 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.218 0.532 . . . . 0.0 110.987 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -149.18 134.88 18.72 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 t70 68.44 25.04 6.98 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.535 0.683 . . . . 0.0 110.359 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.33 -24.05 6.68 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.137 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -93.69 137.55 23.19 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 122.301 -0.529 . . . . 0.0 110.803 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.3 145.54 60.15 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.038 1.825 . . . . 0.0 111.249 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 pt -113.55 160.65 12.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.982 0.42 . . . . 0.0 110.22 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.638 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -121.18 153.88 36.97 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.757 -177.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 41' ' ' SER . 10.0 pt-20 -59.72 -12.6 7.41 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.143 0.497 . . . . 0.0 111.944 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.2 t -95.82 8.12 44.44 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 120.717 0.294 . . . . 0.0 111.135 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.638 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -95.0 156.33 16.36 Favored 'General case' 0 C--O 1.244 0.78 0 O-C-N 121.89 -0.506 . . . . 0.0 110.017 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.4 p -118.12 146.64 39.72 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.613 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 18.4 Cg_endo -60.36 -22.92 73.02 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.762 2.308 . . . . 0.0 112.338 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.488 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -78.1 -22.79 48.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.166 0.508 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -71.59 -55.27 8.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.397 0.618 . . . . 0.0 110.442 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.3 pt? -85.91 9.02 18.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.542 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 55.79 60.08 3.47 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.776 0.798 . . . . 0.0 112.246 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.4 mtt -84.38 141.24 31.01 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.645 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -108.76 177.35 4.8 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.121 0.486 . . . . 0.0 111.15 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 18' ' ' ILE . 5.2 m-20 -64.54 138.27 58.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.745 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 68.82 19.42 8.37 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.678 0.791 . . . . 0.0 112.497 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -73.47 159.0 33.86 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.6 m -124.41 144.56 49.98 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.72 142.22 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.215 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 11.3 m-20 -94.83 122.5 37.53 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 110.505 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.563 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 28.7 t -109.83 136.69 45.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 O-C-N 121.886 -0.509 . . . . 0.0 111.594 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 85' ' ' ASP . 60.1 m-85 -132.73 157.61 44.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.469 0.652 . . . . 0.0 111.133 179.348 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 20.0 p-80 . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.2 pt -132.95 166.79 28.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.108 0.48 . . . . 0.0 110.731 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.658 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -103.78 125.94 50.58 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.17 124.07 47.06 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' THR . 31.8 ttpt -103.95 140.65 37.41 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.102 0.477 . . . . 0.0 110.593 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 29' ' ' VAL . 47.6 t -113.67 125.43 70.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.897 0.379 . . . . 0.0 110.084 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.6 121.75 27.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.533 0.682 . . . . 0.0 110.49 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.56 148.85 16.81 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 120.249 -0.976 . . . . 0.0 112.207 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -6.09 2.85 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.365 0.602 . . . . 0.0 112.294 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.92 -14.14 59.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.728 0.775 . . . . 0.0 109.845 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.6 -15.05 53.51 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.635 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.7 m -77.08 122.76 25.41 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.926 0.393 . . . . 0.0 110.63 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 22' ' ' VAL . 4.2 p -142.28 137.83 29.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.138 0.494 . . . . 0.0 111.253 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 t -143.09 151.08 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.658 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -106.34 142.0 36.73 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.343 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -135.29 146.61 48.68 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.237 0.542 . . . . 0.0 110.461 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -121.65 114.17 20.78 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.03 0.443 . . . . 0.0 110.455 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.8 pt -134.46 177.76 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.24 0.543 . . . . 0.0 111.264 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.484 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 11.3 tmtt? -86.45 152.16 22.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.484 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 13.6 tpp180 -60.53 -19.16 56.33 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.943 0.497 . . . . 0.0 111.734 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -107.73 -3.3 19.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.55 0.691 . . . . 0.0 109.653 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -83.67 132.44 49.14 Favored Pre-proline 0 N--CA 1.441 -0.906 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.217 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.15 149.81 88.46 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.557 2.171 . . . . 0.0 112.853 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.453 HD12 ' OD2' ' A' ' 71' ' ' ASP . 28.0 mt -65.59 -13.95 60.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.065 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 p -55.13 -34.48 63.77 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.327 0.584 . . . . 0.0 110.663 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -55.93 -55.98 26.14 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.603 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -77.38 -32.73 55.11 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.632 ' N ' HD12 ' A' ' 43' ' ' LEU . 38.7 ttm -62.41 -54.01 46.53 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.067 0.46 . . . . 0.0 110.959 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 33.6 mtpt -72.37 -32.99 66.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.491 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -64.18 -43.74 94.16 Favored 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 121.92 -0.488 . . . . 0.0 110.434 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -57.39 -50.53 72.69 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.105 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 14.8 p -61.48 -36.96 81.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 0.0 110.909 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.1 mt-10 -69.02 -40.05 78.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.4 ptp180 -83.85 -24.75 30.77 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.936 -0.477 . . . . 0.0 112.167 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -95.41 -11.83 26.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.182 0.515 . . . . 0.0 111.461 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.43 41.49 13.29 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.491 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.484 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.4 mm? -117.23 158.24 24.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.041 0.448 . . . . 0.0 110.301 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 58' ' ' ILE . 15.2 m -106.38 131.99 52.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.283 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 85.4 mmm -55.07 -29.14 56.91 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.928 0.491 . . . . 0.0 111.817 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.528 ' N ' ' HD3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -83.86 -28.79 27.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.4 0.619 . . . . 0.0 111.179 -177.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.7 -7.53 46.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.117 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.484 HG21 ' HB3' ' A' ' 53' ' ' LEU . 17.5 pt -125.1 170.18 15.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 120.943 0.402 . . . . 0.0 110.965 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -149.99 135.86 18.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.12 0.486 . . . . 0.0 110.164 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -89.82 137.26 32.49 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.028 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -137.28 143.02 41.94 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.258 0.551 . . . . 0.0 110.622 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -150.83 138.59 19.81 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 t70 69.79 25.35 5.08 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.605 0.716 . . . . 0.0 110.282 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.01 -1.56 79.12 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.538 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -122.73 142.92 38.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 O-C-N 122.122 -0.634 . . . . 0.0 111.409 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.04 141.89 59.59 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.503 2.135 . . . . 0.0 111.866 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 pt -117.08 172.83 4.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.102 0.477 . . . . 0.0 111.01 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.688 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.96 156.33 46.38 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.818 -178.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.58 -13.14 12.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.778 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.0 t -96.61 10.21 39.2 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 122.157 -0.339 . . . . 0.0 111.374 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.688 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.81 157.4 16.53 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.96 177.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.3 p -120.76 151.01 53.9 Favored Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.199 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.42 -18.23 52.22 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.968 2.445 . . . . 0.0 112.699 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.02 -27.15 30.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.331 0.586 . . . . 0.0 110.896 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -71.61 -55.9 6.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.478 0.656 . . . . 0.0 110.623 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.489 HD11 ' HE3' ' A' ' 78' ' ' MET . 1.6 pt? -88.49 20.77 3.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.571 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 43.08 62.52 1.79 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.087 0.946 . . . . 0.0 112.662 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.489 ' HE3' HD11 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -78.87 122.5 26.18 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.697 -178.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.58 156.7 30.7 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.051 0.453 . . . . 0.0 110.848 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -68.89 142.86 54.66 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.886 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 66.71 18.21 10.68 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.269 0.627 . . . . 0.0 111.437 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -81.51 171.25 14.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.976 0.417 . . . . 0.0 110.64 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 21.9 m -126.05 145.0 50.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.577 0.703 . . . . 0.0 112.352 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.03 138.74 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.283 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -94.91 121.79 36.88 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.964 0.411 . . . . 0.0 110.225 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.3 t -108.9 137.41 41.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.267 0.555 . . . . 0.0 111.757 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -130.49 151.52 50.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.406 HE21 HG22 ' A' ' 58' ' ' ILE . 1.8 mp0 . . . . . 0 C--N 1.321 -0.632 0 CA-C-O 121.074 0.464 . . . . 0.0 111.931 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.788 0.327 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 pt -135.37 168.05 24.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 120.896 0.379 . . . . 0.0 110.373 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.539 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -106.0 116.52 32.08 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.923 0.392 . . . . 0.0 110.311 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.66 131.68 54.14 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 83' ' ' THR . 32.5 ttpt -111.42 141.32 45.12 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.293 0.568 . . . . 0.0 111.198 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 29' ' ' VAL . 41.0 t -112.77 125.71 70.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.174 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.28 118.1 20.8 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.546 0.688 . . . . 0.0 110.658 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.33 150.47 18.55 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.009 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -11.21 8.0 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.36 0.6 . . . . 0.0 112.202 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.1 -16.82 62.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.658 0.742 . . . . 0.0 110.32 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.07 -12.99 55.87 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -78.05 122.87 26.14 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.932 0.396 . . . . 0.0 110.436 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 22' ' ' VAL . 3.1 p -144.59 137.41 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.424 0.631 . . . . 0.0 111.195 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.7 t -144.47 151.09 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.582 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.539 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -110.15 141.89 42.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.821 0.343 . . . . 0.0 110.526 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -137.06 138.77 40.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.162 0.505 . . . . 0.0 111.534 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -106.48 114.92 29.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.052 0.453 . . . . 0.0 110.51 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.1 pt -132.68 170.46 19.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.139 0.495 . . . . 0.0 110.563 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.579 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.2 tmtp? -80.41 149.24 30.23 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.579 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 9.2 tpp180 -56.83 -25.2 55.66 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -107.28 3.3 25.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.722 0.773 . . . . 0.0 109.749 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 m -81.5 131.03 59.47 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.452 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 33.7 Cg_endo -63.13 147.75 93.89 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.208 1.939 . . . . 0.0 112.152 -177.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.4 HD12 ' OD2' ' A' ' 71' ' ' ASP . 39.6 mt -64.6 -15.24 60.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 57.1 p -50.97 -38.48 51.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.096 0.558 . . . . 0.0 111.466 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 39' ' ' PRO . 12.3 mmmm -55.85 -54.45 44.45 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 44' ' ' MET . 4.3 pp -75.86 -32.27 59.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.999 0.428 . . . . 0.0 111.322 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.6 ' N ' HD12 ' A' ' 43' ' ' LEU . 37.0 ttm -61.47 -50.25 73.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.615 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 69.4 mmtt -70.38 -41.64 72.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.84 0.352 . . . . 0.0 110.094 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.16 -45.46 92.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.265 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -56.49 -50.2 72.45 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.063 0.459 . . . . 0.0 110.466 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.596 ' SG ' HD11 ' A' ' 58' ' ' ILE . 58.2 m -63.1 -38.28 90.57 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.97 0.414 . . . . 0.0 111.498 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 48.6 mt-10 -64.34 -40.22 95.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.117 0.484 . . . . 0.0 111.571 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.3 ptp180 -86.2 -23.14 26.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -98.66 -10.73 22.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.979 0.418 . . . . 0.0 112.081 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.49 43.9 14.35 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.957 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.4 mm? -119.69 157.9 27.56 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 122.307 -0.525 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.2 m -107.53 128.31 54.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.166 0.507 . . . . 0.0 111.235 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.445 ' SD ' ' HD3' ' A' ' 45' ' ' LYS . 58.0 mmm -56.62 -30.57 63.41 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.548 0.739 . . . . 0.0 112.766 -177.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.556 ' HD3' ' N ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -83.35 -28.98 28.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.47 0.652 . . . . 0.0 111.081 -176.354 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -40.18 16.49 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.88 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.596 HD11 ' SG ' ' A' ' 48' ' ' CYS . 12.8 pt -91.63 174.45 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 O-C-N 121.906 -0.496 . . . . 0.0 110.443 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -150.36 130.85 13.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.266 0.555 . . . . 0.0 110.257 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -83.02 137.04 34.28 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.848 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 43.3 ttm180 -136.53 143.04 43.5 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.155 0.503 . . . . 0.0 110.576 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -148.84 130.3 14.8 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 69.24 25.71 5.59 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.83 0.824 . . . . 0.0 110.199 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.91 -24.55 5.91 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.192 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -92.68 136.23 25.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 122.479 -0.424 . . . . 0.0 110.93 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 35.2 Cg_endo -67.81 142.65 58.4 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.11 1.873 . . . . 0.0 111.387 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 pt -112.71 174.8 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.068 0.461 . . . . 0.0 110.985 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.63 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -138.27 159.16 42.78 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.135 0.493 . . . . 0.0 111.995 -176.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 11.6 pt-20 -62.56 -10.21 11.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.775 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -97.99 7.42 46.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.886 0.374 . . . . 0.0 111.396 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.63 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.29 155.94 17.24 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 121.719 -0.613 . . . . 0.0 110.594 179.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 p -120.76 146.83 44.48 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.966 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.555 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 20.2 Cg_endo -60.64 -25.31 80.61 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.778 2.319 . . . . 0.0 112.494 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 -31.66 62.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.377 0.608 . . . . 0.0 110.519 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -68.15 -55.71 11.39 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.252 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 1.6 pt? -85.12 6.92 23.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.883 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 58.73 63.15 1.74 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.958 0.885 . . . . 0.0 112.275 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.5 mtt -84.1 134.52 34.6 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.488 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -96.89 175.12 6.46 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.009 0.433 . . . . 0.0 110.146 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -77.92 147.14 35.15 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 68.51 13.63 8.98 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.13 0.572 . . . . 0.0 112.248 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.97 162.9 23.66 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 15.8 m -124.73 142.14 51.62 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.68 0.753 . . . . 0.0 113.001 -173.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.65 135.28 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.082 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -93.74 121.31 35.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.048 0.452 . . . . 0.0 110.366 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.63 138.93 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.225 0.536 . . . . 0.0 112.006 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -130.92 152.74 49.92 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.86 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 121.271 0.558 . . . . 0.0 111.91 -179.237 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 28.7 p-80 . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.4 pt -124.17 167.63 17.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.0 0.429 . . . . 0.0 110.061 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -106.52 124.1 49.09 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.811 0.338 . . . . 0.0 110.143 -178.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.3 125.09 49.37 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 35.5 ttpt -105.26 140.68 38.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.05 0.452 . . . . 0.0 111.004 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.66 123.89 66.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.77 128.1 43.33 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.502 0.668 . . . . 0.0 110.514 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.39 148.86 16.52 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.692 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -5.4 2.3 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -82.54 -12.18 57.93 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.721 0.772 . . . . 0.0 110.122 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.28 -9.96 57.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.738 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.8 m -78.36 119.7 22.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -145.48 141.22 22.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.365 0.603 . . . . 0.0 111.782 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 40.9 t -146.84 151.23 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.4 0.68 . . . . 0.0 109.174 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -110.41 141.44 43.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.931 0.396 . . . . 0.0 110.336 -179.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -136.54 153.58 50.96 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.067 0.46 . . . . 0.0 110.728 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 90.0 mttt -124.58 113.75 18.48 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.827 0.346 . . . . 0.0 110.246 178.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 46.4 pt -127.26 172.53 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.935 0.398 . . . . 0.0 110.658 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.6 tmtp? -80.91 152.04 28.28 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.487 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 9.6 tpp180 -54.67 -23.9 19.4 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -112.63 2.56 16.22 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.415 -0.803 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 m -79.49 131.65 64.42 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.562 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.33 144.82 92.12 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.636 2.224 . . . . 0.0 112.458 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.422 HD12 ' OD2' ' A' ' 71' ' ' ASP . 40.2 mt -65.01 -15.61 62.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.073 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.612 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 32.1 t -48.96 -37.82 21.19 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.643 0.377 . . . . 0.0 111.417 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -55.37 -53.29 58.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.714 0.293 . . . . 0.0 110.985 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 44' ' ' MET . 4.4 pp -75.48 -32.1 60.45 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.367 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.538 ' N ' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -54.44 -56.74 15.63 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.3 0.571 . . . . 0.0 111.337 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 41' ' ' SER . 6.5 mmmt -71.47 -41.24 69.61 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.254 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.18 -49.01 78.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.939 0.399 . . . . 0.0 111.551 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 29.2 t80 -55.17 -51.66 65.79 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 121.029 0.443 . . . . 0.0 110.744 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.698 ' SG ' HD11 ' A' ' 58' ' ' ILE . 33.5 m -63.99 -36.68 84.78 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.869 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 41.6 mt-10 -65.86 -39.55 90.85 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.909 0.385 . . . . 0.0 111.525 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.5 ptp180 -85.96 -21.93 27.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.879 0.371 . . . . 0.0 111.707 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.404 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 20.1 mm-40 -96.11 -6.25 38.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.885 0.374 . . . . 0.0 111.467 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.87 41.89 71.45 Favored Glycine 0 C--N 1.321 -0.289 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.468 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 mp -115.8 153.54 31.26 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.358 0.599 . . . . 0.0 110.94 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.1 m -102.27 127.39 49.27 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.094 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.414 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 93.1 mmm -55.44 -31.98 62.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.039 0.536 . . . . 0.0 112.279 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.479 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -84.98 -28.3 25.89 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.158 0.504 . . . . 0.0 112.022 -178.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.759 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -91.19 -5.05 55.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.372 0.606 . . . . 0.0 110.488 -178.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.698 HD11 ' SG ' ' A' ' 48' ' ' CYS . 13.7 pt -122.71 170.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.967 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -143.94 138.51 28.54 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 120.875 0.369 . . . . 0.0 110.111 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -96.88 129.21 44.36 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.778 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -136.59 143.02 43.38 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.043 0.449 . . . . 0.0 110.276 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -148.38 133.45 18.24 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t70 68.21 24.56 7.5 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.675 0.75 . . . . 0.0 110.274 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.28 -21.39 6.06 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.144 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -93.11 141.73 24.44 Favored Pre-proline 0 C--N 1.317 -0.83 0 O-C-N 122.35 -0.5 . . . . 0.0 110.494 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.9 137.22 24.07 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.187 1.925 . . . . 0.0 111.649 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.8 pt -114.43 170.94 4.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.241 0.544 . . . . 0.0 110.663 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.693 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.31 155.64 46.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.025 -179.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 41' ' ' SER . 13.4 pt-20 -59.86 -10.17 3.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.08 0.467 . . . . 0.0 111.93 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -100.62 6.43 44.1 Favored 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 121.766 -0.583 . . . . 0.0 111.595 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.693 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -92.93 165.23 12.98 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 121.615 -0.678 . . . . 0.0 110.384 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.1 p -122.4 148.82 53.61 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.524 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.97 -20.14 58.83 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.141 2.561 . . . . 0.0 112.585 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.53 -31.54 37.02 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.052 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -67.53 -56.29 10.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.273 0.559 . . . . 0.0 110.991 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -81.84 8.73 9.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.018 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 57.69 63.08 1.91 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.587 0.708 . . . . 0.0 111.463 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.7 mtt -79.67 -165.58 0.83 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.989 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.44 169.81 15.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.55 139.51 42.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.205 0.526 . . . . 0.0 111.271 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 70.75 18.88 6.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.525 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -84.68 165.55 17.81 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 19.4 m -127.03 141.64 51.74 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.666 0.746 . . . . 0.0 112.852 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.06 140.28 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.223 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.32 121.76 38.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.11 0.481 . . . . 0.0 110.895 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.9 t -109.44 137.66 40.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.343 0.592 . . . . 0.0 111.555 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -128.71 149.55 50.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.963 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.429 HE21 HG22 ' A' ' 58' ' ' ILE . 2.0 mp0 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.366 0.603 . . . . 0.0 110.991 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 . . . . . 0 N--CA 1.447 -0.61 0 CA-C-O 120.719 0.295 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.443 HD11 ' HB2' ' A' ' 73' ' ' PRO . 23.6 pt -140.96 165.71 19.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.99 0.424 . . . . 0.0 110.29 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.579 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -106.22 122.37 46.07 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.37 124.43 47.69 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 36.5 ttpt -100.75 145.71 28.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.02 0.438 . . . . 0.0 110.266 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 29' ' ' VAL . 46.6 t -115.87 125.87 73.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.74 124.02 34.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.57 0.7 . . . . 0.0 110.893 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.99 149.0 17.46 Favored Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.472 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -63.01 -11.4 18.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.525 0.679 . . . . 0.0 111.47 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.81 -14.05 60.64 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.76 0.79 . . . . 0.0 110.062 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.84 -9.78 58.53 Favored Glycine 0 C--N 1.307 -1.067 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.902 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -79.33 117.45 20.33 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.089 0.471 . . . . 0.0 110.055 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.7 p -143.38 139.19 26.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.215 0.531 . . . . 0.0 111.455 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 48.3 t -145.91 151.16 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.579 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -104.73 142.17 35.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 36.6 m-85 -132.41 157.36 44.75 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.556 0.693 . . . . 0.0 111.301 -177.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -134.38 110.61 9.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.407 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 pt -131.45 173.8 14.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.248 0.547 . . . . 0.0 111.256 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HD3' ' H ' ' A' ' 37' ' ' HIS . 2.1 tmtp? -80.48 146.39 31.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.491 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 33.6 ttm180 -64.4 -16.75 62.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.393 0.616 . . . . 0.0 112.157 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.425 ' H ' ' HD3' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -104.6 2.03 30.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.405 0.621 . . . . 0.0 110.241 177.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 5.6 m -88.45 133.45 36.4 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.046 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.43 146.3 93.08 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.655 2.237 . . . . 0.0 112.54 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.436 HD12 ' OD1' ' A' ' 71' ' ' ASP . 30.5 mt -65.49 -15.26 62.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.923 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 13.8 p -54.61 -33.11 59.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.271 0.558 . . . . 0.0 110.568 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -57.65 -53.95 52.43 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.676 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.08 -31.9 58.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.432 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.59 ' N ' HD12 ' A' ' 43' ' ' LEU . 58.2 mtt -57.18 -56.73 18.07 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.994 0.426 . . . . 0.0 111.549 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 41' ' ' SER . 0.4 OUTLIER -71.66 -34.64 69.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.914 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -61.5 -47.03 87.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.996 0.427 . . . . 0.0 110.726 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 20.5 t80 -55.05 -50.22 69.64 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 110.49 177.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.649 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.4 m -63.27 -40.68 98.09 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.568 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 41.5 mt-10 -64.03 -34.97 79.22 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.8 ptp180 -89.66 -26.06 20.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -94.14 -16.39 23.78 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.191 0.52 . . . . 0.0 112.157 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.19 35.94 10.44 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.251 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.635 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.5 mm? -113.81 154.31 27.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.293 0.568 . . . . 0.0 110.821 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -105.17 136.97 43.68 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.548 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.1 mmm -63.4 -22.48 66.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.144 0.497 . . . . 0.0 111.012 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.496 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -83.67 -28.58 28.25 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.421 0.629 . . . . 0.0 110.342 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.496 ' NE2' ' HB2' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -93.67 -10.95 32.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.881 -177.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.649 HD11 ' SG ' ' A' ' 48' ' ' CYS . 7.3 pt -128.3 170.86 17.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.093 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 tpp180 -148.7 135.9 20.17 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.102 0.477 . . . . 0.0 110.291 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.2 m-85 -91.01 138.96 31.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -141.61 140.92 33.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.028 0.442 . . . . 0.0 110.72 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -146.31 134.34 21.48 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 69.53 27.49 4.85 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.907 0.86 . . . . 0.0 110.533 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.26 -6.84 49.16 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.572 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -111.43 140.56 23.17 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 122.165 -0.609 . . . . 0.0 110.826 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.11 139.19 35.08 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.269 1.98 . . . . 0.0 111.273 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.1 pt -113.15 153.62 14.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.333 0.587 . . . . 0.0 111.708 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.718 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -108.56 152.98 24.02 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.343 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.571 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 13.8 pt-20 -60.95 -14.92 25.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.178 0.513 . . . . 0.0 111.924 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -93.42 7.71 43.42 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.718 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -91.58 158.07 16.64 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 121.587 -0.695 . . . . 0.0 110.714 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.5 p -118.55 145.61 37.85 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.881 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.449 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 18.2 Cg_endo -59.14 -21.53 59.89 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.798 2.332 . . . . 0.0 112.664 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -81.26 -19.41 43.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.029 0.443 . . . . 0.0 111.266 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -80.69 -54.67 5.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.311 0.576 . . . . 0.0 110.783 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 2.0 pt? -82.68 10.53 7.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.135 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 57.85 62.44 2.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.35 0.595 . . . . 0.0 111.123 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -83.09 121.1 26.61 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.146 0.498 . . . . 0.0 110.36 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HG3' ' HB2' ' A' ' 82' ' ' ASP . 11.4 pt-20 -80.95 159.64 24.87 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.312 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -74.78 149.19 39.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.881 0.372 . . . . 0.0 111.465 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 63.15 19.31 11.58 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.818 0.847 . . . . 0.0 112.079 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.492 ' HB2' ' HG3' ' A' ' 79' ' ' GLU . 1.7 t70 -89.28 -178.02 5.53 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.543 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 16.4 m -130.11 151.43 50.65 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.376 0.608 . . . . 0.0 112.037 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.81 137.71 42.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 123.387 0.675 . . . . 0.0 109.215 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -91.76 124.67 36.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 110.807 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.422 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 47.4 t -111.52 136.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.296 0.57 . . . . 0.0 111.795 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -126.2 144.47 50.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.12 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.482 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.5 mp0 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 120.628 0.251 . . . . 0.0 110.75 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 22.1 p-80 . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.922 0.391 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.415 HD11 ' HB2' ' A' ' 73' ' ' PRO . 27.6 pt -125.43 167.45 19.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.113 0.482 . . . . 0.0 110.068 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.516 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -107.37 126.82 52.96 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.833 -178.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.82 125.45 48.59 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -104.48 139.72 38.98 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.872 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 40.2 t -111.82 123.21 67.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.967 0.413 . . . . 0.0 110.03 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.72 112.43 14.8 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.763 0.792 . . . . 0.0 110.751 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.95 147.7 18.7 Favored Glycine 0 C--N 1.297 -1.608 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.271 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -10.27 7.91 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.243 0.544 . . . . 0.0 112.143 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.403 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 9.3 t70 -73.36 -13.66 61.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.631 0.729 . . . . 0.0 110.315 177.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.8 -15.25 55.75 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.8 m -74.7 117.03 16.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.247 0.546 . . . . 0.0 110.49 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 3.3 p -142.52 136.48 27.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.397 0.618 . . . . 0.0 111.1 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -145.39 151.66 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.475 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -108.32 140.45 41.58 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -134.2 155.3 50.39 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.133 0.492 . . . . 0.0 110.945 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.516 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 90.1 mttt -128.08 111.1 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.107 0.479 . . . . 0.0 110.642 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.3 pt -127.62 173.58 12.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.029 0.442 . . . . 0.0 110.283 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.6 tmtp? -78.6 146.37 34.2 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.462 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 40.0 ttm180 -64.32 -12.75 45.14 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.334 0.588 . . . . 0.0 111.865 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.427 ' H ' ' HD3' ' A' ' 35' ' ' LYS . 37.8 t-80 -107.04 -3.38 20.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.669 0.747 . . . . 0.0 109.617 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.8 m -83.5 135.05 44.07 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.609 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.88 145.05 89.91 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.708 2.272 . . . . 0.0 112.624 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 48.5 mt -65.67 -16.84 64.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.02 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 32.6 p -54.25 -34.8 61.56 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.01 0.433 . . . . 0.0 111.061 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -57.46 -52.1 66.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.73 -32.16 62.04 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.884 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.577 ' N ' HD12 ' A' ' 43' ' ' LEU . 58.5 mtt -58.12 -53.89 53.12 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.183 0.516 . . . . 0.0 110.903 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 34.2 mmtp -66.69 -41.74 87.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.019 0.438 . . . . 0.0 110.079 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.9 -48.02 83.4 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.115 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -55.73 -49.05 74.1 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.68 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.7 m -67.2 -36.27 81.38 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 47.7 mt-10 -62.61 -39.69 94.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.093 0.473 . . . . 0.0 111.215 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 14.8 ptp180 -86.73 -25.71 24.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -93.52 -8.65 40.8 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.98 -0.45 . . . . 0.0 111.817 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.15 43.78 46.68 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.727 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.9 mp -115.91 152.89 32.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.39 0.614 . . . . 0.0 111.043 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.2 m -99.15 124.33 44.11 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.973 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 95.4 mmm -60.85 -22.33 64.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.949 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.483 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.3 OUTLIER -84.68 -32.62 23.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.482 0.658 . . . . 0.0 110.804 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.784 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -84.73 -20.66 30.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.909 -176.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.588 HD11 ' SG ' ' A' ' 48' ' ' CYS . 16.0 pt -113.02 176.17 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.231 0.539 . . . . 0.0 111.949 -177.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -149.22 140.23 22.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.407 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 44' ' ' MET . 6.4 m-85 -94.61 129.44 41.45 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.594 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -130.55 143.58 50.85 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.538 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -150.12 136.82 19.17 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 t70 67.32 26.98 8.38 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.834 0.826 . . . . 0.0 110.815 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.38 -5.61 59.67 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.991 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -116.63 142.09 29.09 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 122.076 -0.661 . . . . 0.0 110.883 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.11 134.66 34.75 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.067 1.845 . . . . 0.0 110.799 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.709 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 12.1 pt -104.49 -177.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.137 0.494 . . . . 0.0 111.631 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.631 HD22 ' HB3' ' A' ' 71' ' ' ASP . 0.5 OUTLIER -129.39 161.63 29.88 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 121.689 0.757 . . . . 0.0 110.649 -175.132 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.49 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.1 pt-20 -67.98 -15.28 63.54 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.764 0.792 . . . . 0.0 109.583 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 t -110.01 16.49 21.85 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.709 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 1.8 p-10 -98.23 101.5 12.98 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 118.517 -1.273 . . . . 0.0 110.722 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 p -60.31 141.22 91.21 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.73 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 11.1 Cg_endo -56.39 -24.25 51.09 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.991 2.46 . . . . 0.0 112.288 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -72.26 -34.2 68.07 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.128 0.49 . . . . 0.0 110.647 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -64.95 -55.78 17.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.986 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 2.1 pt? -85.09 6.57 24.96 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.712 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 60.37 52.6 4.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.716 0.769 . . . . 0.0 111.499 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.76 131.64 40.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.273 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -94.94 165.75 12.29 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.028 0.442 . . . . 0.0 110.613 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.41 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 9.9 p-10 -76.37 148.28 37.5 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.359 0.6 . . . . 0.0 110.553 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 65.64 14.72 9.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.768 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.62 167.21 20.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.8 m -123.04 140.77 52.68 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.03 135.93 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.191 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -94.98 118.97 32.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.064 0.459 . . . . 0.0 110.296 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.37 138.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.148 0.499 . . . . 0.0 111.793 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -128.6 150.87 50.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.952 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.439 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.1 mp0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 111.672 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 121.78 0.8 . . . . 0.0 111.16 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.506 HD12 HD21 ' A' ' 20' ' ' LEU . 24.7 pt -128.96 160.04 40.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.01 178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.544 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.2 OUTLIER -95.72 123.87 39.49 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.538 HD22 ' SD ' ' A' ' 78' ' ' MET . 86.4 mt -122.89 125.9 46.25 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.229 0.538 . . . . 0.0 110.206 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 83' ' ' THR . 36.7 ttpt -106.82 142.82 35.85 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.283 0.563 . . . . 0.0 110.98 -178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 41.1 t -115.77 126.92 73.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.65 126.51 38.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.401 0.619 . . . . 0.0 110.526 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.51 147.35 16.61 Favored Glycine 0 C--N 1.301 -1.404 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.749 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.4 pp0? -60.64 -15.45 28.53 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 112.221 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -76.37 -11.81 59.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.926 0.87 . . . . 0.0 109.636 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.85 -11.54 45.47 Favored Glycine 0 C--N 1.318 -0.463 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.434 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -73.34 114.63 11.76 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.472 -0.428 . . . . 0.0 110.755 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 4.9 p -141.14 135.9 32.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.312 0.577 . . . . 0.0 111.367 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -145.67 151.04 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.397 -177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.544 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -109.45 138.89 45.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.016 0.436 . . . . 0.0 110.091 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 18.1 m-85 -133.39 164.17 27.72 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 121.12 0.486 . . . . 0.0 110.638 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -135.27 112.38 10.37 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 122.199 -0.313 . . . . 0.0 110.22 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 pt -126.84 168.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.946 0.403 . . . . 0.0 110.779 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 1.1 tmtp? -77.7 152.69 33.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.865 0.364 . . . . 0.0 110.391 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 10.2 tpp180 -60.96 -21.74 63.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.001 0.52 . . . . 0.0 112.071 -177.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -105.76 -2.02 23.7 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.823 -0.548 . . . . 0.0 110.099 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.7 m -82.35 132.21 53.49 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.658 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.99 147.8 85.01 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.707 2.271 . . . . 0.0 112.31 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.19 -16.12 63.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.99 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 22.7 t -49.76 -38.64 34.84 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.495 0.318 . . . . 0.0 111.079 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 6.7 mmpt? -56.55 -53.48 57.09 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -75.79 -32.33 59.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.619 ' N ' HD12 ' A' ' 43' ' ' LEU . 41.2 ttm -61.24 -50.4 73.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.891 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.54 ' HD2' ' SD ' ' A' ' 55' ' ' MET . 13.5 mmmm -70.67 -40.85 72.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.8 0.333 . . . . 0.0 110.184 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.69 -46.37 89.28 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.084 0.469 . . . . 0.0 111.444 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 24.1 t80 -55.73 -50.96 68.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.063 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.663 ' SG ' HD11 ' A' ' 58' ' ' ILE . 35.0 m -63.91 -37.32 86.97 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.032 0.444 . . . . 0.0 111.167 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -62.44 -40.39 96.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.993 0.425 . . . . 0.0 111.695 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.7 ptp180 -87.94 -21.96 24.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.843 0.354 . . . . 0.0 111.8 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -96.36 -11.35 25.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.35 7.07 85.39 Favored Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.694 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 7.2 mp -82.79 155.12 24.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.614 0.721 . . . . 0.0 112.176 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.402 ' O ' HG12 ' A' ' 58' ' ' ILE . 27.6 m -106.15 132.82 51.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.832 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.54 ' SD ' ' HD2' ' A' ' 45' ' ' LYS . 63.7 mmm -56.18 -33.45 65.28 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -177.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -25.84 28.15 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.909 -0.495 . . . . 0.0 111.657 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.99 -19.93 31.31 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.304 0.573 . . . . 0.0 110.85 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.663 HD11 ' SG ' ' A' ' 48' ' ' CYS . 8.4 pt -116.76 174.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.046 0.45 . . . . 0.0 110.971 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -153.81 138.8 17.25 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -92.83 137.35 32.44 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.306 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -136.94 139.37 41.49 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.301 0.572 . . . . 0.0 111.299 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -150.25 143.33 24.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 t70 67.3 24.1 9.13 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.873 0.845 . . . . 0.0 110.115 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.19 -2.44 81.42 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.391 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -121.96 142.36 36.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 122.059 -0.671 . . . . 0.0 110.887 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.97 138.69 53.57 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.012 1.808 . . . . 0.0 110.835 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.44 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 13.6 pt -112.46 172.95 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.096 0.474 . . . . 0.0 110.856 -177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.628 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -133.76 157.98 44.49 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.079 0.466 . . . . 0.0 111.574 -177.491 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' SER . 17.2 pt-20 -60.4 -11.84 7.8 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.714 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -100.97 11.36 39.77 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.817 0.341 . . . . 0.0 111.582 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.628 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -99.5 157.15 16.64 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 121.721 -0.612 . . . . 0.0 109.593 177.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.2 p -118.51 148.06 43.29 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.704 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.86 -18.69 62.34 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.691 2.261 . . . . 0.0 112.284 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.483 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -85.9 -15.69 40.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.196 0.522 . . . . 0.0 111.193 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -82.26 -56.36 3.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.299 0.571 . . . . 0.0 110.436 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -86.8 1.98 50.45 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.221 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 62.28 61.59 1.28 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.609 0.719 . . . . 0.0 112.908 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.601 ' SD ' HD11 ' A' ' 84' ' ' ILE . 29.4 ttm -89.08 137.45 32.31 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -106.83 176.79 5.06 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.897 0.38 . . . . 0.0 110.79 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -75.3 143.52 42.91 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.169 0.509 . . . . 0.0 110.793 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 71.9 13.58 6.01 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.024 0.93 . . . . 0.0 110.855 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -80.38 161.88 24.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 22.9 m -127.34 145.84 50.66 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.342 0.591 . . . . 0.0 112.316 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.601 HD11 ' SD ' ' A' ' 78' ' ' MET . 4.0 mp -110.32 136.89 44.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.426 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -93.76 130.94 39.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.1 0.476 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 46.5 t -112.74 138.63 41.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.508 0.67 . . . . 0.0 111.854 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -134.08 163.64 29.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.361 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--N 1.323 -0.569 0 CA-C-O 120.814 0.34 . . . . 0.0 111.228 179.116 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 . . . . . 0 N--CA 1.446 -0.666 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.513 HD11 ' HB2' ' A' ' 73' ' ' PRO . 19.1 pt -132.28 167.85 25.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.285 0.564 . . . . 0.0 110.815 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.66 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -99.75 129.57 45.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.754 -179.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.415 HD23 HG12 ' A' ' 34' ' ' ILE . 3.1 mm? -125.97 126.93 45.13 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 83' ' ' THR . 35.0 ttpt -109.49 141.81 41.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.329 0.585 . . . . 0.0 111.221 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.27 127.04 70.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.167 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.18 121.95 25.75 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.661 0.743 . . . . 0.0 110.502 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.2 149.39 16.61 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.242 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -11.55 11.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.474 0.654 . . . . 0.0 112.043 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.85 -18.46 62.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.544 0.687 . . . . 0.0 110.435 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.12 -5.37 45.75 Favored Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.9 m -86.82 121.65 29.61 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.884 0.373 . . . . 0.0 110.381 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 p -144.35 138.33 23.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.366 0.603 . . . . 0.0 111.415 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -146.3 151.01 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.66 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -109.93 140.65 43.67 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -132.24 157.82 43.37 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 121.19 0.519 . . . . 0.0 111.255 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -127.82 108.55 10.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.415 HG12 HD23 ' A' ' 20' ' ' LEU . 46.8 pt -124.19 176.36 5.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.203 0.525 . . . . 0.0 110.73 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.3 tmtp? -85.44 149.61 25.29 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.097 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.495 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 17.6 tpp180 -53.06 -26.67 16.73 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.601 0.761 . . . . 0.0 112.576 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -111.87 6.49 19.6 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.588 -0.695 . . . . 0.0 111.748 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 m -81.64 133.93 51.7 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.0 145.07 84.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.645 2.23 . . . . 0.0 112.361 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 48.1 mt -65.2 -17.06 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.927 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 35.5 p -50.47 -37.89 40.95 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.561 0.344 . . . . 0.0 111.686 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.7 mmpt? -56.36 -52.57 64.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.755 0.312 . . . . 0.0 110.72 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.88 -31.86 61.7 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.363 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.576 ' N ' HD12 ' A' ' 43' ' ' LEU . 53.2 mtt -58.2 -54.91 41.67 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.25 0.547 . . . . 0.0 110.979 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 57.6 mmtt -65.49 -44.43 87.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.936 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.728 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -57.56 -49.04 77.67 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.071 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -54.92 -51.7 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.584 ' SG ' HD11 ' A' ' 58' ' ' ILE . 34.1 m -67.19 -35.05 78.82 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.935 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 51.4 mt-10 -66.97 -36.18 81.61 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.209 -0.307 . . . . 0.0 111.682 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.728 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -88.13 -25.81 22.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 178.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -92.25 -6.06 51.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 111.555 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.2 46.38 57.95 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.158 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.8 mp -117.36 151.51 36.86 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.224 0.535 . . . . 0.0 110.827 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 71.4 m -96.76 123.0 40.32 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.905 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.3 mmm -56.64 -28.13 59.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.993 0.517 . . . . 0.0 111.903 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.476 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -84.39 -34.87 23.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.261 0.553 . . . . 0.0 111.116 -178.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.746 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -81.66 -18.91 42.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.066 0.46 . . . . 0.0 111.338 -177.373 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.584 HD11 ' SG ' ' A' ' 48' ' ' CYS . 14.3 pt -110.57 -179.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 120.968 0.413 . . . . 0.0 110.671 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 59' ' ' ARG . 10.0 tpt180 -157.31 133.3 9.49 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.173 0.511 . . . . 0.0 110.433 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.9 m-85 -85.54 135.87 33.64 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.063 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -144.79 148.21 33.8 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.997 0.427 . . . . 0.0 110.362 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -154.69 138.96 16.62 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.1 t70 65.84 25.19 11.28 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.59 0.709 . . . . 0.0 110.306 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 -26.56 5.75 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.763 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -90.94 144.62 30.38 Favored Pre-proline 0 C--N 1.327 -0.386 0 O-C-N 122.408 -0.466 . . . . 0.0 110.811 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.85 141.88 27.67 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.9 1.733 . . . . 0.0 110.338 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.654 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 6.9 pt -106.08 -179.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.832 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.539 HD22 ' HB3' ' A' ' 71' ' ' ASP . 0.4 OUTLIER -129.93 165.42 22.12 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.599 0.714 . . . . 0.0 110.714 -174.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 11.1 pt-20 -67.82 -12.94 61.65 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.943 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -118.87 16.93 13.47 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.654 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 3.6 p-10 -91.27 98.76 11.92 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.415 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 p -58.49 145.56 75.75 Favored Pre-proline 0 C--N 1.301 -1.508 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.044 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.513 ' HB2' HD11 ' A' ' 18' ' ' ILE . 17.9 Cg_endo -59.57 -15.82 32.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.899 2.4 . . . . 0.0 111.58 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.465 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -80.01 -31.1 39.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.462 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -67.54 -54.67 18.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.264 0.554 . . . . 0.0 111.657 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.3 pt? -84.2 7.84 17.69 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.809 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 57.66 40.49 26.56 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.508 0.671 . . . . 0.0 111.224 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.86 130.29 43.55 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.463 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.86 169.75 17.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.14 0.495 . . . . 0.0 110.417 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -79.05 145.4 33.86 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 66.28 20.24 11.04 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.447 0.699 . . . . 0.0 110.975 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.03 161.42 28.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.071 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 30.3 m -121.51 135.35 55.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.645 0.736 . . . . 0.0 112.379 -175.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.84 137.94 24.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.164 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -93.62 117.38 30.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.29 0.567 . . . . 0.0 110.85 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.82 134.89 46.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.427 0.632 . . . . 0.0 111.737 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -131.84 159.87 37.3 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.463 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.1 mp0 . . . . . 0 C--N 1.318 -0.778 0 CA-C-O 121.139 0.495 . . . . 0.0 110.496 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 23.4 p-80 . . . . . 0 N--CA 1.44 -0.938 0 CA-C-O 120.769 0.318 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.8 pt -131.61 163.52 37.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.026 0.441 . . . . 0.0 110.19 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.539 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -97.23 141.22 30.62 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.5 mt -137.51 125.19 22.32 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 83' ' ' THR . 33.4 ttpt -108.36 140.67 41.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.243 0.544 . . . . 0.0 111.422 -176.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.5 t -114.54 127.55 71.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.847 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.61 120.37 23.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.437 0.637 . . . . 0.0 110.582 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.52 150.83 17.7 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.405 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.58 -8.94 7.27 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 112.502 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.54 -13.77 60.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.706 0.765 . . . . 0.0 109.945 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.85 -10.61 58.87 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.0 m -81.42 123.72 28.81 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.001 0.429 . . . . 0.0 110.264 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 22' ' ' VAL . 3.6 p -143.71 138.28 25.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 121.278 0.561 . . . . 0.0 110.955 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.3 t -143.04 150.8 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.595 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.539 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -107.63 137.67 45.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.087 0.47 . . . . 0.0 109.971 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 29.9 m-85 -128.15 166.44 18.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 121.382 0.61 . . . . 0.0 110.503 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -141.63 111.46 6.66 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.469 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.2 pt -131.04 176.29 9.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.395 0.616 . . . . 0.0 111.549 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 1.9 tmtp? -88.45 150.52 23.1 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.267 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.431 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 21.8 tpp180 -54.98 -27.46 44.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.944 0.898 . . . . 0.0 112.712 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -108.47 3.55 23.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.272 0.558 . . . . 0.0 111.026 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.7 m -85.16 131.81 47.32 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.195 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.52 148.7 90.62 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.508 2.139 . . . . 0.0 112.484 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.4 mt -65.61 -15.6 62.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.763 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 54.1 p -50.96 -37.91 47.43 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 122.91 0.484 . . . . 0.0 111.343 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -56.91 -53.68 55.16 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.073 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.38 -32.4 58.55 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.0 0.429 . . . . 0.0 111.317 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.626 ' N ' HD12 ' A' ' 43' ' ' LEU . 41.8 ttm -60.44 -52.12 66.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.682 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 33.1 mmtp -70.49 -37.74 74.25 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.884 0.373 . . . . 0.0 110.283 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.94 -45.4 94.84 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.92 0.391 . . . . 0.0 111.004 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 21.1 t80 -56.78 -51.92 67.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.364 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.3 p -61.63 -36.59 81.19 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.216 0.532 . . . . 0.0 110.608 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 61.6 mm-40 -67.06 -45.41 77.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.878 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.9 ptp180 -78.99 -25.59 43.37 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -93.47 -12.27 30.12 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.979 -0.45 . . . . 0.0 112.2 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.95 43.81 9.59 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.323 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.515 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.0 mm? -120.6 160.06 24.0 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.016 0.436 . . . . 0.0 110.162 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.406 ' O ' HG12 ' A' ' 58' ' ' ILE . 4.7 m -109.65 135.65 50.27 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.737 0.303 . . . . 0.0 111.013 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.424 ' CE ' ' HG2' ' A' ' 44' ' ' MET . 86.3 mmm -58.01 -27.8 63.84 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.459 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -85.25 -24.14 27.91 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.783 -0.573 . . . . 0.0 111.443 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.68 -14.07 32.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.25 0.548 . . . . 0.0 110.136 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 53' ' ' LEU . 16.1 pt -120.5 169.94 11.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 120.944 0.402 . . . . 0.0 110.674 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -149.9 136.6 19.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -95.13 136.04 35.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.146 0.498 . . . . 0.0 110.342 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.35 142.13 37.61 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.109 0.48 . . . . 0.0 110.885 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -153.44 143.27 22.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 64.63 23.76 12.87 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.411 0.624 . . . . 0.0 110.696 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.89 -2.93 82.09 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.491 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -118.35 149.29 45.65 Favored Pre-proline 0 C--N 1.332 -0.153 0 O-C-N 122.163 -0.61 . . . . 0.0 110.376 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.47 139.81 20.98 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.846 1.697 . . . . 0.0 110.575 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.9 pt -113.46 160.73 12.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.43 0.633 . . . . 0.0 111.487 -176.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.651 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -120.2 157.14 29.71 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.424 -178.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 7.3 pt-20 -62.77 -9.78 10.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.994 0.426 . . . . 0.0 111.92 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.0 t -99.02 7.68 45.73 Favored 'General case' 0 N--CA 1.441 -0.916 0 O-C-N 122.036 -0.415 . . . . 0.0 111.898 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.651 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.4 OUTLIER -92.71 156.65 16.91 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 121.682 -0.636 . . . . 0.0 109.898 178.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.2 p -115.99 146.77 37.79 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.8 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.81 -12.89 33.92 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.793 2.329 . . . . 0.0 112.279 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.83 -24.49 23.7 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.326 0.584 . . . . 0.0 110.604 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -72.54 -55.33 7.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.39 0.614 . . . . 0.0 110.851 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -88.7 12.39 14.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.969 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 53.38 62.95 2.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.518 0.675 . . . . 0.0 111.576 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.84 130.15 35.09 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.683 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.48 166.88 11.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.923 0.392 . . . . 0.0 110.602 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.471 ' HB2' HD22 ' A' ' 19' ' ' ASN . 6.2 p-10 -73.06 143.74 47.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.22 0.533 . . . . 0.0 110.941 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 66.8 15.0 10.03 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.863 0.865 . . . . 0.0 112.129 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -76.98 166.63 23.07 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 18.8 m -121.68 138.21 54.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.22 135.91 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.152 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -93.6 121.58 35.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.086 0.47 . . . . 0.0 110.973 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.3 t -109.79 136.83 44.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.201 0.524 . . . . 0.0 111.613 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -129.45 151.06 50.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.089 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--N 1.326 -0.437 0 CA-C-O 121.054 0.454 . . . . 0.0 110.868 178.112 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 16.2 p-80 . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.95 0.405 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 20' ' ' LEU . 15.9 pt -133.87 166.65 28.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.096 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.617 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -102.85 115.45 30.62 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 120.835 0.35 . . . . 0.0 110.226 -179.029 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.558 HD11 HD12 ' A' ' 18' ' ' ILE . 6.6 mp -112.55 125.66 54.49 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.431 0.634 . . . . 0.0 109.947 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 83' ' ' THR . 34.1 ttpt -105.56 146.51 29.52 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.349 0.595 . . . . 0.0 111.356 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 39.4 t -116.64 128.95 73.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.97 121.42 22.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.433 0.635 . . . . 0.0 110.489 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.0 150.31 17.1 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.839 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.46 -10.58 7.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.583 0.706 . . . . 0.0 111.86 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.546 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 21.0 t70 -71.22 -19.45 62.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.253 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.89 -13.89 49.44 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -74.94 112.34 11.08 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.796 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.3 p -139.12 131.97 37.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.281 0.563 . . . . 0.0 110.913 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.53 150.83 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.617 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -106.36 142.22 36.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.847 0.356 . . . . 0.0 110.568 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -137.29 139.0 40.64 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.133 0.492 . . . . 0.0 111.076 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -106.6 113.93 27.74 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.97 -0.456 . . . . 0.0 110.028 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.3 pt -126.9 170.09 17.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.972 0.415 . . . . 0.0 110.743 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 2.0 tmtp? -81.4 148.04 29.51 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.431 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 11.7 tpp180 -56.26 -26.14 50.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.85 0.46 . . . . 0.0 112.032 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -102.46 -2.4 28.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.531 0.681 . . . . 0.0 110.127 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.0 m -81.33 132.07 56.93 Favored Pre-proline 0 N--CA 1.434 -1.231 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.307 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.2 148.2 88.67 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.523 2.149 . . . . 0.0 111.841 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.4 mt -64.81 -15.18 61.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.743 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.49 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 11.8 p -49.22 -37.52 23.28 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 6.7 mmpt? -56.57 -53.42 57.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.85 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 44' ' ' MET . 4.3 pp -74.44 -31.63 62.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.377 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.522 ' N ' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -53.13 -58.06 8.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.023 0.439 . . . . 0.0 111.244 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -72.38 -38.14 68.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.399 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.35 -48.17 82.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.179 0.514 . . . . 0.0 110.958 -177.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -56.51 -51.35 68.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.886 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.784 ' SG ' HD11 ' A' ' 58' ' ' ILE . 31.4 m -63.75 -36.57 84.29 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.968 0.413 . . . . 0.0 111.914 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 40.4 mt-10 -64.35 -42.27 96.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.053 0.454 . . . . 0.0 111.189 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.1 ptp180 -84.35 -19.87 32.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 0.0 111.683 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -100.75 -2.4 32.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.96 48.04 69.19 Favored Glycine 0 C--O 1.235 0.202 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.348 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 58' ' ' ILE . 49.5 mt -122.69 154.53 37.95 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.067 0.46 . . . . 0.0 110.673 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.2 m -103.67 126.66 50.95 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.354 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.41 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 81.0 mmm -57.92 -26.89 62.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.035 0.534 . . . . 0.0 111.808 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.15 -28.12 27.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.243 0.544 . . . . 0.0 111.05 -178.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.716 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -93.01 -27.48 16.98 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.937 -177.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.784 HD11 ' SG ' ' A' ' 48' ' ' CYS . 10.0 pt -103.11 163.63 3.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 O-C-N 121.375 -0.828 . . . . 0.0 110.766 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -136.97 132.15 33.94 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.073 0.463 . . . . 0.0 110.657 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -90.32 126.98 36.04 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -138.29 144.84 40.65 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.281 0.562 . . . . 0.0 111.493 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -149.83 141.83 23.89 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 t70 64.69 25.42 13.04 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.906 0.86 . . . . 0.0 110.0 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.97 -15.38 10.52 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.521 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -100.4 135.35 20.25 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 122.184 -0.597 . . . . 0.0 110.879 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.09 131.95 24.96 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.032 1.821 . . . . 0.0 111.081 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.581 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 5.7 pt -98.75 -177.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.481 HD22 ' HB3' ' A' ' 71' ' ' ASP . 0.7 OUTLIER -133.82 166.75 21.92 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-O 121.54 0.686 . . . . 0.0 110.437 -174.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 10.3 pt-20 -78.9 -8.17 58.61 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.753 0.787 . . . . 0.0 108.964 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -107.38 16.24 24.12 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.058 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.581 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -103.81 151.55 22.94 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.9 p -115.79 150.17 44.42 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.035 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HB3' HD21 ' A' ' 20' ' ' LEU . 19.3 Cg_endo -61.55 -17.0 51.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.509 2.14 . . . . 0.0 111.444 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.44 -20.48 40.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.935 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.64 -53.77 8.7 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.29 0.567 . . . . 0.0 110.468 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.54 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.9 pt? -90.91 12.25 20.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.325 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 57.33 52.78 8.31 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.244 0.545 . . . . 0.0 111.439 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.37 137.08 34.85 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -104.13 -175.61 2.85 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.949 0.404 . . . . 0.0 110.4 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.46 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 11.6 p-10 -80.0 153.86 28.59 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.352 0.596 . . . . 0.0 110.319 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 63.24 18.83 11.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.916 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.75 157.57 25.78 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 25.4 m -130.21 147.68 51.96 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.595 -0.691 . . . . 0.0 112.69 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.25 140.28 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.066 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -93.86 124.25 37.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.937 0.398 . . . . 0.0 111.033 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.5 t -109.79 139.8 31.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.261 0.553 . . . . 0.0 111.522 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -132.14 156.9 45.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.743 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.546 ' OE1' ' HB2' ' A' ' 26' ' ' ASP . 2.0 mp0 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 121.131 0.491 . . . . 0.0 111.85 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.445 HG13 HD21 ' A' ' 20' ' ' LEU . 34.0 pt -127.41 158.14 38.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.073 0.463 . . . . 0.0 110.389 177.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.0 119.27 34.19 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.445 HD21 HG13 ' A' ' 18' ' ' ILE . 2.7 mm? -110.8 125.05 53.16 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 34.1 ttpt -104.55 139.71 39.03 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.063 0.459 . . . . 0.0 110.628 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.26 125.74 69.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.82 120.99 24.52 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.728 0.775 . . . . 0.0 110.959 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA2' ' HB ' ' A' ' 86' ' ' VAL . . . -97.41 146.59 18.33 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -62.61 -6.88 3.89 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.19 -4.46 59.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.735 0.779 . . . . 0.0 110.061 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.14 -10.06 56.62 Favored Glycine 0 C--N 1.316 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.57 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -74.1 113.58 11.45 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 122.753 -0.263 . . . . 0.0 110.307 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.55 137.22 28.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.461 0.648 . . . . 0.0 112.229 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.2 t -145.36 150.86 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -112.36 135.15 53.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.167 0.508 . . . . 0.0 110.569 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -126.36 166.87 16.36 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.217 0.532 . . . . 0.0 111.009 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -133.93 119.41 19.06 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.089 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.422 HG12 HD23 ' A' ' 20' ' ' LEU . 44.8 pt -134.61 170.79 18.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.073 0.463 . . . . 0.0 110.43 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.4 tmtp? -82.95 153.14 25.18 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 13.6 tpp180 -54.21 -24.45 18.46 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.109 0.564 . . . . 0.0 112.27 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -106.67 -5.06 18.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.565 0.697 . . . . 0.0 110.103 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.4 m -78.65 131.16 68.63 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.659 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.33 146.25 85.41 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.748 2.299 . . . . 0.0 112.325 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.44 -17.19 64.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.724 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 30.0 p -50.23 -38.96 43.13 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.76 0.424 . . . . 0.0 111.525 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.6 mmpt? -55.96 -53.33 58.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.86 -31.95 61.76 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.459 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.579 ' N ' HD12 ' A' ' 43' ' ' LEU . 53.8 mtt -60.12 -54.9 40.43 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.018 0.437 . . . . 0.0 111.41 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 11.2 mmmm -67.27 -39.01 86.01 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.227 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.78 79.77 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 111.298 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.432 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 26.4 t80 -55.33 -50.77 68.78 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.042 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.76 ' SG ' HD11 ' A' ' 58' ' ' ILE . 35.3 m -63.96 -34.27 77.6 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.842 0.353 . . . . 0.0 111.873 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.9 mt-10 -66.57 -39.54 88.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.911 0.386 . . . . 0.0 111.376 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -86.25 -21.94 27.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.976 0.417 . . . . 0.0 111.622 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.432 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 21.5 mm-40 -96.99 0.33 48.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.021 0.439 . . . . 0.0 111.561 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.01 45.19 96.63 Favored Glycine 0 CA--C 1.512 -0.145 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.964 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.644 ' HB3' HG21 ' A' ' 58' ' ' ILE . 86.2 mt -119.41 157.58 27.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.166 0.508 . . . . 0.0 110.587 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 58' ' ' ILE . 36.3 m -106.33 131.81 53.1 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.394 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 88.1 mmm -58.99 -23.37 61.8 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.253 0.549 . . . . 0.0 111.255 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.5 OUTLIER -84.66 -34.12 23.1 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.211 0.529 . . . . 0.0 111.236 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.533 ' NE2' ' HB2' ' A' ' 56' ' ' ARG . 0.8 OUTLIER -88.38 -17.1 31.26 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.992 0.425 . . . . 0.0 111.612 -176.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.76 HD11 ' SG ' ' A' ' 48' ' ' CYS . 6.3 pt -117.33 172.56 4.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -152.79 144.78 23.73 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.141 0.496 . . . . 0.0 110.628 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CE2' ' HG2' ' A' ' 44' ' ' MET . 6.1 m-85 -99.37 136.61 39.07 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.744 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -137.21 141.0 42.1 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.022 0.439 . . . . 0.0 110.379 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -151.18 140.69 21.57 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t0 68.65 24.68 6.73 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.832 0.825 . . . . 0.0 110.068 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.9 -0.72 65.24 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.964 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -118.45 136.07 23.88 Favored Pre-proline 0 N--CA 1.445 -0.721 0 O-C-N 122.157 -0.614 . . . . 0.0 110.466 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.58 136.38 49.87 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.906 1.738 . . . . 0.0 110.685 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.466 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 15.0 pt -112.21 169.94 4.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.383 0.611 . . . . 0.0 111.251 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.683 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -129.9 153.52 48.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.004 -177.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.6 pt-20 -59.17 -11.13 3.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.045 0.45 . . . . 0.0 112.207 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -96.63 5.3 50.99 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 122.043 -0.41 . . . . 0.0 111.65 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.683 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -96.54 161.76 13.76 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 121.574 -0.704 . . . . 0.0 110.425 -179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.5 p -121.63 150.94 56.26 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.708 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 18.5 Cg_endo -58.4 -23.15 62.13 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.955 2.437 . . . . 0.0 112.244 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.576 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -77.03 -31.67 56.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.219 0.533 . . . . 0.0 110.788 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -72.11 -55.85 6.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.565 -176.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.432 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 1.5 pt? -81.96 10.07 7.15 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 56.48 62.25 2.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 111.84 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 mtt -77.75 -169.91 1.67 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.347 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -156.59 158.61 37.41 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.63 141.98 40.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.16 0.505 . . . . 0.0 110.489 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 67.87 17.49 9.67 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.945 0.898 . . . . 0.0 112.017 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.57 171.66 11.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 m -125.11 138.57 54.17 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.581 0.705 . . . . 0.0 112.665 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.51 134.78 35.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -93.9 122.06 36.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.115 0.483 . . . . 0.0 110.602 -178.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 49.7 t -109.43 138.17 38.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.325 0.583 . . . . 0.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.86 155.24 46.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.523 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.536 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.7 mp0 . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 120.704 0.287 . . . . 0.0 110.879 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 120.794 0.331 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.18 -53.82 1.04 Allowed 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -112.71 -10.58 13.61 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.367 0.604 . . . . 0.0 112.028 -176.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -109.69 -34.19 6.55 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.227 0.536 . . . . 0.0 109.662 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -150.76 71.42 8.84 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.325 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -75.14 153.67 41.27 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.343 2.029 . . . . 0.0 111.62 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -69.65 -15.86 63.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.032 0.444 . . . . 0.0 111.454 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -72.86 -72.39 0.25 Allowed 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.878 0.847 . . . . 0.0 110.082 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.29 -54.4 3.9 Favored Glycine 0 C--N 1.291 -1.937 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.115 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.33 152.15 4.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 120.939 0.4 . . . . 0.0 110.348 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.545 ' N ' ' HE3' ' A' ' 11' ' ' LYS . 0.8 OUTLIER -66.12 173.61 3.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.016 0.436 . . . . 0.0 110.854 178.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 m -71.74 93.15 1.25 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.801 0.81 . . . . 0.0 110.501 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -93.34 151.38 19.81 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.386 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -82.02 166.56 19.68 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -79.77 73.96 6.49 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.883 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.427 ' OD2' ' HB3' ' A' ' 36' ' ' ARG . 2.6 p-10 -107.2 91.28 3.59 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 122.344 1.069 . . . . 0.0 108.725 171.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 39.0 p-80 -118.73 150.53 39.62 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.506 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 73' ' ' PRO . 33.3 pt -129.6 156.44 41.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.148 0.499 . . . . 0.0 110.658 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.467 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -96.53 113.61 25.2 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.887 -178.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.481 ' HG ' ' SD ' ' A' ' 78' ' ' MET . 1.5 mm? -109.57 128.58 55.31 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.094 0.473 . . . . 0.0 109.752 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 37.3 ttpt -106.66 141.89 37.19 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.127 0.489 . . . . 0.0 111.168 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 45.1 t -112.48 124.18 68.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.38 112.05 13.43 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.509 0.671 . . . . 0.0 110.81 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.26 148.68 19.07 Favored Glycine 0 C--N 1.299 -1.499 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.143 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -60.58 -11.65 7.76 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.342 0.591 . . . . 0.0 112.355 178.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -71.25 -18.49 62.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.601 0.715 . . . . 0.0 110.132 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.24 -10.21 50.63 Favored Glycine 0 C--N 1.316 -0.557 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.6 m -78.51 116.87 19.2 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 120.973 0.416 . . . . 0.0 109.982 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 3.8 p -142.34 135.49 27.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.318 0.58 . . . . 0.0 111.282 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.41 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 25.0 t -145.27 151.89 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.301 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -109.62 136.23 49.31 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CZ ' ' HB ' ' A' ' 30' ' ' VAL . 17.0 m-85 -131.9 133.06 44.17 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.075 0.464 . . . . 0.0 111.095 -175.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 60.7 mtpt -107.51 107.67 18.63 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.911 -0.493 . . . . 0.0 110.988 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.4 pt -121.59 173.18 7.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.227 0.536 . . . . 0.0 110.459 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.8 tmtt? -81.27 150.57 28.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.12 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.427 ' HB3' ' OD2' ' A' ' 16' ' ' ASP . 7.3 tpp180 -58.32 -20.9 46.84 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.893 0.477 . . . . 0.0 111.926 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -108.73 2.64 21.95 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.861 -0.525 . . . . 0.0 111.014 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.7 m -85.89 133.12 42.03 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.793 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.21 146.47 81.45 Favored 'Trans proline' 0 C--O 1.242 0.684 0 C-N-CA 122.728 2.285 . . . . 0.0 112.383 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.435 HD12 ' OD2' ' A' ' 71' ' ' ASP . 31.0 mt -65.86 -16.95 64.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.941 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.4 p -50.15 -37.62 35.38 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.797 0.439 . . . . 0.0 111.365 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -57.41 -52.49 65.17 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.91 -31.64 61.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.336 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.562 ' N ' HD12 ' A' ' 43' ' ' LEU . 56.3 mtt -59.44 -54.7 43.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.55 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.571 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 38.0 mmtm -66.06 -41.18 91.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.001 0.429 . . . . 0.0 109.911 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.68 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.79 -47.31 86.22 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.373 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -54.49 -49.74 69.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.597 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.559 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 75.4 m -66.28 -34.99 79.25 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 84.3 mt-10 -61.03 -44.6 97.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.188 0.518 . . . . 0.0 111.141 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.9 ptp85 -85.42 -28.22 25.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -90.8 -18.7 24.46 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.817 -0.552 . . . . 0.0 112.184 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.36 41.59 9.98 Favored Glycine 0 C--N 1.309 -0.971 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.748 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.3 mm? -114.06 153.41 29.49 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 122.294 -0.533 . . . . 0.0 110.806 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 75.2 m -95.7 124.11 39.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.747 0.308 . . . . 0.0 110.447 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.436 ' HE2' ' HB3' ' A' ' 44' ' ' MET . 92.0 mmm -60.11 -25.51 65.51 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.71 -28.55 26.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.299 0.571 . . . . 0.0 111.178 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.723 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -83.17 -40.91 19.1 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.163 0.506 . . . . 0.0 110.772 -178.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.522 HD11 ' SG ' ' A' ' 48' ' ' CYS . 13.0 pt -90.86 178.06 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.115 0.484 . . . . 0.0 110.929 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -155.43 142.66 19.34 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.874 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.411 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.7 m-85 -92.33 137.08 32.66 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.085 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -140.6 134.71 30.9 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.051 0.453 . . . . 0.0 110.028 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 78' ' ' MET . 72.3 t80 -143.81 135.53 26.23 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.04 26.43 5.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.512 0.672 . . . . 0.0 111.11 176.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.03 -6.35 71.57 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.1 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -118.4 142.61 31.65 Favored Pre-proline 0 C--N 1.319 -0.76 0 O-C-N 122.284 -0.539 . . . . 0.0 110.53 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.37 141.22 46.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.112 1.875 . . . . 0.0 111.104 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 pt -115.8 160.39 15.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.236 0.541 . . . . 0.0 110.905 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.649 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -118.97 153.31 34.84 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.566 -178.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.463 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.7 pt-20 -60.5 -12.0 8.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.019 0.438 . . . . 0.0 112.039 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -94.15 4.83 53.35 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.626 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.649 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -91.84 156.7 17.32 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 121.672 -0.643 . . . . 0.0 110.395 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.7 p -119.06 148.64 45.27 Favored Pre-proline 0 N--CA 1.439 -0.981 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.838 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.46 ' HB2' HD11 ' A' ' 18' ' ' ILE . 19.6 Cg_endo -60.29 -17.48 46.96 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.705 2.27 . . . . 0.0 112.417 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.37 -16.52 32.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.095 0.474 . . . . 0.0 111.268 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -82.61 -55.68 4.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.335 0.588 . . . . 0.0 110.567 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -85.11 3.37 39.25 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.996 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 62.74 62.31 1.09 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.449 0.642 . . . . 0.0 112.455 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 84' ' ' ILE . 29.7 ttm -90.41 139.27 30.83 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -109.33 171.14 7.61 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.416 0.627 . . . . 0.0 111.705 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -65.91 141.27 58.29 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.085 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 65.47 13.95 9.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.687 177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.96 170.66 15.33 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.2 m -128.55 144.21 51.11 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.519 HD11 ' SD ' ' A' ' 78' ' ' MET . 4.1 mp -104.8 133.08 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.764 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -94.15 125.57 38.86 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.31 0.576 . . . . 0.0 110.873 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 41.6 t -108.82 136.28 45.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.245 0.545 . . . . 0.0 111.147 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -128.78 153.01 47.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.034 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.436 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.6 mp0 -102.75 111.07 23.22 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 176.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.445 ' H ' ' NE2' ' A' ' 89' ' ' GLN . 2.1 mp0 -59.01 -57.47 12.92 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.582 0.706 . . . . 0.0 110.762 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.406 ' NE2' ' HG3' ' A' ' 57' ' ' GLN . 52.9 mt-30 -83.73 -170.21 2.95 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.082 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -81.77 -173.15 4.28 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.874 0.368 . . . . 0.0 111.424 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.87 -17.99 0.1 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.392 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.766 0 CA-C-O 118.938 -0.923 . . . . 0.0 111.584 179.506 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 121.469 0.652 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.5 20.78 2.2 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.15 23.13 6.82 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.776 -175.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -76.97 -59.62 2.7 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.922 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.567 ' O ' ' HG2' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -159.37 82.27 2.47 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 121.927 0.87 . . . . 0.0 110.82 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.97 148.5 35.5 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.265 1.977 . . . . 0.0 110.625 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.426 ' N ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -143.77 40.61 1.41 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.54 174.92 6.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.68 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.44 -11.66 16.38 Favored Glycine 0 CA--C 1.5 -0.893 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.671 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.55 120.5 10.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.299 -0.45 . . . . 0.0 110.067 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -127.29 22.35 6.57 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.614 0.721 . . . . 0.0 111.025 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -85.17 80.83 9.08 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.763 0.792 . . . . 0.0 110.436 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -93.6 96.28 9.75 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.86 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -131.43 42.06 3.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.842 0.83 . . . . 0.0 109.825 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -157.76 167.08 31.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.176 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -81.38 82.1 7.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.876 0.37 . . . . 0.0 110.237 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 17.7 p-80 -124.68 151.78 44.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.6 pt -130.92 159.15 43.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.285 0.564 . . . . 0.0 110.744 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.2 OUTLIER -93.75 127.15 39.33 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.7 mt -126.49 125.59 42.33 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 83' ' ' THR . 31.9 ttpt -106.41 141.37 37.84 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.401 0.62 . . . . 0.0 111.224 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.9 t -114.15 126.88 71.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.503 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.29 121.95 27.06 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.454 0.645 . . . . 0.0 110.803 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.2 148.89 18.57 Favored Glycine 0 C--N 1.298 -1.567 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.54 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -16.49 27.34 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.262 0.553 . . . . 0.0 112.142 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -70.36 -15.7 62.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.548 0.689 . . . . 0.0 110.709 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.68 -10.9 53.29 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.566 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.533 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . 70.2 m -78.54 115.34 18.18 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.107 0.48 . . . . 0.0 110.242 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.73 135.21 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.329 0.585 . . . . 0.0 111.781 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.4 t -140.68 150.12 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.93 -177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.513 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -108.51 140.55 41.68 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.9 0.381 . . . . 0.0 110.667 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -134.81 163.45 29.79 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.055 0.455 . . . . 0.0 110.367 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -134.85 110.31 9.09 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.3 pt -126.03 166.95 21.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.916 0.389 . . . . 0.0 110.434 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 2.1 tmtp? -74.71 147.43 41.42 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.523 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 42.7 ttm180 -65.16 -15.41 62.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.187 0.518 . . . . 0.0 111.909 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -103.11 -3.52 25.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.746 0.784 . . . . 0.0 109.079 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 m -88.99 133.55 35.2 Favored Pre-proline 0 N--CA 1.439 -1.01 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.132 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.0 150.67 87.77 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.643 2.228 . . . . 0.0 112.708 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.1 mt -65.44 -15.67 62.85 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.578 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 34.3 p -49.97 -37.4 32.17 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 122.768 0.427 . . . . 0.0 111.731 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 7.4 mmpt? -57.61 -52.39 65.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.242 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.44 -31.94 62.46 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.366 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.59 ' N ' HD12 ' A' ' 43' ' ' LEU . 57.7 mtt -60.98 -54.53 43.83 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 34.8 mmtp -68.54 -37.03 79.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.554 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.84 -47.94 81.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.986 0.422 . . . . 0.0 110.543 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.438 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 57.1 t80 -56.06 -51.93 66.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.343 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 p -61.09 -35.12 76.15 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.068 -0.395 . . . . 0.0 111.425 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 37.6 mt-10 -67.38 -43.27 81.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.021 0.439 . . . . 0.0 111.798 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 13.3 ptp180 -80.66 -25.89 37.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.809 0.337 . . . . 0.0 111.646 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.533 ' OE1' ' HB3' ' A' ' 28' ' ' SER . 20.5 mm-40 -93.85 -2.63 53.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.793 0.33 . . . . 0.0 111.822 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.3 43.91 91.84 Favored Glycine 0 CA--C 1.508 -0.344 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.74 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.655 ' HB3' HG21 ' A' ' 58' ' ' ILE . 84.9 mt -119.25 157.04 28.83 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.19 0.519 . . . . 0.0 110.714 -177.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.7 m -107.12 129.51 54.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.568 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.451 ' CE ' ' HB3' ' A' ' 44' ' ' MET . 98.4 mmm -63.17 -22.47 66.89 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.164 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.06 -23.91 30.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.436 0.636 . . . . 0.0 110.422 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.85 -44.47 8.92 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.076 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.655 HG21 ' HB3' ' A' ' 53' ' ' LEU . 15.3 pt -88.52 166.83 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 O-C-N 121.661 -0.649 . . . . 0.0 110.348 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -144.43 137.85 27.29 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.951 0.405 . . . . 0.0 110.155 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -93.5 139.99 30.1 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.853 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -144.88 143.42 30.58 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.035 0.445 . . . . 0.0 110.291 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -152.28 135.85 16.1 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t70 67.34 25.77 8.64 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.471 0.653 . . . . 0.0 111.107 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.02 0.58 76.58 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.622 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -118.74 145.04 36.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 O-C-N 121.912 -0.758 . . . . 0.0 110.088 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.36 141.98 23.43 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.872 1.715 . . . . 0.0 111.166 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.8 pt -115.01 160.45 14.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.275 0.559 . . . . 0.0 111.289 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.611 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -121.66 155.42 35.2 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.805 -178.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 9.8 pt-20 -61.97 -9.76 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.172 0.511 . . . . 0.0 111.738 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -97.09 9.45 42.07 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 122.054 -0.404 . . . . 0.0 111.313 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.611 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -96.57 154.58 17.19 Favored 'General case' 0 C--O 1.243 0.718 0 O-C-N 121.74 -0.6 . . . . 0.0 109.734 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.3 p -117.16 146.98 39.37 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.551 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.87 -22.48 68.61 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.649 2.233 . . . . 0.0 112.091 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -80.35 -17.25 52.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.159 0.504 . . . . 0.0 110.904 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -79.23 -54.86 5.56 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.341 0.591 . . . . 0.0 110.023 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.9 pt? -87.54 12.25 12.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.223 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 57.08 58.73 3.79 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.491 0.662 . . . . 0.0 111.55 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.61 131.77 34.57 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.726 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -97.35 167.13 11.2 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.164 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.495 ' HB2' HD22 ' A' ' 19' ' ' ASN . 4.3 p-10 -76.69 150.58 36.31 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.111 0.481 . . . . 0.0 110.82 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 67.28 13.87 9.52 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 124.015 0.926 . . . . 0.0 112.209 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.17 171.38 13.74 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 17.6 m -125.97 147.7 49.45 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.393 0.616 . . . . 0.0 112.354 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.3 133.66 54.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.38 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.03 121.39 31.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.235 0.541 . . . . 0.0 111.275 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.81 138.93 35.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.244 0.545 . . . . 0.0 111.384 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -128.45 150.21 50.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.489 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.452 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.7 mp0 -101.86 112.69 25.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.284 0.564 . . . . 0.0 111.643 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -99.93 -176.12 3.16 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.633 ' HA ' HE21 ' A' ' 90' ' ' GLN . 0.0 OUTLIER 60.43 21.33 10.97 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.331 0.653 . . . . 0.0 109.99 -178.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.7 m 58.86 65.46 1.22 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.736 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.01 -20.87 77.2 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.498 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.462 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.385 178.863 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.713 0.292 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.407 ' O ' ' HE3' ' A' ' 11' ' ' LYS . . . 65.58 27.62 11.48 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.474 0.71 . . . . 0.0 111.293 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -136.45 18.76 3.13 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.853 0.835 . . . . 0.0 109.621 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -83.77 27.52 0.63 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.614 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt 68.48 56.51 0.65 Allowed Pre-proline 0 N--CA 1.466 0.375 0 C-N-CA 123.394 0.677 . . . . 0.0 110.564 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.68 161.84 44.66 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.541 2.16 . . . . 0.0 111.713 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -86.09 -13.19 47.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.197 0.522 . . . . 0.0 111.09 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -121.77 132.93 54.88 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.96 56.08 18.32 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.874 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.21 38.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 122.005 0.907 . . . . 0.0 110.571 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.491 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER 49.21 34.47 6.13 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.016 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 p -113.09 -84.73 0.59 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.825 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.72 160.74 42.41 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.368 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.1 m120 62.95 43.58 6.65 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.857 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -67.62 174.62 3.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.442 0.639 . . . . 0.0 111.651 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.13 85.74 5.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.272 1.034 . . . . 0.0 110.743 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 31.9 p-80 -121.03 143.87 48.83 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.126 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.407 HG13 HD21 ' A' ' 20' ' ' LEU . 31.4 pt -130.63 165.1 31.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.047 0.451 . . . . 0.0 110.591 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.12 120.51 40.57 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.407 HD21 HG13 ' A' ' 18' ' ' ILE . 2.5 mm? -111.83 124.57 52.63 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 83' ' ' THR . 33.5 ttpt -104.81 142.16 35.23 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.046 0.45 . . . . 0.0 110.634 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.84 127.71 71.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 120.958 0.409 . . . . 0.0 110.112 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.18 123.38 26.95 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.491 0.662 . . . . 0.0 110.146 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.9 148.41 16.47 Favored Glycine 0 C--N 1.3 -1.437 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.986 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -7.26 4.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -82.94 -10.63 58.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.482 0.658 . . . . 0.0 109.897 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.67 -13.36 46.54 Favored Glycine 0 CA--C 1.511 -0.193 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.338 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.1 m -77.31 119.24 20.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.962 0.41 . . . . 0.0 110.678 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 p -140.81 135.31 33.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.583 0.706 . . . . 0.0 111.366 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -143.33 149.46 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.41 ' C ' HE21 ' A' ' 31' ' ' GLN . 0.0 OUTLIER -108.0 139.77 42.15 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.106 -0.371 . . . . 0.0 110.4 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -128.43 163.7 24.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.32 0.581 . . . . 0.0 110.758 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -137.7 111.73 8.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.951 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 pt -136.44 173.33 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.323 0.582 . . . . 0.0 111.085 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 11.5 tmtt? -77.08 147.98 36.36 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.591 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.481 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 40.1 ttm180 -60.29 -18.12 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -112.59 5.11 17.68 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.227 -0.921 . . . . 0.0 110.372 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.3 m -83.03 133.98 47.25 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.29 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.1 140.34 83.45 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 122.684 2.256 . . . . 0.0 113.045 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.431 HD12 ' OD2' ' A' ' 71' ' ' ASP . 42.3 mt -65.1 -15.7 62.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.824 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 23.0 t -49.27 -39.63 31.3 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 122.615 0.366 . . . . 0.0 111.27 -178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.533 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -58.3 -52.46 65.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.617 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.6 -32.01 62.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.922 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.617 ' N ' HD12 ' A' ' 43' ' ' LEU . 38.9 ttm -61.78 -52.01 65.97 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.61 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 50.5 mmtt -68.61 -42.57 77.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.001 0.429 . . . . 0.0 110.03 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.76 -45.24 90.18 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.955 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.426 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 49.2 t80 -57.95 -52.34 65.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.455 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.531 ' SG ' ' HG2' ' A' ' 55' ' ' MET . 14.4 p -62.4 -37.62 86.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.119 0.485 . . . . 0.0 110.982 -177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 48.1 mt-10 -67.63 -37.59 82.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.987 0.422 . . . . 0.0 111.898 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.6 ptp180 -85.7 -23.41 27.41 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 122.104 -0.372 . . . . 0.0 111.552 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.426 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 19.6 mm-40 -97.01 -4.53 39.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.938 0.399 . . . . 0.0 111.75 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.45 54.62 Favored Glycine 0 C--N 1.322 -0.201 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.249 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.6 mp -116.65 154.43 30.56 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.156 0.503 . . . . 0.0 110.614 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.0 m -102.45 122.37 44.19 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.493 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.531 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 97.8 mmm -56.09 -25.48 45.67 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.516 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -83.75 -30.92 26.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.614 0.721 . . . . 0.0 109.985 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.759 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -88.52 -24.34 22.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.256 -177.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 54' ' ' SER . 21.9 pt -107.25 174.26 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 121.895 -0.503 . . . . 0.0 110.158 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.487 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 1.9 tpp180 -159.05 134.35 8.43 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.203 0.525 . . . . 0.0 110.509 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 4.1 m-85 -85.64 143.18 28.57 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.625 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.441 ' HG3' ' C ' ' A' ' 65' ' ' GLN . 26.0 ttm180 -142.1 141.78 32.74 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.066 0.46 . . . . 0.0 110.541 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -150.32 136.91 19.0 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.25 27.68 8.28 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.342 0.592 . . . . 0.0 111.207 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.4 2.08 83.28 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.239 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.441 ' C ' ' HG3' ' A' ' 61' ' ' ARG . 7.5 pt20 -125.5 144.52 48.18 Favored Pre-proline 0 C--N 1.317 -0.836 0 O-C-N 122.178 -0.601 . . . . 0.0 110.26 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.85 143.0 53.79 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.039 1.826 . . . . 0.0 111.442 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.7 pt -113.63 171.45 3.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.058 0.456 . . . . 0.0 110.552 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.661 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.59 155.48 47.46 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.7 -177.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.597 ' O ' ' HB2' ' A' ' 41' ' ' SER . 12.6 pt-20 -63.02 -8.83 8.12 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.134 0.492 . . . . 0.0 111.897 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 t -99.11 9.39 43.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 121.982 -0.449 . . . . 0.0 111.293 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.661 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.4 157.74 16.21 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.789 179.1 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.6 p -123.61 151.7 64.08 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 12.2 Cg_endo -57.54 -19.85 38.71 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.76 2.307 . . . . 0.0 112.641 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.0 -29.2 35.23 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.94 -0.475 . . . . 0.0 110.97 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -72.44 -56.26 5.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.186 0.517 . . . . 0.0 110.86 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 1.7 pt? -81.88 6.06 16.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.634 -178.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 56.64 64.14 1.76 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.722 0.772 . . . . 0.0 111.145 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.79 -170.69 1.12 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.258 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -147.57 149.73 33.13 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.74 143.87 47.84 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 68.3 14.93 9.28 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.228 0.611 . . . . 0.0 111.878 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -87.61 173.95 8.74 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.044 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 28.3 m -126.41 142.42 51.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.699 0.761 . . . . 0.0 112.757 -175.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.76 133.09 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.786 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -90.55 119.95 31.23 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.041 0.448 . . . . 0.0 110.623 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.27 136.7 41.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.491 0.662 . . . . 0.0 111.609 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -134.78 165.71 24.64 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.403 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.1 mp0 -107.54 110.86 22.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.079 0.466 . . . . 0.0 110.196 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.487 ' NE2' ' HB3' ' A' ' 59' ' ' ARG . 2.0 mp0 -110.25 70.28 0.72 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.39 0.614 . . . . 0.0 110.877 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -86.87 -27.82 23.22 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.7 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.4 p -81.46 -70.82 0.51 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.223 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.06 26.88 0.02 OUTLIER Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.857 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.82 0 CA-C-O 119.16 -0.8 . . . . 0.0 111.479 179.7 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.963 0.411 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.05 -5.13 42.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.56 0.695 . . . . 0.0 110.599 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -80.53 -21.41 41.85 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.972 177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -78.94 -36.68 41.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.463 0.649 . . . . 0.0 109.408 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -151.59 87.97 4.37 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-O 121.605 0.717 . . . . 0.0 111.962 178.15 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.0 -177.02 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.497 2.132 . . . . 0.0 111.392 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -82.04 -34.38 29.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -78.33 130.06 35.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.971 0.415 . . . . 0.0 110.564 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.16 -30.46 34.34 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.725 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -63.26 119.26 6.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.522 0.677 . . . . 0.0 110.413 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -101.74 89.89 3.83 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.564 0.697 . . . . 0.0 111.117 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -103.42 42.03 1.21 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 122.195 0.998 . . . . 0.0 109.446 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -165.46 -173.67 2.88 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.48 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -138.7 131.6 29.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.136 0.493 . . . . 0.0 110.986 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.605 ' OD1' ' HE3' ' A' ' 35' ' ' LYS . 50.0 t30 -124.37 132.92 53.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.369 0.604 . . . . 0.0 110.29 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -105.35 -85.75 0.48 Allowed 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.791 0.805 . . . . 0.0 109.098 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 72.92 104.41 0.07 Allowed 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.418 -178.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.2 pt -116.05 158.07 16.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.19 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.424 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -96.79 114.49 26.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.7 mt -110.98 124.8 52.86 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 83' ' ' THR . 32.3 ttpt -102.38 136.8 41.56 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.284 0.564 . . . . 0.0 111.185 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 29' ' ' VAL . 48.2 t -112.46 125.71 69.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.226 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.15 125.84 41.86 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.44 0.638 . . . . 0.0 110.61 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.95 152.07 20.16 Favored Glycine 0 C--N 1.302 -1.354 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.018 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -19.38 38.49 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 117.227 0.513 . . . . 0.0 112.32 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -69.13 -22.97 63.92 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.942 0.877 . . . . 0.0 109.742 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.47 -9.3 38.28 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.486 ' HB3' ' OE1' ' A' ' 51' ' ' GLN . 67.1 m -68.97 125.36 26.4 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 22' ' ' VAL . 7.1 p -146.36 145.35 19.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.24 0.543 . . . . 0.0 111.569 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.1 t -146.79 151.51 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.424 ' NE2' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -111.08 132.26 54.4 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.236 0.541 . . . . 0.0 109.879 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 32.7 m-85 -122.02 168.16 12.26 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.782 -175.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -137.58 119.67 15.51 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 pt -138.47 163.6 28.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 32.0 tttt -76.32 165.13 25.29 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.293 0.568 . . . . 0.0 111.795 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 16.0 tpp180 -71.65 -19.31 62.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.408 -177.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -105.55 -6.8 19.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.9 0.857 . . . . 0.0 108.872 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.4 m -78.19 131.75 68.48 Favored Pre-proline 0 N--CA 1.435 -1.183 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.576 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.86 148.58 86.44 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.415 2.077 . . . . 0.0 111.707 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.15 -16.48 63.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.737 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 13.2 p -50.64 -37.45 40.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 122.824 0.449 . . . . 0.0 112.091 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 9.4 mmpt? -55.47 -53.88 50.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.912 0.387 . . . . 0.0 110.925 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 44' ' ' MET . 4.0 pp -75.66 -32.58 60.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.325 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.64 ' N ' HD12 ' A' ' 43' ' ' LEU . 46.2 ttm -59.33 -50.32 74.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.082 0.468 . . . . 0.0 110.458 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.644 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 1.9 mmmp? -69.9 -44.24 70.1 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.001 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.64 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.54 -42.97 93.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.739 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 34.1 t80 -54.27 -51.11 65.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.882 0.372 . . . . 0.0 110.623 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 58' ' ' ILE . 23.3 m -63.66 -34.54 78.06 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.023 0.44 . . . . 0.0 111.12 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 48.9 mm-40 -63.64 -39.47 94.42 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.067 0.461 . . . . 0.0 111.734 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -90.68 -20.82 22.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.791 0.329 . . . . 0.0 111.862 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.486 ' OE1' ' HB3' ' A' ' 28' ' ' SER . 19.5 mm-40 -95.11 -4.57 45.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.95 9.78 85.19 Favored Glycine 0 C--O 1.236 0.279 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.76 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.41 162.46 17.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.552 0.691 . . . . 0.0 112.007 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 58' ' ' ILE . 7.3 m -114.07 136.94 52.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.87 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.448 ' SD ' ' HA ' ' A' ' 45' ' ' LYS . 68.8 mmm -60.17 -28.35 67.86 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.776 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -83.39 -33.24 25.82 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.417 0.627 . . . . 0.0 110.911 -178.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.5 -20.91 46.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.395 0.616 . . . . 0.0 111.187 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.651 HD11 ' SG ' ' A' ' 48' ' ' CYS . 9.4 pt -118.15 179.72 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.134 0.492 . . . . 0.0 111.915 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -158.51 142.25 15.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.842 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -96.52 142.16 28.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.076 0.465 . . . . 0.0 111.008 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -144.18 143.15 30.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.075 0.464 . . . . 0.0 110.789 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -152.68 139.35 18.81 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.1 t70 65.47 23.97 11.89 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.828 0.823 . . . . 0.0 110.079 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.27 -23.47 8.24 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.885 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -94.68 140.14 22.5 Favored Pre-proline 0 C--N 1.322 -0.587 0 O-C-N 122.427 -0.455 . . . . 0.0 110.984 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.15 136.14 31.24 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.868 1.712 . . . . 0.0 110.623 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.605 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 10.8 pt -102.95 177.63 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.738 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.34 170.03 16.73 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 121.827 0.822 . . . . 0.0 111.066 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 12.0 pt-20 -73.44 -9.87 59.14 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.523 0.677 . . . . 0.0 109.708 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.2 t -107.9 10.94 28.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.211 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.605 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -99.84 155.4 17.68 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.908 178.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.8 p -118.53 147.87 42.91 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.329 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.12 -18.81 63.98 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.008 2.472 . . . . 0.0 112.177 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -79.65 -29.63 41.0 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.237 0.541 . . . . 0.0 110.511 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -67.85 -55.26 13.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.202 0.525 . . . . 0.0 110.825 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -88.53 12.44 14.48 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.738 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 52.28 62.81 2.51 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.724 0.773 . . . . 0.0 112.085 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -81.78 126.84 32.32 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.891 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.04 157.0 19.01 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -74.39 153.21 39.34 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 121.742 -0.599 . . . . 0.0 110.44 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 69.57 14.79 8.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.112 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -81.77 166.43 20.04 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.809 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 18.9 m -124.85 137.6 54.29 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.583 0.706 . . . . 0.0 112.88 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.99 140.53 19.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.659 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -95.31 117.86 31.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.089 0.471 . . . . 0.0 110.897 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -106.41 137.94 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.173 0.511 . . . . 0.0 111.414 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -129.55 155.71 45.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.899 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -102.14 111.74 24.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.987 0.422 . . . . 0.0 110.293 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.606 HE21 ' N ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -111.12 63.51 0.61 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.521 0.677 . . . . 0.0 111.126 179.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -131.49 83.82 2.13 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.1 m -73.67 110.94 8.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.227 0.537 . . . . 0.0 112.215 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.49 -122.64 5.13 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.925 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.449 179.133 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.105 0.479 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.98 1.19 55.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.795 0.807 . . . . 0.0 110.328 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -88.8 17.89 5.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.576 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -73.87 -48.98 27.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.524 0.678 . . . . 0.0 109.363 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -135.06 81.4 45.3 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-O 121.504 0.669 . . . . 0.0 111.692 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.1 144.23 29.67 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 123.254 2.636 . . . . 0.0 112.381 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -89.76 57.81 4.02 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.768 0.794 . . . . 0.0 109.404 176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -75.38 142.5 43.1 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.635 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.93 39.83 32.15 Favored Glycine 0 CA--C 1.505 -0.587 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.342 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.45 146.93 6.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 120.922 0.391 . . . . 0.0 110.743 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -145.58 161.89 38.74 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.176 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.1 p -132.69 139.21 47.56 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.189 0.519 . . . . 0.0 112.147 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -140.68 117.0 10.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 57.44 85.76 0.08 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.745 0.783 . . . . 0.0 111.424 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -151.73 143.02 23.37 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.631 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.656 ' OD2' ' HD2' ' A' ' 36' ' ' ARG . 1.9 t70 -88.68 85.74 6.85 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.591 0.71 . . . . 0.0 109.334 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 27.4 p-80 -119.28 146.48 45.22 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.507 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.17 166.98 27.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.075 0.464 . . . . 0.0 110.168 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.435 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -108.45 121.26 44.58 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.36 131.22 56.63 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 31.1 ttpt -107.81 140.66 40.56 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.072 0.463 . . . . 0.0 110.521 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 39.1 t -114.08 127.5 71.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.099 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.99 127.26 35.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.143 0.497 . . . . 0.0 110.333 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.57 153.72 16.8 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.221 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.6 pp0? -61.39 -17.74 55.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.402 0.62 . . . . 0.0 111.126 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -70.1 -15.1 62.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.982 0.896 . . . . 0.0 109.757 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.65 -16.1 55.11 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.796 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -70.11 118.6 13.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.049 0.452 . . . . 0.0 110.688 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.6 p -142.98 136.27 25.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.148 0.499 . . . . 0.0 111.527 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 t -146.86 151.99 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.246 0.618 . . . . 0.0 109.516 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.432 HE21 ' HB3' ' A' ' 31' ' ' GLN . 1.0 OUTLIER -110.77 141.85 43.53 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.231 -0.293 . . . . 0.0 110.497 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 24.1 m-85 -135.59 156.43 48.87 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.055 0.455 . . . . 0.0 110.826 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 48.3 mttp -125.46 110.32 13.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.14 0.495 . . . . 0.0 110.433 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.2 pt -125.27 173.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.282 0.563 . . . . 0.0 110.673 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 2.4 tmtp? -83.54 148.36 27.24 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.656 ' HD2' ' OD2' ' A' ' 16' ' ' ASP . 28.7 ttm180 -64.59 -14.51 58.18 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -107.6 -1.52 21.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.542 0.686 . . . . 0.0 109.835 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.8 m -86.73 133.54 39.46 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.679 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.01 151.0 85.05 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.606 2.204 . . . . 0.0 112.473 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.8 mt -65.18 -16.63 63.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.631 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 24.5 p -49.9 -37.76 32.89 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.933 0.493 . . . . 0.0 111.822 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 8.7 mmpt? -56.27 -53.56 55.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.872 0.368 . . . . 0.0 110.654 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -75.39 -31.85 60.58 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.47 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.572 ' N ' HD12 ' A' ' 43' ' ' LEU . 53.4 mtt -57.32 -55.99 27.64 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 120.793 0.33 . . . . 0.0 111.721 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -70.13 -39.19 75.56 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.54 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.25 -44.99 88.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.145 0.497 . . . . 0.0 110.609 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 25.0 t80 -60.17 -51.92 67.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.675 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.765 ' SG ' HD11 ' A' ' 58' ' ' ILE . 40.0 m -63.63 -34.55 78.08 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.009 0.433 . . . . 0.0 111.801 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 17.9 mm-40 -67.83 -39.38 83.88 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.051 0.453 . . . . 0.0 111.474 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.0 ptp180 -84.55 -22.54 30.06 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.917 0.389 . . . . 0.0 111.417 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.413 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 20.0 mm-40 -96.77 -3.05 43.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.253 0.549 . . . . 0.0 111.697 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.81 43.33 91.89 Favored Glycine 0 C--N 1.32 -0.351 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.349 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.538 ' HB3' HG21 ' A' ' 58' ' ' ILE . 28.6 mt -117.94 154.96 31.04 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.12 0.486 . . . . 0.0 110.594 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 75.2 m -102.03 126.51 48.98 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.696 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.481 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 92.7 mmm -55.5 -27.97 51.78 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.476 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -84.21 -30.76 25.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.419 0.628 . . . . 0.0 111.185 -177.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 54' ' ' SER . 0.8 OUTLIER -87.01 -28.88 22.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.686 -178.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.765 HD11 ' SG ' ' A' ' 48' ' ' CYS . 5.8 pt -105.07 177.71 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -157.31 141.18 16.02 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.113 0.482 . . . . 0.0 110.59 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 5.2 m-85 -91.97 141.9 28.12 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.135 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -139.81 138.79 36.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.154 0.502 . . . . 0.0 110.706 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -148.48 140.88 24.25 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 t70 67.72 23.46 8.63 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.766 0.793 . . . . 0.0 109.822 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.41 -0.24 75.98 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.26 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -119.4 138.01 26.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 O-C-N 122.206 -0.585 . . . . 0.0 110.411 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.85 141.46 71.57 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.015 1.81 . . . . 0.0 111.25 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.9 pt -114.78 167.55 7.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.86 0.362 . . . . 0.0 111.05 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.669 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -128.17 155.97 43.63 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.553 -177.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.3 pt-20 -60.12 -10.75 4.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 112.001 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.2 t -99.29 9.1 44.01 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 122.039 -0.413 . . . . 0.0 111.786 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.669 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -98.03 159.75 14.74 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 121.658 -0.651 . . . . 0.0 110.65 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.1 p -117.76 148.99 44.35 Favored Pre-proline 0 N--CA 1.443 -0.811 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.617 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.97 -19.8 69.97 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.514 2.142 . . . . 0.0 111.904 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.12 -20.95 40.31 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.005 0.431 . . . . 0.0 111.074 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -74.76 -53.86 8.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.545 0.688 . . . . 0.0 110.565 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.31 4.4 31.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.333 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 61.39 62.84 1.28 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.61 0.719 . . . . 0.0 111.832 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 mtt -79.19 126.56 30.91 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.176 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -88.69 157.75 18.43 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.517 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.6 147.26 49.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.859 0.361 . . . . 0.0 110.264 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 67.18 15.18 9.99 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.426 0.69 . . . . 0.0 112.167 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -82.73 168.28 17.36 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 19.1 m -125.6 140.41 52.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.842 0.83 . . . . 0.0 112.849 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.84 134.27 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.85 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -95.79 125.23 40.21 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.191 0.52 . . . . 0.0 111.254 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.447 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 44.0 t -108.48 137.94 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.414 0.626 . . . . 0.0 112.12 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -136.12 166.54 23.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.426 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.5 mp0 -112.3 112.78 24.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.028 0.442 . . . . 0.0 111.406 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.53 45.38 0.98 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.481 0.658 . . . . 0.0 110.245 176.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.446 ' HG3' ' HA ' ' A' ' 57' ' ' GLN . 23.9 mm-40 -162.33 123.68 2.64 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 124.299 1.04 . . . . 0.0 108.852 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.8 m -87.99 104.53 16.72 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.133 0.492 . . . . 0.0 110.358 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.72 105.89 3.26 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 121.041 -0.599 . . . . 0.0 111.653 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.292 0 CA-C-O 118.479 -1.178 . . . . 0.0 111.643 -179.219 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.442 ' O ' ' HG2' ' A' ' 4' ' ' GLU . 46.7 mtt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 121.455 0.645 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.06 14.56 30.23 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.858 0.837 . . . . 0.0 109.41 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.65 17.36 23.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.291 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.497 ' HG3' HG21 ' A' ' 38' ' ' THR . 17.1 mm-40 -88.76 34.06 0.77 Allowed 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.369 0.604 . . . . 0.0 111.636 -175.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.546 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 10.0 mtpm? -142.24 -51.09 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.023 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 2.3 Cg_endo -83.38 171.72 10.98 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.094 1.863 . . . . 0.0 111.062 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -83.35 1.33 41.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.948 0.404 . . . . 0.0 111.527 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.85 171.8 7.64 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.897 0.38 . . . . 0.0 110.493 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.01 66.97 1.26 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.574 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.77 127.0 17.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.374 0.607 . . . . 0.0 111.259 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -62.29 118.24 7.17 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.532 0.682 . . . . 0.0 109.574 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.434 HG22 ' HG3' ' A' ' 13' ' ' GLU . 2.5 m -89.24 150.49 22.61 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.441 -172.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' HG3' HG22 ' A' ' 12' ' ' THR . 31.0 mt-10 60.56 19.53 9.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.011 0.924 . . . . 0.0 113.31 176.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.5 t30 49.06 72.1 0.32 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.976 0.893 . . . . 0.0 109.534 -176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.8 p-10 -78.65 174.58 11.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.525 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.54 86.7 6.31 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.805 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 38.1 p-80 -125.22 150.53 46.92 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.591 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 pt -129.77 167.9 24.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.027 0.441 . . . . 0.0 110.382 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.613 ' OD1' ' HE3' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -103.69 128.37 51.04 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.61 124.94 44.63 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 83' ' ' THR . 36.0 ttpt -104.1 140.04 38.33 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.171 0.51 . . . . 0.0 111.037 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.0 t -112.86 124.71 69.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.884 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.38 126.17 40.12 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.623 0.725 . . . . 0.0 110.096 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.41 146.66 17.38 Favored Glycine 0 C--N 1.295 -1.708 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.656 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -4.59 1.56 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.566 0.698 . . . . 0.0 112.023 177.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.617 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 27.6 t70 -77.65 -16.87 58.25 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.647 0.779 . . . . 0.0 110.188 177.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.54 -13.18 50.92 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -82.06 119.93 24.64 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.116 0.484 . . . . 0.0 110.624 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.51 137.83 28.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 111.156 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.443 ' HB ' ' CZ ' ' A' ' 32' ' ' PHE . 11.3 t -144.75 151.82 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.36 137.78 46.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.443 ' CZ ' ' HB ' ' A' ' 30' ' ' VAL . 30.8 m-85 -130.55 139.48 50.46 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.406 0.622 . . . . 0.0 111.406 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.613 ' HE3' ' OD1' ' A' ' 19' ' ' ASN . 22.9 tttt -112.17 107.96 17.04 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.674 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 pt -128.89 172.18 15.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.148 0.499 . . . . 0.0 111.186 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.8 tmtt? -80.23 149.77 30.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.877 0.37 . . . . 0.0 110.294 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 20.0 tpp85 -61.31 -19.48 61.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.144 0.577 . . . . 0.0 111.574 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -107.52 -1.95 20.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.476 0.655 . . . . 0.0 109.825 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.497 HG21 ' HG3' ' A' ' 4' ' ' GLU . 6.7 m -82.24 131.52 55.9 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.917 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.94 147.4 89.17 Favored 'Trans proline' 0 C--O 1.241 0.638 0 C-N-CA 122.377 2.051 . . . . 0.0 112.151 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.84 -15.73 62.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.137 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.549 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 37.4 p -49.89 -39.78 40.78 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.198 0.599 . . . . 0.0 111.366 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.61 -53.19 60.52 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.374 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.94 -32.38 61.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.022 0.439 . . . . 0.0 111.045 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.609 ' N ' HD12 ' A' ' 43' ' ' LEU . 45.7 ttm -60.6 -50.04 75.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 110.369 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 30.0 mmtp -71.39 -42.58 68.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.429 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.652 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.48 -46.11 91.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.594 0.357 . . . . 0.0 111.898 -177.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -53.89 -49.39 68.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.992 0.425 . . . . 0.0 110.323 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 58' ' ' ILE . 37.1 m -66.34 -34.32 77.7 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.27 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 45.6 mm-40 -58.14 -49.22 77.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.431 0.634 . . . . 0.0 110.992 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 5.7 ptp180 -83.99 -24.92 30.37 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -95.8 -11.61 26.62 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.93 44.86 35.4 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.973 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.419 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.1 mm? -114.4 153.22 30.25 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.379 -0.483 . . . . 0.0 110.689 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.4 ' O ' HG12 ' A' ' 58' ' ' ILE . 68.1 m -95.75 126.14 40.81 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 120.776 0.322 . . . . 0.0 111.03 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.451 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 52.9 mmm -61.6 -26.71 68.15 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.454 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -82.54 -29.78 30.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.14 0.495 . . . . 0.0 111.257 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.99 -45.64 10.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.366 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 48' ' ' CYS . 8.7 pt -84.6 172.98 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 O-C-N 121.692 -0.63 . . . . 0.0 111.317 -177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 23.6 tpt180 -151.7 137.38 17.9 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.259 0.552 . . . . 0.0 110.351 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 8.1 m-85 -92.07 134.08 35.16 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.987 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -139.55 139.74 36.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.104 0.478 . . . . 0.0 110.509 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -145.76 137.83 25.38 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t70 67.08 24.7 9.35 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.849 0.833 . . . . 0.0 110.314 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.52 0.95 81.21 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.334 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -119.17 131.92 24.17 Favored Pre-proline 0 N--CA 1.451 -0.405 0 O-C-N 122.283 -0.54 . . . . 0.0 110.622 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -64.02 138.58 63.05 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.288 1.992 . . . . 0.0 111.295 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.7 pt -111.79 167.97 5.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.138 0.494 . . . . 0.0 111.259 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.623 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.32 158.94 39.34 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.29 -177.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.549 ' O ' ' HB3' ' A' ' 41' ' ' SER . 5.4 pt-20 -63.21 -9.66 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.226 0.536 . . . . 0.0 111.604 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 t -99.59 10.66 40.97 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.939 -0.475 . . . . 0.0 111.604 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.623 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -100.07 157.34 16.62 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 121.714 -0.616 . . . . 0.0 110.686 178.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.7 p -120.72 147.77 46.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.693 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.445 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 34.6 Cg_endo -63.89 -19.02 66.17 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.917 2.411 . . . . 0.0 112.35 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.59 -25.95 41.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.008 0.432 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -73.49 -55.71 5.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.398 0.618 . . . . 0.0 111.286 -176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.453 HD21 ' HG3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -81.61 -2.69 51.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.613 -178.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 67.31 63.31 0.44 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.014 0.912 . . . . 0.0 110.799 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.453 ' HG3' HD21 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -82.31 128.71 34.47 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.684 -178.228 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.05 164.02 16.69 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.952 0.406 . . . . 0.0 110.095 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.19 147.0 31.47 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.039 0.447 . . . . 0.0 110.88 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 69.17 14.83 8.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.308 1.043 . . . . 0.0 111.896 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -81.21 169.64 17.09 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 21.6 m -124.97 141.46 52.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.509 0.671 . . . . 0.0 112.564 -175.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.36 138.17 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.243 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.04 120.45 33.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.076 0.465 . . . . 0.0 110.544 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.46 137.48 42.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.343 0.592 . . . . 0.0 111.594 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -130.97 153.84 48.78 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.729 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.617 ' OE1' ' HB2' ' A' ' 26' ' ' ASP . 2.0 mp0 -101.62 113.08 25.9 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.08 0.467 . . . . 0.0 111.582 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -104.47 -176.72 3.16 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.976 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 62.11 9.3 3.05 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.361 0.665 . . . . 0.0 111.045 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.3 m 53.86 69.05 0.76 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.647 0.737 . . . . 0.0 110.667 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.48 3.95 56.58 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.656 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.74 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.281 0.562 . . . . 0.0 111.556 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.95 15.33 17.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.722 0.772 . . . . 0.0 109.411 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.68 16.12 23.08 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.169 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -103.15 50.06 0.82 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.209 0.528 . . . . 0.0 111.199 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm 69.22 69.57 0.41 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.198 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.5 107.63 2.52 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.651 2.234 . . . . 0.0 111.96 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -102.57 41.37 1.24 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.944 0.878 . . . . 0.0 109.433 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.27 118.7 19.26 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.306 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.44 145.35 4.47 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.48 114.82 27.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.306 0.574 . . . . 0.0 111.069 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -112.56 140.24 47.48 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.535 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.3 p -68.22 130.82 44.05 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.12 65.49 0.51 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.826 0.822 . . . . 0.0 109.916 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -168.05 116.21 0.74 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.501 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -151.31 78.8 1.29 Allowed 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.474 0.654 . . . . 0.0 109.773 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.4 81.35 2.47 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 12.8 p-80 -120.33 151.6 39.01 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 73' ' ' PRO . 35.0 pt -131.34 161.46 41.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.509 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -102.05 125.15 48.66 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.428 HD21 HG13 ' A' ' 18' ' ' ILE . 2.6 mm? -118.72 125.3 49.36 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 33.1 ttpt -103.14 140.32 37.5 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.955 0.407 . . . . 0.0 110.535 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -111.19 124.14 67.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 29' ' ' VAL . . . -121.14 123.72 42.99 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.582 0.706 . . . . 0.0 110.778 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.46 139.55 14.46 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 120.111 -1.042 . . . . 0.0 111.075 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -64.06 -9.07 14.09 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.195 0.497 . . . . 0.0 112.33 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -83.6 -8.16 59.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.681 0.753 . . . . 0.0 109.554 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.47 -9.52 45.27 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.602 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.2 m -78.27 110.72 13.53 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 122.366 -0.491 . . . . 0.0 109.95 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 23' ' ' ALA . 61.8 t -137.27 134.72 47.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 122.087 -0.383 . . . . 0.0 110.362 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.416 HG11 ' HD3' ' A' ' 50' ' ' ARG . 21.1 t -148.64 152.7 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -108.94 142.33 39.74 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.166 -0.334 . . . . 0.0 110.603 -178.05 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -136.95 155.88 49.16 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.048 0.452 . . . . 0.0 111.229 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 44.5 mtmt -127.62 120.12 27.42 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.415 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 pt -136.93 170.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.882 0.372 . . . . 0.0 110.393 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 6.2 tmtt? -73.34 147.35 44.49 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' A' ' 73' ' ' PRO . 33.7 ttm180 -64.37 -14.64 57.56 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.203 0.525 . . . . 0.0 111.665 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -110.09 1.34 18.81 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.496 0.665 . . . . 0.0 109.738 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.0 m -84.79 135.02 40.69 Favored Pre-proline 0 N--CA 1.444 -0.739 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.007 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.44 143.78 97.71 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.524 2.15 . . . . 0.0 112.301 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.402 HD12 ' OD2' ' A' ' 71' ' ' ASP . 43.3 mt -65.14 -16.18 63.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.609 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 55.6 p -49.46 -38.19 28.84 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.034 0.534 . . . . 0.0 111.633 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.9 mmpt? -56.25 -53.72 53.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.754 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 44' ' ' MET . 4.0 pp -75.59 -32.19 60.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.876 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.614 ' N ' HD12 ' A' ' 43' ' ' LEU . 58.7 mtt -59.23 -55.43 34.99 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.315 0.579 . . . . 0.0 111.208 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 41.9 mtpt -70.91 -34.41 71.51 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.197 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -62.65 -44.11 97.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.144 0.497 . . . . 0.0 110.136 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -58.95 -51.12 71.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.48 ' SG ' ' HG2' ' A' ' 55' ' ' MET . 17.8 p -63.15 -36.61 84.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.056 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 36.8 mt-10 -68.31 -39.06 82.13 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.422 ' HG3' HE21 ' A' ' 51' ' ' GLN . 11.5 ptm180 -83.53 -23.82 31.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.006 0.432 . . . . 0.0 111.376 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.422 HE21 ' HG3' ' A' ' 50' ' ' ARG . 20.3 mm-40 -95.03 -6.44 42.21 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.72 42.74 53.37 Favored Glycine 0 C--N 1.322 -0.222 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.689 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.95 156.38 28.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.228 0.537 . . . . 0.0 110.608 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.496 ' O ' HG12 ' A' ' 58' ' ' ILE . 45.0 m -104.8 125.91 51.34 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.341 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.48 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 97.2 mmm -59.09 -22.6 61.06 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.102 0.477 . . . . 0.0 111.89 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.473 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -83.64 -33.85 25.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.517 0.675 . . . . 0.0 110.467 -179.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.473 ' NE2' ' HB2' ' A' ' 56' ' ' ARG . 0.8 OUTLIER -90.61 -10.59 42.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.942 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 54' ' ' SER . 21.0 pt -117.74 171.89 5.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 O-C-N 121.896 -0.503 . . . . 0.0 110.788 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -151.96 138.03 18.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.973 0.416 . . . . 0.0 110.089 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.8 m-85 -93.22 139.37 30.69 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.214 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -141.16 141.18 34.14 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.239 0.542 . . . . 0.0 110.721 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -146.75 132.17 18.62 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 68.44 25.45 6.87 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.749 0.785 . . . . 0.0 110.303 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.02 -24.7 5.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.957 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -91.58 133.68 30.68 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 122.369 -0.489 . . . . 0.0 111.222 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.88 143.09 59.56 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.239 1.959 . . . . 0.0 111.385 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.8 pt -117.28 162.6 15.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.164 0.507 . . . . 0.0 111.006 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.665 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -123.47 156.88 34.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.313 -177.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 3.9 pt-20 -57.81 -14.55 6.15 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.114 0.483 . . . . 0.0 111.866 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -98.32 8.81 44.33 Favored 'General case' 0 N--CA 1.436 -1.156 0 O-C-N 122.021 -0.424 . . . . 0.0 111.971 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.665 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -95.84 159.52 14.93 Favored 'General case' 0 C--O 1.24 0.598 0 O-C-N 121.894 -0.504 . . . . 0.0 110.372 178.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.3 p -121.27 144.03 38.81 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.531 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.516 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 14.4 Cg_endo -57.47 -24.82 63.24 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.032 2.488 . . . . 0.0 112.65 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.75 -26.79 57.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.21 0.529 . . . . 0.0 111.075 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -71.31 -55.71 7.48 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.26 0.552 . . . . 0.0 110.546 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.437 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.0 pt? -85.07 2.65 42.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.041 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 61.57 64.2 1.08 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.854 0.835 . . . . 0.0 112.034 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.1 ttt -82.66 128.86 34.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.131 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -84.55 154.39 22.68 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 120.86 0.362 . . . . 0.0 110.187 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -72.82 147.33 45.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.992 0.425 . . . . 0.0 110.068 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 68.91 14.11 8.86 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.694 0.798 . . . . 0.0 111.256 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -82.61 172.37 13.03 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.1 m -126.29 141.79 51.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.568 0.699 . . . . 0.0 112.704 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -103.15 139.58 23.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.107 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -97.53 121.69 39.73 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.211 0.529 . . . . 0.0 110.701 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.46 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 39.0 t -108.47 137.5 39.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.237 0.541 . . . . 0.0 111.82 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -131.36 158.19 41.39 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -101.48 111.49 23.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.167 0.508 . . . . 0.0 110.801 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.55 52.22 1.1 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.752 0.787 . . . . 0.0 111.498 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.79 74.38 3.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.2 m -88.1 100.48 12.98 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.261 0.553 . . . . 0.0 112.344 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.25 70.66 0.95 Allowed Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.909 -0.587 . . . . 0.0 113.448 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.377 0 CA-C-O 118.272 -1.293 . . . . 0.0 111.392 179.643 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 121.905 0.86 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . -145.72 -25.24 0.46 Allowed 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.187 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -90.49 -21.19 21.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.517 0.675 . . . . 0.0 110.79 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -90.04 -6.25 55.74 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.146 0.974 . . . . 0.0 108.499 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 46.1 tttm -78.59 -46.92 1.92 Allowed Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.699 -175.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 5' ' ' LYS . 7.1 Cg_exo -74.69 -177.93 3.72 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.136 1.891 . . . . 0.0 111.93 177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -111.37 16.41 20.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.302 0.572 . . . . 0.0 110.845 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -74.89 165.73 24.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.14 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.72 -65.13 0.15 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.374 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.54 136.69 23.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.16 0.505 . . . . 0.0 110.495 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.22 173.68 11.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.845 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -150.77 11.84 0.67 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.489 0.662 . . . . 0.0 111.471 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -41.12 94.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.36 0.6 . . . . 0.0 110.5 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -143.39 100.61 3.65 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -83.78 93.51 7.97 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.249 0.547 . . . . 0.0 111.784 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.673 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 6.9 m-20 -99.78 84.41 2.91 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 13.7 p-80 -116.42 142.78 46.4 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 121.659 -0.651 . . . . 0.0 109.956 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.9 pt -128.86 159.77 40.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.294 0.569 . . . . 0.0 111.244 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.432 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -101.57 119.62 39.06 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.004 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.7 140.99 47.79 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.987 0.422 . . . . 0.0 109.862 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -115.32 139.66 49.79 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.319 0.581 . . . . 0.0 111.085 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 29' ' ' VAL . 46.4 t -112.04 124.81 69.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.676 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.39 122.95 35.02 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.479 0.656 . . . . 0.0 110.437 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.33 147.69 16.33 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.934 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -7.89 2.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -78.12 -14.61 59.41 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.747 0.784 . . . . 0.0 110.243 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.92 -11.78 56.04 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.2 m -78.61 118.76 21.02 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 120.945 0.402 . . . . 0.0 110.09 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.7 p -141.94 137.9 30.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.215 0.531 . . . . 0.0 111.116 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.4 t -142.93 150.96 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.44 HE21 ' HB3' ' A' ' 31' ' ' GLN . 1.1 tm0? -110.29 141.23 43.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.888 0.375 . . . . 0.0 110.374 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -135.87 147.26 48.13 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.034 0.445 . . . . 0.0 110.996 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -115.2 109.59 18.21 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.061 0.458 . . . . 0.0 110.649 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.7 pt -124.38 178.42 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.673 ' HG2' ' O ' ' A' ' 16' ' ' ASP . 22.4 tttt -89.91 159.2 17.06 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.465 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -62.25 -24.16 67.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.47 0.708 . . . . 0.0 111.884 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -105.74 -1.92 23.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.574 0.702 . . . . 0.0 109.857 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 m -83.96 132.18 49.15 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.64 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.88 149.86 86.18 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.593 2.195 . . . . 0.0 112.424 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.6 mt -65.65 -15.6 62.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.036 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 22.3 p -49.37 -39.83 33.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.078 0.551 . . . . 0.0 111.995 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -55.5 -53.25 58.69 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.792 0.33 . . . . 0.0 111.19 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.29 -31.87 62.67 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.713 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.577 ' N ' HD12 ' A' ' 43' ' ' LEU . 57.1 mtt -59.96 -56.43 21.77 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.003 0.43 . . . . 0.0 111.596 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -67.16 -39.86 86.56 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.815 0.341 . . . . 0.0 110.499 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.45 -46.47 86.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.121 0.486 . . . . 0.0 110.582 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -57.81 -52.05 67.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.177 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.8 p -61.57 -36.79 81.65 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.059 0.457 . . . . 0.0 111.072 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -64.77 -47.98 76.19 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.959 0.409 . . . . 0.0 111.853 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 18.5 ptp180 -78.17 -24.97 47.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.83 0.348 . . . . 0.0 111.567 -177.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -96.88 -7.63 32.91 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.43 45.76 22.63 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.986 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.1 mm? -120.05 159.96 23.75 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.413 -0.463 . . . . 0.0 110.547 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.8 m -106.09 126.26 51.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.645 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.457 ' CE ' ' HB3' ' A' ' 44' ' ' MET . 93.0 mmm -57.39 -28.17 62.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.71 -28.67 26.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.294 0.568 . . . . 0.0 110.839 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.749 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -83.19 -34.12 26.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.383 0.611 . . . . 0.0 110.549 -177.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.512 HG22 ' HG3' ' A' ' 88' ' ' GLN . 20.5 pt -92.94 165.66 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.354 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 20.1 tpt180 -143.36 128.69 18.87 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.909 0.385 . . . . 0.0 110.167 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -87.05 139.67 30.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.026 0.441 . . . . 0.0 110.054 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -142.14 143.12 32.85 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.115 0.483 . . . . 0.0 111.057 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -149.38 132.41 16.23 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.18 25.33 7.33 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.884 0.85 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.51 -25.57 5.01 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.156 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -91.36 138.43 25.57 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.429 -0.454 . . . . 0.0 110.784 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.16 143.69 49.66 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.047 1.832 . . . . 0.0 110.981 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.552 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 12.7 pt -114.11 170.69 4.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.794 0.331 . . . . 0.0 111.116 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.427 ' HB2' HG22 ' A' ' 70' ' ' THR . 0.5 OUTLIER -130.71 164.68 24.53 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-O 121.555 0.693 . . . . 0.0 110.921 -175.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 12.0 pt-20 -69.45 -7.67 39.94 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.39 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 68' ' ' ASN . 10.0 t -102.03 6.19 40.98 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.599 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.552 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -99.21 155.04 17.69 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.918 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 71.5 p -120.63 152.01 55.03 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.49 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.34 -15.66 46.4 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.629 2.22 . . . . 0.0 112.165 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.56 -16.17 37.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.176 0.513 . . . . 0.0 110.829 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -80.2 -55.03 5.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.368 0.604 . . . . 0.0 111.215 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.5 pt? -93.16 12.58 23.86 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.848 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 53.33 63.43 2.22 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 84' ' ' ILE . 25.4 ttm -87.63 133.06 33.88 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 5.8 mm-40 -104.67 174.18 5.99 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.855 0.359 . . . . 0.0 110.636 -176.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -66.21 141.56 58.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.972 0.415 . . . . 0.0 110.693 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 69.88 15.94 7.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.625 0.77 . . . . 0.0 111.747 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.9 OUTLIER -80.11 160.7 25.65 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -126.24 143.78 51.02 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.487 0.66 . . . . 0.0 112.645 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.519 HD11 ' SD ' ' A' ' 78' ' ' MET . 4.1 mp -108.16 138.9 32.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -95.05 123.97 38.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.122 0.487 . . . . 0.0 110.486 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.423 HG12 HE22 ' A' ' 88' ' ' GLN . 44.1 t -110.13 139.85 31.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.307 0.575 . . . . 0.0 111.448 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.436 ' HB3' ' OE1' ' A' ' 89' ' ' GLN . 73.6 m-85 -130.78 154.5 47.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.694 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 89' ' ' GLN . 1.8 mp0 -113.35 110.96 21.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 0.3 OUTLIER 165.75 96.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.349 0.595 . . . . 0.0 112.266 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -85.92 14.12 6.52 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 120.5 -1.375 . . . . 0.0 110.699 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -53.3 124.66 15.25 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 111.13 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.29 -93.55 0.48 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.695 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.97 0 CA-C-O 118.927 -0.929 . . . . 0.0 111.61 179.78 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 121.251 0.548 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.41 11.41 5.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.281 1.039 . . . . 0.0 108.343 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.57 39.88 0.94 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.875 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -150.48 -12.61 0.25 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.961 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 74.4 mmtt -95.56 -52.98 0.23 Allowed Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 122.038 -0.414 . . . . 0.0 111.119 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.536 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 95.9 Cg_endo -84.36 -1.11 9.66 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 121.875 1.717 . . . . 0.0 111.116 176.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 7' ' ' LYS . 50.8 mmtt 51.66 32.61 9.5 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.61 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.85 115.08 2.38 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.92 -46.95 0.88 Allowed Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.6 p -126.11 102.2 9.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.857 0.837 . . . . 0.0 111.322 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -152.42 139.11 18.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.261 0.553 . . . . 0.0 111.011 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 t -136.08 -6.58 2.09 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.258 0.552 . . . . 0.0 111.053 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -51.61 134.2 29.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.735 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -97.9 27.76 4.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.898 0.856 . . . . 0.0 109.047 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -71.26 177.45 3.87 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.538 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -79.87 80.44 6.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.071 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 28.2 p-80 -123.14 145.66 48.41 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 120.842 0.353 . . . . 0.0 110.202 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.2 pt -125.11 165.61 22.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 121.318 0.58 . . . . 0.0 110.881 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -100.09 135.5 41.42 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.82 126.38 30.41 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -107.19 140.08 40.61 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.245 0.545 . . . . 0.0 111.49 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 29' ' ' VAL . 45.0 t -113.82 124.36 70.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.006 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.9 124.17 34.51 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.605 0.717 . . . . 0.0 110.846 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.35 151.87 19.45 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.259 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.5 pp0? -60.53 -20.22 59.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.187 0.517 . . . . 0.0 111.681 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.7 -7.44 55.34 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.634 0.731 . . . . 0.0 110.454 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.35 -16.07 55.57 Favored Glycine 0 C--N 1.315 -0.614 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.686 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 m -68.76 116.73 9.59 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.851 0.357 . . . . 0.0 110.241 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.9 p -143.83 139.6 25.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.032 0.444 . . . . 0.0 111.423 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.2 t -145.83 151.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.463 HE21 ' HB3' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -107.22 139.91 40.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.935 0.397 . . . . 0.0 110.1 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -133.42 166.97 21.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.033 0.444 . . . . 0.0 110.385 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -140.29 114.12 8.87 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.903 0.382 . . . . 0.0 110.516 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 pt -127.91 174.8 10.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.116 0.484 . . . . 0.0 110.757 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.7 tmtt? -87.46 149.76 24.21 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.183 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.425 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 22.7 tpp180 -54.02 -28.64 39.47 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.49 0.716 . . . . 0.0 112.376 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -105.08 -0.26 26.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.48 0.657 . . . . 0.0 110.613 -177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 m -85.83 133.6 41.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.181 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.99 151.87 84.33 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.502 2.135 . . . . 0.0 112.316 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 mt -64.92 -15.23 61.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.943 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 69' ' ' GLU . 25.8 p -49.28 -38.24 26.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 122.967 0.507 . . . . 0.0 111.976 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -56.35 -54.09 49.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.502 0.191 . . . . 0.0 110.845 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.96 -33.6 57.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.887 0.375 . . . . 0.0 111.629 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.644 ' N ' HD12 ' A' ' 43' ' ' LEU . 45.3 ttm -62.07 -53.27 57.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.02 0.438 . . . . 0.0 111.002 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.646 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 8.7 mmmm -70.3 -36.7 74.49 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.207 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.664 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -61.3 -45.66 93.55 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 122.001 -0.437 . . . . 0.0 111.05 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -56.33 -51.45 68.18 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.431 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.1 p -63.53 -35.31 80.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.107 0.48 . . . . 0.0 110.843 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 6.2 mm-40 -65.75 -43.78 87.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.009 0.433 . . . . 0.0 111.586 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 13.1 ptp180 -83.22 -20.98 33.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -96.95 -9.66 27.88 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.831 -0.543 . . . . 0.0 111.818 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.67 40.71 26.1 Favored Glycine 0 C--N 1.317 -0.488 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.031 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.412 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.1 mm? -117.41 157.9 25.4 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.038 0.446 . . . . 0.0 110.016 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.424 ' O ' HG12 ' A' ' 58' ' ' ILE . 8.2 m -109.65 134.76 51.59 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.702 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.519 ' HE1' ' HG2' ' A' ' 44' ' ' MET . 97.1 mmm -58.76 -25.99 63.56 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.42 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -85.15 -24.94 27.75 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.325 0.583 . . . . 0.0 111.109 178.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.64 -19.34 26.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.296 0.57 . . . . 0.0 110.7 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 54' ' ' SER . 14.4 pt -120.94 174.32 5.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.095 0.474 . . . . 0.0 111.173 -177.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 59' ' ' ARG . 9.0 tpt180 -154.29 138.98 16.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.113 0.482 . . . . 0.0 109.927 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -91.87 137.3 32.48 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.227 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' HG3' ' C ' ' A' ' 65' ' ' GLN . 16.3 ttm180 -136.62 134.59 37.51 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.321 0.581 . . . . 0.0 110.881 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -145.29 144.26 30.66 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 68.33 24.35 7.38 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.855 0.836 . . . . 0.0 109.447 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.34 -5.62 59.53 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.366 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.481 ' C ' ' HG3' ' A' ' 61' ' ' ARG . 5.0 pt20 -118.69 143.96 34.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 O-C-N 122.196 -0.591 . . . . 0.0 111.26 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -65.64 133.96 36.23 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.067 1.845 . . . . 0.0 111.145 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.6 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 12.0 pt -106.87 -177.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.92 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.86 164.53 27.36 Favored 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 121.394 0.616 . . . . 0.0 109.793 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 41' ' ' SER . 15.9 pt-20 -74.39 -9.47 58.62 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.714 0.769 . . . . 0.0 109.403 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 t -103.4 10.31 37.4 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.853 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.6 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER -98.39 159.0 15.24 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.4 p -117.08 148.51 42.46 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.568 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.84 -12.17 34.06 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.798 2.332 . . . . 0.0 112.081 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.5 -28.35 23.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.125 0.488 . . . . 0.0 110.654 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -69.63 -55.32 10.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 111.685 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -88.38 9.9 21.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.002 0.429 . . . . 0.0 111.636 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 53.74 63.88 2.04 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.935 0.874 . . . . 0.0 112.735 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -78.48 129.01 34.38 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.222 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -91.19 158.11 16.8 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 4.7 p-10 -70.05 147.8 49.6 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.986 -0.446 . . . . 0.0 110.478 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.4 ' HG2' HD22 ' A' ' 19' ' ' ASN . 5.7 mm-40 66.72 15.25 10.08 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.342 0.657 . . . . 0.0 111.733 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -79.57 167.04 21.27 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -121.83 137.48 54.76 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.659 0.742 . . . . 0.0 112.923 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.13 134.35 41.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.986 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.87 122.14 36.05 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.123 0.487 . . . . 0.0 110.471 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 40.3 t -107.68 138.38 34.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.234 0.54 . . . . 0.0 111.64 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -131.55 155.67 47.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.734 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.419 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.6 mp0 -106.55 112.8 25.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.08 0.467 . . . . 0.0 111.192 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -103.09 47.87 0.87 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.746 0.784 . . . . 0.0 109.856 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.411 HE21 ' HB2' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -112.78 131.68 55.58 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.792 -178.131 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.2 m -73.41 -59.28 2.79 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.983 0.42 . . . . 0.0 111.051 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.1 170.62 29.28 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.607 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.09 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.503 179.378 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.864 0.364 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.26 -37.03 58.14 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.337 0.589 . . . . 0.0 110.571 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -84.76 22.27 1.38 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.475 0.655 . . . . 0.0 110.464 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -90.68 -12.8 35.67 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.224 0.535 . . . . 0.0 110.222 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.583 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 68.3 mmtt -77.86 -56.7 1.06 Allowed Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.715 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 63.0 Cg_endo -85.19 107.05 1.02 Allowed 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 121.544 1.496 . . . . 0.0 111.083 176.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -91.8 38.05 0.98 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.292 0.568 . . . . 0.0 110.683 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -103.26 16.51 26.38 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.83 55.07 4.28 Favored Glycine 0 C--N 1.314 -0.671 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.838 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.39 145.17 36.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 120.966 0.413 . . . . 0.0 110.492 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -138.86 106.71 5.66 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.346 0.593 . . . . 0.0 109.765 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 p -130.25 160.71 33.04 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.309 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 54.51 50.04 16.94 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.719 0.771 . . . . 0.0 111.453 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -165.92 117.95 1.08 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.984 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -134.05 59.29 1.74 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.521 0.677 . . . . 0.0 110.334 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -82.79 81.95 8.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 6.1 p-80 -118.79 142.2 47.93 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 80' ' ' ASP . 45.2 pt -131.08 160.44 42.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.269 0.556 . . . . 0.0 110.233 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.561 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.4 OUTLIER -98.65 120.95 39.95 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.055 -178.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.06 125.16 54.08 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -104.17 140.55 37.65 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.222 0.534 . . . . 0.0 110.596 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.75 124.21 68.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' A' ' 29' ' ' VAL . . . -122.31 122.44 39.08 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.549 0.69 . . . . 0.0 110.993 -176.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.72 139.51 14.46 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.228 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.6 OUTLIER -60.06 -17.07 36.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.382 0.611 . . . . 0.0 111.398 178.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.29 -6.61 58.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.751 0.786 . . . . 0.0 110.127 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.95 -11.16 48.89 Favored Glycine 0 CA--C 1.507 -0.462 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.048 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.8 m -78.6 108.08 11.73 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.153 0.502 . . . . 0.0 109.836 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 23' ' ' ALA . 59.6 t -135.33 131.29 51.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 120.959 0.409 . . . . 0.0 110.112 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -141.92 150.7 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.561 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -109.5 139.38 44.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.864 0.364 . . . . 0.0 110.121 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 30.4 m-85 -130.11 159.46 36.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.321 0.582 . . . . 0.0 111.263 -176.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 42.3 mtmt -131.43 113.25 13.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.302 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.6 pt -135.04 176.3 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 0.0 110.69 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 9.4 tmtt? -82.6 149.03 27.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.488 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 22.1 ttm-85 -61.87 -19.42 62.62 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -105.61 1.31 27.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.695 0.76 . . . . 0.0 109.526 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.5 m -84.99 131.9 47.38 Favored Pre-proline 0 N--CA 1.442 -0.863 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.231 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.2 145.33 88.76 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 122.633 2.222 . . . . 0.0 112.177 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.47 HD12 ' OD1' ' A' ' 71' ' ' ASP . 34.3 mt -64.93 -16.29 63.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.933 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.526 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 12.3 t -50.06 -37.19 32.29 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 122.457 0.303 . . . . 0.0 111.102 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.439 ' HA ' ' HE3' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -56.04 -53.46 56.73 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-O 120.848 0.356 . . . . 0.0 111.026 179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.81 -31.87 61.83 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.529 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.584 ' N ' HD12 ' A' ' 43' ' ' LEU . 56.9 mtt -60.4 -54.56 44.1 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.927 0.394 . . . . 0.0 111.537 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 41' ' ' SER . 31.2 mmtp -66.71 -39.96 88.23 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.84 -47.98 83.88 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 28.0 t80 -55.22 -51.72 65.67 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.857 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.631 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.3 m -63.94 -38.53 91.44 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.568 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 40.2 mt-10 -64.09 -42.32 96.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.743 0.306 . . . . 0.0 111.356 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.2 ptp180 -80.39 -24.29 39.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.908 0.385 . . . . 0.0 111.573 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -96.0 -8.74 32.84 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.63 2.98 90.69 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.897 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 7.3 mp -80.53 158.17 25.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.615 0.722 . . . . 0.0 112.005 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.0 m -107.81 132.27 53.59 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.034 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.431 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 95.7 mmm -57.36 -31.06 65.37 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -84.35 -31.21 24.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.341 0.591 . . . . 0.0 111.126 -178.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.571 ' HG2' HE21 ' A' ' 90' ' ' GLN . 0.7 OUTLIER -84.42 -16.69 41.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.39 0.614 . . . . 0.0 110.816 -177.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.631 HD11 ' SG ' ' A' ' 48' ' ' CYS . 10.3 pt -117.81 179.17 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.369 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -156.07 132.77 10.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 120.983 0.42 . . . . 0.0 110.088 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.401 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.4 m-85 -83.54 139.32 32.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.669 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -144.11 144.24 31.5 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.218 0.532 . . . . 0.0 110.987 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -149.18 134.88 18.72 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 t70 68.44 25.04 6.98 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.535 0.683 . . . . 0.0 110.359 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.33 -24.05 6.68 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.137 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -93.69 137.55 23.19 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 122.301 -0.529 . . . . 0.0 110.803 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.3 145.54 60.15 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.038 1.825 . . . . 0.0 111.249 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.7 pt -113.55 160.65 12.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.982 0.42 . . . . 0.0 110.22 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.638 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -121.18 153.88 36.97 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.757 -177.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 41' ' ' SER . 10.0 pt-20 -59.72 -12.6 7.41 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.143 0.497 . . . . 0.0 111.944 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.2 t -95.82 8.12 44.44 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 120.717 0.294 . . . . 0.0 111.135 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.638 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -95.0 156.33 16.36 Favored 'General case' 0 C--O 1.244 0.78 0 O-C-N 121.89 -0.506 . . . . 0.0 110.017 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.4 p -118.12 146.64 39.72 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.613 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 18.4 Cg_endo -60.36 -22.92 73.02 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.762 2.308 . . . . 0.0 112.338 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.488 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -78.1 -22.79 48.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.166 0.508 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -71.59 -55.27 8.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.397 0.618 . . . . 0.0 110.442 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.3 pt? -85.91 9.02 18.07 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.542 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 55.79 60.08 3.47 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.776 0.798 . . . . 0.0 112.246 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.4 mtt -84.38 141.24 31.01 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.645 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -108.76 177.35 4.8 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.121 0.486 . . . . 0.0 111.15 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 18' ' ' ILE . 5.2 m-20 -64.54 138.27 58.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.745 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 68.82 19.42 8.37 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.678 0.791 . . . . 0.0 112.497 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -73.47 159.0 33.86 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.6 m -124.41 144.56 49.98 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.72 142.22 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.215 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 11.3 m-20 -94.83 122.5 37.53 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 110.505 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.563 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 28.7 t -109.83 136.69 45.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 O-C-N 121.886 -0.509 . . . . 0.0 111.594 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 85' ' ' ASP . 60.1 m-85 -132.73 157.61 44.46 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -99.12 110.72 23.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.469 0.652 . . . . 0.0 111.133 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.702 HE21 ' N ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -100.07 47.53 0.94 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.334 177.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.571 HE21 ' HG2' ' A' ' 57' ' ' GLN . 0.7 OUTLIER -116.18 122.35 44.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.178 0.513 . . . . 0.0 111.412 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.9 m -109.26 90.02 3.17 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.452 0.644 . . . . 0.0 109.709 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -117.13 117.68 3.89 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.288 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.411 0 CA-C-O 119.023 -0.876 . . . . 0.0 111.125 179.164 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.52 55.54 2.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.11 0.481 . . . . 0.0 111.868 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.05 -15.21 61.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.199 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -60.48 -52.13 66.49 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.297 0.57 . . . . 0.0 109.541 175.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -133.98 89.68 28.66 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-O 121.779 0.8 . . . . 0.0 110.198 177.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.23 -158.42 0.08 OUTLIER 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.027 2.485 . . . . 0.0 112.38 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -86.92 34.89 0.67 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.241 0.543 . . . . 0.0 110.029 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 66.58 16.43 10.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.114 0.966 . . . . 0.0 112.3 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.21 59.63 0.62 Allowed Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.746 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.08 129.22 33.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.246 0.546 . . . . 0.0 109.687 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -155.54 140.91 17.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.385 0.612 . . . . 0.0 111.641 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -139.86 143.86 36.96 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.36 -49.19 77.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.007 0.432 . . . . 0.0 111.336 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -126.64 114.99 18.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -117.27 143.09 46.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.24 0.543 . . . . 0.0 110.807 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.59 ' OD1' ' HB3' ' A' ' 36' ' ' ARG . 0.5 OUTLIER -137.67 105.48 5.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.836 0.827 . . . . 0.0 110.494 178.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 20.0 p-80 -120.63 146.76 46.05 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.2 pt -132.95 166.79 28.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.108 0.48 . . . . 0.0 110.731 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.658 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -103.78 125.94 50.58 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.17 124.07 47.06 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' THR . 31.8 ttpt -103.95 140.65 37.41 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.102 0.477 . . . . 0.0 110.593 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 29' ' ' VAL . 47.6 t -113.67 125.43 70.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.897 0.379 . . . . 0.0 110.084 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.6 121.75 27.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.533 0.682 . . . . 0.0 110.49 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.56 148.85 16.81 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 120.249 -0.976 . . . . 0.0 112.207 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -6.09 2.85 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.365 0.602 . . . . 0.0 112.294 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.92 -14.14 59.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.728 0.775 . . . . 0.0 109.845 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.6 -15.05 53.51 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.635 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.7 m -77.08 122.76 25.41 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.926 0.393 . . . . 0.0 110.63 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 22' ' ' VAL . 4.2 p -142.28 137.83 29.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.138 0.494 . . . . 0.0 111.253 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 t -143.09 151.08 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.658 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -106.34 142.0 36.73 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.343 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -135.29 146.61 48.68 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-O 121.237 0.542 . . . . 0.0 110.461 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -121.65 114.17 20.78 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.03 0.443 . . . . 0.0 110.455 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.8 pt -134.46 177.76 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.24 0.543 . . . . 0.0 111.264 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.523 ' HE2' ' H ' ' A' ' 16' ' ' ASP . 11.3 tmtt? -86.45 152.16 22.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.884 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.59 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 13.6 tpp180 -60.53 -19.16 56.33 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.943 0.497 . . . . 0.0 111.734 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -107.73 -3.3 19.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.55 0.691 . . . . 0.0 109.653 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -83.67 132.44 49.14 Favored Pre-proline 0 N--CA 1.441 -0.906 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.217 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.15 149.81 88.46 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.557 2.171 . . . . 0.0 112.853 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.453 HD12 ' OD2' ' A' ' 71' ' ' ASP . 28.0 mt -65.59 -13.95 60.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.065 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.4 p -55.13 -34.48 63.77 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.327 0.584 . . . . 0.0 110.663 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -55.93 -55.98 26.14 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.603 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -77.38 -32.73 55.11 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.632 ' N ' HD12 ' A' ' 43' ' ' LEU . 38.7 ttm -62.41 -54.01 46.53 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.067 0.46 . . . . 0.0 110.959 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 33.6 mtpt -72.37 -32.99 66.91 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.491 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -64.18 -43.74 94.16 Favored 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 121.92 -0.488 . . . . 0.0 110.434 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -57.39 -50.53 72.69 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.105 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 14.8 p -61.48 -36.96 81.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 0.0 110.909 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.1 mt-10 -69.02 -40.05 78.89 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.4 ptp180 -83.85 -24.75 30.77 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.936 -0.477 . . . . 0.0 112.167 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -95.41 -11.83 26.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.182 0.515 . . . . 0.0 111.461 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.43 41.49 13.29 Favored Glycine 0 C--N 1.315 -0.614 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.491 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.484 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.4 mm? -117.23 158.24 24.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.041 0.448 . . . . 0.0 110.301 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 58' ' ' ILE . 15.2 m -106.38 131.99 52.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.283 178.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 85.4 mmm -55.07 -29.14 56.91 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.928 0.491 . . . . 0.0 111.817 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.528 ' HD3' ' N ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -83.86 -28.79 27.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.4 0.619 . . . . 0.0 111.179 -177.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.468 ' HG2' ' HG3' ' A' ' 90' ' ' GLN . 0.9 OUTLIER -92.7 -7.53 46.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.117 -178.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.484 HG21 ' HB3' ' A' ' 53' ' ' LEU . 17.5 pt -125.1 170.18 15.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 120.943 0.402 . . . . 0.0 110.965 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -149.99 135.86 18.56 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.12 0.486 . . . . 0.0 110.164 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -89.82 137.26 32.49 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.028 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -137.28 143.02 41.94 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.258 0.551 . . . . 0.0 110.622 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -150.83 138.59 19.81 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 t70 69.79 25.35 5.08 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.605 0.716 . . . . 0.0 110.282 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.01 -1.56 79.12 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.538 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -122.73 142.92 38.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 O-C-N 122.122 -0.634 . . . . 0.0 111.409 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.04 141.89 59.59 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.503 2.135 . . . . 0.0 111.866 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 pt -117.08 172.83 4.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.102 0.477 . . . . 0.0 111.01 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.688 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.96 156.33 46.38 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.818 -178.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.58 -13.14 12.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.778 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.0 t -96.61 10.21 39.2 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 122.157 -0.339 . . . . 0.0 111.374 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.688 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.81 157.4 16.53 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.96 177.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.3 p -120.76 151.01 53.9 Favored Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.199 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.42 -18.23 52.22 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.968 2.445 . . . . 0.0 112.699 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.02 -27.15 30.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.331 0.586 . . . . 0.0 110.896 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -71.61 -55.9 6.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.478 0.656 . . . . 0.0 110.623 -178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.489 HD11 ' HE3' ' A' ' 78' ' ' MET . 1.6 pt? -88.49 20.77 3.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.571 -178.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 43.08 62.52 1.79 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 122.087 0.946 . . . . 0.0 112.662 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.489 ' HE3' HD11 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -78.87 122.5 26.18 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.697 -178.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -77.58 156.7 30.7 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.051 0.453 . . . . 0.0 110.848 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -68.89 142.86 54.66 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.886 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 66.71 18.21 10.68 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.269 0.627 . . . . 0.0 111.437 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -81.51 171.25 14.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.976 0.417 . . . . 0.0 110.64 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 21.9 m -126.05 145.0 50.5 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.577 0.703 . . . . 0.0 112.352 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.03 138.74 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.283 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -94.91 121.79 36.88 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.964 0.411 . . . . 0.0 110.225 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.3 t -108.9 137.41 41.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.267 0.555 . . . . 0.0 111.757 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -130.49 151.52 50.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.406 HE21 HG22 ' A' ' 58' ' ' ILE . 1.8 mp0 -101.09 112.18 24.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.074 0.464 . . . . 0.0 111.931 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -119.26 75.52 1.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.992 0.425 . . . . 0.0 110.763 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.568 ' H ' ' NE2' ' A' ' 90' ' ' GLN . 1.7 mp0 -69.31 147.71 50.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.9 0.381 . . . . 0.0 110.423 178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -67.95 104.55 1.76 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.35 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.12 125.52 7.21 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.876 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.187 0 CA-C-O 118.938 -0.924 . . . . 0.0 111.461 -178.793 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.3 mtt . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 121.203 0.525 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.55 11.7 15.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.799 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -110.01 15.03 22.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.24 0.543 . . . . 0.0 110.726 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -75.15 63.5 1.31 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.938 -0.476 . . . . 0.0 111.696 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 3.5 mptp? 55.96 58.23 9.65 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.786 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.68 121.32 4.12 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.374 2.049 . . . . 0.0 112.389 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -83.6 -12.63 55.81 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.341 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 48.97 43.62 21.99 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.733 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.38 59.77 4.01 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.043 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.91 111.71 24.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.256 0.55 . . . . 0.0 110.513 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.11 46.76 2.6 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.579 0.704 . . . . 0.0 109.479 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -126.24 126.61 44.31 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.936 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -118.44 -178.04 3.43 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.197 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.5 m120 64.92 19.9 11.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.952 0.501 . . . . 0.0 111.43 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -92.27 126.94 37.56 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.748 0.785 . . . . 0.0 111.575 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -89.69 91.2 8.55 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.181 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -124.81 150.75 46.03 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.707 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 pt -135.37 168.05 24.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 120.896 0.379 . . . . 0.0 110.373 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.539 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -106.0 116.52 32.08 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.923 0.392 . . . . 0.0 110.311 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.66 131.68 54.14 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 83' ' ' THR . 32.5 ttpt -111.42 141.32 45.12 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.293 0.568 . . . . 0.0 111.198 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 29' ' ' VAL . 41.0 t -112.77 125.71 70.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.174 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.28 118.1 20.8 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.546 0.688 . . . . 0.0 110.658 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.33 150.47 18.55 Favored Glycine 0 C--N 1.302 -1.327 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.009 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -11.21 8.0 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.36 0.6 . . . . 0.0 112.202 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.1 -16.82 62.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.658 0.742 . . . . 0.0 110.32 177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.07 -12.99 55.87 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -78.05 122.87 26.14 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.932 0.396 . . . . 0.0 110.436 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 22' ' ' VAL . 3.1 p -144.59 137.41 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.424 0.631 . . . . 0.0 111.195 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.7 t -144.47 151.09 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.582 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.539 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -110.15 141.89 42.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.821 0.343 . . . . 0.0 110.526 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -137.06 138.77 40.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.162 0.505 . . . . 0.0 111.534 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -106.48 114.92 29.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.052 0.453 . . . . 0.0 110.51 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.1 pt -132.68 170.46 19.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.139 0.495 . . . . 0.0 110.563 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.579 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.2 tmtp? -80.41 149.24 30.23 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.579 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 9.2 tpp180 -56.83 -25.2 55.66 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -107.28 3.3 25.32 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.722 0.773 . . . . 0.0 109.749 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.4 m -81.5 131.03 59.47 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.452 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 33.7 Cg_endo -63.13 147.75 93.89 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.208 1.939 . . . . 0.0 112.152 -177.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.4 HD12 ' OD2' ' A' ' 71' ' ' ASP . 39.6 mt -64.6 -15.24 60.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.122 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 57.1 p -50.97 -38.48 51.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.096 0.558 . . . . 0.0 111.466 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 39' ' ' PRO . 12.3 mmmm -55.85 -54.45 44.45 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 44' ' ' MET . 4.3 pp -75.86 -32.27 59.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.999 0.428 . . . . 0.0 111.322 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.6 ' N ' HD12 ' A' ' 43' ' ' LEU . 37.0 ttm -61.47 -50.25 73.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.615 -177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 69.4 mmtt -70.38 -41.64 72.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.84 0.352 . . . . 0.0 110.094 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.16 -45.46 92.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.265 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -56.49 -50.2 72.45 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.063 0.459 . . . . 0.0 110.466 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.596 ' SG ' HD11 ' A' ' 58' ' ' ILE . 58.2 m -63.1 -38.28 90.57 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.97 0.414 . . . . 0.0 111.498 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 48.6 mt-10 -64.34 -40.22 95.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.117 0.484 . . . . 0.0 111.571 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.3 ptp180 -86.2 -23.14 26.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.965 0.358 . . . . 0.0 111.965 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -98.66 -10.73 22.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.979 0.418 . . . . 0.0 112.081 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.49 43.9 14.35 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.957 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.4 mm? -119.69 157.9 27.56 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 122.307 -0.525 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.2 m -107.53 128.31 54.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.166 0.507 . . . . 0.0 111.235 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.445 ' SD ' ' HD3' ' A' ' 45' ' ' LYS . 58.0 mmm -56.62 -30.57 63.41 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.548 0.739 . . . . 0.0 112.766 -177.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.556 ' HD3' ' N ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -83.35 -28.98 28.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.47 0.652 . . . . 0.0 111.081 -176.354 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -40.18 16.49 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.88 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.596 HD11 ' SG ' ' A' ' 48' ' ' CYS . 12.8 pt -91.63 174.45 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 O-C-N 121.906 -0.496 . . . . 0.0 110.443 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -150.36 130.85 13.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.266 0.555 . . . . 0.0 110.257 177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -83.02 137.04 34.28 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.371 -0.832 . . . . 0.0 108.848 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 43.3 ttm180 -136.53 143.04 43.5 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.155 0.503 . . . . 0.0 110.576 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -148.84 130.3 14.8 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 69.24 25.71 5.59 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.83 0.824 . . . . 0.0 110.199 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.91 -24.55 5.91 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.192 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -92.68 136.23 25.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 122.479 -0.424 . . . . 0.0 110.93 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 35.2 Cg_endo -67.81 142.65 58.4 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.11 1.873 . . . . 0.0 111.387 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 pt -112.71 174.8 2.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.068 0.461 . . . . 0.0 110.985 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.63 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -138.27 159.16 42.78 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.135 0.493 . . . . 0.0 111.995 -176.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 11.6 pt-20 -62.56 -10.21 11.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.775 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -97.99 7.42 46.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.886 0.374 . . . . 0.0 111.396 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.63 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -99.29 155.94 17.24 Favored 'General case' 0 C--O 1.244 0.809 0 O-C-N 121.719 -0.613 . . . . 0.0 110.594 179.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 p -120.76 146.83 44.48 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.966 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.555 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 20.2 Cg_endo -60.64 -25.31 80.61 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.778 2.319 . . . . 0.0 112.494 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 -31.66 62.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.377 0.608 . . . . 0.0 110.519 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -68.15 -55.71 11.39 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.252 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 1.6 pt? -85.12 6.92 23.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.883 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 58.73 63.15 1.74 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.958 0.885 . . . . 0.0 112.275 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.5 mtt -84.1 134.52 34.6 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.488 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -96.89 175.12 6.46 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.009 0.433 . . . . 0.0 110.146 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -77.92 147.14 35.15 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 68.51 13.63 8.98 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.13 0.572 . . . . 0.0 112.248 177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -80.97 162.9 23.66 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 15.8 m -124.73 142.14 51.62 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.68 0.753 . . . . 0.0 113.001 -173.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.65 135.28 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.082 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -93.74 121.31 35.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.048 0.452 . . . . 0.0 110.366 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.63 138.93 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.225 0.536 . . . . 0.0 112.006 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -130.92 152.74 49.92 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.86 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.45 113.78 27.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.271 0.558 . . . . 0.0 111.91 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -105.95 -170.43 1.73 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.991 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 65.71 19.32 11.39 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.603 0.761 . . . . 0.0 111.503 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 p -84.58 -80.91 0.19 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.342 0.591 . . . . 0.0 111.167 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.27 27.18 21.57 Favored Glycine 0 C--N 1.314 -0.676 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.137 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.269 0 CA-C-O 118.31 -1.272 . . . . 0.0 111.01 -179.308 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 121.085 0.469 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.55 14.97 13.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.016 0.912 . . . . 0.0 109.434 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -81.04 5.77 15.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.626 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -97.24 41.53 1.11 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.863 0.839 . . . . 0.0 109.783 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.511 ' H ' ' CD ' ' A' ' 6' ' ' PRO . 60.6 mttm -138.46 -50.97 0.02 OUTLIER Pre-proline 0 C--N 1.304 -1.402 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.974 -175.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.511 ' CD ' ' H ' ' A' ' 5' ' ' LYS . 8.0 Cg_exo -71.16 152.6 62.16 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 121.931 1.754 . . . . 0.0 112.434 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -101.99 1.4 36.58 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.144 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -69.35 109.22 4.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.248 0.547 . . . . 0.0 111.439 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.63 47.73 0.98 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.44 144.57 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.062 0.458 . . . . 0.0 110.651 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -138.19 148.07 44.45 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.1 p -111.31 116.34 30.83 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -154.54 170.53 21.23 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -123.58 126.28 46.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.285 0.564 . . . . 0.0 111.564 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -147.81 159.8 43.43 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.461 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -86.81 82.87 7.68 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.752 0.787 . . . . 0.0 110.49 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 28.7 p-80 -122.04 150.4 42.17 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.223 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.4 pt -124.17 167.63 17.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.0 0.429 . . . . 0.0 110.061 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -106.52 124.1 49.09 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.811 0.338 . . . . 0.0 110.143 -178.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.3 125.09 49.37 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 35.5 ttpt -105.26 140.68 38.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.05 0.452 . . . . 0.0 111.004 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.66 123.89 66.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.77 128.1 43.33 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.502 0.668 . . . . 0.0 110.514 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.39 148.86 16.52 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.692 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -5.4 2.3 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -82.54 -12.18 57.93 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.721 0.772 . . . . 0.0 110.122 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.28 -9.96 57.89 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.738 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.8 m -78.36 119.7 22.07 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -145.48 141.22 22.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.365 0.603 . . . . 0.0 111.782 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 40.9 t -146.84 151.23 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.4 0.68 . . . . 0.0 109.174 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -110.41 141.44 43.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.931 0.396 . . . . 0.0 110.336 -179.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -136.54 153.58 50.96 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.067 0.46 . . . . 0.0 110.728 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 90.0 mttt -124.58 113.75 18.48 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.827 0.346 . . . . 0.0 110.246 178.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 46.4 pt -127.26 172.53 14.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.935 0.398 . . . . 0.0 110.658 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.6 tmtp? -80.91 152.04 28.28 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.487 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 9.6 tpp180 -54.67 -23.9 19.4 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -112.63 2.56 16.22 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.415 -0.803 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 m -79.49 131.65 64.42 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.562 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.33 144.82 92.12 Favored 'Trans proline' 0 C--O 1.24 0.605 0 C-N-CA 122.636 2.224 . . . . 0.0 112.458 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.422 HD12 ' OD2' ' A' ' 71' ' ' ASP . 40.2 mt -65.01 -15.61 62.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.073 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.612 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 32.1 t -48.96 -37.82 21.19 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.643 0.377 . . . . 0.0 111.417 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -55.37 -53.29 58.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.714 0.293 . . . . 0.0 110.985 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 44' ' ' MET . 4.4 pp -75.48 -32.1 60.45 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.367 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.538 ' N ' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -54.44 -56.74 15.63 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.3 0.571 . . . . 0.0 111.337 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 41' ' ' SER . 6.5 mmmt -71.47 -41.24 69.61 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.254 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.18 -49.01 78.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.939 0.399 . . . . 0.0 111.551 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.404 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 29.2 t80 -55.17 -51.66 65.79 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 121.029 0.443 . . . . 0.0 110.744 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.698 ' SG ' HD11 ' A' ' 58' ' ' ILE . 33.5 m -63.99 -36.68 84.78 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.869 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 41.6 mt-10 -65.86 -39.55 90.85 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.909 0.385 . . . . 0.0 111.525 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.5 ptp180 -85.96 -21.93 27.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.879 0.371 . . . . 0.0 111.707 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.404 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 20.1 mm-40 -96.11 -6.25 38.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.885 0.374 . . . . 0.0 111.467 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.87 41.89 71.45 Favored Glycine 0 C--N 1.321 -0.289 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.468 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 mp -115.8 153.54 31.26 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.358 0.599 . . . . 0.0 110.94 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.1 m -102.27 127.39 49.27 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.094 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.414 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 93.1 mmm -55.44 -31.98 62.36 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.039 0.536 . . . . 0.0 112.279 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.479 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -84.98 -28.3 25.89 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.158 0.504 . . . . 0.0 112.022 -178.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.759 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -91.19 -5.05 55.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.372 0.606 . . . . 0.0 110.488 -178.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.698 HD11 ' SG ' ' A' ' 48' ' ' CYS . 13.7 pt -122.71 170.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.967 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.653 ' HB2' ' NE2' ' A' ' 89' ' ' GLN . 16.0 tpp180 -143.94 138.51 28.54 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 120.875 0.369 . . . . 0.0 110.111 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -96.88 129.21 44.36 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.778 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -136.59 143.02 43.38 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.043 0.449 . . . . 0.0 110.276 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -148.38 133.45 18.24 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t70 68.21 24.56 7.5 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.675 0.75 . . . . 0.0 110.274 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.28 -21.39 6.06 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.144 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -93.11 141.73 24.44 Favored Pre-proline 0 C--N 1.317 -0.83 0 O-C-N 122.35 -0.5 . . . . 0.0 110.494 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.9 137.22 24.07 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.187 1.925 . . . . 0.0 111.649 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.8 pt -114.43 170.94 4.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 121.241 0.544 . . . . 0.0 110.663 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.693 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.31 155.64 46.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.025 -179.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 41' ' ' SER . 13.4 pt-20 -59.86 -10.17 3.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.08 0.467 . . . . 0.0 111.93 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -100.62 6.43 44.1 Favored 'General case' 0 N--CA 1.436 -1.133 0 O-C-N 121.766 -0.583 . . . . 0.0 111.595 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.693 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -92.93 165.23 12.98 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 121.615 -0.678 . . . . 0.0 110.384 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.1 p -122.4 148.82 53.61 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.524 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.97 -20.14 58.83 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 123.141 2.561 . . . . 0.0 112.585 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.53 -31.54 37.02 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.052 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -67.53 -56.29 10.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.273 0.559 . . . . 0.0 110.991 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -81.84 8.73 9.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.018 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 57.69 63.08 1.91 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.587 0.708 . . . . 0.0 111.463 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.7 mtt -79.67 -165.58 0.83 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.989 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.44 169.81 15.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.55 139.51 42.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.205 0.526 . . . . 0.0 111.271 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 70.75 18.88 6.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.525 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -84.68 165.55 17.81 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 19.4 m -127.03 141.64 51.74 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.666 0.746 . . . . 0.0 112.852 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.06 140.28 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.223 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.32 121.76 38.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.11 0.481 . . . . 0.0 110.895 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.9 t -109.44 137.66 40.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.343 0.592 . . . . 0.0 111.555 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -128.71 149.55 50.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.963 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.429 HE21 HG22 ' A' ' 58' ' ' ILE . 2.0 mp0 -98.14 112.17 24.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.366 0.603 . . . . 0.0 110.991 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.653 ' NE2' ' HB2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -164.55 173.98 11.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.952 179.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -128.07 -68.42 0.77 Allowed 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.067 0.461 . . . . 0.0 110.66 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 p -98.28 75.92 2.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.134 0.492 . . . . 0.0 110.582 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.03 -50.72 3.73 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.687 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.565 0 CA-C-O 118.264 -1.298 . . . . 0.0 110.733 179.01 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.787 0.327 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.35 -38.94 13.0 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.257 0.551 . . . . 0.0 111.05 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -74.77 -6.19 47.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.576 0.703 . . . . 0.0 110.889 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -101.6 1.08 37.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.174 0.512 . . . . 0.0 110.258 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.404 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 10.2 mtpm? -70.13 -49.65 17.86 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.789 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 86.5 Cg_endo -82.81 124.4 3.94 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 121.597 1.532 . . . . 0.0 110.399 175.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 47.0 mmtm -99.26 7.61 45.52 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 121.919 -0.488 . . . . 0.0 111.149 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 57.6 30.39 18.71 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.338 0.59 . . . . 0.0 111.038 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.59 74.85 1.27 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.21 -178.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.451 ' HB ' ' CB ' ' A' ' 7' ' ' LYS . 7.3 p -70.63 127.87 33.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.489 0.662 . . . . 0.0 111.225 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.596 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 8.7 mmpt? -91.7 93.05 8.71 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.4 p -83.8 178.34 7.96 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.822 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.15 4.51 13.62 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.698 0.761 . . . . 0.0 109.776 178.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -151.31 166.93 29.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.573 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -138.19 96.61 3.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.578 0.704 . . . . 0.0 110.192 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -82.85 91.39 7.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.271 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -127.17 157.54 39.49 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.355 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.443 HD11 ' HB2' ' A' ' 73' ' ' PRO . 23.6 pt -140.96 165.71 19.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.99 0.424 . . . . 0.0 110.29 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.579 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -106.22 122.37 46.07 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.37 124.43 47.69 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 30' ' ' VAL . 36.5 ttpt -100.75 145.71 28.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.02 0.438 . . . . 0.0 110.266 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 29' ' ' VAL . 46.6 t -115.87 125.87 73.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -128.74 124.02 34.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.57 0.7 . . . . 0.0 110.893 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.99 149.0 17.46 Favored Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.472 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -63.01 -11.4 18.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.525 0.679 . . . . 0.0 111.47 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.81 -14.05 60.64 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.76 0.79 . . . . 0.0 110.062 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.84 -9.78 58.53 Favored Glycine 0 C--N 1.307 -1.067 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.902 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -79.33 117.45 20.33 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.089 0.471 . . . . 0.0 110.055 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.7 p -143.38 139.19 26.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.215 0.531 . . . . 0.0 111.455 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 48.3 t -145.91 151.16 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.579 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -104.73 142.17 35.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 36.6 m-85 -132.41 157.36 44.75 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 121.556 0.693 . . . . 0.0 111.301 -177.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -134.38 110.61 9.56 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.407 -176.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 pt -131.45 173.8 14.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.248 0.547 . . . . 0.0 111.256 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HD3' ' H ' ' A' ' 37' ' ' HIS . 2.1 tmtp? -80.48 146.39 31.39 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.491 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 33.6 ttm180 -64.4 -16.75 62.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.393 0.616 . . . . 0.0 112.157 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.425 ' H ' ' HD3' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -104.6 2.03 30.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.405 0.621 . . . . 0.0 110.241 177.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 5.6 m -88.45 133.45 36.4 Favored Pre-proline 0 N--CA 1.44 -0.93 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.046 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.43 146.3 93.08 Favored 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.655 2.237 . . . . 0.0 112.54 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.436 HD12 ' OD1' ' A' ' 71' ' ' ASP . 30.5 mt -65.49 -15.26 62.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.923 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' A' ' 45' ' ' LYS . 13.8 p -54.61 -33.11 59.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.271 0.558 . . . . 0.0 110.568 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -57.65 -53.95 52.43 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.676 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.59 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.08 -31.9 58.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.432 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.59 ' N ' HD12 ' A' ' 43' ' ' LEU . 58.2 mtt -57.18 -56.73 18.07 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.994 0.426 . . . . 0.0 111.549 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 41' ' ' SER . 0.4 OUTLIER -71.66 -34.64 69.89 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.914 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -61.5 -47.03 87.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.996 0.427 . . . . 0.0 110.726 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 20.5 t80 -55.05 -50.22 69.64 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 110.49 177.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.649 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.4 m -63.27 -40.68 98.09 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.568 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 41.5 mt-10 -64.03 -34.97 79.22 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.8 ptp180 -89.66 -26.06 20.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -94.14 -16.39 23.78 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.191 0.52 . . . . 0.0 112.157 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.19 35.94 10.44 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.251 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.635 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.5 mm? -113.81 154.31 27.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.293 0.568 . . . . 0.0 110.821 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -105.17 136.97 43.68 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.548 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.1 mmm -63.4 -22.48 66.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.144 0.497 . . . . 0.0 111.012 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.496 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -83.67 -28.58 28.25 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.421 0.629 . . . . 0.0 110.342 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.496 ' NE2' ' HB2' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -93.67 -10.95 32.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.881 -177.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.649 HD11 ' SG ' ' A' ' 48' ' ' CYS . 7.3 pt -128.3 170.86 17.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.093 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 tpp180 -148.7 135.9 20.17 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.102 0.477 . . . . 0.0 110.291 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.2 m-85 -91.01 138.96 31.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -141.61 140.92 33.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.028 0.442 . . . . 0.0 110.72 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -146.31 134.34 21.48 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 69.53 27.49 4.85 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.907 0.86 . . . . 0.0 110.533 177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.26 -6.84 49.16 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.572 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -111.43 140.56 23.17 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 122.165 -0.609 . . . . 0.0 110.826 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.11 139.19 35.08 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.269 1.98 . . . . 0.0 111.273 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.1 pt -113.15 153.62 14.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.333 0.587 . . . . 0.0 111.708 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.718 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -108.56 152.98 24.02 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.343 179.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.571 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 13.8 pt-20 -60.95 -14.92 25.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.178 0.513 . . . . 0.0 111.924 -177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.2 t -93.42 7.71 43.42 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.718 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -91.58 158.07 16.64 Favored 'General case' 0 C--O 1.242 0.699 0 O-C-N 121.587 -0.695 . . . . 0.0 110.714 -179.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.5 p -118.55 145.61 37.85 Favored Pre-proline 0 N--CA 1.439 -0.989 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.881 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.449 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 18.2 Cg_endo -59.14 -21.53 59.89 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.798 2.332 . . . . 0.0 112.664 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -81.26 -19.41 43.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.029 0.443 . . . . 0.0 111.266 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -80.69 -54.67 5.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.311 0.576 . . . . 0.0 110.783 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 2.0 pt? -82.68 10.53 7.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.135 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 57.85 62.44 2.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.35 0.595 . . . . 0.0 111.123 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -83.09 121.1 26.61 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.146 0.498 . . . . 0.0 110.36 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HG3' ' HB2' ' A' ' 82' ' ' ASP . 11.4 pt-20 -80.95 159.64 24.87 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.312 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -74.78 149.19 39.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.881 0.372 . . . . 0.0 111.465 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 63.15 19.31 11.58 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.818 0.847 . . . . 0.0 112.079 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.492 ' HB2' ' HG3' ' A' ' 79' ' ' GLU . 1.7 t70 -89.28 -178.02 5.53 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.543 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 16.4 m -130.11 151.43 50.65 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.376 0.608 . . . . 0.0 112.037 -175.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.81 137.71 42.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 123.387 0.675 . . . . 0.0 109.215 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -91.76 124.67 36.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 0.0 110.807 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.422 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 47.4 t -111.52 136.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.296 0.57 . . . . 0.0 111.795 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -126.2 144.47 50.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.12 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.482 ' HG3' HG22 ' A' ' 58' ' ' ILE . 1.5 mp0 -99.25 110.98 23.45 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.628 0.251 . . . . 0.0 110.75 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -56.7 -53.69 54.84 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.613 0.72 . . . . 0.0 110.69 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -70.2 125.71 27.56 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.111 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.3 p -68.99 120.67 15.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.278 0.561 . . . . 0.0 111.481 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.06 81.98 0.64 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.31 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.032 0 CA-C-O 118.583 -1.12 . . . . 0.0 111.5 179.395 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HG2' ' OE2' ' A' ' 4' ' ' GLU . 56.5 mtt . . . . . 0 CA--C 1.507 -0.693 0 CA-C-O 121.63 0.729 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.79 -32.84 0.13 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.577 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -69.23 -26.23 64.7 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.082 0.468 . . . . 0.0 110.674 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.407 ' OE2' ' HG2' ' A' ' 1' ' ' MET . 6.2 pt-20 -66.87 -42.94 84.76 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-O 121.265 0.555 . . . . 0.0 110.325 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 5' ' ' LYS . 12.8 tppt? -144.22 82.49 10.73 Favored Pre-proline 0 N--CA 1.417 -2.093 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.787 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.5 146.7 27.76 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.4 2.067 . . . . 0.0 111.661 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -112.41 48.94 0.95 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.58 119.52 9.99 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.918 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.04 -64.78 2.86 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.566 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.89 98.7 3.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.948 0.88 . . . . 0.0 112.439 -177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 11' ' ' LYS . 1.3 pptp? -160.27 144.92 14.56 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.011 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 p -71.56 91.9 1.1 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.064 0.459 . . . . 0.0 111.168 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.61 -51.17 69.69 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.53 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 56.8 70.07 0.69 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.872 0.844 . . . . 0.0 109.253 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -141.14 132.13 26.13 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.055 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.437 ' HB2' ' HE3' ' A' ' 35' ' ' LYS . 6.4 m-20 -81.87 83.17 7.28 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 22.1 p-80 -119.27 144.23 46.89 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.883 -0.511 . . . . 0.0 110.897 -177.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.415 HD11 ' HB2' ' A' ' 73' ' ' PRO . 27.6 pt -125.43 167.45 19.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-O 121.113 0.482 . . . . 0.0 110.068 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.516 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -107.37 126.82 52.96 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.833 -178.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.82 125.45 48.59 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -104.48 139.72 38.98 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.872 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 40.2 t -111.82 123.21 67.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 120.967 0.413 . . . . 0.0 110.03 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -127.72 112.43 14.8 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.763 0.792 . . . . 0.0 110.751 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.95 147.7 18.7 Favored Glycine 0 C--N 1.297 -1.608 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.271 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -10.27 7.91 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.243 0.544 . . . . 0.0 112.143 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.403 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 9.3 t70 -73.36 -13.66 61.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.631 0.729 . . . . 0.0 110.315 177.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.8 -15.25 55.75 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.8 m -74.7 117.03 16.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.247 0.546 . . . . 0.0 110.49 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 3.3 p -142.52 136.48 27.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.397 0.618 . . . . 0.0 111.1 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -145.39 151.66 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.475 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -108.32 140.45 41.58 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -134.2 155.3 50.39 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.133 0.492 . . . . 0.0 110.945 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.516 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 90.1 mttt -128.08 111.1 13.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.107 0.479 . . . . 0.0 110.642 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.3 pt -127.62 173.58 12.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.029 0.442 . . . . 0.0 110.283 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.6 tmtp? -78.6 146.37 34.2 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.462 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 40.0 ttm180 -64.32 -12.75 45.14 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.334 0.588 . . . . 0.0 111.865 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.427 ' H ' ' HD3' ' A' ' 35' ' ' LYS . 37.8 t-80 -107.04 -3.38 20.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.669 0.747 . . . . 0.0 109.617 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.8 m -83.5 135.05 44.07 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.609 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.88 145.05 89.91 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.708 2.272 . . . . 0.0 112.624 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 48.5 mt -65.67 -16.84 64.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.02 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 32.6 p -54.25 -34.8 61.56 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.01 0.433 . . . . 0.0 111.061 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -57.46 -52.1 66.74 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.73 -32.16 62.04 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.884 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.577 ' N ' HD12 ' A' ' 43' ' ' LEU . 58.5 mtt -58.12 -53.89 53.12 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.183 0.516 . . . . 0.0 110.903 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 34.2 mmtp -66.69 -41.74 87.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.019 0.438 . . . . 0.0 110.079 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.9 -48.02 83.4 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.115 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -55.73 -49.05 74.1 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.68 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 58' ' ' ILE . 62.7 m -67.2 -36.27 81.38 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 47.7 mt-10 -62.61 -39.69 94.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.093 0.473 . . . . 0.0 111.215 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 14.8 ptp180 -86.73 -25.71 24.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -93.52 -8.65 40.8 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.98 -0.45 . . . . 0.0 111.817 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.15 43.78 46.68 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.727 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 3.9 mp -115.91 152.89 32.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.39 0.614 . . . . 0.0 111.043 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.2 m -99.15 124.33 44.11 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.973 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 95.4 mmm -60.85 -22.33 64.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.949 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.483 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.3 OUTLIER -84.68 -32.62 23.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.482 0.658 . . . . 0.0 110.804 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.784 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -84.73 -20.66 30.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.909 -176.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.588 HD11 ' SG ' ' A' ' 48' ' ' CYS . 16.0 pt -113.02 176.17 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.231 0.539 . . . . 0.0 111.949 -177.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -149.22 140.23 22.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.407 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 44' ' ' MET . 6.4 m-85 -94.61 129.44 41.45 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.594 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -130.55 143.58 50.85 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.538 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -150.12 136.82 19.17 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 t70 67.32 26.98 8.38 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.834 0.826 . . . . 0.0 110.815 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.38 -5.61 59.67 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.991 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -116.63 142.09 29.09 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 122.076 -0.661 . . . . 0.0 110.883 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.11 134.66 34.75 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.067 1.845 . . . . 0.0 110.799 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.709 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 12.1 pt -104.49 -177.31 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.137 0.494 . . . . 0.0 111.631 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.631 HD22 ' HB3' ' A' ' 71' ' ' ASP . 0.5 OUTLIER -129.39 161.63 29.88 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 121.689 0.757 . . . . 0.0 110.649 -175.132 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.49 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.1 pt-20 -67.98 -15.28 63.54 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.764 0.792 . . . . 0.0 109.583 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 t -110.01 16.49 21.85 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.709 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 1.8 p-10 -98.23 101.5 12.98 Favored 'General case' 0 C--O 1.207 -1.134 0 C-N-CA 118.517 -1.273 . . . . 0.0 110.722 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 p -60.31 141.22 91.21 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.73 177.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 11.1 Cg_endo -56.39 -24.25 51.09 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.991 2.46 . . . . 0.0 112.288 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' A' ' 36' ' ' ARG . . . -72.26 -34.2 68.07 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.128 0.49 . . . . 0.0 110.647 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -64.95 -55.78 17.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.986 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.463 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 2.1 pt? -85.09 6.57 24.96 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.712 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 60.37 52.6 4.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.716 0.769 . . . . 0.0 111.499 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.76 131.64 40.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.273 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -94.94 165.75 12.29 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.028 0.442 . . . . 0.0 110.613 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.41 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 9.9 p-10 -76.37 148.28 37.5 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.359 0.6 . . . . 0.0 110.553 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 65.64 14.72 9.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.768 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.62 167.21 20.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.8 m -123.04 140.77 52.68 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.03 135.93 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.191 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -94.98 118.97 32.7 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.064 0.459 . . . . 0.0 110.296 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.37 138.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.148 0.499 . . . . 0.0 111.793 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -128.6 150.87 50.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.952 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.439 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.1 mp0 -104.61 112.8 26.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 111.672 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.441 HE21 ' N ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -125.02 77.19 1.6 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.146 0.974 . . . . 0.0 110.348 174.43 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.491 ' HG2' ' HB3' ' A' ' 57' ' ' GLN . 70.8 mt-30 -75.06 90.06 2.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.47 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -103.17 103.91 14.0 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.088 0.471 . . . . 0.0 109.906 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 160.89 158.34 9.25 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.572 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.029 0 CA-C-O 118.714 -1.048 . . . . 0.0 111.299 -179.779 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.598 0.237 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.89 -66.51 0.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.98 0.419 . . . . 0.0 111.479 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -92.39 7.1 44.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.535 0.683 . . . . 0.0 110.424 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -88.9 -49.41 6.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.673 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -142.36 73.18 21.2 Favored Pre-proline 0 N--CA 1.462 0.142 0 CA-C-O 120.733 0.301 . . . . 0.0 110.831 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -86.95 158.37 8.71 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.529 2.153 . . . . 0.0 112.21 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -91.59 47.25 1.35 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.176 0.512 . . . . 0.0 109.95 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.21 133.71 51.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.769 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.76 142.9 6.44 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.09 124.28 28.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.191 0.519 . . . . 0.0 110.574 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -140.48 111.29 6.93 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 p -78.7 130.34 35.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.104 0.478 . . . . 0.0 110.737 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -127.69 87.71 2.66 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.406 0.622 . . . . 0.0 109.795 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -87.69 87.61 7.43 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.553 0.692 . . . . 0.0 109.68 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -105.9 144.61 32.39 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.967 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -112.6 -91.22 0.49 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.919 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 73.95 134.94 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.192 0.997 . . . . 0.0 111.16 179.497 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.506 HD12 HD21 ' A' ' 20' ' ' LEU . 24.7 pt -128.96 160.04 40.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.01 178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.544 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.2 OUTLIER -95.72 123.87 39.49 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.176 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.538 HD22 ' SD ' ' A' ' 78' ' ' MET . 86.4 mt -122.89 125.9 46.25 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.229 0.538 . . . . 0.0 110.206 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 83' ' ' THR . 36.7 ttpt -106.82 142.82 35.85 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.283 0.563 . . . . 0.0 110.98 -178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 41.1 t -115.77 126.92 73.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -129.65 126.51 38.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.401 0.619 . . . . 0.0 110.526 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.51 147.35 16.61 Favored Glycine 0 C--N 1.301 -1.404 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.749 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 1.4 pp0? -60.64 -15.45 28.53 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 112.221 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -76.37 -11.81 59.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.926 0.87 . . . . 0.0 109.636 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.85 -11.54 45.47 Favored Glycine 0 C--N 1.318 -0.463 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.434 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -73.34 114.63 11.76 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.472 -0.428 . . . . 0.0 110.755 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 4.9 p -141.14 135.9 32.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.312 0.577 . . . . 0.0 111.367 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -145.67 151.04 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.397 -177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.544 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -109.45 138.89 45.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.016 0.436 . . . . 0.0 110.091 -179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 18.1 m-85 -133.39 164.17 27.72 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 121.12 0.486 . . . . 0.0 110.638 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -135.27 112.38 10.37 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 122.199 -0.313 . . . . 0.0 110.22 177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 pt -126.84 168.2 20.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.946 0.403 . . . . 0.0 110.779 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 1.1 tmtp? -77.7 152.69 33.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.865 0.364 . . . . 0.0 110.391 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 10.2 tpp180 -60.96 -21.74 63.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.001 0.52 . . . . 0.0 112.071 -177.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -105.76 -2.02 23.7 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.823 -0.548 . . . . 0.0 110.099 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.7 m -82.35 132.21 53.49 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.658 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.99 147.8 85.01 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.707 2.271 . . . . 0.0 112.31 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.19 -16.12 63.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.99 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 22.7 t -49.76 -38.64 34.84 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.495 0.318 . . . . 0.0 111.079 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 6.7 mmpt? -56.55 -53.48 57.09 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -75.79 -32.33 59.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.619 ' N ' HD12 ' A' ' 43' ' ' LEU . 41.2 ttm -61.24 -50.4 73.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.891 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.54 ' HD2' ' SD ' ' A' ' 55' ' ' MET . 13.5 mmmm -70.67 -40.85 72.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.8 0.333 . . . . 0.0 110.184 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.69 -46.37 89.28 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.084 0.469 . . . . 0.0 111.444 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 24.1 t80 -55.73 -50.96 68.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.063 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.663 ' SG ' HD11 ' A' ' 58' ' ' ILE . 35.0 m -63.91 -37.32 86.97 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.032 0.444 . . . . 0.0 111.167 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -62.44 -40.39 96.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.993 0.425 . . . . 0.0 111.695 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.7 ptp180 -87.94 -21.96 24.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.843 0.354 . . . . 0.0 111.8 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -96.36 -11.35 25.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.35 7.07 85.39 Favored Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.694 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 48' ' ' CYS . 7.2 mp -82.79 155.12 24.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.614 0.721 . . . . 0.0 112.176 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.402 ' O ' HG12 ' A' ' 58' ' ' ILE . 27.6 m -106.15 132.82 51.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.832 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.54 ' SD ' ' HD2' ' A' ' 45' ' ' LYS . 63.7 mmm -56.18 -33.45 65.28 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -177.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -25.84 28.15 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.909 -0.495 . . . . 0.0 111.657 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.518 ' HA ' ' CG ' ' A' ' 90' ' ' GLN . 0.6 OUTLIER -84.99 -19.93 31.31 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.304 0.573 . . . . 0.0 110.85 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.663 HD11 ' SG ' ' A' ' 48' ' ' CYS . 8.4 pt -116.76 174.76 3.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.046 0.45 . . . . 0.0 110.971 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -153.81 138.8 17.25 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -92.83 137.35 32.44 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.306 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -136.94 139.37 41.49 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.301 0.572 . . . . 0.0 111.299 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -150.25 143.33 24.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 t70 67.3 24.1 9.13 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.873 0.845 . . . . 0.0 110.115 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.19 -2.44 81.42 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.391 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -121.96 142.36 36.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 122.059 -0.671 . . . . 0.0 110.887 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.97 138.69 53.57 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.012 1.808 . . . . 0.0 110.835 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.44 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 13.6 pt -112.46 172.95 2.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.096 0.474 . . . . 0.0 110.856 -177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.628 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -133.76 157.98 44.49 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.079 0.466 . . . . 0.0 111.574 -177.491 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' SER . 17.2 pt-20 -60.4 -11.84 7.8 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.714 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -100.97 11.36 39.77 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.817 0.341 . . . . 0.0 111.582 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.628 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -99.5 157.15 16.64 Favored 'General case' 0 C--O 1.244 0.778 0 O-C-N 121.721 -0.612 . . . . 0.0 109.593 177.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.2 p -118.51 148.06 43.29 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.704 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.86 -18.69 62.34 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.691 2.261 . . . . 0.0 112.284 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.483 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -85.9 -15.69 40.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.196 0.522 . . . . 0.0 111.193 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -82.26 -56.36 3.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.299 0.571 . . . . 0.0 110.436 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -86.8 1.98 50.45 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.221 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 62.28 61.59 1.28 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.609 0.719 . . . . 0.0 112.908 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.601 ' SD ' HD11 ' A' ' 84' ' ' ILE . 29.4 ttm -89.08 137.45 32.31 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -106.83 176.79 5.06 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 120.897 0.38 . . . . 0.0 110.79 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -75.3 143.52 42.91 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.169 0.509 . . . . 0.0 110.793 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 71.9 13.58 6.01 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.024 0.93 . . . . 0.0 110.855 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -80.38 161.88 24.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 22.9 m -127.34 145.84 50.66 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.342 0.591 . . . . 0.0 112.316 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.601 HD11 ' SD ' ' A' ' 78' ' ' MET . 4.0 mp -110.32 136.89 44.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.426 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -93.76 130.94 39.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.1 0.476 . . . . 0.0 111.009 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 46.5 t -112.74 138.63 41.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.508 0.67 . . . . 0.0 111.854 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -134.08 163.64 29.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.361 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -111.65 112.83 24.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.814 0.34 . . . . 0.0 111.228 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.0 49.22 0.96 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.239 0.543 . . . . 0.0 111.031 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.518 ' CG ' ' HA ' ' A' ' 57' ' ' GLN . 13.8 mm100 -151.83 80.91 1.27 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.323 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.9 p -130.71 109.06 10.34 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.96 -67.32 2.21 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.678 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.724 -1.042 . . . . 0.0 112.274 179.539 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.045 0.45 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.02 -65.77 1.15 Allowed 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.039 -0.413 . . . . 0.0 110.403 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.459 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 7.7 m-20 -68.94 -42.79 76.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.089 0.471 . . . . 0.0 110.409 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 67.05 32.2 6.42 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.804 0.812 . . . . 0.0 110.558 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 59.16 68.76 1.51 Allowed Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.297 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 59.4 Cg_endo -71.59 -178.44 3.03 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.196 2.597 . . . . 0.0 112.191 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -52.06 -34.19 42.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.657 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.31 125.24 28.82 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.43 95.1 0.12 Allowed Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.803 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.5 p -81.51 152.36 4.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.114 0.483 . . . . 0.0 110.09 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -137.52 172.23 13.28 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -99.5 28.03 4.88 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.653 0.74 . . . . 0.0 110.554 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.23 -175.39 4.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.546 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -81.71 85.75 6.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.52 0.676 . . . . 0.0 109.915 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -148.27 172.19 14.77 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.375 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.97 78.8 4.45 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.347 0.594 . . . . 0.0 111.363 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -124.96 145.41 49.88 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.513 HD11 ' HB2' ' A' ' 73' ' ' PRO . 19.1 pt -132.28 167.85 25.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.285 0.564 . . . . 0.0 110.815 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.66 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -99.75 129.57 45.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.754 -179.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.415 HD23 HG12 ' A' ' 34' ' ' ILE . 3.1 mm? -125.97 126.93 45.13 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 83' ' ' THR . 35.0 ttpt -109.49 141.81 41.41 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.329 0.585 . . . . 0.0 111.221 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -113.27 127.04 70.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.167 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.18 121.95 25.75 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.661 0.743 . . . . 0.0 110.502 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.2 149.39 16.61 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.242 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -11.55 11.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.474 0.654 . . . . 0.0 112.043 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.85 -18.46 62.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.544 0.687 . . . . 0.0 110.435 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.12 -5.37 45.75 Favored Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.9 m -86.82 121.65 29.61 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.884 0.373 . . . . 0.0 110.381 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 p -144.35 138.33 23.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.366 0.603 . . . . 0.0 111.415 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -146.3 151.01 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.66 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -109.93 140.65 43.67 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -132.24 157.82 43.37 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 121.19 0.519 . . . . 0.0 111.255 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -127.82 108.55 10.81 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.415 HG12 HD23 ' A' ' 20' ' ' LEU . 46.8 pt -124.19 176.36 5.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.203 0.525 . . . . 0.0 110.73 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.3 tmtp? -85.44 149.61 25.29 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.097 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.495 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 17.6 tpp180 -53.06 -26.67 16.73 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.601 0.761 . . . . 0.0 112.576 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -111.87 6.49 19.6 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.588 -0.695 . . . . 0.0 111.748 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 m -81.64 133.93 51.7 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.0 145.07 84.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.645 2.23 . . . . 0.0 112.361 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 48.1 mt -65.2 -17.06 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.927 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 35.5 p -50.47 -37.89 40.95 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.561 0.344 . . . . 0.0 111.686 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.7 mmpt? -56.36 -52.57 64.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.755 0.312 . . . . 0.0 110.72 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 44' ' ' MET . 4.2 pp -74.88 -31.86 61.7 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.363 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.576 ' N ' HD12 ' A' ' 43' ' ' LEU . 53.2 mtt -58.2 -54.91 41.67 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.25 0.547 . . . . 0.0 110.979 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 57.6 mmtt -65.49 -44.43 87.11 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.936 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.728 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -57.56 -49.04 77.67 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.071 -177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -54.92 -51.7 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.584 ' SG ' HD11 ' A' ' 58' ' ' ILE . 34.1 m -67.19 -35.05 78.82 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.935 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 51.4 mt-10 -66.97 -36.18 81.61 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 122.209 -0.307 . . . . 0.0 111.682 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.728 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -88.13 -25.81 22.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 178.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -92.25 -6.06 51.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 111.555 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.2 46.38 57.95 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.158 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.8 mp -117.36 151.51 36.86 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.224 0.535 . . . . 0.0 110.827 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 71.4 m -96.76 123.0 40.32 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.905 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.3 mmm -56.64 -28.13 59.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.993 0.517 . . . . 0.0 111.903 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.476 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -84.39 -34.87 23.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.261 0.553 . . . . 0.0 111.116 -178.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.746 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -81.66 -18.91 42.92 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.066 0.46 . . . . 0.0 111.338 -177.373 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.584 HD11 ' SG ' ' A' ' 48' ' ' CYS . 14.3 pt -110.57 -179.53 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 120.968 0.413 . . . . 0.0 110.671 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 59' ' ' ARG . 10.0 tpt180 -157.31 133.3 9.49 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.173 0.511 . . . . 0.0 110.433 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 44' ' ' MET . 6.9 m-85 -85.54 135.87 33.64 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.063 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -144.79 148.21 33.8 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.997 0.427 . . . . 0.0 110.362 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -154.69 138.96 16.62 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.1 t70 65.84 25.19 11.28 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.59 0.709 . . . . 0.0 110.306 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 -26.56 5.75 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.763 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -90.94 144.62 30.38 Favored Pre-proline 0 C--N 1.327 -0.386 0 O-C-N 122.408 -0.466 . . . . 0.0 110.811 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.85 141.88 27.67 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.9 1.733 . . . . 0.0 110.338 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.654 ' HB ' ' OD1' ' A' ' 71' ' ' ASP . 6.9 pt -106.08 -179.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.832 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.539 HD22 ' HB3' ' A' ' 71' ' ' ASP . 0.4 OUTLIER -129.93 165.42 22.12 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.599 0.714 . . . . 0.0 110.714 -174.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 11.1 pt-20 -67.82 -12.94 61.65 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.943 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -118.87 16.93 13.47 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.654 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 3.6 p-10 -91.27 98.76 11.92 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.415 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 p -58.49 145.56 75.75 Favored Pre-proline 0 C--N 1.301 -1.508 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.044 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.513 ' HB2' HD11 ' A' ' 18' ' ' ILE . 17.9 Cg_endo -59.57 -15.82 32.93 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.899 2.4 . . . . 0.0 111.58 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.465 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -80.01 -31.1 39.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.462 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -67.54 -54.67 18.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.264 0.554 . . . . 0.0 111.657 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.3 pt? -84.2 7.84 17.69 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.809 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 57.66 40.49 26.56 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.508 0.671 . . . . 0.0 111.224 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.86 130.29 43.55 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.463 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.86 169.75 17.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.14 0.495 . . . . 0.0 110.417 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -79.05 145.4 33.86 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 66.28 20.24 11.04 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.447 0.699 . . . . 0.0 110.975 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.03 161.42 28.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.071 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 30.3 m -121.51 135.35 55.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.645 0.736 . . . . 0.0 112.379 -175.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.84 137.94 24.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.164 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -93.62 117.38 30.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.29 0.567 . . . . 0.0 110.85 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.82 134.89 46.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.427 0.632 . . . . 0.0 111.737 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -131.84 159.87 37.3 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.463 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.1 mp0 -101.47 111.03 23.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.139 0.495 . . . . 0.0 110.496 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.503 HE21 ' N ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -123.16 85.2 2.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.213 0.53 . . . . 0.0 110.397 178.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -73.48 101.02 3.41 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.373 0.606 . . . . 0.0 110.54 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.6 m -116.05 97.65 6.2 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.863 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 156.79 158.02 8.66 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.159 0 CA-C-O 118.544 -1.142 . . . . 0.0 111.672 -179.727 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 121.143 0.497 . . . . 0.0 111.5 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.82 -73.41 0.67 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.866 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.432 ' HB3' ' CG ' ' A' ' 6' ' ' PRO . 6.9 m-20 -96.91 -45.13 6.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.044 0.449 . . . . 0.0 110.287 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 32.58 54.82 0.38 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.03 1.332 . . . . 0.0 113.211 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -176.18 -59.48 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 72.2 Cg_endo -80.16 132.06 9.13 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.619 2.212 . . . . 0.0 114.147 -175.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 3.9 mptp? -107.86 59.4 0.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.043 175.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' OE1' ' HB2' ' A' ' 6' ' ' PRO . 4.4 mp0 -69.01 105.99 2.6 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.851 -0.53 . . . . 0.0 110.71 176.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.75 -47.54 0.52 Allowed Glycine 0 CA--C 1.492 -1.393 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.5 p -77.7 157.68 5.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -137.8 129.59 28.49 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.052 0.453 . . . . 0.0 109.908 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 t -169.17 158.26 8.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.121 0.486 . . . . 0.0 110.328 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.11 10.31 16.1 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.812 0.815 . . . . 0.0 108.809 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -121.15 121.1 37.09 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -113.57 111.86 22.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.747 0.784 . . . . 0.0 111.67 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.44 87.88 5.05 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.643 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 23.4 p-80 -124.85 147.77 48.6 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.398 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.8 pt -131.61 163.52 37.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.026 0.441 . . . . 0.0 110.19 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.539 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.3 OUTLIER -97.23 141.22 30.62 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.5 mt -137.51 125.19 22.32 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 83' ' ' THR . 33.4 ttpt -108.36 140.67 41.31 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.243 0.544 . . . . 0.0 111.422 -176.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 29' ' ' VAL . 42.5 t -114.54 127.55 71.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.847 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.61 120.37 23.89 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.437 0.637 . . . . 0.0 110.582 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.52 150.83 17.7 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.405 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.58 -8.94 7.27 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 112.502 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -74.54 -13.77 60.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.706 0.765 . . . . 0.0 109.945 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.85 -10.61 58.87 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.0 m -81.42 123.72 28.81 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.001 0.429 . . . . 0.0 110.264 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 22' ' ' VAL . 3.6 p -143.71 138.28 25.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 121.278 0.561 . . . . 0.0 110.955 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.3 t -143.04 150.8 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.595 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.539 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -107.63 137.67 45.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.087 0.47 . . . . 0.0 109.971 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 47' ' ' TYR . 29.9 m-85 -128.15 166.44 18.49 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 121.382 0.61 . . . . 0.0 110.503 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -141.63 111.46 6.66 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.469 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.2 pt -131.04 176.29 9.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.395 0.616 . . . . 0.0 111.549 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 1.9 tmtp? -88.45 150.52 23.1 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.267 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.431 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 21.8 tpp180 -54.98 -27.46 44.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.944 0.898 . . . . 0.0 112.712 -178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -108.47 3.55 23.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.272 0.558 . . . . 0.0 111.026 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.7 m -85.16 131.81 47.32 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.195 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.52 148.7 90.62 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.508 2.139 . . . . 0.0 112.484 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.4 mt -65.61 -15.6 62.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.763 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 54.1 p -50.96 -37.91 47.43 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 122.91 0.484 . . . . 0.0 111.343 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -56.91 -53.68 55.16 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.073 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -76.38 -32.4 58.55 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.0 0.429 . . . . 0.0 111.317 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.626 ' N ' HD12 ' A' ' 43' ' ' LEU . 41.8 ttm -60.44 -52.12 66.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.682 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 33.1 mmtp -70.49 -37.74 74.25 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.884 0.373 . . . . 0.0 110.283 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.94 -45.4 94.84 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.92 0.391 . . . . 0.0 111.004 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . 21.1 t80 -56.78 -51.92 67.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.364 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.3 p -61.63 -36.59 81.19 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.216 0.532 . . . . 0.0 110.608 -177.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 61.6 mm-40 -67.06 -45.41 77.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.878 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.9 ptp180 -78.99 -25.59 43.37 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -93.47 -12.27 30.12 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.979 -0.45 . . . . 0.0 112.2 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.95 43.81 9.59 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.323 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.515 ' HB3' HG21 ' A' ' 58' ' ' ILE . 3.0 mm? -120.6 160.06 24.0 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.016 0.436 . . . . 0.0 110.162 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.406 ' O ' HG12 ' A' ' 58' ' ' ILE . 4.7 m -109.65 135.65 50.27 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.737 0.303 . . . . 0.0 111.013 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.424 ' CE ' ' HG2' ' A' ' 44' ' ' MET . 86.3 mmm -58.01 -27.8 63.84 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.459 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -85.25 -24.14 27.91 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.783 -0.573 . . . . 0.0 111.443 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.68 -14.07 32.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.25 0.548 . . . . 0.0 110.136 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 53' ' ' LEU . 16.1 pt -120.5 169.94 11.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 120.944 0.402 . . . . 0.0 110.674 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -149.9 136.6 19.27 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -95.13 136.04 35.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.146 0.498 . . . . 0.0 110.342 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.35 142.13 37.61 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.109 0.48 . . . . 0.0 110.885 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -153.44 143.27 22.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 64.63 23.76 12.87 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.411 0.624 . . . . 0.0 110.696 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.89 -2.93 82.09 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.491 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -118.35 149.29 45.65 Favored Pre-proline 0 C--N 1.332 -0.153 0 O-C-N 122.163 -0.61 . . . . 0.0 110.376 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.47 139.81 20.98 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.846 1.697 . . . . 0.0 110.575 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.9 pt -113.46 160.73 12.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.43 0.633 . . . . 0.0 111.487 -176.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.651 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -120.2 157.14 29.71 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.424 -178.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 7.3 pt-20 -62.77 -9.78 10.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.994 0.426 . . . . 0.0 111.92 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.0 t -99.02 7.68 45.73 Favored 'General case' 0 N--CA 1.441 -0.916 0 O-C-N 122.036 -0.415 . . . . 0.0 111.898 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.651 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.4 OUTLIER -92.71 156.65 16.91 Favored 'General case' 0 C--O 1.242 0.685 0 O-C-N 121.682 -0.636 . . . . 0.0 109.898 178.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.2 p -115.99 146.77 37.79 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.8 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.81 -12.89 33.92 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.793 2.329 . . . . 0.0 112.279 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.83 -24.49 23.7 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.326 0.584 . . . . 0.0 110.604 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -72.54 -55.33 7.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.39 0.614 . . . . 0.0 110.851 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -88.7 12.39 14.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.969 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 53.38 62.95 2.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.518 0.675 . . . . 0.0 111.576 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.84 130.15 35.09 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.683 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -95.48 166.88 11.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.923 0.392 . . . . 0.0 110.602 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.471 ' HB2' HD22 ' A' ' 19' ' ' ASN . 6.2 p-10 -73.06 143.74 47.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.22 0.533 . . . . 0.0 110.941 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 66.8 15.0 10.03 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.863 0.865 . . . . 0.0 112.129 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -76.98 166.63 23.07 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 18.8 m -121.68 138.21 54.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.22 135.91 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.152 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -93.6 121.58 35.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.086 0.47 . . . . 0.0 110.973 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.3 t -109.79 136.83 44.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.201 0.524 . . . . 0.0 111.613 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -129.45 151.06 50.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.089 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -106.8 111.68 24.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.054 0.454 . . . . 0.0 110.868 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.523 ' H ' ' NE2' ' A' ' 89' ' ' GLN . 0.8 OUTLIER -124.03 89.88 3.17 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 122.14 0.971 . . . . 0.0 111.741 177.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -143.63 142.26 30.96 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.7 m -63.82 -47.74 79.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 110.977 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 165.74 -155.97 27.62 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.487 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.026 0 CA-C-O 118.791 -1.005 . . . . 0.0 111.628 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.959 0.409 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.65 15.89 25.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -101.95 28.97 5.3 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.954 0.883 . . . . 0.0 110.429 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -121.7 125.24 46.14 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 2.5 mppt? 57.7 50.19 3.92 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -174.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' A' ' 5' ' ' LYS . 95.3 Cg_endo -89.15 111.87 0.56 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 122.004 1.802 . . . . 0.0 110.712 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -96.45 18.38 14.12 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.412 0.625 . . . . 0.0 111.175 -177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -120.7 -155.21 0.62 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.49 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.79 36.05 6.58 Favored Glycine 0 C--N 1.316 -0.548 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.181 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.05 117.18 53.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.416 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -115.08 96.3 5.62 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.186 0.993 . . . . 0.0 112.881 -177.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -136.92 -66.25 0.53 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 13' ' ' GLU . 7.0 pt-20 -142.82 122.95 13.7 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -86.17 -174.86 5.28 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.819 -0.551 . . . . 0.0 110.417 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -131.42 165.24 23.94 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.379 0.609 . . . . 0.0 110.587 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -86.49 84.27 7.46 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 16.2 p-80 -120.94 150.3 41.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.95 0.405 . . . . 0.0 110.68 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 20' ' ' LEU . 15.9 pt -133.87 166.65 28.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.096 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.617 ' HB3' ' OE1' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -102.85 115.45 30.62 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 120.835 0.35 . . . . 0.0 110.226 -179.029 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.558 HD11 HD12 ' A' ' 18' ' ' ILE . 6.6 mp -112.55 125.66 54.49 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.431 0.634 . . . . 0.0 109.947 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 83' ' ' THR . 34.1 ttpt -105.56 146.51 29.52 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.349 0.595 . . . . 0.0 111.356 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 39.4 t -116.64 128.95 73.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.97 121.42 22.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.433 0.635 . . . . 0.0 110.489 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.0 150.31 17.1 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.839 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.46 -10.58 7.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.583 0.706 . . . . 0.0 111.86 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.546 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 21.0 t70 -71.22 -19.45 62.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.253 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.89 -13.89 49.44 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -74.94 112.34 11.08 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.796 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.3 p -139.12 131.97 37.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.281 0.563 . . . . 0.0 110.913 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.53 150.83 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.617 ' OE1' ' HB3' ' A' ' 19' ' ' ASN . 1.0 OUTLIER -106.36 142.22 36.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.847 0.356 . . . . 0.0 110.568 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -137.29 139.0 40.64 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.133 0.492 . . . . 0.0 111.076 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' HB2' ' HZ2' ' A' ' 33' ' ' LYS . 7.7 mtmp? -106.6 113.93 27.74 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.97 -0.456 . . . . 0.0 110.028 177.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.3 pt -126.9 170.09 17.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.972 0.415 . . . . 0.0 110.743 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 17' ' ' HIS . 2.0 tmtp? -81.4 148.04 29.51 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.431 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 11.7 tpp180 -56.26 -26.14 50.48 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.85 0.46 . . . . 0.0 112.032 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -102.46 -2.4 28.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.531 0.681 . . . . 0.0 110.127 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.0 m -81.33 132.07 56.93 Favored Pre-proline 0 N--CA 1.434 -1.231 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.307 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.2 148.2 88.67 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.523 2.149 . . . . 0.0 111.841 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.4 mt -64.81 -15.18 61.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.743 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.49 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 11.8 p -49.22 -37.52 23.28 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 6.7 mmpt? -56.57 -53.42 57.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.05 0.452 . . . . 0.0 110.85 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 44' ' ' MET . 4.3 pp -74.44 -31.63 62.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.377 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.522 ' N ' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -53.13 -58.06 8.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.023 0.439 . . . . 0.0 111.244 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -72.38 -38.14 68.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.399 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.35 -48.17 82.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.179 0.514 . . . . 0.0 110.958 -177.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -56.51 -51.35 68.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.886 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.784 ' SG ' HD11 ' A' ' 58' ' ' ILE . 31.4 m -63.75 -36.57 84.29 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.968 0.413 . . . . 0.0 111.914 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 40.4 mt-10 -64.35 -42.27 96.31 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.053 0.454 . . . . 0.0 111.189 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 17.1 ptp180 -84.35 -19.87 32.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 0.0 111.683 -178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -100.75 -2.4 32.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.96 48.04 69.19 Favored Glycine 0 C--O 1.235 0.202 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.348 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 58' ' ' ILE . 49.5 mt -122.69 154.53 37.95 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.067 0.46 . . . . 0.0 110.673 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 57' ' ' GLN . 58.2 m -103.67 126.66 50.95 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.354 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.41 ' SD ' ' SG ' ' A' ' 48' ' ' CYS . 81.0 mmm -57.92 -26.89 62.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.035 0.534 . . . . 0.0 111.808 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -84.15 -28.12 27.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.243 0.544 . . . . 0.0 111.05 -178.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.716 HE21 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -93.01 -27.48 16.98 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.937 -177.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.784 HD11 ' SG ' ' A' ' 48' ' ' CYS . 10.0 pt -103.11 163.63 3.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 O-C-N 121.375 -0.828 . . . . 0.0 110.766 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -136.97 132.15 33.94 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.073 0.463 . . . . 0.0 110.657 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -90.32 126.98 36.04 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -138.29 144.84 40.65 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.281 0.562 . . . . 0.0 111.493 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -149.83 141.83 23.89 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 t70 64.69 25.42 13.04 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.906 0.86 . . . . 0.0 110.0 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.97 -15.38 10.52 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.521 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -100.4 135.35 20.25 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 122.184 -0.597 . . . . 0.0 110.879 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.09 131.95 24.96 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.032 1.821 . . . . 0.0 111.081 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.581 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 5.7 pt -98.75 -177.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.481 HD22 ' HB3' ' A' ' 71' ' ' ASP . 0.7 OUTLIER -133.82 166.75 21.92 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-O 121.54 0.686 . . . . 0.0 110.437 -174.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 10.3 pt-20 -78.9 -8.17 58.61 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.753 0.787 . . . . 0.0 108.964 177.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -107.38 16.24 24.12 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.058 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.581 ' OD2' ' HB ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -103.81 151.55 22.94 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.9 p -115.79 150.17 44.42 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.035 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HB3' HD21 ' A' ' 20' ' ' LEU . 19.3 Cg_endo -61.55 -17.0 51.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.509 2.14 . . . . 0.0 111.444 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.44 -20.48 40.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.935 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.64 -53.77 8.7 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.29 0.567 . . . . 0.0 110.468 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.54 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.9 pt? -90.91 12.25 20.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.325 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 57.33 52.78 8.31 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.244 0.545 . . . . 0.0 111.439 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.37 137.08 34.85 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -104.13 -175.61 2.85 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.949 0.404 . . . . 0.0 110.4 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.46 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 11.6 p-10 -80.0 153.86 28.59 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.352 0.596 . . . . 0.0 110.319 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 63.24 18.83 11.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.916 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -80.75 157.57 25.78 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 25.4 m -130.21 147.68 51.96 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.595 -0.691 . . . . 0.0 112.69 -174.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.25 140.28 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.066 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -93.86 124.25 37.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.937 0.398 . . . . 0.0 111.033 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.5 t -109.79 139.8 31.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.261 0.553 . . . . 0.0 111.522 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -132.14 156.9 45.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.743 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.546 ' OE1' ' HB2' ' A' ' 26' ' ' ASP . 2.0 mp0 -108.79 117.42 34.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.131 0.491 . . . . 0.0 111.85 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -114.21 -171.93 2.0 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.016 175.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.471 ' NE2' ' HG3' ' A' ' 89' ' ' GLN . 2.0 mp0 53.14 25.09 3.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.056 0.542 . . . . 0.0 111.44 -175.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.3 m -72.33 -51.02 22.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.676 0.751 . . . . 0.0 110.393 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.44 -67.92 0.55 Allowed Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.481 0 CA-C-O 118.241 -1.311 . . . . 0.0 111.14 179.048 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 CA--C 1.506 -0.741 0 CA-C-O 121.347 0.594 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.85 59.61 1.07 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.925 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -85.21 -28.79 25.19 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.743 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -81.56 85.93 6.44 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.315 0.578 . . . . 0.0 109.903 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm 63.81 78.01 0.29 Allowed Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.064 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 7.1 Cg_endo -62.51 146.28 95.49 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.254 1.969 . . . . 0.0 110.902 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -98.96 50.83 0.96 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.687 0.755 . . . . 0.0 110.552 -175.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 6' ' ' PRO . 48.9 mm-40 -78.35 162.57 26.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.434 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 154.5 112.04 0.43 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.178 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.5 t -84.8 118.9 32.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -117.29 101.27 8.29 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.542 0.686 . . . . 0.0 111.42 -179.011 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -99.7 119.24 37.8 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.035 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -59.8 -72.18 0.11 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 51.85 35.22 15.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.905 0.383 . . . . 0.0 111.755 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.6 ' OD1' ' HB3' ' A' ' 17' ' ' HIS . 8.5 p30 -143.18 175.18 10.07 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.136 0.493 . . . . 0.0 110.872 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -88.87 82.02 6.82 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 122.075 0.94 . . . . 0.0 109.441 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.6 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . 30.6 p-80 -117.96 146.69 43.81 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.195 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.445 HG13 HD21 ' A' ' 20' ' ' LEU . 34.0 pt -127.41 158.14 38.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.073 0.463 . . . . 0.0 110.389 177.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.0 119.27 34.19 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD21 HG13 ' A' ' 18' ' ' ILE . 2.7 mm? -110.8 125.05 53.16 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 31' ' ' GLN . 34.1 ttpt -104.55 139.71 39.03 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.063 0.459 . . . . 0.0 110.628 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.26 125.74 69.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -130.82 120.99 24.52 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.728 0.775 . . . . 0.0 110.959 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA2' ' HB ' ' A' ' 86' ' ' VAL . . . -97.41 146.59 18.33 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 86' ' ' VAL . 0.1 OUTLIER -62.61 -6.88 3.89 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.19 -4.46 59.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.735 0.779 . . . . 0.0 110.061 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.14 -10.06 56.62 Favored Glycine 0 C--N 1.316 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.57 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -74.1 113.58 11.45 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 122.753 -0.263 . . . . 0.0 110.307 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.55 137.22 28.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.461 0.648 . . . . 0.0 112.229 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.2 t -145.36 150.86 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -112.36 135.15 53.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.167 0.508 . . . . 0.0 110.569 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -126.36 166.87 16.36 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.217 0.532 . . . . 0.0 111.009 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -133.93 119.41 19.06 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.089 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.422 HG12 HD23 ' A' ' 20' ' ' LEU . 44.8 pt -134.61 170.79 18.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.073 0.463 . . . . 0.0 110.43 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HD3' ' N ' ' A' ' 36' ' ' ARG . 2.4 tmtp? -82.95 153.14 25.18 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 13.6 tpp180 -54.21 -24.45 18.46 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.109 0.564 . . . . 0.0 112.27 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -106.67 -5.06 18.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.565 0.697 . . . . 0.0 110.103 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.4 m -78.65 131.16 68.63 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.659 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.33 146.25 85.41 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.748 2.299 . . . . 0.0 112.325 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.9 mt -65.44 -17.19 64.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.724 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 30.0 p -50.23 -38.96 43.13 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.76 0.424 . . . . 0.0 111.525 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 42' ' ' LYS . 11.6 mmpt? -55.96 -53.33 58.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 44' ' ' MET . 4.1 pp -74.86 -31.95 61.76 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.459 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.579 ' N ' HD12 ' A' ' 43' ' ' LEU . 53.8 mtt -60.12 -54.9 40.43 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.018 0.437 . . . . 0.0 111.41 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 11.2 mmmm -67.27 -39.01 86.01 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.227 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.78 79.77 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 111.298 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 26.4 t80 -55.33 -50.77 68.78 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.042 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.76 ' SG ' HD11 ' A' ' 58' ' ' ILE . 35.3 m -63.96 -34.27 77.6 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.842 0.353 . . . . 0.0 111.873 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.9 mt-10 -66.57 -39.54 88.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.911 0.386 . . . . 0.0 111.376 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -86.25 -21.94 27.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.976 0.417 . . . . 0.0 111.622 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.432 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 21.5 mm-40 -96.99 0.33 48.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.021 0.439 . . . . 0.0 111.561 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.01 45.19 96.63 Favored Glycine 0 CA--C 1.512 -0.145 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.964 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.644 ' HB3' HG21 ' A' ' 58' ' ' ILE . 86.2 mt -119.41 157.58 27.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.166 0.508 . . . . 0.0 110.587 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 58' ' ' ILE . 36.3 m -106.33 131.81 53.1 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.394 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 88.1 mmm -58.99 -23.37 61.8 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.253 0.549 . . . . 0.0 111.255 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HB2' ' NE2' ' A' ' 57' ' ' GLN . 0.5 OUTLIER -84.66 -34.12 23.1 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.211 0.529 . . . . 0.0 111.236 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.533 ' NE2' ' HB2' ' A' ' 56' ' ' ARG . 0.8 OUTLIER -88.38 -17.1 31.26 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.992 0.425 . . . . 0.0 111.612 -176.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.76 HD11 ' SG ' ' A' ' 48' ' ' CYS . 6.3 pt -117.33 172.56 4.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -152.79 144.78 23.73 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.141 0.496 . . . . 0.0 110.628 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CE2' ' HG2' ' A' ' 44' ' ' MET . 6.1 m-85 -99.37 136.61 39.07 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.744 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -137.21 141.0 42.1 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.022 0.439 . . . . 0.0 110.379 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -151.18 140.69 21.57 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t0 68.65 24.68 6.73 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.832 0.825 . . . . 0.0 110.068 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.9 -0.72 65.24 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.964 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -118.45 136.07 23.88 Favored Pre-proline 0 N--CA 1.445 -0.721 0 O-C-N 122.157 -0.614 . . . . 0.0 110.466 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.58 136.38 49.87 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.906 1.738 . . . . 0.0 110.685 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.466 ' HB ' ' OD2' ' A' ' 71' ' ' ASP . 15.0 pt -112.21 169.94 4.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.383 0.611 . . . . 0.0 111.251 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.683 ' ND2' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -129.9 153.52 48.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.004 -177.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HA ' ' SD ' ' A' ' 44' ' ' MET . 12.6 pt-20 -59.17 -11.13 3.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.045 0.45 . . . . 0.0 112.207 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -96.63 5.3 50.99 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 122.043 -0.41 . . . . 0.0 111.65 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.683 ' HB3' ' ND2' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -96.54 161.76 13.76 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 121.574 -0.704 . . . . 0.0 110.425 -179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.5 p -121.63 150.94 56.26 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.708 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 18.5 Cg_endo -58.4 -23.15 62.13 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.955 2.437 . . . . 0.0 112.244 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.576 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . . . -77.03 -31.67 56.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.219 0.533 . . . . 0.0 110.788 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -72.11 -55.85 6.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.565 -176.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.432 ' CD2' ' HA ' ' A' ' 73' ' ' PRO . 1.5 pt? -81.96 10.07 7.15 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -177.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 56.48 62.25 2.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.578 0.704 . . . . 0.0 111.84 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.3 mtt -77.75 -169.91 1.67 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.347 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -156.59 158.61 37.41 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.63 141.98 40.83 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.16 0.505 . . . . 0.0 110.489 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 67.87 17.49 9.67 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.945 0.898 . . . . 0.0 112.017 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.57 171.66 11.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 m -125.11 138.57 54.17 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.581 0.705 . . . . 0.0 112.665 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.51 134.78 35.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -93.9 122.06 36.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.115 0.483 . . . . 0.0 110.602 -178.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 25' ' ' GLN . 49.7 t -109.43 138.17 38.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.325 0.583 . . . . 0.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -129.86 155.24 46.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.523 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.536 ' HG3' HG22 ' A' ' 58' ' ' ILE . 2.7 mp0 -108.95 112.35 24.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.704 0.287 . . . . 0.0 110.879 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.93 73.56 0.9 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.686 1.231 . . . . 0.0 111.61 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.04 97.24 8.04 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.536 176.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.4 m -53.22 -59.58 4.38 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.178 0.513 . . . . 0.0 112.008 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.0 -124.54 1.25 Allowed Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.275 0 CA-C-O 118.211 -1.327 . . . . 0.0 111.206 178.625 . . . . . . . . 0 0 . 1 stop_ save_